<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>è¦³å¯Ÿè¨¼æ‹ : RCT ãŒä¸å¯èƒ½ãªå ´åˆ</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&amp;family=Source+Sans+Pro:wght@400;600&amp;display=swap" rel="stylesheet"/>
<script src="https://cdn.plot.ly/plotly-2.27.0.min.js"></script>
<script>
if (typeof Plotly === 'undefined') {
  document.addEventListener('DOMContentLoaded', function() {
    document.querySelectorAll('[id*="plot"], [id*="chart"], .plotly-graph-div, .js-plotly-plot').forEach(function(el) {
      el.innerHTML = '<div style="padding:2rem;text-align:center;background:#2a2a4a;border:1px dashed #D4AF37;border-radius:8px;color:#FAF8F5;margin:1rem 0;"><p style="font-size:1.1rem;margin-bottom:0.5rem;">Interactive chart unavailable offline</p><p style="font-size:0.85rem;opacity:0.7;">Connect to the internet to load interactive Plotly.js visualizations</p></div>';
    });
  });
}
</script>
<style>
:root {
  --navy: #1E2761;
  --deep-navy: #141B3D;
  --gold: #D4AF37;
  --cream: #FAF8F5;
  --red: #BF2D2D;
  --teal: #2D8B8B;
  --light-text: #718096;
  --green: #2D8B5F;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  font-family: 'Source Sans Pro', sans-serif;
  background: var(--cream);
  color: var(--navy);
  min-height: 100vh;
  display: flex;
}

/* Skip Link for Accessibility */
.skip-link {
  position: absolute;
  top: -40px;
  left: 0;
  background: var(--gold);
  color: var(--navy);
  padding: 8px 16px;
  z-index: 1000;
  font-weight: 600;
  text-decoration: none;
  border-radius: 0 0 8px 0;
}

.skip-link:focus {
  top: 0;
}

/* Hamburger Menu */
.hamburger {
  display: none;
  position: fixed;
  top: 1rem;
  left: 1rem;
  z-index: 1001;
  background: var(--navy);
  border: none;
  border-radius: 8px;
  padding: 12px;
  cursor: pointer;
  flex-direction: column;
  gap: 4px;
}

.hamburger span {
  display: block;
  width: 24px;
  height: 3px;
  background: var(--gold);
  border-radius: 2px;
  transition: transform 0.3s;
}

.sidebar-overlay {
  display: none;
  position: fixed;
  inset: 0;
  background: rgba(0,0,0,0.5);
  z-index: 999;
}

/* Sidebar */
.sidebar {
  width: 280px;
  background: var(--navy);
  padding: 2rem 1rem;
  display: flex;
  flex-direction: column;
  position: fixed;
  height: 100vh;
  overflow-y: auto;
  z-index: 1000;
}

.logo {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--gold);
  margin-bottom: 0.5rem;
  text-align: center;
}

.tagline {
  font-size: 0.75rem;
  color: rgba(255,255,255,0.6);
  text-align: center;
  margin-bottom: 2rem;
  font-style: italic;
}

.nav-section {
  margin-bottom: 1.5rem;
}

.nav-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: rgba(255,255,255,0.4);
  margin-bottom: 0.75rem;
  padding-left: 0.5rem;
}

.module-item {
  display: flex;
  align-items: center;
  padding: 0.75rem;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  margin-bottom: 0.25rem;
  border: none;
  background: transparent;
  width: 100%;
  text-align: left;
  font-family: inherit;
  font-size: inherit;
}

.module-item:hover {
  background: rgba(255,255,255,0.1);
}

.module-item.active {
  background: rgba(212, 175, 55, 0.2);
  border-left: 3px solid var(--gold);
}

.module-item.completed .module-number {
  background: var(--green);
}

.module-number {
  width: 28px;
  height: 28px;
  border-radius: 50%;
  background: rgba(255,255,255,0.2);
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.8rem;
  color: white;
  margin-right: 0.75rem;
  flex-shrink: 0;
}

.module-info {
  flex: 1;
  min-width: 0;
}

.module-title {
  font-size: 0.9rem;
  color: white;
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}

.module-subtitle {
  font-size: 0.7rem;
  color: rgba(255,255,255,0.5);
}

/* Main Content */
.main-content {
  flex: 1;
  margin-left: 280px;
  display: flex;
  flex-direction: column;
  min-height: 100vh;
}

.top-bar {
  display: flex;
  justify-content: space-between;
  align-items: center;
  padding: 1rem 2rem;
  background: white;
  border-bottom: 1px solid rgba(0,0,0,0.1);
  flex-wrap: wrap;
  gap: 1rem;
}

.progress-section {
  display: flex;
  align-items: center;
  gap: 1rem;
}

.progress-bar {
  width: 200px;
  height: 8px;
  background: rgba(0,0,0,0.1);
  border-radius: 4px;
  overflow: hidden;
}

.progress-fill {
  height: 100%;
  background: linear-gradient(90deg, var(--gold), var(--teal));
  border-radius: 4px;
  transition: width 0.3s;
}

.progress-text {
  font-size: 0.85rem;
  color: var(--light-text);
}

.points-display {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  color: var(--gold);
  padding: 0.5rem 1rem;
  border-radius: 20px;
  font-weight: 600;
}

.top-actions {
  display: flex;
  gap: 0.5rem;
}

.action-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.action-btn:hover {
  background: var(--navy);
  color: white;
}

/* Slide Container */
.slide-container {
  flex: 1;
  padding: 2rem;
  max-width: 900px;
  margin: 0 auto;
  width: 100%;
}

/* Slide Types */
.slide-title {
  text-align: center;
  padding: 4rem 2rem;
}

.slide-title h1 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 3rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.slide-title .subtitle {
  font-size: 1.5rem;
  color: var(--gold);
  margin-bottom: 1rem;
}

.slide-title .description {
  font-size: 1.1rem;
  color: var(--light-text);
  max-width: 600px;
  margin: 0 auto;
}

/* Principle Display */
.principle-box {
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 3rem;
  text-align: center;
  margin: 2rem 0;
}

.principle-box .number {
  font-size: 4rem;
  color: var(--gold);
  font-family: 'Cormorant Garamond', serif;
  line-height: 1;
}

.principle-box .text {
  font-size: 1.8rem;
  color: white;
  font-family: 'Cormorant Garamond', serif;
  margin-top: 1rem;
  font-style: italic;
}

/* Story Deep */
.story-deep {
  background: linear-gradient(135deg, rgba(191,45,45,0.08), rgba(30,39,97,0.12));
  border-left: 4px solid var(--red);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
}

.story-label {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--red);
  margin-bottom: 0.5rem;
  font-weight: 600;
}

.story-source {
  font-size: 0.8rem;
  color: var(--light-text);
  margin-bottom: 1rem;
  font-style: italic;
}

.timeline {
  position: relative;
  padding-left: 2rem;
  margin: 1.5rem 0;
}

.timeline::before {
  content: '';
  position: absolute;
  left: 0.5rem;
  top: 0;
  bottom: 0;
  width: 2px;
  background: linear-gradient(to bottom, var(--gold), var(--red), var(--green));
}

.timeline-event {
  position: relative;
  margin-bottom: 1rem;
  padding-left: 1rem;
}

.timeline-event::before {
  content: '';
  position: absolute;
  left: -1.5rem;
  top: 0.5rem;
  width: 10px;
  height: 10px;
  border-radius: 50%;
  background: var(--gold);
}

.timeline-event.crisis::before {
  background: var(--red);
}

.timeline-event.revelation::before {
  background: var(--green);
}

.timeline-year {
  font-weight: 600;
  color: var(--gold);
  font-size: 0.9rem;
}

.timeline-text {
  color: var(--navy);
  font-size: 0.95rem;
  margin-top: 0.25rem;
}

.real-data-card {
  background: white;
  border: 2px solid var(--gold);
  border-radius: 12px;
  padding: 1rem;
  margin: 1rem 0;
}

.real-data-card h4 {
  color: var(--gold);
  font-size: 0.8rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  margin-bottom: 0.75rem;
  display: flex;
  align-items: center;
  gap: 0.5rem;
}

.real-data-card h4::before {
  content: 'ğŸ“Š';
}

.data-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
  gap: 0.75rem;
}

.data-item {
  text-align: center;
}

.data-value {
  font-size: 1.1rem;
  font-weight: 600;
  color: var(--navy);
}

.data-label {
  font-size: 0.75rem;
  color: var(--light-text);
}

.story-hook {
  background: rgba(212, 175, 55, 0.1);
  border-left: 3px solid var(--gold);
  padding: 1rem;
  margin-top: 1rem;
  font-style: italic;
  color: var(--navy);
}

/* Story Box - Real World Case Studies */
.story-box {
  background: linear-gradient(135deg, rgba(45,139,95,0.08), rgba(30,39,97,0.10));
  border-left: 4px solid var(--green);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
  box-shadow: 0 2px 12px rgba(0,0,0,0.06);
}

.story-box-header {
  display: flex;
  align-items: center;
  gap: 0.75rem;
  margin-bottom: 1rem;
}

.story-box-icon {
  font-size: 1.5rem;
}

.story-box-title {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--navy);
  font-weight: 600;
}

.story-box-source {
  font-size: 0.75rem;
  color: var(--light-text);
  font-style: italic;
  margin-bottom: 1rem;
  padding-bottom: 0.75rem;
  border-bottom: 1px solid rgba(0,0,0,0.08);
}

.story-box-content {
  color: var(--navy);
  line-height: 1.7;
  font-size: 0.95rem;
}

.story-box-content p {
  margin-bottom: 1rem;
}

.story-box-content p:last-child {
  margin-bottom: 0;
}

.story-box-lesson {
  background: rgba(212, 175, 55, 0.15);
  border-left: 3px solid var(--gold);
  padding: 1rem;
  margin-top: 1.25rem;
  border-radius: 0 8px 8px 0;
}

.story-box-lesson-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1.5px;
  color: var(--gold);
  font-weight: 700;
  margin-bottom: 0.5rem;
}

.story-box-lesson-text {
  color: var(--navy);
  font-weight: 500;
  font-size: 0.95rem;
  line-height: 1.5;
}

/* Content Box */
.content-box {
  background: white;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.content-box h3 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.5rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.content-section {
  margin-bottom: 1.25rem;
}

.content-section h4 {
  color: var(--teal);
  font-size: 1rem;
  margin-bottom: 0.5rem;
}

.content-section p {
  color: var(--navy);
  line-height: 1.6;
}

.content-section ul {
  list-style: none;
  padding-left: 0;
}

.content-section li {
  padding: 0.4rem 0;
  padding-left: 1.5rem;
  position: relative;
  color: var(--navy);
}

.content-section li::before {
  content: 'â†’';
  position: absolute;
  left: 0;
  color: var(--gold);
}

/* Method Box */
.method-box {
  background: linear-gradient(135deg, rgba(45,139,139,0.08), rgba(30,39,97,0.08));
  border-left: 4px solid var(--teal);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
}

.method-label {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--teal);
  margin-bottom: 0.5rem;
  font-weight: 600;
}

.method-box h3 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.5rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

/* Quiz */
.quiz-container {
  background: white;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.quiz-question {
  font-size: 1.1rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
  font-weight: 600;
}

.quiz-options {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.quiz-option {
  padding: 1rem;
  border: 2px solid rgba(0,0,0,0.1);
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  background: white;
  text-align: left;
  font-size: 1rem;
  font-family: inherit;
  color: var(--navy);
}

.quiz-option:hover {
  border-color: var(--gold);
  background: rgba(212, 175, 55, 0.05);
}

.quiz-option.selected {
  border-color: var(--navy);
  background: rgba(30, 39, 97, 0.05);
}

.quiz-option.correct {
  border-color: var(--green);
  background: rgba(45, 139, 95, 0.1);
}

.quiz-option.incorrect {
  border-color: var(--red);
  background: rgba(191, 45, 45, 0.1);
}

.quiz-feedback {
  margin-top: 1rem;
  padding: 1rem;
  border-radius: 8px;
  display: none;
}

.quiz-feedback.show {
  display: block;
}

.quiz-feedback.correct {
  background: rgba(45, 139, 95, 0.1);
  border-left: 3px solid var(--green);
}

.quiz-feedback.incorrect {
  background: rgba(191, 45, 45, 0.1);
  border-left: 3px solid var(--red);
}

/* Decision Tree */
.decision-tree {
  background: white;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.decision-tree h3 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.decision-scenario {
  background: rgba(212, 175, 55, 0.1);
  padding: 1rem;
  border-radius: 8px;
  margin-bottom: 1rem;
  font-style: italic;
}

.decision-situation {
  background: rgba(30, 39, 97, 0.05);
  padding: 1rem;
  border-radius: 8px;
  margin-bottom: 1rem;
}

.decision-question {
  font-weight: 600;
  color: var(--navy);
  margin-bottom: 1rem;
}

.decision-branches {
  display: flex;
  flex-direction: column;
  gap: 0.5rem;
}

.decision-branch {
  padding: 1rem;
  border: 2px solid rgba(0,0,0,0.1);
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  background: white;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
  color: var(--navy);
  min-height: 48px;
}

.decision-branch:hover {
  border-color: var(--gold);
  background: rgba(212, 175, 55, 0.05);
}

.decision-outcome {
  padding: 1.5rem;
  border-radius: 8px;
  margin-top: 1rem;
}

.decision-outcome.good {
  background: rgba(45, 139, 95, 0.1);
  border-left: 4px solid var(--green);
}

.decision-outcome.bad {
  background: rgba(191, 45, 45, 0.1);
  border-left: 4px solid var(--red);
}

.decision-outcome.neutral {
  background: rgba(212, 175, 55, 0.1);
  border-left: 4px solid var(--gold);
}

.decision-outcome h4 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.2rem;
  margin-bottom: 0.5rem;
}

.decision-lesson {
  margin-top: 1rem;
  padding-top: 1rem;
  border-top: 1px solid rgba(0,0,0,0.1);
  font-style: italic;
}

.decision-history {
  display: flex;
  flex-wrap: wrap;
  gap: 0.5rem;
  margin-bottom: 1rem;
}

.history-step {
  background: var(--navy);
  color: white;
  padding: 0.25rem 0.75rem;
  border-radius: 12px;
  font-size: 0.8rem;
}

.undo-btn {
  background: transparent;
  border: 1px solid var(--red);
  color: var(--red);
  padding: 0.5rem 1rem;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  margin-bottom: 1rem;
}

.undo-btn:hover {
  background: var(--red);
  color: white;
}

/* Tool Container */
.tool-container {
  background: white;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
  border: 2px solid var(--teal);
}

.tool-container h3 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--teal);
  margin-bottom: 0.5rem;
}

.tool-description {
  color: var(--light-text);
  margin-bottom: 1rem;
}

.tool-inputs {
  display: grid;
  gap: 1rem;
  margin-bottom: 1rem;
}

.input-group {
  display: flex;
  flex-direction: column;
  gap: 0.25rem;
}

.input-group label {
  font-size: 0.85rem;
  font-weight: 600;
  color: var(--navy);
}

.input-group input, .input-group select, .input-group textarea {
  padding: 0.75rem;
  border: 1px solid rgba(0,0,0,0.2);
  border-radius: 6px;
  font-size: 1rem;
  font-family: inherit;
}

.input-group input:focus, .input-group select:focus, .input-group textarea:focus {
  outline: none;
  border-color: var(--teal);
}

.tool-btn {
  background: var(--teal);
  color: white;
  border: none;
  padding: 0.75rem 1.5rem;
  border-radius: 6px;
  cursor: pointer;
  font-size: 1rem;
  font-weight: 600;
  transition: background 0.2s;
}

.tool-btn:hover {
  background: #247070;
}

.tool-output {
  margin-top: 1rem;
  padding: 1rem;
  background: rgba(45, 139, 139, 0.05);
  border-radius: 8px;
  border: 1px solid rgba(45, 139, 139, 0.2);
}

.plot-area {
  min-height: 350px;
  background: white;
  border-radius: 8px;
  margin: 1rem 0;
}

/* Navigation */
.nav-buttons {
  display: flex;
  justify-content: space-between;
  padding: 1rem 2rem;
  background: white;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.nav-btn {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  padding: 0.75rem 1.5rem;
  border: none;
  border-radius: 8px;
  cursor: pointer;
  font-size: 1rem;
  font-weight: 600;
  transition: all 0.2s;
}

.nav-btn.prev {
  background: transparent;
  border: 2px solid var(--navy);
  color: var(--navy);
}

.nav-btn.prev:hover {
  background: var(--navy);
  color: white;
}

.nav-btn.next {
  background: var(--gold);
  color: var(--navy);
}

.nav-btn.next:hover {
  background: #c9a032;
}

.nav-btn:disabled {
  opacity: 0.5;
  cursor: not-allowed;
}

/* Focus States for Accessibility */
button:focus, .module-item:focus, .quiz-option:focus,
.decision-branch:focus, input:focus, select:focus, a:focus {
  outline: 3px solid var(--gold);
  outline-offset: 2px;
}

/* High Contrast Mode */
@media (prefers-contrast: high) {
  :root {
    --gold: #FFD700;
    --cream: #FFFFFF;
  }
}

/* Focus-visible styles for keyboard navigation */
:focus-visible {
  outline: 2px solid var(--gold, #D4AF37);
  outline-offset: 2px;
}

:focus:not(:focus-visible) {
  outline: none;
}

button:focus-visible,
a:focus-visible,
[role="button"]:focus-visible,
input:focus-visible,
select:focus-visible,
textarea:focus-visible {
  outline: 2px solid var(--gold, #D4AF37);
  outline-offset: 2px;
  box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
}

/* Reduced Motion */
@media (prefers-reduced-motion: reduce) {
  *, *::before, *::after {
    animation-duration: 0.01ms !important;
    transition-duration: 0.01ms !important;
  }
}

/* Screen Reader Only */
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  padding: 0;
  margin: -1px;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  white-space: nowrap;
  border: 0;
}

/* Responsive Design */
@media (max-width: 768px) {
  .hamburger {
    display: flex;
  }

  .sidebar {
    transform: translateX(-100%);
    transition: transform 0.3s;
  }

  .sidebar.open {
    transform: translateX(0);
  }

  .sidebar-overlay.show {
    display: block;
  }

  .main-content {
    margin-left: 0;
  }

  .slide-title h1 {
    font-size: 2rem;
  }

  .principle-box .text {
    font-size: 1.4rem;
  }

  .top-bar {
    padding: 1rem;
  }

  .progress-bar {
    width: 120px;
  }

  .decision-branch {
    min-height: 48px;
  }

  .quiz-option {
    min-height: 48px;
  }
}

@media (max-width: 480px) {
  .sidebar {
    width: 100%;
  }

  .slide-container {
    padding: 1rem;
  }

  .story-deep, .method-box, .content-box {
    padding: 1rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-actions {
    width: 100%;
    justify-content: center;
  }
}

/* Time Estimates */
.time-estimate {
  color: var(--teal);
  font-weight: 600;
  font-size: 0.65rem;
}

.course-time {
  font-size: 0.8rem;
  color: var(--light-text);
  padding: 0.25rem 0.75rem;
  background: rgba(45, 139, 139, 0.1);
  border-radius: 12px;
}

/* Badge Notification */
.badge-notification {
  position: fixed;
  bottom: 2rem;
  right: 2rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 1rem 1.5rem;
  display: flex;
  align-items: center;
  gap: 1rem;
  box-shadow: 0 8px 32px rgba(0,0,0,0.3);
  z-index: 3000;
  transform: translateY(100px);
  opacity: 0;
  transition: all 0.5s cubic-bezier(0.34, 1.56, 0.64, 1);
}

.badge-notification.show {
  transform: translateY(0);
  opacity: 1;
}

.badge-icon {
  width: 48px;
  height: 48px;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 1.5rem;
  box-shadow: 0 4px 12px rgba(0,0,0,0.2);
}

.badge-info {
  color: white;
}

.badge-earned {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: var(--gold);
  margin-bottom: 0.25rem;
}

.badge-name {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.2rem;
  font-weight: 600;
}

/* Badge Grid in Modal */
.badge-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(140px, 1fr));
  gap: 1rem;
  margin-top: 1rem;
}

.badge-card {
  background: white;
  border-radius: 12px;
  padding: 1rem;
  text-align: center;
  border: 2px solid transparent;
  transition: all 0.3s;
}

.badge-card.earned {
  border-color: var(--gold);
  box-shadow: 0 4px 12px rgba(212, 175, 55, 0.2);
}

.badge-card.locked {
  opacity: 0.5;
  filter: grayscale(1);
}

.badge-card .badge-icon {
  width: 56px;
  height: 56px;
  margin: 0 auto 0.75rem;
  font-size: 1.75rem;
}

.badge-card .badge-name {
  color: var(--navy);
  font-size: 0.9rem;
  font-weight: 600;
  margin-bottom: 0.25rem;
}

.badge-card .badge-requirement {
  font-size: 0.75rem;
  color: var(--light-text);
}

/* Mastery Checkpoint */
.mastery-checkpoint {
  background: linear-gradient(135deg, rgba(45, 139, 95, 0.15), rgba(45, 139, 139, 0.1));
  border: 2px solid var(--green);
  border-radius: 16px;
  padding: 1.5rem;
  margin: 2rem 0;
  text-align: center;
}

.mastery-checkpoint h3 {
  color: var(--green);
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.5rem;
  margin-bottom: 0.5rem;
}

.mastery-checkpoint .mastery-icon {
  font-size: 2.5rem;
  margin-bottom: 0.5rem;
}

.mastery-checkpoint p {
  color: var(--navy);
  font-size: 1rem;
  margin: 0;
}

.mastery-checkpoint .mastery-stats {
  display: flex;
  justify-content: center;
  gap: 2rem;
  margin-top: 1rem;
  padding-top: 1rem;
  border-top: 1px solid rgba(45, 139, 95, 0.3);
}

.mastery-stat {
  text-align: center;
}

.mastery-stat .stat-value {
  font-size: 1.5rem;
  font-weight: 700;
  color: var(--green);
}

.mastery-stat .stat-label {
  font-size: 0.75rem;
  color: var(--light-text);
  text-transform: uppercase;
  letter-spacing: 0.5px;
}

/* IPTW Deep Dive Box */
.iptw-deepdive {
  background: linear-gradient(135deg, rgba(212, 175, 55, 0.1), rgba(30, 39, 97, 0.08));
  border-left: 4px solid var(--gold);
  border-radius: 0 12px 12px 0;
  padding: 1.25rem;
  margin: 1rem 0;
}

.iptw-deepdive h4 {
  color: var(--gold);
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.1rem;
  margin-bottom: 0.75rem;
}

.iptw-formula {
  font-family: monospace;
  background: rgba(30, 39, 97, 0.1);
  padding: 0.5rem 1rem;
  border-radius: 6px;
  margin: 0.5rem 0;
  color: var(--navy);
}
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="hamburger">
<span></span>
<span></span>
<span></span>
</button>
<div class="sidebar-overlay"></div>
<nav aria-label="ã‚³ãƒ¼ã‚¹ãƒ¢ã‚¸ãƒ¥ãƒ¼ãƒ«" class="sidebar" role="navigation">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;padding:0.5rem 1rem 0;">â† Course Library</a>
<div class="logo">Observational Evidence</div>
<div class="tagline">RCT ãŒä¸å¯èƒ½ãªå ´åˆ</div>
<div class="nav-section">
<div class="nav-label">Modules</div>
<div id="module-nav"></div>
</div>
</nav>
<main class="main-content" id="main-content">
<div class="top-bar">
<div class="progress-section">
<div class="progress-bar">
<div class="progress-fill" id="progress-fill" style="width: 0%"></div>
</div>
<span class="progress-text" id="progress-text">0% Complete</span>
</div>
<div class="points-display">
<span id="points-display">0</span> XP
      </div>
<div class="course-time">
<span id="total-time">5h 30m total</span>
</div>
<div class="top-actions">
<button class="action-btn" onclick="openBadges()">ğŸ† Badges</button>
<button class="action-btn" onclick="openGlossary()">Glossary</button>
<button class="action-btn" onclick="openToolLibrary()">Tools</button>
</div>
</div>
<div class="slide-container" id="slide-container"></div>
<div aria-live="polite" class="sr-only" id="slide-announce"></div>
<div class="nav-buttons">
<button class="nav-btn prev" id="prev-btn" onclick="prevSlide()">
<span>â†</span> Previous
      </button>
<button class="nav-btn next" id="next-btn" onclick="nextSlide()">
        Next <span>â†’</span>
</button>
</div>
</main>
<script>
// Course Data
const STORAGE_KEY = 'observational-evidence-course-progress';

let currentModule = 0;
let currentSlide = 0;
let gameState = {
  points: 0,
  earnedBadges: [],
  toolsUsed: [],
  modulesCompleted: [],
  scenariosCompleted: {},
  decisionTrees: {}
};

// Badge Definitions with visual designs
const BADGES = {
  'bias-detective': { name: 'Bias Detective', icon: 'ğŸ”', color: '#BF2D2D', requirement: 'ã™ã¹ã¦ã®ãƒã‚¤ã‚¢ã‚¹ ãƒ¢ã‚¸ãƒ¥ãƒ¼ãƒ«ã‚’å®Œäº†ã™ã‚‹' },
  'dag-master': { name: 'DAG Master', icon: 'ğŸ•¸ï¸', color: '#2D8B8B', requirement: 'Build 3 DAGs correctly' },
  'robins-ranger': { name: 'ROBINS Ranger', icon: 'ğŸ›¡ï¸', color: '#D4AF37', requirement: '5 ã¤ã® ROBINS-I è©•ä¾¡ã‚’å®Œäº†ã™ã‚‹' },
  'story-scholar': { name: 'Story Scholar', icon: 'ğŸ“š', color: '#1e2761', requirement: '16 ã®ã‚±ãƒ¼ã‚¹ ã‚¹ã‚¿ãƒ‡ã‚£ã‚’ã™ã¹ã¦èª­ã‚€' },
  'decision-ace': { name: 'Decision Ace', icon: 'ğŸ¯', color: '#2D8B5F', requirement: '19 ã®ãƒ‡ã‚·ã‚¸ãƒ§ãƒ³ ãƒ„ãƒªãƒ¼ã‚’ã™ã¹ã¦å®Œäº†ã™ã‚‹' },
  'quiz-champion': { name: 'Quiz Champion', icon: 'ğŸ†', color: '#9B59B6', requirement: 'Score 100% on all quizzes' },
  'methods-master': { name: 'Methods Master', icon: 'ğŸ“', color: '#E67E22', requirement: 'ã‚³ãƒ¼ã‚¹å…¨ä½“ã‚’å®Œäº†ã™ã‚‹' },
  'capstone-conqueror': { name: 'Capstone Conqueror', icon: 'ğŸ‘‘', color: '#C0392B', requirement: '3 ã¤ã®ã‚­ãƒ£ãƒƒãƒ—ã‚¹ãƒˆãƒ¼ãƒ³ã‚’ã™ã¹ã¦å®Œäº†ã™ã‚‹ã‚·ãƒŠãƒªã‚ª' }
};

const modules = [
  {
    id: 0,
    title: "The Opening",
    subtitle: "ãªãœè¦³å¯Ÿè¨¼æ‹ ãŒé‡è¦ãªã®ã‹",
    principle: null,
    estimatedTime: "15 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "Observational Evidence",
          subtitle: "RCT ãŒä¸å¯èƒ½ãªå ´åˆ",
          text: "ã ã¾ã•ã‚ŒãŸäººã€…ã€ãã—ã¦ä¸€åº¦ã®ãƒ©ãƒ³ãƒ€ãƒ åŒ–è©¦é¨“ãªã—ã§å‘½ã‚’æ•‘ã£ãŸäººã€…ã®ç‰©èªã‚’é€šã—ã¦ã€ä¹±é›‘ãªç¾å®Ÿä¸–ç•Œã®ãƒ‡ãƒ¼ã‚¿ã‹ã‚‰çœŸå®Ÿã‚’æŠ½å‡ºã™ã‚‹æ–¹æ³•ã‚’å­¦ã³ã¾ã—ã‚‡ã†ã€‚"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE SALVATION: THALIDOMIDE â€” WHEN OBSERVATION SAVED LIVES",
          source: "Lancet 1961; McBride | BMJ 1961; Lenz | No RCT existed",
          timeline: [
            { year: "1957", text: "Thalidomide marketed in Germany as 'completely safe' sedative. Sold over-the-counter. Pregnant women take it for morning sickness.", type: "normal" },
            { year: "1959-60", text: "Reports of peripheral neuropathy emerge. Company dismisses concerns. No systematic monitoring exists.", type: "normal" },
            { year: "Nov 1961", text: "Dr. William McBride in Australia notices pattern: mothers of babies with limb defects took thalidomide. He writes to Lancet.", type: "revelation" },
            { year: "Nov 1961", text: "Dr. Widukind Lenz in Germany independently identifies the same pattern through case-control reasoning.", type: "revelation" },
            { year: "Dec 1961", text: "Drug withdrawn worldwide. 10,000+ children affected. Two observant physicians saved countless more.", type: "crisis" },
            { year: "Legacy", text: "Modern pharmacovigilance born. FDA strengthened. The lesson: OBSERVATIONAL DATA can detect harms RCTs miss.", type: "revelation" }
          ],
          realData: {
            endpoint: "Phocomelia (limb defects)",
            drug: "Thalidomide exposure in first trimester",
            placebo: "No exposure",
            rr: "Case-control OR > 100",
            ci: "Unquestionable association",
            nnh: "~10,000 children affected"
          },
          hook: "THE HOOK: No RCT detected thalidomide's harm. Two physicians, using observational reasoning, saw a pattern and saved a generation. This course teaches you to see patterns â€” and to know when they're real."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ ä¸»ãªæ´å¯Ÿ: ã‚µãƒªãƒ‰ãƒã‚¤ãƒ‰ã¯ã€è¦³å¯Ÿè¨¼æ‹ ãŒå‘½ã‚’æ•‘ãˆã‚‹ã“ã¨ã‚’è¨¼æ˜ã—ã¦ã„ã¾ã™ã€‚ã—ã‹ã—ã€HRT ã¯æ¬ºãã“ã¨ã‚‚ã§ãã‚‹ã“ã¨ã‚’è¨¼æ˜ã—ã¦ã„ã¾ã™ã€‚å•é¡Œã¯è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã‚’ä½¿ç”¨ã™ã‚‹ã‹ã©ã†ã‹ã§ã¯ãªãã€ãã‚Œã‚’ã©ã®ã‚ˆã†ã«è³¢æ˜ã«ä½¿ç”¨ã™ã‚‹ã‹ã§ã™ã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "When RCTs Are Impossible or Insufficient",
          sections: [
            {
              heading: "RCTs Cannot Answer These Questions:",
              items: [
                "Rare harms (need millions of patients, decades of follow-up)",
                "Long-term outcomes (RCTs rarely last >5 years)",
                "Real-world effectiveness (RCTs select ideal patients)",
                "Unethical randomization (can't randomize smoking, poverty)",
                "Historical questions (what happened before RCTs existed?)"
              ]
            },
            {
              heading: "Observational Data Can:",
              items: [
                "Detect rare adverse events (thalidomide, Vioxx)",
                "Track lifetime outcomes (Framingham, Nurses' Health)",
                "ç¾å®Ÿä¸–ç•Œã®æ¯é›†å›£ï¼ˆè©¦é¨“å¯¾è±¡è€…ã ã‘ã§ãªãï¼‰ã‚’ç ”ç©¶ã™ã‚‹",
                "Generate hypotheses for future RCTs",
                "Monitor post-marketing drug safety"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "è¦³å¯Ÿè¨¼æ‹ ã® 7 ã¤ã®åŸå‰‡",
          sections: [
            {
              heading: "Your Guide Through This Course:",
              items: [
                "1. \"Association is not causation\" â€” Confounding deceives",
                "2. \"Time flows one direction\" â€” Temporality matters",
                "3ã€‚ \\\"æ¢ã—ã¦ã„ã‚‹ã‚‚ã®ã¯ã‚ã‹ã‚Šã¾ã™\\\" â€” é¸æŠãƒã‚¤ã‚¢ã‚¹ã¯éš ã‚Œã¦ã„ã¾ã™",
                "4. \"Measurement shapes reality\" â€” Information bias distorts",
                "5. \"Context determines meaning\" â€” Effect modification exists",
                "6. \"Adjustment is not magic\" â€” Residual confounding remains",
                "7. \"Replication builds confidence\" â€” One study is never enough"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "ã“ã®ã‚³ãƒ¼ã‚¹ã®ä»•çµ„ã¿",
          sections: [
            {
              heading: "Each Module Contains:",
              items: [
                "ğŸ“– ã‚¹ãƒˆãƒ¼ãƒªãƒ¼ â€” è¦³å¯Ÿç ”ç©¶ã‹ã‚‰å¾—ã‚‰ã‚Œã‚‹å®Ÿéš›ã®ç½å®³ã¨å‹åˆ©",
                "ğŸ”§ æ–¹æ³• â€” ã‚„ã‚Šæ–¹æ­£ã—ã",
                "âš™ï¸ ãƒ„ãƒ¼ãƒ« â€” ã‚¤ãƒ³ã‚¿ãƒ©ã‚¯ãƒ†ã‚£ãƒ–ãªç·´ç¿’",
                "ğŸ”€ ã‚·ãƒŠãƒªã‚ª â€” åˆ¤æ–­ã‚’ä¸‹ã™",
                "âœ… ã‚¯ã‚¤ã‚º â€” ç†è§£åº¦ã‚’ãƒ†ã‚¹ãƒˆã—ã¾ã™"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'rct-vs-obs-decision',
          title: "è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã¯ã„ã¤å¿…è¦ã§ã™ã‹?",
          situation: "You're a researcher deciding how to study a clinical question. For each scenario, decide: RCT or observational?",
          nodes: {
            start: {
              question: "ã‚·ãƒŠãƒªã‚ª: å–«ç…™ãŒè‚ºãŒã‚“ã®åŸå› ã¨ãªã‚‹ã‹ã©ã†ã‹ã‚’ç ”ç©¶ã—ãŸã„ã¨è€ƒãˆã¦ã„ã¾ã™ã€‚ã©ã®ã‚ˆã†ãªç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã§ã™ã‹?",
              branches: [
                { text: "RCT â€” randomize people to smoke or not smoke", nextNode: "rct_smoking_wrong" },
                { text: "è¦³å¯Ÿçš„ â€” å–«ç…™è€…ã¨éå–«ç…™è€…ã‚’é•·æœŸã«ã‚ãŸã£ã¦è¿½è·¡ã—ã¾ã™", nextNode: "obs_smoking_correct" }
              ]
            },
            rct_smoking_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Ethically impossible!",
              text: "äººã€…ã‚’ãƒ©ãƒ³ãƒ€ãƒ ã«å–«ç…™ã™ã‚‹ã‚ˆã†ã«æŒ‡å®šã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚å®³ã‚’å¼•ãèµ·ã“ã™å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ã¾ã•ã«ã“ã‚ŒãŒã€å–«ç…™â†’è‚ºãŒã‚“ã‚’ç«‹è¨¼ã™ã‚‹ãŸã‚ã«è¦³å¯Ÿè¨¼æ‹ ãŒä¸å¯æ¬ ã ã£ãŸç†ç”±ã§ã™ã€‚ãƒ‰ãƒ¼ãƒ«ã¨ãƒ’ãƒ«ã¯ã€RCT ãŒéå€«ç†çš„ã§ã‚ã‚‹ãŸã‚ã€ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã‚’ä½¿ç”¨ã—ã¾ã—ãŸã€‚",
              lesson: "æš´éœ²ãŒå®³ã‚’å¼•ãèµ·ã“ã™å ´åˆã€ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã¯éå€«ç†çš„ã§ã™ã€‚è¦³æ¸¬ãƒ‡ãƒ¼ã‚¿ãŒå”¯ä¸€ã®é¸æŠè‚¢ã§ã™ã€‚"
            },
            obs_smoking_correct: {
              situation: "Correct! Smoking studies must be observational. NEXT SCENARIO:",
              question: "You want to know if a new diabetes drug reduces heart attacks. What design?",
              branches: [
                { text: "RCT â€” randomize patients to drug vs placebo", nextNode: "rct_drug_correct" },
                { text: "Observational â€” compare patients who chose the drug", nextNode: "obs_drug_partial" }
              ]
            },
            rct_drug_correct: {
              situation: "ç†æƒ³çš„ã§ã™!ã—ã‹ã—ã€RCTã«ã¯5å¹´ã¨1ä¸‡äººã®æ‚£è€…ãŒã‹ã‹ã‚‹ã€‚çµŒå–¶è€…ã¯ã€è«‹æ±‚ãƒ‡ãƒ¼ã‚¿ã‚’ä½¿ç”¨ã—ã¦ 6 ã‹æœˆä»¥å†…ã«å›ç­”ã‚’æ±‚ã‚ã¦ã„ã¾ã™ã€‚ã‚ãªãŸã¯ä½•ã¨è¨€ã„ã¾ã™ã‹?",
              question: "Your response:",
              branches: [
                { text: "è¦³å¯Ÿç ”ç©¶ã‚’ã—ã¦ãã ã•ã„ â€” ã‚¹ãƒ”ãƒ¼ãƒ‰ãŒé‡è¦ã§ã™", nextNode: "speed_wrong" },
                { text: "ã“ã®è³ªå•ã®è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã¯äº¤çµ¡ã•ã‚Œã‚‹ã“ã¨ã‚’èª¬æ˜ã—ã¦ãã ã•ã„", nextNode: "explain_correct" }
              ]
            },
            obs_drug_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possible, but risky",
              text: "è–¬ã®åŠ¹æœã«é–¢ã™ã‚‹è¦³å¯Ÿç ”ç©¶ã¯é©å¿œç—‡ã«ã‚ˆã£ã¦æ·±åˆ»ãªäº¤çµ¡ã‚’å¼•ãèµ·ã“ã—ã¾ã™ â€” ã‚ˆã‚Šç—…æ°—ã®æ‚£è€…ãŒè–¬ã‚’æœç”¨ã—ã¾ã™ã€‚å¿ƒè‡“ç™ºä½œã‚’èµ·ã“ã—ã‚„ã™ã„æ‚£è€…ã«ãã®è–¬ãŒå‡¦æ–¹ã•ã‚Œã¦ã„ã‚‹ã¨ã„ã†ç†ç”±ã ã‘ã§ã€ãã®è–¬ãŒå¿ƒè‡“ç™ºä½œã‚’å¼•ãèµ·ã“ã™ã¨æ€ã†ã‹ã‚‚ã—ã‚Œã¾ã›ã‚“ã€‚ã“ã‚Œã¯ HRT ã®æ•™è¨“ã§ã™ã€‚",
              lesson: "æ²»ç™‚å¯èƒ½ãªç—‡çŠ¶ã«ã¤ã„ã¦ã¯ã€å¯èƒ½ã§ã‚ã‚Œã° RCT ãŒå„ªå…ˆã•ã‚Œã¾ã™ã€‚è–¬ç‰©è¦³å¯Ÿç ”ç©¶ã«ã¯ã€éå¸¸ã«æ…é‡ãªè¨­è¨ˆãŒå¿…è¦ã§ã™ (ã‚¢ã‚¯ãƒ†ã‚£ãƒ–ãªã‚³ãƒ³ãƒ‘ãƒ¬ãƒ¼ã‚¿ãƒ¼ã€æ–°è¦ãƒ¦ãƒ¼ã‚¶ãƒ¼ã€ã‚¿ãƒ¼ã‚²ãƒƒãƒˆè©¦é¨“ã‚¨ãƒŸãƒ¥ãƒ¬ãƒ¼ã‚·ãƒ§ãƒ³)ã€‚"
            },
            speed_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚ŒãŒ HRT ã®å§‹ã¾ã‚Šã§ã™!",
              text: "HRT ã®è¦³å¯Ÿç ”ç©¶ã¯ã€RCT ã‚ˆã‚Šã‚‚è¿…é€Ÿã‹ã¤ç°¡å˜ã§ã‚ã‚‹ãŸã‚è¡Œã‚ã‚Œã¾ã—ãŸã€‚å½¼ã‚‰ã¯20å¹´é–“ã‚‚é–“é•ã£ãŸç­”ãˆã‚’å‡ºã—ç¶šã‘ã¦ãã¾ã—ãŸã€‚æœ‰åŠ¹æ€§ã®ãªã„ã‚¹ãƒ”ãƒ¼ãƒ‰ã¯å¾…ã¤ã“ã¨ã‚ˆã‚Šæ‚ªã„ã§ã™ã€‚",
              lesson: "ç´ æ—©ã„é–“é•ã£ãŸç­”ãˆã¯æ‚£è€…ã«å®³ã‚’ä¸ãˆã¾ã™ã€‚è¦³å¯Ÿè¨¼æ‹ ãŒã‚ã¾ã‚Šã«ã‚‚åã£ã¦ã„ã‚‹å ´åˆã¯ã€RCT ã‚’å¾…ã£ãŸã»ã†ãŒã‚ˆã„ã§ã—ã‚‡ã†ã€‚"
            },
            explain_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent scientific judgment!",
              text: "ã“ã®è³ªå• (è–¬å‰¤ â†’ å¿ƒè¡€ç®¡è»¢å¸°) ã¯é©å¿œç—‡ã«ã‚ˆã‚‹äº¤çµ¡ã®å½±éŸ¿ã‚’éå¸¸ã«å—ã‘ã‚„ã™ã„ã“ã¨ã‚’æ­£ã—ãç‰¹å®šã—ã¾ã—ãŸã€‚ã“ã“ã§ã®è¦³å¯Ÿè¨¼æ‹ ã¯ä¿¡é ¼ã§ããªã„ã§ã—ã‚‡ã†ã€‚ RCT ã¯å¾…ã¤ä¾¡å€¤ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "è¦³æ¸¬ãƒ‡ãƒ¼ã‚¿ãŒè³ªå•ã«ç­”ãˆã‚‰ã‚Œã‚‹ã¨ãã¨ç­”ãˆã‚‰ã‚Œãªã„ã¨ãã‚’çŸ¥ã£ã¦ãã ã•ã„ã€‚é©å¿œç—‡ã«ã‚ˆã‚‹äº¤çµ¡ã‚’ä¼´ã†è–¬åŠ¹ã¯å±é™ºãªé ˜åŸŸã§ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: As you learn observational methods, remember both faces of the coin. Thalidomide shows observation SAVES lives. But this course will also show how it COSTS lives when done carelessly. Stay humble. Stay skeptical. Stay curious."
        }
      }
    ]
  },
  {
    id: 1,
    title: "The Trap",
    subtitle: "Confounding",
    principle: 0,
    story: "HRT",
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "é–¢é€£æ€§ã¯å› æœé–¢ä¿‚ã§ã¯ã‚ã‚Šã¾ã›ã‚“"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "æ¬ºç: HRT â€” 30 ä»¶ã®ç ”ç©¶ãŒå˜˜ã‚’ã¤ã„ãŸå ´åˆ",
          source: "JAMA 2002; 288:321-333 | WHI Writing Group | PubMed: 12117397",
          timeline: [
            { year: "1960s-80s", text: "Observational studies consistently show HRT reduces CHD by 40-50%. Biological rationale compelling: estrogen improves lipids.", type: "normal" },
            { year: "1985", text: "Framingham: Women on HRT have 50% lower CHD risk. Millions of prescriptions written for 'cardioprotection.'", type: "normal" },
            { year: "1991", text: "çœ‹è­·å¸«ã®å¥åº·èª¿æŸ»: RR 0.56 (95% CI) CHDã®å ´åˆã¯0.40-0.80ï¼‰ã€‚ 'Definitive' evidence. HRT ãŒæ¨™æº–æ²»ç™‚ã«ãªã‚Šã¾ã™ã€‚", type: "normal" },
            { year: "1998", text: "HERS trial (first large RCT): HR 0.99 (0.81-1.22). NO BENEFIT. Dismissed as 'wrong population.'", type: "crisis" },
            { year: "Jul 2002", text: "WHI ã¯ HARM ã®ãŸã‚ã«åœæ­¢ã•ã‚Œã¾ã—ãŸã€‚ CHD HR 1.29 (1.02-1.63)ã€‚ä¹³ãŒã‚“ãŒå¢—ãˆãŸã€‚ 30 ä»¥ä¸Šã®ç ”ç©¶ã¯ã™ã¹ã¦é–“é•ã£ã¦ã„ã¾ã—ãŸã€‚", type: "crisis" },
            { year: "The Truth", text: "Healthy user bias: Women who chose HRT were healthier, richer, more educated, exercised more. The 'benefit' was confounding.", type: "revelation" }
          ],
          realData: {
            endpoint: "Coronary heart disease",
            drug: "Observational: RR 0.56 (0.40-0.80)",
            placebo: "RCT (WHI): HR 1.29 (1.02-1.63)",
            rr: "OPPOSITE DIRECTIONS",
            ci: "Confounding flipped benefit to harm",
            nnh: "Millions of women misled for decades"
          },
          hook: "THE QUESTION: How can 30 observational studies, 40+ meta-analyses, and 'compelling' biological rationale all be wrong? Because they measured WHO TAKES HRT, not WHAT HRT DOES. The women who chose HRT were already healthier. Confounding is invisible â€” until an RCT exposes it."
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'ğŸ’”',
          title: "The HRT Reversal: 20 Years of Wrong Answers",
          source: "Women's Health Initiative, JAMA 2002",
          paragraphs: [
            "For decades, observational studies showed women on hormone replacement therapy had 50% fewer heart attacks. The biological rationale was compelling: estrogen improves lipid profiles. Millions of women were prescribed HRT specifically for 'cardioprotection.'",
            "ãã®å¾Œã€Women's Health Initiative ã® RCT (2002) ãŒè¡æ’ƒã‚’ä¸ãˆã¾ã—ãŸã€‚HRT ã¯å®Ÿéš›ã«å¿ƒè‡“ç™ºä½œã‚’ 29% å¢—åŠ ã•ã›ã¾ã—ãŸã€‚è©¦é¨“ã¯å±å®³ã‚’ç†ç”±ã«æ—©æœŸã«ä¸­æ­¢ã•ã‚Œã¾ã—ãŸã€‚",
            "What went wrong? The observational studies suffered from 'healthy user bias.' Women who chose HRT were wealthier, more educated, more health-conscious, and more likely to exercise. They would have had fewer heart attacks regardless of HRT. The studies were measuring the TYPE of woman who took HRT, not what HRT actually did."
          ],
          lesson: "Confounding created a false signal that lasted 20 years and influenced millions of prescriptions. When you observe that users of something have better outcomes, always ask: are they better off BECAUSE of the treatment, or were they already different?"
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY TAKEAWAY: HRT's 'benefit' wasn't from the drug â€” it was from the type of woman who chose to take it. Confounders are variables that affect BOTH the exposure and the outcome. Unless you account for them, you're measuring the confounder, not the treatment."
        }
      },
      {
        type: 'content',
        content: {
          title: "What is Confounding?",
          sections: [
            {
              heading: "The Three Conditions for Confounding:",
              items: [
                "1ã€‚äº¤çµ¡å› å­ã¯ EXPOSURE",
                "2 ã«é–¢é€£ä»˜ã‘ã‚‰ã‚Œã¦ã„ã¾ã™ã€‚äº¤çµ¡å› å­ã¯ OUTCOME",
                "3 ã«é–¢é€£ä»˜ã‘ã‚‰ã‚Œã¦ã„ã¾ã™ã€‚äº¤çµ¡å› å­ã¯å› æœçµŒè·¯ä¸Šã«ã‚ã‚Šã¾ã›ã‚“"
              ]
            },
            {
              heading: "HRT Example:",
              items: [
                "Confounder: Socioeconomic status / health consciousness",
                "Associated with exposure: Wealthy, educated women more likely to seek HRT",
                "Associated with outcome: Wealthy, educated women have lower CHD risk anyway",
                "Not on causal pathway: SES doesn't mediate HRT's biological effect",
                "çµæœ: HRT ãƒ¦ãƒ¼ã‚¶ãƒ¼ã¯ã‚‚ã¨ã‚‚ã¨å¥åº·ã ã£ãŸãŸã‚ã€HRT ã¯æœ‰ç›Šã§ã‚ã‚‹ã‚ˆã†ã«è¦‹ãˆã¾ã—ãŸ"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: äº¤çµ¡å› å­ã®ç‰¹å®š",
          title: "Thinking Causally",
          sections: [
            {
              heading: "Step 1: Draw a DAG (Directed Acyclic Graph)",
              text: "ã‚¨ã‚¯ã‚¹ãƒãƒ¼ã‚¸ãƒ£ãƒ¼ã€çµæœã€ãŠã‚ˆã³æ½œåœ¨çš„ãªäº¤çµ¡å› å­ã®é–“ã®å› æœé–¢ä¿‚ã‚’è¦–è¦šåŒ–ã—ã¾ã™ã€‚çŸ¢å°ã¯å› æœé–¢ä¿‚ã®æ–¹å‘ã‚’ç¤ºã—ã¾ã™ã€‚"
            },
            {
              heading: "Step 2: Identify Backdoor Paths",
              text: "æš´éœ²ã‹ã‚‰çµæœã¾ã§ã€å…±é€šã®åŸå› ã‚’é€†æ–¹å‘ã«é€²ã‚€çµŒè·¯ã¯ã€ãƒ–ãƒ­ãƒƒã‚¯ã™ã‚‹å¿…è¦ãŒã‚ã‚‹äº¤çµ¡çµŒè·¯ã§ã™ã€‚"
            },
            {
              heading: "Step 3: Decide What to Adjust For",
              text: "äº¤çµ¡å› å­ (ä¸€èˆ¬çš„ãªåŸå› ) ã‚’èª¿æ•´ã—ã¾ã™ã€‚ãƒ¡ãƒ‡ã‚£ã‚¨ãƒ¼ã‚¿ãƒ¼ (åŸå› çµŒè·¯ä¸Šã®) ã¾ãŸã¯ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ (å…±é€šã®å½±éŸ¿) ã‚’èª¿æ•´ã—ãªã„ã§ãã ã•ã„ã€‚"
            },
            {
              heading: "Step 4: Assess Residual Confounding",
              text: "Even after adjustment, unmeasured confounders remain. Sensitivity analysis can estimate their potential impact."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'dag-builder',
          title: "DAG Builder",
          description: "Build a Directed Acyclic Graph to visualize causal relationships and identify confounders"
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'â˜•',
          title: "çœ‹è­·å¸«ã®å¥åº·èª¿æŸ»ã®ã‚³ãƒ¼ãƒ’ãƒ¼ã®ãƒ‘ãƒ©ãƒ‰ãƒƒã‚¯ã‚¹",
          source: "Nurses' Health Study, Multiple Publications 1980s-2000s",
          paragraphs: [
            "çœ‹è­·å¸«ã®å¥åº·èª¿æŸ»ã®åˆæœŸã®åˆ†æã§ã¯ã€ã‚³ãƒ¼ãƒ’ãƒ¼ã‚’é£²ã‚€äººã®å¿ƒè‡“ç—…ã®ç™ºç”Ÿç‡ãŒé«˜ã„ã¨ã„ã†å„ä»‹ãªé–¢é€£æ€§ãŒè¦‹ã¤ã‹ã‚Šã¾ã—ãŸã€‚åŒ»ç™‚ã‚¬ã‚¤ãƒ‰ãƒ©ã‚¤ãƒ³ã§ã¯ã‚³ãƒ¼ãƒ’ãƒ¼ã®æ‘‚å–ã«å¯¾ã™ã‚‹è­¦å‘ŠãŒå§‹ã¾ã‚Šã¾ã—ãŸã€‚ãƒ‡ãƒ¼ã‚¿ã§ã¯é–¢é€£æ€§ãŒæ˜ã‚‰ã‹ã§ã‚ã‚‹ã‚ˆã†ã«è¦‹ãˆã¾ã—ãŸã€‚",
            "Then researchers noticed something: coffee drinkers smoked more. In that era, coffee and cigarettes went together. When smoking was properly adjusted for, the coffee-heart disease link vanished entirely.",
            "ã—ã‹ã—ã€è©±ã¯ãã“ã§çµ‚ã‚ã‚Šã¾ã›ã‚“ã§ã—ãŸã€‚ã‚ˆã‚Šè‰¯ã„æ–¹æ³•ã¨é•·æœŸã®è¿½è·¡èª¿æŸ»ã«ã‚ˆã‚‹ãã®å¾Œã®ç ”ç©¶ã§ã¯ã€ã‚³ãƒ¼ãƒ’ãƒ¼ãŒå®Ÿéš›ã«å¿ƒè‡“ç—…ã€2å‹â€‹â€‹ç³–å°¿ç—…ã€ãŠã‚ˆã³ç‰¹å®šã®ç™Œã‚’äºˆé˜²ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã“ã¨ãŒç¤ºã•ã‚Œã¾ã—ãŸã€‚åŒã˜ãƒ‡ãƒ¼ã‚¿ã‚»ãƒƒãƒˆã‚’ã€ã‚ˆã‚Šå„ªã‚ŒãŸäº¤çµ¡åˆ¶å¾¡ã‚’ä½¿ç”¨ã—ã¦åˆ†æã™ã‚‹ã¨ã€åå¯¾ã®çµè«–ã«é”ã—ã¾ã—ãŸã€‚"
          ],
          lesson: "äº¤çµ¡åˆ¶å¾¡ã¯é‡è¦ãªã ã‘ã§ã¯ãªãã€çµè«–ã‚’å®Œå…¨ã«è¦†ã™å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ã‚³ãƒ¼ãƒ’ãƒ¼ã®ç‰©èªã¯ã€åŒã˜åŸºç¤ãƒ‡ãƒ¼ã‚¿ã‚’åŸºã«ã€å¾ã€…ã«å„ªã‚ŒãŸæ–¹æ³•ã§åˆ†æã™ã‚‹ã¨ã€æœ‰å®³ãªé–¢é€£æ€§ãŒã©ã®ã‚ˆã†ã«ç„¡åŠ¹ã«ãªã‚Šã€ãã®å¾Œä¿è­·çš„ãªã‚‚ã®ã«ãªã‚‹ã‹ã‚’ç¤ºã—ã¦ã„ã¾ã™ã€‚"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'confounding_decision_tree',
          title: "ã‚³ãƒ¼ãƒ’ãƒ¼ã®é›£é¡Œ",
          situation: "You're analyzing observational data on coffee consumption and mortality. Your crude analysis shows coffee drinkers have 15% higher mortality (RR 1.15, p<0.01). A colleague suggests this proves coffee is harmful.",
          nodes: {
            start: {
              id: 'start',
              situation: "ã€ŒCOFFEE KILLSã€ã‚’å…¬é–‹ã™ã‚‹å‰ã«ã€æ½œåœ¨çš„ãªäº¤çµ¡å› å­ã‚’æ¤œè¨ã—ã¾ã™ã€‚æœ€åˆã«è€ƒãˆãŸã“ã¨ã¯ä½•ã§ã™ã‹?",
              question: "ã©ã®äº¤çµ¡å› å­ãŒæœ€ã‚‚æ‡¸å¿µã•ã‚Œã¾ã™ã‹?",
              branches: [
                { id: 'smoking', text: "Smoking â€” coffee drinkers smoke more", nextNode: 'smoking_path' },
                { id: 'age', text: "Age â€” older people drink more coffee", nextNode: 'age_path' },
                { id: 'no_confounder', text: "ãã®é–¢é€£æ€§ã¯æœ¬ç‰©ã§ã™ â€” ç¾çŠ¶ã®ã¾ã¾å…¬é–‹ã—ã¾ã™", nextNode: 'publish_crude' }
              ]
            },
            smoking_path: {
              id: 'smoking_path',
              situation: "å–«ç…™çŠ¶æ³ã«ã‚ˆã£ã¦éšå±¤åŒ–ã—ã¾ã™ã€‚éå–«ç…™è€…ã®é–“: RR 0.92 (0.85-0.99)ã€‚å–«ç…™è€…ã®å ´åˆ: RR 1.35 (1.20-1.52)ã€‚ç²—é›‘ãª RR 1.15 ã¯å–«ç…™ã«ã‚ˆã£ã¦æ··ä¹±ã—ã¾ã—ãŸã€‚",
              question: "ä½•ã‚’çµè«–ä»˜ã‘ã¾ã™ã‹?",
              branches: [
                { id: 'coffee_protective', text: "Coffee is actually protective (in non-smokers)", nextNode: 'protective_finding' },
                { id: 'more_analysis', text: "Need to adjust for more confounders before concluding", nextNode: 'multivariate' },
                { id: 'effect_modification', text: "ã“ã‚Œã¯å˜ãªã‚‹æ··ä¹±ã§ã¯ãªãã€åŠ¹æœã®ä¿®æ­£ã®ã‚ˆã†ã«è¦‹ãˆã¾ã™", nextNode: 'effect_mod_insight' }
              ]
            },
            age_path: {
              id: 'age_path',
              situation: "You check age distribution. Mean age: coffee drinkers 58 years, non-drinkers 52 years. Older people drink more coffee AND have higher mortality. Classic confounding.",
              question: "ã©ã†ã‚„ã£ã¦é€²ã‚ã¾ã™ã‹?",
              branches: [
                { id: 'age_adjust', text: "å¹´é½¢ã‚’èª¿æ•´ã—ã¦å†åˆ†æã—ã¾ã™", nextNode: 'age_adjusted' },
                { id: 'age_stratify', text: "Stratify by age groups", nextNode: 'age_stratified' }
              ]
            },
            publish_crude: {
              id: 'publish_crude',
              type: 'outcome',
              consequence: 'bad',
              title: "ã‚³ãƒ¼ãƒ’ãƒ¼ãƒ‘ãƒ‹ãƒƒã‚¯",
              text: "Your paper is published. Headlines: 'COFFEE INCREASES DEATH RISK BY 15%'. Three months later, another team adjusts for smoking â€” finding coffee is protective. Your paper is criticized as a textbook example of confounding. Your credibility suffers.",
              lesson: "çµæœ: ã™ã¹ã¦ã®è¦³å¯Ÿä¸Šã®é–¢é€£æ€§ã«ã¯å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™äº¤çµ¡è€…ã€‚äº¤çµ¡ã‚’è€ƒæ…®ã›ãšã«ç²—é›‘ãªé–¢é€£æ€§ã‚’ç™ºè¡¨ã™ã‚‹ã“ã¨ã¯ç§‘å­¦ã§ã¯ãªãã€æ¨æ¸¬ã«éãã¾ã›ã‚“ã€‚ HRT ã®è©±ã¯ã“ã‚Œã‚’ç§ãŸã¡ã«æ•™ãˆã¦ãã‚ŒãŸã¯ãšã§ã™ã€‚"
            },
            protective_finding: {
              id: 'protective_finding',
              type: 'outcome',
              consequence: 'neutral',
              title: "Partial Credit",
              text: "Adjusting for smoking reveals coffee's apparent protective effect. But other confounders remain: socioeconomic status, diet, exercise. The non-smokers who drink coffee may still differ from non-smokers who don't.",
              lesson: "THE GRADUAL REVEAL: Adjusting for one confounder is better than none, but rarely sufficient. Multiple confounders usually exist. Each adjustment can reveal new associations â€” or new biases."
            },
            multivariate: {
              id: 'multivariate',
              situation: "You build a multivariate model adjusting for: smoking, age, BMI, alcohol, income, education, exercise. Adjusted RR: 0.88 (0.82-0.95). Coffee appears protective after accounting for measured confounders.",
              question: "Can you now conclude coffee prevents death?",
              branches: [
                { id: 'conclude_protective', text: "ã¯ã„ â€” èª¿æ•´ã•ã‚ŒãŸåˆ†æã¯å› æœé–¢ä¿‚ã§ã™", nextNode: 'overclaiming' },
                { id: 'residual_confounding', text: "No â€” unmeasured confounders may remain", nextNode: 'wise_conclusion' }
              ]
            },
            effect_mod_insight: {
              id: 'effect_mod_insight',
              type: 'outcome',
              consequence: 'good',
              title: "Sharp Thinking",
              text: "åŠ¹æœãŒå–«ç…™çŠ¶æ…‹ã«ã‚ˆã£ã¦ç•°ãªã‚‹ã“ã¨ã«æ°—ã¥ãã¾ã—ãŸã­ (å–«ç…™è€…ã«ã¯æœ‰å®³ã€éå–«ç…™è€…ã«ã¯ä¿è­·çš„)ã€‚ã“ã‚Œã¯åŠ¹æœã®ä¿®æ­£ã§ã™ã€‚ã‚³ãƒ¼ãƒ’ãƒ¼ã®åŠ¹æœã¯ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ—ã«ã‚ˆã£ã¦ã¾ã£ãŸãç•°ãªã‚Šã¾ã™ã€‚å˜ä¸€ã®å¹³å‡åŠ¹æœã‚’å ±å‘Šã™ã‚‹ã“ã¨ã¯èª¤è§£ã‚’æ‹›ãå¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "THE PROTECTION: Confounding distorts the overall effect. Effect modification means the effect truly varies. In your paper, report stratum-specific effects: 'Coffee was associated with lower mortality in non-smokers (RR 0.92) but higher mortality in smokers (RR 1.35).'"
            },
            age_adjusted: {
              id: 'age_adjusted',
              situation: "å¹´é½¢èª¿æ•´å¾Œ: RR 1.02 (0.95-1.10)ã€‚å”ä¼šãŒæ¶ˆæ»…ã—ãŸï¼å¹´é½¢ã¯å¼·åŠ›ãªäº¤çµ¡å› å­ã§ã—ãŸã€‚ã—ã‹ã—ã€å¾…ã£ã¦ãã ã•ã„ â€” å–«ç…™ã«ã¤ã„ã¦ã‚‚èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: One confounder down, potentially many to go. Age adjustment removed most of the crude association. But comprehensive analysis requires considering ALL major confounders. The job isn't done."
            },
            age_stratified: {
              id: 'age_stratified',
              situation: "Age-stratified results: <50 years: RR 0.95. 50-65 years: RR 1.01. >65 years: RR 0.98. No age group shows significant association. The crude RR 1.15 was entirely due to age confounding.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE REVELATION: Stratification lets you SEE the confounding. In every age stratum, coffee shows no association with mortality. The crude association was an artifact of age differences between coffee drinkers and non-drinkers."
            },
            overclaiming: {
              id: 'overclaiming',
              type: 'outcome',
              consequence: 'bad',
              title: "è‡ªä¿¡éå‰°ãªçµè«–",
              text: "You conclude 'coffee prevents death.' But unmeasured confounders remain: genetics, personality type, sleep quality, stress levels. The HRT studies also 'adjusted for everything' â€” and were still wrong. Observational data, no matter how adjusted, cannot prove causation.",
              lesson: "è­¦å‘Š: èª¿æ•´ã«ã‚ˆã‚Šäº¤çµ¡ã¯è»½æ¸›ã•ã‚Œã¾ã™ãŒã€æ’é™¤ã•ã‚Œã‚‹ã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚æ¸¬å®šã•ã‚Œã¦ã„ãªã„äº¤çµ¡å› å­ãŒå¸¸ã«å­˜åœ¨ã—ã¾ã™ã€‚ ã€ŒåŸå› ã€ã§ã¯ãªãã€Œé–¢é€£ã™ã‚‹ã€ã¨è¨€ã„ã¾ã—ã‚‡ã†ã€‚ ã€Œè¨¼æ˜ã€ã§ã¯ãªãã€Œç¤ºå”†ã€ã¨è¨€ã†ã€‚è¬™è™šã•ã¯å¼±ã•ã§ã¯ãªãã€æ­£ç›´ã•ã§ã™ã€‚"
            },
            wise_conclusion: {
              id: 'wise_conclusion',
              type: 'outcome',
              consequence: 'good',
              title: "æ­£ç›´ãªçµè«–",
              text: "Your paper states: 'After adjustment for measured confounders, coffee consumption was associated with lower mortality (RR 0.88, 0.82-0.95). However, residual confounding cannot be excluded. These findings are hypothesis-generating and require confirmation in randomized trials.'",
              lesson: "THE PROTECTION: This is honest science. You report the finding, acknowledge limitations, and don't overclaim. If coffee truly is protective, future studies will confirm it. If it's residual confounding, you haven't misled anyone."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "çœ‹è­·å¸«ã®å¥åº·èª¿æŸ»ã§ã¯ã€HRT ãƒ¦ãƒ¼ã‚¶ãƒ¼ã® CHD ãƒªã‚¹ã‚¯ãŒ 44% ä½ã„ã“ã¨ãŒã‚ã‹ã‚Šã¾ã—ãŸ (RR 0.56)ã€‚ WHI RCT ã§ã¯ã€HRT ãŒ CHD ãƒªã‚¹ã‚¯ã‚’ 29% å¢—åŠ ã•ã›ã‚‹ã“ã¨ãŒã‚ã‹ã‚Šã¾ã—ãŸ (HR 1.29)ã€‚ã“ã®çŸ›ç›¾ã‚’æœ€ã‚‚ã‚ˆãèª¬æ˜ã—ã¦ã„ã‚‹ã‚‚ã®ã¯ä½•ã§ã™ã‹?",
          options: [
            { id: 'a', text: "RCT ã¯ç•°ãªã‚‹ HRT å®šå¼åŒ–ã‚’ä½¿ç”¨ã—ãŸãŸã‚é–“é•ã£ã¦ã„ã¾ã—ãŸ", correct: false },
            { id: 'b', text: "è¦³å¯Ÿç ”ç©¶ã«ãŠã‘ã‚‹å¥åº·ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã®ç‰¹æ€§ã«ã‚ˆã‚‹æ··ä¹±", correct: true },
            { id: 'c', text: "è¦³å¯Ÿç ”ç©¶ã®æ–¹ãŒçµ±è¨ˆçš„æ¤œå‡ºåŠ›ãŒé«˜ã‹ã£ãŸ", correct: false },
            { id: 'd', text: "Effect modification by age of participants", correct: false }
          ],
          explanation: "Healthy user bias (confounding): Women who chose HRT were systematically healthier, more educated, and had better healthcare access. These factors independently reduce CHD risk. When an RCT randomized women regardless of these characteristics, the 'benefit' disappeared and harm emerged. This is the canonical example of confounding in epidemiology."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE REVERSAL: BETA-CAROTENE â€” WHEN MECHANISM MET REALITY",
          source: "NEJM 1994 ATBC | NEJM 1996 CARET | Observational promise, RCT destruction",
          timeline: [
            { year: "1980s", text: "è¦³å¯Ÿç ”ç©¶ã§ã¯ã€ä¸€è²«ã—ã¦äººã€…ã®çµ±è¨ˆçš„æ¤œå‡ºåŠ›ãŒé«˜ã„ã“ã¨ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚ãƒ™ãƒ¼ã‚¿ã‚«ãƒ­ãƒ†ãƒ³ãƒ¬ãƒ™ãƒ«ã¯ç™Œç™ºç”Ÿç‡ã‚’ä½ãã—ã¾ã™ã€‚æŠ—é…¸åŒ–ä»®èª¬: ãƒ™ãƒ¼ã‚¿ã‚«ãƒ­ãƒ†ãƒ³ã¯ã€ãŒã‚“ã®åŸå› ã¨ãªã‚‹ãƒ•ãƒªãƒ¼ãƒ©ã‚¸ã‚«ãƒ«ã‚’ä¸­å’Œã—ã¾ã™ã€‚", type: "normal" },
            { year: "Mechanism", text: "Compelling biology: oxidative stress â†’ DNA damage â†’ cancer. Antioxidants should prevent this. Prospective cohorts show 30-40% lower lung cancer in high beta-carotene consumers.", type: "normal" },
            { year: "1994 ATBC", text: "Finnish RCT of beta-carotene in smokers: INCREASED lung cancer by 18% (RR 1.18, 95% CI 1.03-1.36). 8% higher total mortality. Trial stopped for harm.", type: "crisis" },
            { year: "1996 CARET", text: "US RCT stopped 21 months early: 28% INCREASE in lung cancer (RR 1.28, 95% CI 1.04-1.57). 17% higher death rate. Two RCTs showed same harm.", type: "crisis" },
            { year: "The Explanation", text: "Confounding: People who eat vegetables are healthier overall. Beta-carotene was a MARKER of healthy diet, not the CAUSE of protection. Supplementing the chemical didn't help â€” it may have hurt.", type: "revelation" },
            { year: "Lesson", text: "ç”Ÿç‰©å­¦çš„ãªå¦¥å½“æ€§ã¯è¨¼æ‹ ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã‚’è¡Œã‚ãªã„ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã¯ã‚¹ãƒˆãƒ¼ãƒªãƒ¼ãƒ†ãƒªãƒ³ã‚°ã§ã™ã€‚ä½“ã¯è¤‡é›‘ã§ã™ã€‚å˜ç‹¬ã®ã‚µãƒ—ãƒªãƒ¡ãƒ³ãƒˆã§ã¯è‡ªç„¶é£Ÿå“ã®åˆ©ç‚¹ãŒå†ç¾ã•ã‚Œã¾ã›ã‚“ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Lung cancer incidence",
            drug: "Beta-carotene supplements",
            placebo: "Placebo",
            rr: "Observational: RR ~0.70 | RCT ATBC: RR 1.18 | RCT CARET: RR 1.28",
            ci: "Observational WRONG direction",
            nnh: "Supplements INCREASED cancer, opposite of observational prediction"
          },
          hook: "THE HOOK: Beta-carotene was the 'perfect' hypothesis â€” strong observational association, compelling mechanism, clear dose-response. And it was COMPLETELY WRONG. This is why we need RCTs, and why observational data showing protective effects of interventions must be treated with deep skepticism."
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: Every observational finding of benefit should be treated as provisional until an RCT confirms it. HRT, beta-carotene, vitamin E, hormone replacement â€” all showed 'benefit' observationally, all showed harm or null in RCTs. The pattern is clear: CONFOUNDING MAKES THINGS LOOK HELPFUL THAT AREN'T."
        }
      }
    ]
  },
  {
    id: 2,
    title: "The Designs",
    subtitle: "Study Architecture",
    principle: 1,
    story: "Framingham",
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Time flows one direction"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE FOUNDATION: FRAMINGHAM â€” 75 YEARS OF WATCHING",
          source: "Framingham Heart Study | Est. 1948 | 15,000+ participants across 3 generations",
          timeline: [
            { year: "1948", text: "NIH recruits 5,209 residents of Framingham, Massachusetts. Goal: understand cardiovascular disease. No one knows what 'risk factors' are yet.", type: "normal" },
            { year: "1960s", text: "First major findings: smoking, high cholesterol, high blood pressure linked to heart disease. The term 'risk factor' is coined.", type: "revelation" },
            { year: "1971", text: "Offspring Study begins: 5,124 children of original participants enrolled. Multigenerational follow-up starts.", type: "normal" },
            { year: "1988", text: "Landmark finding: HDL cholesterol is protective. Distinguishing 'good' from 'bad' cholesterol transforms cardiology.", type: "revelation" },
            { year: "2002", text: "Third Generation Study enrolls grandchildren. 75 years of continuous observation.", type: "normal" },
            { year: "Legacy", text: "3,000ä»¥ä¸Šã®è«–æ–‡ãŒå‡ºç‰ˆã•ã‚Œã¦ã„ã¾ã™ã€‚ä¸–ç•Œä¸­ã§ä½¿ç”¨ã•ã‚Œã¦ã„ã‚‹ãƒªã‚¹ã‚¯äºˆæ¸¬ãƒ¢ãƒ‡ãƒ«ã€‚ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ãŒåŒ»å­¦ã‚’å¤‰ãˆã‚‹ã“ã¨ãŒã§ãã‚‹ã¨ã„ã†è¨¼æ‹ ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Cardiovascular disease incidence and mortality",
            drug: "Prospective cohort design",
            placebo: "75+ years of follow-up",
            rr: "Identified smoking, cholesterol, BP, diabetes as risk factors",
            ci: "Risk prediction equations used globally",
            nnh: "Transformed preventive cardiology"
          },
          hook: "THE HOOK: Framingham didn't randomize anyone. It just watched â€” carefully, systematically, for 75 years. It discovered that smoking causes heart disease, that cholesterol matters, that prevention is possible. Sometimes the most powerful studies are the most patient."
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'â¤ï¸',
          title: "The Framingham Heart Study's 70-Year Legacy",
          source: "ãƒ•ãƒ©ãƒŸãƒ³ã‚¬ãƒ å¿ƒè‡“ç ”ç©¶ | NIH å›½ç«‹å¿ƒè‚ºè¡€æ¶²ç ”ç©¶æ‰€ | 1948-ç¾åœ¨",
          paragraphs: [
            "1948 å¹´ã€ãƒã‚µãƒãƒ¥ãƒ¼ã‚»ãƒƒãƒ„å·ãƒ•ãƒ¬ãƒ¼ãƒŸãƒ³ã‚°ãƒãƒ ã®ä½æ°‘ 5,209 äººãŒæ˜ç¢ºãªä»®èª¬ã®ãªã„ç ”ç©¶ã«ç™»éŒ²ã—ã¾ã—ãŸã€‚ç ”ç©¶è€…ãŸã¡ã¯è‡ªåˆ†ãŸã¡ãŒä½•ã‚’æ¢ã—ã¦ã„ã‚‹ã®ã‹åˆ†ã‹ã£ã¦ã„ã¾ã›ã‚“ã§ã—ãŸã€‚ãŸã ã€ã‚¢ãƒ¡ãƒªã‚«äººãŒå¿ƒè‡“ç—…ã§å‘½ã‚’è½ã¨ã—ã¦ã„ã‚‹ã¨ã„ã†ã“ã¨ã ã‘ã¯åˆ†ã‹ã£ã¦ã„ã¾ã—ãŸãŒã€ãã®ç†ç”±ã¯èª°ã‚‚ç†è§£ã—ã¦ã„ã¾ã›ã‚“ã§ã—ãŸã€‚",
            "75 å¹´å¾Œã€3 ä¸–ä»£ã«ã‚ãŸã‚‹ãƒ•ãƒ¬ãƒ¼ãƒŸãƒ³ã‚°ãƒãƒ¼ãƒãƒ¼ã¯ã€å¿ƒè‡“è¡€ç®¡ã®ãƒªã‚¹ã‚¯ã«ã¤ã„ã¦ç§ãŸã¡ãŒçŸ¥ã£ã¦ã„ã‚‹ã“ã¨ã®ã»ã¨ã‚“ã©ã‚’ç§ãŸã¡ã«æ•™ãˆã¦ãã‚Œã¾ã—ãŸã€‚ LDLã‚³ãƒ¬ã‚¹ãƒ†ãƒ­ãƒ¼ãƒ«ã€‚å–«ç…™ã€‚é«˜è¡€åœ§ã€‚ç³–å°¿ç—…ã€‚è‚¥æº€ã€‚ãƒ•ãƒ©ãƒŸãƒ³ã‚¬ãƒ  ãƒªã‚¹ã‚¯ ã‚¹ã‚³ã‚¢ã€‚ ã€Œå±é™ºå› å­ã€ã¨ã„ã†æ¦‚å¿µè‡ªä½“ãŒã“ã“ã§ç™ºæ˜ã•ã‚Œã¾ã—ãŸã€‚",
            "èª°ã‚‚ç„¡ä½œç‚ºã«é¸ã°ã‚Œã¾ã›ã‚“ã§ã—ãŸã€‚ä»‹å…¥ã¯ãƒ†ã‚¹ãƒˆã•ã‚Œã¾ã›ã‚“ã§ã—ãŸã€‚ç ”ç©¶è€…ãŸã¡ã¯ã€ã§ãã‚‹ã“ã¨ã¯ã™ã¹ã¦æ¸¬å®šã—ã€ãã®å¾Œä½•åå¹´ã‚‚å¾…ã¡ã€è¦³å¯Ÿã—ã¦ã„ã¾ã—ãŸã€‚ç¾ä»£ã®å¿ƒè¡€ç®¡ç–«å­¦ã‚’ç™ºæ˜ã—ãŸç ”ç©¶ã¯ã€å¿è€å¼·ãç´°å¿ƒã®æ³¨æ„ã‚’æ‰•ã£ã¦è¦³å¯Ÿã™ã‚‹ã“ã¨ã«ã‚ˆã£ã¦ãã‚Œã‚’è¡Œã„ã¾ã—ãŸã€‚"
          ],
          lesson: "ã„ãã¤ã‹ã®è³ªå•ã¯ã€éå¸¸ã«é•·æœŸé–“ã«ã‚ãŸã£ã¦æ³¨æ„æ·±ãè¦³å¯Ÿã™ã‚‹ã“ã¨ã«ã‚ˆã£ã¦ã®ã¿ç­”ãˆã‚‹ã“ã¨ãŒã§ãã¾ã™ã€‚ãƒ•ãƒ©ãƒŸãƒ³ã‚¬ãƒ ã¯ã€ååˆ†ãªæ™‚é–“ã‚’ã‹ã‘ã¦å³å¯†ã«å®Ÿæ–½ã•ã‚ŒãŸè¦³å¯Ÿã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã¯ã€ç„¡ä½œç‚ºåŒ–ã‚’è¡Œã‚ãªãã¦ã‚‚åŒ»ç™‚ã‚’å¤‰é©ã§ãã‚‹ã“ã¨ã‚’è¨¼æ˜ã—ã¾ã—ãŸã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "The Three Major Observational Designs",
          sections: [
            {
              heading: "1ã€‚ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ â€” ãƒ•ã‚©ãƒ­ãƒ¼ãƒ•ã‚©ãƒ¯ãƒ¼ãƒ‰",
              items: [
                "çµæœãŒå¾—ã‚‰ã‚Œãªã‹ã£ãŸäººã€…ã‹ã‚‰é–‹å§‹",
                "Measure exposures at baseline",
                "Follow over time, count who develops outcome",
                "Calculate INCIDENCE rates and RISK ratios",
                "Strength: Temporal sequence clear (exposure before outcome)",
                "Weakness: Expensive, time-consuming, rare outcomes difficult"
              ]
            },
            {
              heading: "2ã€‚ã‚±ãƒ¼ã‚¹ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã®ç ”ç©¶ â€” éå»ã‚’æŒ¯ã‚Šè¿”ã‚‹",
              items: [
                "çµæœ (ã‚±ãƒ¼ã‚¹) ã‚’é”æˆã—ãŸäººã‹ã‚‰å§‹ã‚ã¾ã™",
                "Match to people WITHOUT the outcome (controls)",
                "Look backward: what exposures did they have?",
                "Calculate ODDS ratios (cannot calculate RR directly)",
                "Strength: Efficient for rare outcomes",
                "Weakness: Recall bias, selection bias in choosing controls"
              ]
            },
            {
              heading: "3ã€‚æ¨ªæ–­çš„ç ”ç©¶ â€” ã‚¹ãƒŠãƒƒãƒ—ã‚·ãƒ§ãƒƒãƒˆ",
              items: [
                "Measure exposure and outcome at SAME TIME",
                "Cannot determine temporal sequence",
                "Calculate PREVALENCE ratios or odds ratios",
                "Strength: Quick, cheap, good for prevalence estimation",
                "Weakness: Cannot establish causation (chicken vs egg)"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: ãƒ‡ã‚¶ã‚¤ãƒ³ã®é¸æŠ",
          title: "ãƒ‡ã‚¶ã‚¤ãƒ³ã¨è³ªå•ã®ãƒãƒƒãƒãƒ³ã‚°",
          sections: [
            {
              heading: "Use COHORT When:",
              text: "â€¢ Exposure is common, outcome is common\nâ€¢ You can wait for outcomes to occur\nâ€¢ You want to calculate incidence/risk\nâ€¢ You need clear temporal sequence\nâ€¢ Example: Framingham (CVD risk factors)"
            },
            {
              heading: "Use CASE-CONTROL When:",
              text: "â€¢ çµæœã¯ã¾ã‚Œã§ã™ â€¢ ã™ãã«ç­”ãˆãŒå¿…è¦ã§ã™ â€¢ ãƒªã‚½ãƒ¼ã‚¹ã¯é™ã‚‰ã‚Œã¦ã„ã¾ã™ â€¢ ä¾‹: ã‚µãƒªãƒ‰ãƒã‚¤ãƒ‰ (ã¾ã‚Œãªå‡ºç”Ÿ)æ¬ é™¥)"
            },
            {
              heading: "Use CROSS-SECTIONAL When:",
              text: "â€¢ You need prevalence, not incidence\nâ€¢ Resources are very limited\nâ€¢ Temporal sequence doesn't matter\nâ€¢ Example: Disease burden surveys"
            },
            {
              heading: "The Nested Designs:",
              text: "â€¢ ãƒã‚¹ãƒˆã•ã‚ŒãŸã‚±ãƒ¼ã‚¹ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«: ã‚³ãƒ›ãƒ¼ãƒˆå†…ã®ã‚±ãƒ¼ã‚¹ã¨ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ« â€¢ ã‚±ãƒ¼ã‚¹ã‚³ãƒ›ãƒ¼ãƒˆ: ãƒ©ãƒ³ãƒ€ãƒ ãªã‚µãƒ–ã‚³ãƒ›ãƒ¼ãƒˆ + ã™ã¹ã¦ã®ã‚±ãƒ¼ã‚¹ â€¢ ã“ã‚Œã‚‰ã¯ã€ã‚±ãƒ¼ã‚¹ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã®åŠ¹ç‡æ€§ã¨ã‚³ãƒ›ãƒ¼ãƒˆã®æœ‰åŠ¹æ€§ã‚’çµ„ã¿åˆã‚ã›ã¾ã™"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Why Temporal Sequence Matters",
          sections: [
            {
              heading: "The Reverse Causation Trap:",
              items: [
                "Cross-sectional: Low BMI associated with cancer",
                "Interpretation A: Being thin causes cancer",
                "Interpretation B: Cancer causes weight loss (the truth)",
                "ä¸€æ™‚çš„ãªãƒ‡ãƒ¼ã‚¿ãŒãªã‘ã‚Œã°ã€ã©ã¡ã‚‰ãŒæœ€åˆã«ç™ºç”Ÿã—ãŸã‹ã‚ã‹ã‚Šã¾ã›ã‚“"
              ]
            },
            {
              heading: "Cohort Advantage:",
              items: [
                "Measure BMI in healthy people",
                "10 åˆ†é–“ãƒ•ã‚©ãƒ­ãƒ¼å¹´",
                "See who develops cancer",
                "Now temporal sequence is clear: BMI preceded cancer",
                "But still can't prove causation (confounding possible)"
              ]
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "åšå£«ã€‚ãƒã‚¯ãƒ–ãƒ©ã‚¤ãƒ‰ã•ã‚“ã¯ã€æ‰‹è¶³ã«æ¬ é™¥ã®ã‚ã‚‹èµ¤ã¡ã‚ƒã‚“ã®æ¯è¦ªãŒã‚µãƒªãƒ‰ãƒã‚¤ãƒ‰ã‚’æœç”¨ã—ã¦ã„ã‚‹ã“ã¨ã«æ°—ã¥ãã¾ã—ãŸã€‚å½¼ã¯å½¼ã‚‰ã‚’å¥åº·ãªèµ¤ã¡ã‚ƒã‚“ã®æ¯è¦ªã¨æ¯”è¼ƒã—ã¾ã—ãŸã€‚å½¼ã¯æš—é»™ã®ã†ã¡ã«ã©ã®ã‚ˆã†ãªç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã‚’ä½¿ç”¨ã—ã¾ã—ãŸã‹?",
          options: [
            { id: 'a', text: "Cohort study â€” following pregnant women forward", correct: false },
            { id: 'b', text: "ç—‡ä¾‹å¯¾ç…§ç ”ç©¶ â€” ç½¹æ‚£ã—ãŸä¹³å… (ç—‡ä¾‹) ã‹ã‚‰é–‹å§‹", correct: true },
            { id: 'c', text: "æ¨ªæ–­ç ”ç©¶ â€” æ›éœ²ã¨çµæœã‚’åŒæ™‚ã«æ¸¬å®š", correct: false },
            { id: 'd', text: "Randomized trial â€” assigning thalidomide exposure", correct: false }
          ],
          explanation: "McBride started with the outcome (babies with phocomelia = cases), compared to babies without defects (controls), and looked backward at maternal exposures. This is the essence of case-control design â€” efficient for rare outcomes, which is why it detected thalidomide so quickly."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "é…å»¶ã—ãŸææ€–: DES â€” å¨˜ãŸã¡ãŒæ¯è¦ªã®è²»ç”¨ã‚’æ”¯æ‰•ã£ãŸã¨ãåŒ»å­¦",
          source: "NEJM 1971; Herbst et al | Cancer 1977 | Delayed harm 20+ years",
          timeline: [
            { year: "1940s-70s", text: "æµç”£ã‚’é˜²ããŸã‚ã«æ•°ç™¾ä¸‡äººã®å¦Šå©¦ã«æŠ•ä¸ã•ã‚Œã‚‹ã‚¸ã‚¨ãƒãƒ«ã‚¹ãƒãƒ«ãƒ™ã‚¹ãƒˆãƒ­ãƒ¼ãƒ« (DES)ã€‚è¦³å¯Ÿä¸Šã®ã€Œè¨¼æ‹ ã€ã¨ç”Ÿç‰©å­¦çš„å¦¥å½“æ€§ã«åŸºã¥ã„ã¦ã„ã¾ã™ã€‚", type: "normal" },
            { year: "1953", text: "RCT shows DES doesn't prevent miscarriage. Drug continues to be prescribed anyway â€” 'it might help, can't hurt.'", type: "crisis" },
            { year: "1971", text: "Herbst notices cluster of vaginal clear cell adenocarcinoma in young women. EXTREMELY RARE cancer. Case-control study: 7/8 cases had DES-exposed mothers.", type: "revelation" },
            { year: "The Horror", text: "è¢«å®³ã¯æš´éœ²å¾Œ 15 ï½ 25 å¹´å¾Œã«ç™ºç”Ÿã—ã¾ã—ãŸã€‚æ¯è¦ªã§ã¯ãªãå¨˜ãŸã¡ãŒç™Œã‚’ç™ºç—‡ã—ãŸã€‚ã©ã® RCT ã‚‚ã“ã‚Œã‚’æ¤œå‡ºã§ãã¾ã›ã‚“ã§ã—ãŸã€‚", type: "crisis" },
            { year: "Observational Power", text: "Only case-control design could link rare cancer to decades-old exposure. Cohort would have taken 30 years. RCT would have ended long before cancers appeared.", type: "revelation" },
            { year: "Lesson", text: "ä¸€éƒ¨ã®è¢«å®³ã¯æ•°åå¹´é…ã‚Œã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ä¸€éƒ¨ã¯æ¬¡ä¸–ä»£ã«å½±éŸ¿ã‚’ä¸ãˆã¾ã™ã€‚è¦³å¯Ÿç–«å­¦ã ã‘ãŒãã‚Œã‚‰ã‚’æ¤œå‡ºã§ãã¾ã™ã€‚ã“ã‚ŒãŒã€ãƒ•ã‚¡ãƒ¼ãƒã‚³ãƒ“ã‚¸ãƒ©ãƒ³ã‚¹ãŒå­˜åœ¨ã™ã‚‹ç†ç”±ã§ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Clear cell adenocarcinoma of vagina/cervix",
            drug: "DES exposure in utero",
            placebo: "No DES exposure",
            rr: "OR = 40+ (case-control)",
            ci: "Extremely rare cancer in young women",
            nnh: "~1 in 1000 exposed daughters developed cancer"
          },
          hook: "ã‚¶ãƒ»ãƒ•ãƒƒã‚¯: DES ã¯ã€å®³ãŒä¸–ä»£ã‚’é£›ã³è¶Šã—ã¦æ•°åå¹´å¾Œã«ç¾ã‚Œã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã“ã¨ã‚’è¨¼æ˜ã—ã¦ã„ã¾ã™ã€‚ä¸–ä»£ã‚’è¶…ãˆã¦ 25 å¹´é–“ã®çµæœã‚’è¿½è·¡ã§ãã‚‹ RCT ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã®ãƒªãƒ³ã‚¯ã‚’æ¤œå‡ºã™ã‚‹ã«ã¯ã€ã‚±ãƒ¼ã‚¹ ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«è¨­è¨ˆãŒå”¯ä¸€ã®æ–¹æ³•ã§ã—ãŸã€‚è¦³å¯Ÿã¯å½¹ç«‹ã¤ã ã‘ã§ãªãã€å”¯ä¸€ã®é¸æŠè‚¢ã§ã—ãŸã€‚"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'study-design-choice',
          title: "é©åˆ‡ãªç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã‚’é¸æŠ",
          situation: "ã‚ãªãŸã¯ç–«å­¦è€…ã§ã€ã•ã¾ã–ã¾ãªç ”ç©¶èª²é¡Œã«ç›´é¢ã—ã¦ã„ã¾ã™ã€‚ãã‚Œãã‚Œã«ã¤ã„ã¦ã€æœ€ã‚‚é©åˆ‡ãªè¦³å¯Ÿè¨ˆç”»ã‚’é¸æŠã—ã¦ãã ã•ã„ã€‚",
          nodes: {
            start: {
              question: "QUESTION 1: A rare childhood leukemia (1 in 100,000) may be linked to living near power lines. Resources are limited. Which design?",
              branches: [
                { text: "Cohort study â€” follow children near power lines", nextNode: "cohort_leukemia_wrong" },
                { text: "ç—‡ä¾‹å¯¾ç…§ç ”ç©¶ - ç™½è¡€ç—…ã®ç—‡ä¾‹ã‹ã‚‰é–‹å§‹ã—ã€å±…ä½åœ°ã‚’ç¢ºèª", nextNode: "casecontrol_leukemia_correct" },
                { text: "Cross-sectional â€” survey current residence and disease", nextNode: "cross_leukemia_wrong" }
              ]
            },
            cohort_leukemia_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã¾ã‚Œãªçµæœã«ã¯éç¾å®Ÿçš„!",
              text: "100,000 åˆ†ã® 1 ã®å‰²åˆã§ã¯ã€ã‚ãšã‹ 10 ä»¶ã®ç—‡ä¾‹ã‚’æœŸå¾…ã™ã‚‹ã«ã¯ 100 ä¸‡äººã®å­ä¾›ã‚’è¿½è·¡ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã¯ã€ã¾ã‚Œãªçµæœã«å¯¾ã—ã¦ã¯ã²ã©ã„ã‚‚ã®ã§ã™ã€‚ã“ã‚Œã«ã¯æ•°åå¹´ã¨è†¨å¤§ãªãƒªã‚½ãƒ¼ã‚¹ãŒå¿…è¦ã¨ãªã‚Šã¾ã™ã€‚",
              lesson: "ã¾ã‚Œãªçµæœ â†’ ã‚±ãƒ¼ã‚¹ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã€‚æ—¢å­˜ã®ã‚±ãƒ¼ã‚¹ã‹ã‚‰å§‹ã‚ã‚‹ã¨åŠ¹ç‡çš„ã§ã™ã€‚"
            },
            cross_leukemia_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ç™ºç”Ÿç‡ã«é–¢ã™ã‚‹è³ªå•ã¯é–“é•ã£ã¦ã„ã¾ã™!",
              text: "æ–­é¢ã¯ã€ç™ºç”Ÿç‡ (èª°ãŒç—…æ°—ã‚’ç™ºç—‡ã—ã¦ã„ã‚‹ã‹) ã§ã¯ãªãã€æœ‰ç—…ç‡ (èª°ãŒç¾åœ¨ç—…æ°—ã«ã‹ã‹ã£ã¦ã„ã‚‹ã‹) ã‚’æ¸¬å®šã—ã¾ã™ã€‚ãŒã‚“ã®å ´åˆã¯ã€æ–°ãŸãªç—‡ä¾‹ã«ã¤ã„ã¦çŸ¥ã‚ŠãŸã„ã¨è€ƒãˆã¾ã™ã€‚æ–­é¢å›³ã§ã‚‚ä¸€æ™‚æ€§ã‚’ç¢ºç«‹ã§ãã¾ã›ã‚“ã€‚å½¼ã‚‰ã¯ç™Œã«ãªã‚‹å‰ã«é€é›»ç·šã®è¿‘ãã«ä½ã‚“ã§ã„ã¾ã—ãŸã‹?",
              lesson: "Cross-sectional can't establish temporal sequence. Useless for cancer etiology."
            },
            casecontrol_leukemia_correct: {
              situation: "ç´ æ™´ã‚‰ã—ã„!ã‚±ãƒ¼ã‚¹ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã¯ã€ã¾ã‚Œãªçµæœã«å¯¾ã—ã¦åŠ¹æœçš„ã§ã™ã€‚è³ªå• 2: 30 å¹´é–“ã«ã‚ãŸã‚‹å¿ƒè¡€ç®¡ç–¾æ‚£ã®ã™ã¹ã¦ã®å±é™ºå› å­ã‚’ç‰¹å®šã—ãŸã„ã¨è€ƒãˆã¦ã„ã¾ã™ã€‚ã©ã®è¨­è¨ˆã§ã™ã‹?",
              question: "Choose:",
              branches: [
                { text: "ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ - ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ã§ã™ã¹ã¦ã‚’æ¸¬å®šã—ã€CVD ã‚’è¿½è·¡ã—ã¾ã™", nextNode: "cohort_cvd_correct" },
                { text: "ç—‡ä¾‹å¯¾ç…§ç ”ç©¶ - CVD ç—‡ä¾‹ã‚’è¦‹ã¤ã‘ã€éå»ã®æ›éœ²ã«ã¤ã„ã¦å°‹ã­ã¾ã™", nextNode: "casecontrol_cvd_partial" }
              ]
            },
            cohort_cvd_correct: {
              situation: "å®Œç’§ã§ã™!ã“ã‚Œã¯ã¾ã•ã«ãƒ•ãƒ¬ãƒ¼ãƒŸãƒ³ã‚¬ãƒ ãŒã‚„ã£ãŸã“ã¨ã ã€‚è³ªå• 3: æ–°ã—ã„ãƒ¯ã‚¯ãƒãƒ³ãŒå…ˆæœˆå°å…¥ã•ã‚Œã¾ã—ãŸã€‚å ±å‘Šã«ã‚ˆã‚‹ã¨ã€ãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®å¾Œ2é€±é–“ä»¥å†…ã«ã¾ã‚Œã«è‡ªå·±å…ç–«åå¿œã‚’å¼•ãèµ·ã“ã™å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚æœ€é©ãªè¨­è¨ˆ?",
              question: "Choose:",
              branches: [
                { text: "Case-control â€” find autoimmune cases, check vaccination status", nextNode: "casecontrol_vaccine_partial" },
                { text: "Self-controlled case series â€” compare each person's risk during exposed vs unexposed time", nextNode: "sccs_vaccine_correct" }
              ]
            },
            casecontrol_cvd_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possible, but limited",
              text: "ç—‡ä¾‹å¯¾ç…§ã§ã¯ CVD å±é™ºå› å­ã‚’ç ”ç©¶ã§ãã¾ã™ãŒã€ãƒªã‚³ãƒ¼ãƒ«ãƒã‚¤ã‚¢ã‚¹ (ç—‡ä¾‹ã«ã‚ˆã£ã¦æ›éœ²ã®è¨˜æ†¶ãŒç•°ãªã‚‹) ãŒã‚ã‚Šã€ä¸€åº¦ã« 1 ã¤ã®çµæœã—ã‹ç ”ç©¶ã§ãã¾ã›ã‚“ã€‚ã‚³ãƒ›ãƒ¼ãƒˆã‚’ä½¿ç”¨ã™ã‚‹ã¨ã€è¤‡æ•°ã®çµæœã‚’ç ”ç©¶ã—ã€ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ã§æ­£ç¢ºãªæ›éœ²æ¸¬å®šã‚’å–å¾—ã§ãã¾ã™ã€‚",
              lesson: "æ­£ç¢ºãªæ›éœ²æ¸¬å®šã«ã‚ˆã‚‹åŒ…æ‹¬çš„ãªãƒªã‚¹ã‚¯å› å­ã®ç‰¹å®šã«ã¯ã€ã‚³ãƒ›ãƒ¼ãƒˆãŒæ¨å¥¨ã•ã‚Œã¾ã™ã€‚"
            },
            casecontrol_vaccine_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Works, but there's a better option",
              text: "ç—‡ä¾‹ç®¡ç†ã¯æ©Ÿèƒ½ã—ã¾ã™ãŒã€å¥åº·ãªãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®è€…ãƒã‚¤ã‚¢ã‚¹ï¼ˆã‚ˆã‚Šå¥åº·ãªäººãŒãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®ã‚’å—ã‘ã¾ã™ï¼‰ã®å½±éŸ¿ã‚’å—ã‘ã‚„ã™ããªã‚Šã¾ã™ã€‚å®šç¾©ã•ã‚ŒãŸãƒªã‚¹ã‚¯ã‚¦ã‚£ãƒ³ãƒ‰ã‚¦ã‚’æŒã¤ãƒ¯ã‚¯ãƒãƒ³ã«å¯¾ã™ã‚‹æ€¥æ€§åå¿œã®å ´åˆã€è‡ªå·±åˆ¶å¾¡è¨­è¨ˆã¯ã€å€‹äººé–“ã®äº¤çµ¡ã‚’æ’é™¤ã—ã¾ã™ã€‚",
              lesson: "è‡ªå·±åˆ¶å¾¡ãƒ‡ã‚¶ã‚¤ãƒ³ã¯ã€æ˜ç¢ºãªæ™‚é–“ã‚¦ã‚£ãƒ³ãƒ‰ã‚¦ã‚’æŒã¤æ€¥æ€§åå¿œã«å¼·åŠ›ã§ã™ã€‚"
            },
            sccs_vaccine_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent choice!",
              text: "è‡ªå·±åˆ¶å¾¡ã‚±ãƒ¼ã‚¹ã‚·ãƒªãƒ¼ã‚ºã§ã¯ã€ãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®å¾Œ 2 é€±é–“ã®å„äººã®ãƒªã‚¹ã‚¯ã‚’ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³æœŸé–“ã¨æ¯”è¼ƒã—ã¾ã™ã€‚å„äººãŒç‹¬è‡ªã«åˆ¶å¾¡ã§ãã‚‹ãŸã‚ã€ã™ã¹ã¦ã®å€‹äººé–“ã®äº¤çµ¡å› å­ (å¹´é½¢ã€å¥åº·çŠ¶æ…‹ã€éºä¼çš„ç‰¹å¾´) ã¯è‡ªå‹•çš„ã«åˆ¶å¾¡ã•ã‚Œã¾ã™ã€‚",
              lesson: "SCCS ã¯ã€MMR è‡ªé–‰ç—‡ç¥è©±ã®èª¤ã‚Šã‚’æš´ããªã©ã€ãƒ¯ã‚¯ãƒãƒ³ã®å®‰å…¨æ€§ç ”ç©¶ã«ãŠã„ã¦é‡è¦ã§ã—ãŸã€‚ãƒªã‚¹ã‚¯ã‚¦ã‚£ãƒ³ãƒ‰ã‚¦ãŒæ˜ç¢ºã«å®šç¾©ã•ã‚Œã¦ã„ã‚‹å ´åˆã€ã“ã‚Œã¯å¼·åŠ›ã§ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ è­¦å‘Š: å®Œç’§ãªç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã«ã¯æ™‚é–“ã¨ãƒªã‚½ãƒ¼ã‚¹ãŒå¿…è¦ã§ã™ã€‚ç—‡ä¾‹å¯¾ç…§ç ”ç©¶ã§ã¯æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ãŒç™ºç”Ÿã—ã¾ã™ã€‚æ¨ªæ–­æ€§ã¯æ™‚é–“æ€§ã‚’ç¢ºç«‹ã§ããªã„ã€‚è‡ªå·±åˆ¶å¾¡å‹ã®è¨­è¨ˆã§ã¯ã€æ™‚é–“ã¨ã¨ã‚‚ã«å¤‰åŒ–ã™ã‚‹äº¤çµ¡å› å­ã«å¯¾å‡¦ã§ãã¾ã›ã‚“ã€‚çµæœã‚’ä¿¡é ¼ã™ã‚‹å‰ã«ã€è‡ªåˆ†ã®ãƒ‡ã‚¶ã‚¤ãƒ³ã®å¼±ç‚¹ã‚’çŸ¥ã£ã¦ãã ã•ã„ã€‚"
        }
      },
      {
        type: 'principle',
        content: {
          text: "ğŸ¯ PROGRESS CHECK: You've completed the foundations. You understand WHY observational evidence matters (Module 0), HOW confounding deceives (Module 1), and WHICH study designs exist (Module 2). Now we go deeper: DAGs for causal reasoning, specific biases, and the tools to handle them."
        }
      }
    ]
  },
  // MODULE 3: THE CONFOUNDERS (DAGs and Causal Diagrams)
  {
    id: 3,
    title: "The Confounders",
    subtitle: "DAGs & Causal Thinking",
    principle: 5,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "èª¿æ•´ã¯é­”æ³•ã§ã¯ã‚ã‚Šã¾ã›ã‚“"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ãƒ‘ãƒ©ãƒ‰ãƒƒã‚¯ã‚¹: è‚¥æº€ã¨æ­»äº¡ â€” èª¿æ•´ãŒç„¡åŠ¹ã«ãªã£ãŸå ´åˆ",
          source: "JAMA 2005; Flegal et al | Epidemiology wars | Multiple analyses",
          timeline: [
            { year: "2005", text: "CDC èª¿æŸ»: éä½“é‡ (BMI 25-30) ã¯ã€æ¨™æº–ä½“é‡ã‚ˆã‚Šã‚‚æ­»äº¡ç‡ãŒä½ã„ã€‚è¦‹å‡ºã—ã¯ã€Œè„‚è‚ªã¯å¥åº·ã«è‰¯ã„ã€ã¨å®£è¨€ã—ã¦ã„ã¾ã™ã€‚", type: "normal" },
            { year: "2005-10", text: "Scientists divided: Some see 'obesity paradox,' others see confounding and collider bias. Adjustment strategies differ dramatically.", type: "crisis" },
            { year: "Key Issue", text: "å–«ç…™ã«ã¤ã„ã¦èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?å–«ç…™è€…ã¯ç—©ã›ã¦ã„ã¦æ—©ãæ­»äº¡ã—ã¾ã™ã€‚å–«ç…™ã‚’èª¿æ•´ã™ã‚‹ã¨å¤ªã‚Šã™ãã®è¦‹ãŸç›®ãŒæ‚ªåŒ–ã—ã¾ã™ï¼ˆæ­£è§£ï¼‰ã€‚èª¿æ•´ã—ãªã„ã¨ã€ä¿è­·ã—ã¦ã„ã‚‹ã‚ˆã†ã«è¦‹ãˆã¾ã™ (é–“é•ã£ã¦ã„ã¾ã™)ã€‚", type: "revelation" },
            { year: "Another Issue", text: "è‚¥æº€ã«ã‚ˆã£ã¦å¼•ãèµ·ã“ã•ã‚Œã‚‹ç—…æ°—ã‚’èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?ç³–å°¿ç—…ã€å¿ƒè‡“ç—…ã¯ä»²ä»‹è€…ã§ã™ã€‚èª¿æ•´ã«ã‚ˆã‚Šã€æ¨å®šã—ãŸã„å› æœçµŒè·¯ãŒãƒ–ãƒ­ãƒƒã‚¯ã•ã‚Œã¾ã™ã€‚", type: "revelation" },
            { year: "Resolution", text: "ç•°ãªã‚‹ DAG ä»®å®š â†’ ç•°ãªã‚‹èª¿æ•´æˆ¦ç•¥ â†’ ç•°ãªã‚‹çµè«–ã€‚ DAG ã¯ã‚ªãƒ—ã‚·ãƒ§ãƒ³ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚DAG ãŒç­”ãˆã‚’æ±ºå®šã—ã¾ã™ã€‚", type: "revelation" },
            { year: "Lesson", text: "å› æœé–¢ä¿‚ã®ä»®å®šã‚’æ˜ç¤ºçš„ã«å¼•ãå‡ºã™å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ãã†ã—ãªã„ã¨ã€ã‚„ã¿ãã‚‚ã«èª¿æ•´ã™ã‚‹ã“ã¨ã«ãªã‚Šã€(æ˜è¨€ã•ã‚Œã¦ã„ãªã„) ä»®å®šãŒç¤ºã™é€šã‚Šã®ç­”ãˆãŒå¾—ã‚‰ã‚Œã‚‹ã“ã¨ã«ãªã‚Šã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "All-cause mortality",
            drug: "Overweight (BMI 25-30)",
            placebo: "Normal weight (BMI 18.5-25)",
            rr: "HR 0.88 (unadjusted) to 1.20+ (smoking-adjusted)",
            ci: "Conclusion flips based on adjustment",
            nnh: "Public health messaging chaos"
          },
          hook: "THE HOOK: The same data, analyzed by competent scientists, gave opposite answers. Not because anyone cheated â€” but because they had different causal models in their heads. DAGs make those models explicit."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ ä¸»ãªæ´å¯Ÿ: èª¿æ•´ã¯å˜ã«ã€Œå¤‰æ•°ã‚’åˆ¶å¾¡ã™ã‚‹ã€ã“ã¨ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚èª¿æ•´ã™ã‚‹å„å¤‰æ•°ã«ã‚ˆã£ã¦ã€å› æœé–¢ä¿‚ã®ã‚ã‚‹ä¸»å¼µãŒä½œæˆã•ã‚Œã¾ã™ã€‚äº¤çµ¡å› å­ã‚’èª¿æ•´ â†’ ãƒã‚¤ã‚¢ã‚¹ã‚’ãƒ–ãƒ­ãƒƒã‚¯ã—ã¾ã™ã€‚ä»²ä»‹è€…ã«åˆã‚ã›ã¦èª¿æ•´â†’å¿…è¦ãªåŠ¹æœã‚’ãƒ–ãƒ­ãƒƒã‚¯ã—ã¾ã™ã€‚ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ç”¨ã«èª¿æ•´ â†’ ãƒã‚¤ã‚¢ã‚¹ã‚’ä½œæˆã—ã¾ã™ã€‚ DAG ã§ã¯ã€è‡ªåˆ†ã®ä¸»å¼µã‚’æ˜ç¤ºçš„ã«è¿°ã¹ã‚‹ã“ã¨ãŒå¼·åˆ¶ã•ã‚Œã¾ã™ã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is a DAG?",
          sections: [
            {
              heading: "Directed Acyclic Graph",
              items: [
                "DIRECTED: Arrows show causal direction (cause â†’ effect)",
                "éå¾ªç’°: ãƒ«ãƒ¼ãƒ—ãªã— â€” è‡ªåˆ†è‡ªèº«ã®åŸå› ã‚’å¼•ãèµ·ã“ã™ã“ã¨ã¯ã§ãã¾ã›ã‚“",
                "GRAPH: Visual network of variables and relationships",
                "Purpose: Makes causal assumptions EXPLICIT and testable"
              ]
            },
            {
              heading: "Three Types of Variables:",
              items: [
                "CONFOUNDER: æš´éœ²ã¨çµæœã®ä¸€èˆ¬çš„ãªåŸå›  (èª¿æ•´ã—ã¦ãã ã•ã„)",
                "MEDIATOR: æš´éœ²ã‹ã‚‰çµæœã¾ã§ã®å› æœé–¢ä¿‚ã®çµŒè·¯ã«ã¤ã„ã¦ (ç¦æ­¢)èª¿æ•´)",
                "COLLIDER: Common effect of two variables (DON'T adjust â€” creates bias)"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: DAG ã®èª­ã¿å–ã‚Š",
          title: "ãƒãƒƒã‚¯ãƒ‰ã‚¢ ãƒ‘ã‚¹ã¨èª¿æ•´",
          sections: [
            {
              heading: "ã‚¹ãƒ†ãƒƒãƒ— 1: è³ªå•ã‚’ç‰¹å®šã™ã‚‹",
              text: "æš´éœ²ãŒçµæœã«åŠã¼ã™å› æœé–¢ä¿‚ã¯ä½•ã§ã™ã‹?éœ²å‡ºâ†’çµæœã¸ç›´æ¥çŸ¢å°ã‚’æãã¾ã™ã€‚ã“ã‚ŒãŒæ¨å®šã—ãŸã„ã‚‚ã®ã§ã™ã€‚"
            },
            {
              heading: "Step 2: Find Backdoor Paths",
              text: "ãƒãƒƒã‚¯ãƒ‰ã‚¢ ãƒ‘ã‚¹ã¯ã€çµæœã«è‡³ã‚‹ã¾ã§ã®ä»»æ„ã®ãƒ‘ã‚¹ã‚’é€šã£ã¦ã€éœ²å‡ºã‹ã‚‰ (çŸ¢å°ã«é€†ã‚‰ã£ã¦) é€†æ–¹å‘ã«é€²ã¿ã¾ã™ã€‚ä¾‹: éœ²å‡º â† äº¤çµ¡å› å­ â†’ çµæœã€‚ã“ã‚Œã«ã‚ˆã‚Šã€å½ã®é–¢é€£ä»˜ã‘ãŒä½œæˆã•ã‚Œã¾ã™ã€‚"
            },
            {
              heading: "Step 3: Block Backdoor Paths",
              text: "ã™ã¹ã¦ã®ãƒãƒƒã‚¯ãƒ‰ã‚¢ ãƒ‘ã‚¹ã‚’ãƒ–ãƒ­ãƒƒã‚¯ã™ã‚‹å¤‰æ•°ã‚’èª¿æ•´ã—ã¾ã™ã€‚é€šå¸¸ã€ã“ã‚Œã¯äº¤çµ¡å› å­ã‚’èª¿æ•´ã™ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ãŸã ã—ã€ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã«ã¤ã„ã¦ã¯çµ¶å¯¾ã«èª¿æ•´ã—ãªã„ã§ãã ã•ã„ã€‚ã“ã‚Œã«ã‚ˆã‚Šãƒ‘ã‚¹ãŒé–‹ãã¾ã™ã€‚"
            },
            {
              heading: "Step 4: Check for Collider Bias",
              text: "ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã¯å…±é€šã®åŠ¹æœã§ã™: A â†’ ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ â† Bã€‚ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã‚’æ¡ä»¶ä»˜ã‘ã‚‹ã¨ã€å­˜åœ¨ã—ãªã„å ´åˆã§ã‚‚ A ã¨ B ã®é–“ã«é–¢é€£ä»˜ã‘ãŒä½œæˆã•ã‚Œã¾ã™ã€‚å¤å…¸çš„ãªç½ : ç—…é™¢ãƒ™ãƒ¼ã‚¹ã®ç ”ç©¶ã«ãŠã‘ã‚‹ã€Œå…¥é™¢ã€ã®èª¿æ•´"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "The Collider Trap: Berkson's Paradox",
          sections: [
            {
              heading: "The Classic Example:",
              items: [
                "Question: Does diabetes cause respiratory disease?",
                "Hospital-based study: Among hospitalized patients, diabetes is NEGATIVELY associated with respiratory disease",
                "é›†å›£ãƒ™ãƒ¼ã‚¹ã®ç ”ç©¶: é–¢é€£ãªã—",
                "Why? Hospitalization is a COLLIDER â€” both diabetes and respiratory disease cause hospitalization"
              ]
            },
            {
              heading: "The Mechanism:",
              items: [
                "Among hospitalized patients, if someone DOESN'T have diabetes, they must have respiratory disease (otherwise why hospitalized?)",
                "This creates artificial negative association",
                "å…¥é™¢ã®èª¿æ•´ (ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã§ã®æ¡ä»¶ä»˜ã‘) é›†å›£ã«ã¯å­˜åœ¨ã—ãªã‹ã£ãŸèª˜ç™ºãƒã‚¤ã‚¢ã‚¹"
              ]
            },
            {
              heading: "Modern Examples:",
              items: [
                "COVID severity paradox: Smokers seemed protected because hospitalized non-smokers had other severe conditions",
                "Obesity paradox in heart failure: Sicker thin patients, healthier obese patients selected into studies",
                "If it seems paradoxical, look for a collider"
              ]
            }
          ]
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'ğŸ§¬',
          title: "è‹±å›½ãƒã‚¤ã‚ªãƒãƒ³ã‚¯ ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼å•é¡Œ",
          source: "UK Biobank | Nature Communications 2020 | COVID-19 Studies",
          paragraphs: [
            "UK Biobank is a treasureâ€”500,000 participants with genetic and health data. But participants are systematically different from the UK average: healthier, wealthier, and more educated. This is selection into a study.",
            "In 2020, researchers using UK Biobank found something strange: obesity appeared to be PROTECTIVE against COVID-19 death. This contradicted everything known about COVID risk factors. How could obesity protect against a disease where obesity is a major risk factor?",
            "The answer was a collider effect. The same factors that led to UK Biobank participation (health consciousness, education, access) also reduced COVID risk. Among UK Biobank participants, those who were obese but still healthy enough to participate were a selected, healthier group. Selection into the study created a spurious protective association."
          ],
          lesson: "Even the best datasets can produce wrong answers if you don't account for how people got into the study. Selection is a collider. When your study population is selected (and it always is, somehow), ask: could that selection distort the relationship I'm studying?"
        }
      },
      {
        type: 'tool',
        content: {
          type: 'dag-builder',
          title: "DAG ãƒ“ãƒ«ãƒ€ãƒ¼ ãƒ„ãƒ¼ãƒ«",
          description: "Build a causal diagram to identify confounders, mediators, and colliders."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'dag-adjustment',
          title: "èª¿æ•´ã®æ±ºå®š",
          situation: "You're studying whether a new diabetes drug reduces cardiovascular events. You have data on: the drug, CV events, age, prior CV disease, and HbA1c (blood sugar control). HbA1c improves with the drug. What should you adjust for?",
          nodes: {
            start: {
              question: "å¹´é½¢ã¯ã€è–¬å‰¤ã®å‡¦æ–¹ (é«˜é½¢ã®æ‚£è€…ã»ã©å¤šãã®è–¬å‰¤ã‚’æŠ•ä¸ã•ã‚Œã‚‹) ã¨ CV ã‚¤ãƒ™ãƒ³ãƒˆã®ä¸¡æ–¹ã«é–¢é€£ã—ã¦ã„ã¾ã™ã€‚ age ã¯ã©ã®ã‚ˆã†ãªç¨®é¡ã®å¤‰æ•°ã§ã™ã‹?",
              branches: [
                { text: "äº¤çµ¡å› å­ â€” èª¿æ•´ã—ã¦ãã ã•ã„", nextNode: "age_correct" },
                { text: "Mediator â€” don't adjust", nextNode: "age_wrong" },
                { text: "Collider â€” adjusting would create bias", nextNode: "age_wrong" }
              ]
            },
            age_correct: {
              situation: "æ­£è§£ã§ã™ã€‚å¹´é½¢ã¯äº¤çµ¡å› å­ï¼ˆä¸€èˆ¬çš„ãªåŸå› ï¼‰ã§ã™ã€‚ç¾åœ¨: HbA1c (è¡€ç³–å€¤) ã¯è–¬ã«ã‚ˆã£ã¦æ”¹å–„ã•ã‚Œã€CV ã‚¤ãƒ™ãƒ³ãƒˆã«ã‚‚å½±éŸ¿ã—ã¾ã™ã€‚ HbA1c ã¯ã©ã®ã‚ˆã†ãªã‚¿ã‚¤ãƒ—ã®å¤‰æ•°ã§ã™ã‹?",
              question: "HbA1c ã‚’èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?",
              branches: [
                { text: "Yes â€” it's a confounder", nextNode: "hba1c_wrong" },
                { text: "No â€” it's a mediator on the causal pathway", nextNode: "hba1c_correct" },
                { text: "ç ”ç©¶ã®ç–‘å•ã«ã‚ˆã£ã¦ç•°ãªã‚Šã¾ã™", nextNode: "hba1c_nuanced" }
              ]
            },
            age_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã‚ã¾ã‚Šæ­£ã—ãã‚ã‚Šã¾ã›ã‚“",
              text: "å¹´é½¢ã¯äº¤çµ¡å› å­ã§ã™ â€” æ›éœ² (é«˜é½¢ã®æ‚£è€…ã¯è–¬ã‚’æœç”¨ã™ã‚‹å¯èƒ½æ€§ãŒé«˜ããªã‚Šã¾ã™) ã¨çµæœã®ä¸¡æ–¹ã‚’å¼•ãèµ·ã“ã—ã¾ã™ï¼ˆé«˜é½¢ã®æ‚£è€…ã§ã¯ã‚ˆã‚Šå¤šãã®CVã‚¤ãƒ™ãƒ³ãƒˆãŒç™ºç”Ÿã—ã¾ã™ï¼‰ã€‚ã“ã®ãƒãƒƒã‚¯ãƒ‰ã‚¢ ãƒ‘ã‚¹ã‚’ãƒ–ãƒ­ãƒƒã‚¯ã™ã‚‹ã«ã¯ã€çµŒéæ™‚é–“ã‚’èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "äº¤çµ¡å› å­ã¯ä¸€èˆ¬çš„ãªåŸå› ã§ã™ã€‚å¹´é½¢ã¯æ²»ç™‚æ³•ã‚’æ±ºå®šã—ã€CV ã‚¤ãƒ™ãƒ³ãƒˆã‚’å¼•ãèµ·ã“ã—ã¾ã™ã€‚è–¬ç‰©â†’CV ã‚¤ãƒ™ãƒ³ãƒˆã¨ã„ã†å› æœé–¢ä¿‚ã®çµŒè·¯ä¸Šã«ã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            hba1c_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Careful!",
              text: "HbA1c is on the CAUSAL PATHWAY: Drug â†’ HbA1c â†’ CV events. If the drug works by improving blood sugar, adjusting for HbA1c blocks the very effect you're trying to measure!",
              lesson: "ãƒ¡ãƒ‡ã‚£ã‚¨ãƒ¼ã‚¿ãƒ¼ã‚’èª¿æ•´ã—ãªã„ã§ãã ã•ã„ã€‚ãã®çµŒè·¯ã‚’ä»‹ã•ãªã„ã€Œç›´æ¥åŠ¹æœã€ã®ã¿ã‚’æ¨å®šã—ã¾ã™ã€‚è–¬ãŒæœ¬å½“ã«åŠ¹æœãŒã‚ã‚‹å ´åˆã§ã‚‚ã€ã“ã‚Œã¯ã‚¼ãƒ­ã«ãªã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚"
            },
            hba1c_correct: {
              situation: "Excellent! Now the final question: Prior CV disease predicts both drug prescribing (doctors give the drug to high-risk patients) AND CV events. What is it?",
              question: "ä»¥å‰ã®å¿ƒè¡€ç®¡ç–¾æ‚£ã‚’è€ƒæ…®ã—ã¦èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?",
              branches: [
                { text: "Yes â€” it's a confounder (confounding by indication)", nextNode: "final_success" },
                { text: "No â€” it might be a collider", nextNode: "final_partial" }
              ]
            },
            hba1c_nuanced: {
              type: 'outcome',
              outcome: 'partial',
              title: "ãã‚Œã¯æ´—ç·´ã•ã‚ŒãŸç­”ãˆã§ã™",
              text: "ãã‚Œã¯çŠ¶æ³ã«å¿œã˜ã¦æ±ºã¾ã‚‹ã¨ã„ã†ã®ã¯æ­£ã—ã„ã§ã™!è–¬ã®ç·åˆçš„ãªåŠ¹æœã‚’æœ›ã‚€å ´åˆã¯ã€HbA1c ã‚’èª¿æ•´ã—ãªã„ã§ãã ã•ã„ (HbA1c ã¯ãƒ¡ãƒ‡ã‚£ã‚¨ãƒ¼ã‚¿ãƒ¼ã§ã™)ã€‚è–¬ãŒè¡€ç³–ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã‚’è¶…ãˆãŸåŠ¹æœãŒã‚ã‚‹ã‹ã©ã†ã‹çŸ¥ã‚ŠãŸã„å ´åˆã¯ã€èª¿æ•´ã™ã‚‹ã“ã¨ã‚‚ã§ãã¾ã™ãŒã€ãã‚Œã¯åˆ¥ã®è³ªå•ã§ã™ã€‚",
              lesson: "DAG ã¯ã€ç‰¹å®šã®å› æœé–¢ä¿‚ã®è³ªå•ã‚’åæ˜ ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ç•°ãªã‚‹è³ªå• â†’ ç•°ãªã‚‹èª¿æ•´ã‚»ãƒƒãƒˆã€‚"
            },
            final_success: {
              type: 'outcome',
              outcome: 'success',
              title: "Perfect DAG reasoning!",
              text: "You correctly identified: Age = confounder (adjust), HbA1c = mediator (don't adjust), Prior CV disease = confounder by indication (adjust). Your analysis will estimate the causal effect of the drug.",
              lesson: "ã“ã‚Œã¯ã€Œé©å¿œç—‡ã«ã‚ˆã‚‹äº¤çµ¡ã€ã¨å‘¼ã°ã‚Œã€åŒ»è–¬å“ç ”ç©¶ã«ãŠã‘ã‚‹æœ€ã‚‚ä¸€èˆ¬çš„ãªãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚ç—…æ°—ã®æ‚£è€…ãŒæ²»ç™‚ã‚’å—ã‘ã‚‹ãŸã‚ã€æ²»ç™‚ã¯æœ‰å®³ã§ã‚ã‚‹ã‚ˆã†ã«è¦‹ãˆã¾ã™ã€‚ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ã®é‡ç—‡åº¦ã«åˆã‚ã›ã¦èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚"
            },
            final_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Almost!",
              text: "ä»¥å‰ã® CV ç–¾æ‚£ã¯ã“ã“ã§ã¯äº¤çµ¡å› å­ã§ã‚ã‚Šã€æ²»ç™‚ã®æ±ºå®šã¨çµæœã®ä¸¡æ–¹ã‚’å¼•ãèµ·ã“ã—ã¾ã™ã€‚ãã‚Œã«åˆã‚ã›ã¦èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ CV ã‚¤ãƒ™ãƒ³ãƒˆ (çµæœ) ã¯ä»¥å‰ã® CV ç–¾æ‚£ã‚’å¼•ãèµ·ã“ã•ãªã„ (æ™‚é–“çš„ã«ä¸å¯èƒ½) ãŸã‚ã€ã“ã‚Œã¯ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚",
              lesson: "ã‚³ãƒ©ã‚¤ãƒ€ãƒ¼ã«ã¯ã€å¤‰æ•°ã®å†…éƒ¨ã‚’æŒ‡ã™ 2 ã¤ã®çŸ¢å°ãŒå¿…è¦ã§ã™ã€‚ä»¥å‰ã® CV ç–¾æ‚£ã«ã¯ OUT (è–¬å‰¤ã¸ã€çµæœã¸) ã‚’æŒ‡ã™çŸ¢å°ãŒä»˜ã„ã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯äº¤çµ¡å› å­ã§ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "ã‚³ãƒ¼ãƒ’ãƒ¼ã¨è‚ºãŒã‚“ã«é–¢ã™ã‚‹ç ”ç©¶ã§ã¯ã€å–«ç…™ã¯ã‚³ãƒ¼ãƒ’ãƒ¼æ‘‚å–ã¨è‚ºãŒã‚“ã®ä¸¡æ–¹ã«é–¢é€£ã—ã¦ã„ã¾ã™ã€‚å–«ç…™ã‚’èª¿æ•´ã™ã‚‹ã¨ã€ã‚³ãƒ¼ãƒ’ãƒ¼ã¨ç™Œã®é–¢é€£æ€§ã¯æ¶ˆãˆã¾ã™ã€‚ä½•ãŒèµ·ã“ã£ãŸã®ã§ã—ã‚‡ã†ã‹?",
          options: [
            { id: 'a', text: "Smoking was a mediator â€” coffee causes smoking which causes cancer", correct: false },
            { id: 'b', text: "Smoking was a confounder â€” adjusting removed spurious association", correct: true },
            { id: 'c', text: "Smoking was a collider â€” adjusting induced bias", correct: false },
            { id: 'd', text: "Coffee protects against cancer but smoking cancels the benefit", correct: false }
          ],
          explanation: "Smoking is a classic confounder: Coffee â† Smoking â†’ Cancer. Smokers drink more coffee AND get more cancer. The coffee-cancer association was spurious, created by the common cause (smoking). Adjusting for the confounder blocked the backdoor path and revealed no true effect."
        }
      }
    ]
  },
  // MODULE 4: THE BIAS (Selection, Information, Time-Related Biases)
  {
    id: 4,
    title: "The Bias",
    subtitle: "Selection & Information Bias",
    principle: 2,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Time flows one direction"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ä¸æ­»ã®å¹»æƒ³: ã‚¹ã‚¿ãƒãƒ³ã¨æ­»ã®ãªã„æ™‚é–“",
          source: "Am J Epidemiol 2003; Suissa | Drug Safety 2007 | 'Immortal Time Bias'",
          timeline: [
            { year: "2001-04", text: "Multiple observational studies find statins reduce cancer mortality by 30-50%. Biologically plausible: anti-inflammatory effects, cell cycle regulation.", type: "normal" },
            { year: "The Design", text: "ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶: ã‚¹ã‚¿ãƒãƒ³ã®å‡¦æ–¹ç®‹ã‚’è¨˜å…¥ã—ãŸã“ã¨ãŒã‚ã‚‹æ‚£è€…ã¯ã€Œã‚¹ã‚¿ãƒãƒ³ä½¿ç”¨è€…ã€ã¨ã—ã¦åˆ†é¡ã•ã‚Œã¾ã—ãŸã€‚ã¾ã£ãŸããƒ¦ãƒ¼ã‚¶ãƒ¼ã¨æ¯”è¼ƒã—ãŸå ´åˆã€‚è¨ºæ–­ã‹ã‚‰æ­»äº¡ã¾ã§ã®è¿½è·¡èª¿æŸ»ã€‚", type: "normal" },
            { year: "The Flaw", text: "ã€Œã‚¹ã‚¿ãƒãƒ³ä½¿ç”¨è€…ã€ã¨ã—ã¦åˆ†é¡ã•ã‚Œã‚‹ã«ã¯ã€å‡¦æ–¹ç®‹ã‚’æº€ãŸã™ã¾ã§ç”Ÿå­˜ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚æœ€åˆã®å‡¦æ–¹ã¾ã§ã®æ™‚é–“ã¯ã€Œä¸æ»…ã€ã§ã™ã€‚å®šç¾©ä¸Šã€ãã®é–“ã«æ­»ã¬ã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚", type: "revelation" },
            { year: "The Math", text: "ä¸æ»…ã®æ™‚é–“ã¯ã€Œéœ²å‡ºã€ã¨ã—ã¦èª¤ã£ã¦åˆ†é¡ã•ã‚Œã¾ã™ã€‚ã“ã‚Œã«ã‚ˆã‚Šã€æš´éœ²ã•ã‚ŒãŸã‚°ãƒ«ãƒ¼ãƒ—ã®ç”Ÿå­˜ç‡ãŒäººç‚ºçš„ã«å¢—å¤§ã—ã¾ã™ã€‚ ã€Œåˆ©ç‚¹ã€ã¯æ•°å­¦çš„ãªæˆæœç‰©ã§ã™ã€‚", type: "crisis" },
            { year: "Correction", text: "When immortal time is properly handled (time-varying exposure), statin's cancer mortality benefit disappears: HR 0.99 (0.89-1.10)", type: "revelation" },
            { year: "Lesson", text: "éœ²å…‰ã‚¿ã‚¤ãƒŸãƒ³ã‚°ãŒé‡è¦ãªå ´åˆã€ã€Œä¸€åº¦ã§ã‚‚ã€ã¨ã€Œä¸€åº¦ã‚‚ã€ã‚’æ¯”è¼ƒã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚æ™‚é–“ã¯æ­£ã—ãåˆ†é¡ã•ã‚Œãªã‘ã‚Œã°ãªã‚Šã¾ã›ã‚“ã€‚ãã†ã—ãªã„ã¨ã€ä¸æ­»ã®å¹»æƒ³ãŒç”Ÿã¾ã‚Œã¦ã—ã¾ã„ã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Cancer mortality",
            drug: "Statins (immortal time bias)",
            placebo: "No statins",
            rr: "HR 0.52 (biased) â†’ HR 0.99 (corrected)",
            ci: "Artifact â†’ null",
            nnh: "False hope for cancer patients"
          },
          hook: "THE HOOK: Immortal time bias is everywhere. Any study comparing 'ever vs never' users is at risk. The bias direction is ALWAYS toward benefit for the exposure. If your observational study shows a drug prevents cancer/death/etc, check for immortal time first."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY TAKEAWAY: Immortal time bias occurs when the definition of 'exposed' requires surviving to a certain point, but that survival time is misclassified as 'exposed' time. The bias ALWAYS makes the exposure look beneficial. Landmark analysis or time-varying covariates can fix it."
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'ğŸ’Š',
          title: "ã‚¹ã‚¿ãƒãƒ³ãŒã‚“ç ”ç©¶ã«ãŠã‘ã‚‹ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹",
          source: "Am J Epidemiol 2003; Suissa S. | Drug Safety 2007",
          paragraphs: [
            "In the early 2000s, several observational studies reported exciting findings: statins appeared to reduce cancer risk by 20-30%. The biological mechanism seemed plausibleâ€”statins have anti-inflammatory properties and might inhibit cancer cell growth.",
            "ã—ã‹ã—ã€ç–«å­¦è€…ã®ã‚µãƒŸãƒ¼ãƒ»ã‚¹ã‚¤ãƒƒã‚µã¯é‡å¤§ãªæ¬ é™¥ã‚’æŒ‡æ‘˜ã—ã¾ã—ãŸã€‚ã“ã‚Œã‚‰ã®ç ”ç©¶ã§ã¯ã€è¨ºæ–­æ—¥ã¾ãŸã¯ã‚³ãƒ›ãƒ¼ãƒˆç™»éŒ²æ—¥ã§ã‚ã‚‹ã“ã¨ãŒå¤šã„æ™‚é–“ã‚¼ãƒ­ã‹ã‚‰ã€Œã‚¹ã‚¿ãƒãƒ³ä½¿ç”¨è€…ã€ã¨ã€Œéä½¿ç”¨è€…ã€ã‚’æ¯”è¼ƒã—ã¾ã—ãŸã€‚å•é¡Œ: ä¸€éƒ¨ã®ã€Œãƒ¦ãƒ¼ã‚¶ãƒ¼ã€ã¯ã€æ™‚é–“ã‚¼ãƒ­ã®æ™‚ç‚¹ã§ã¯ã¾ã ã‚¹ã‚¿ãƒãƒ³ã‚’é–‹å§‹ã—ã¦ã„ã¾ã›ã‚“ã§ã—ãŸã€‚",
            "The time between cohort entry and first statin prescription was 'immortal time'â€”by definition, patients couldn't die during this period (they had to survive to become statin users). This immortal time was misclassified as 'exposed' time, artificially inflating survival in the statin group. When properly analyzed with time-varying exposure, the cancer benefit disappeared completely."
          ],
          lesson: "Whenever you see an observational study showing a drug 'prevents' cancer or death, ask: How was exposure defined? Did patients need to survive to become 'exposed'? If the answer is yes, immortal time bias is likely inflating the benefit."
        }
      },
      {
        type: 'content',
        content: {
          title: "The Three Major Bias Families",
          sections: [
            {
              heading: "1. SELECTION BIAS",
              items: [
                "èª°ãŒç ”ç©¶ã«å‚åŠ ã™ã‚‹ã®ã§ã—ã‚‡ã†ã‹?èª°ãŒæ®‹ç•™ã—ã¾ã™ã‹?",
                "Healthy user bias: HRT users were healthier to start",
                "Sick quitter bias: People quit smoking because they're ill, making quitters look worse",
                "Loss to follow-up: Sicker patients drop out, making survivors look better",
                "Berkson's bias: Hospital-based selection distorts associations"
              ]
            },
            {
              heading: "2. INFORMATION BIAS",
              items: [
                "How accurately is exposure/outcome measured?",
                "Recall bias: Cases remember exposures better than controls",
                "Interviewer bias: Interviewers probe harder when they know disease status",
                "Misclassification: Errors in exposure or outcome measurement",
                "Differential misclassification can bias in either direction"
              ]
            },
            {
              heading: "3. TIME-RELATED BIAS",
              items: [
                "Immortal time bias: Survival required to become 'exposed'",
                "Time-lag bias: Comparing prevalent vs incident users",
                "Depletion of susceptibles: Early deaths remove high-risk from 'current user' category",
                "Lead time bias: Screening advances diagnosis without extending life"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã®æ¤œå‡º",
          title: "å±é™ºä¿¡å·ã¨è§£æ±ºç­–",
          sections: [
            {
              heading: "Red Flags (Study Design):",
              text: "â€¢ Exposure defined as 'ever vs never' with no time component\nâ€¢ Exposure requires multiple prescriptions/visits\nâ€¢ Time zero differs between groups\nâ€¢ Exposure definition is based on future events"
            },
            {
              heading: "Red Flags (Results):",
              text: "â€¢ Unexpectedly large protective effect (HR < 0.70)\nâ€¢ Exposure 'protects' against multiple unrelated outcomes\nâ€¢ Biologically implausible benefit for plausible exposure\nâ€¢ Dose-response goes the 'wrong' direction"
            },
            {
              heading: "Solutions:",
              text: "1. LANDMARK ANALYSIS: Start follow-up at a fixed time point (e.g., 6 months post-diagnosis). Classify exposure based on that time.\n\n2. TIME-VARYING EXPOSURE: Change exposure status on the day it occurs. Before first statin = unexposed time. After = exposed time.\n\n3. CLONING METHODS: Create copies of patients, assign to exposure groups, censor appropriately."
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "é¸æŠãƒã‚¤ã‚¢ã‚¹: å¥åº·ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã¨ç—…æ°—ã®ç¦ç…™è€…",
          sections: [
            {
              heading: "Healthy User Bias:",
              items: [
                "People who choose treatment are systematically different",
                "HRT: Women who chose HRT were wealthier, more health-conscious",
                "Vaccines: Parents who vaccinate also do other healthy behaviors",
                "Supplements: Users have healthier lifestyles overall",
                "æ²»ç™‚ã®ã€Œåˆ©ç›Šã€ã¯å®Ÿéš›ã«ã¯é¸æŠã§ã™åŠ¹æœ"
              ]
            },
            {
              heading: "Sick Quitter Bias:",
              items: [
                "People stop behaviors when they feel ill",
                "Alcohol: Former drinkers have higher mortality than current drinkers",
                "But former drinkers quit because they were sick",
                "Smoking: Recent quitters have higher cancer rates (cancer caused quitting)",
                "Creates the appearance of 'J-shaped' curves or protective effects"
              ]
            },
            {
              heading: "Detection and Correction:",
              items: [
                "Compare to 'never users,' not 'former users'",
                "Look at TIME of quitting relative to outcome",
                "Use active comparators (another drug) not non-users",
                "Consider intentions (prescriptions filled vs filled and taken)"
              ]
            }
          ]
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'ğŸ¥',
          title: "The Hospitalized Patient Paradox: Berkson's Bias",
          source: "Berkson J, Biometrics 1946 | Classic Selection Bias",
          paragraphs: [
            "In hospital-based studies, researchers noticed something strange: diabetes appeared to be PROTECTIVE against infections. Diabetic patients seemed less likely to have infectious diseases. This was paradoxicalâ€”diabetes impairs immune function.",
            "ãã®èª¬æ˜ã¯ã€é¸æŠãƒã‚¤ã‚¢ã‚¹ã®ä¸€å½¢æ…‹ã§ã‚ã‚‹ãƒãƒ¼ã‚¯ã‚½ãƒ³ãƒã‚¤ã‚¢ã‚¹ã§ã—ãŸã€‚å…¥é™¢ã—ã¦ã„ã‚‹ç³–å°¿ç—…æ‚£è€…ã¯ã€æ„ŸæŸ“ç—‡ã§ã¯ãªãã€ä¸»ã«ç³–å°¿ç—…ã®ç®¡ç†ã‚’ç›®çš„ã¨ã—ã¦å…¥é™¢ã—ã¦ã„ã¾ã—ãŸã€‚ã—ã‹ã—ã€ç³–å°¿ç—…ä»¥å¤–ã®å…¥é™¢æ‚£è€…ã¯ã€ï¼ˆæ€¥æ€§ç–¾æ‚£ã®ä¸­ã§ã‚‚ã¨ã‚Šã‚ã‘ï¼‰æ„ŸæŸ“ç—‡ã®ãŸã‚ã«å…¥é™¢ã—ã¦ã„ã‚‹å¯èƒ½æ€§ãŒé«˜ã‹ã£ãŸã€‚",
            "ç ”ç©¶è€…ã‚‰ã¯ã€å…¥é™¢æ‚£è€…ã®ã¿ã‚’ç ”ç©¶ã™ã‚‹ã“ã¨ã«ã‚ˆã£ã¦ã€å½ã®è² ã®é–¢é€£æ€§ã‚’ä½œã‚Šå‡ºã—ãŸã€‚ä¸€èˆ¬é›†å›£ã‚’å¯¾è±¡ã«ç ”ç©¶ã•ã‚ŒãŸåŒã˜ç³–å°¿ç—…ã¨æ„ŸæŸ“ç—‡ã®é–¢ä¿‚ã¯ã€äºˆæƒ³ã•ã‚ŒãŸæ­£ã®é–¢é€£æ€§ã‚’ç¤ºã—ã¾ã—ãŸã€‚ã¤ã¾ã‚Šã€ç³–å°¿ç—…ã¯æ„ŸæŸ“ç—‡ãƒªã‚¹ã‚¯ã‚’å¢—åŠ ã•ã›ã¾ã™ã€‚"
          ],
          lesson: "Studying only hospitalized (or otherwise selected) populations can create, eliminate, or reverse associations that exist in the general population. Always ask: how did patients get INTO this study, and could that selection process distort the exposure-outcome relationship?"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'bias-detection',
          title: "ãƒã‚¤ã‚¢ã‚¹æ¤œå‡ºå™¨",
          situation: "ã‚ã‚‹ç ”ç©¶ã§ã¯ã€ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ãŒç³–å°¿ç—…æ‚£è€…ã®ãŒã‚“ãƒªã‚¹ã‚¯ã‚’è»½æ¸›ã™ã‚‹ã¨ä¸»å¼µã—ã¦ã„ã¾ã™ (HR 0.63ã€95% CI 0.58-0.68)ã€‚ã“ã®ç ”ç©¶ã§ã¯ã€ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ä½¿ç”¨è€…ã¨éä½¿ç”¨è€…ã‚’æ¯”è¼ƒã—ã¾ã—ãŸã€‚æ‚£è€…ã¯ã€2 ã¤ä»¥ä¸Šã®å‡¦æ–¹ç®‹ã‚’è¨˜å…¥ã—ãŸå ´åˆã€ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ä½¿ç”¨è€…ã¨ã—ã¦åˆ†é¡ã•ã‚Œã¾ã—ãŸã€‚è¿½è·¡èª¿æŸ»ã¯ç³–å°¿ç—…ã®è¨ºæ–­æ™‚ã«é–‹å§‹ã•ã‚Œã¾ã—ãŸã€‚",
          nodes: {
            start: {
              question: "ã“ã®ç ”ç©¶ã§æœ€ã‚‚å¯èƒ½æ€§ã®é«˜ã„ãƒã‚¤ã‚¢ã‚¹ã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "Confounding by indication â€” metformin given to healthier patients", nextNode: "confounding" },
                { text: "Immortal time bias â€” must survive to fill 2 prescriptions", nextNode: "immortal_correct" },
                { text: "Healthy user bias â€” metformin users are health-conscious", nextNode: "healthy_user" },
                { text: "No bias â€” the confidence interval is narrow", nextNode: "no_bias_wrong" }
              ]
            },
            immortal_correct: {
              situation: "æ­£è§£ã§ã™ã€‚ 2 ã¤ã®å‡¦æ–¹ç®‹ã‚’èª¿å‰¤ã™ã‚‹ã«ã¯ã€æ‚£è€…ã¯å°‘ãªãã¨ã‚‚ãã®é–“ã®æ™‚é–“ã‚’ç”Ÿãã¦ã„ãªã‘ã‚Œã°ãªã‚Šã¾ã›ã‚“ã€‚ã“ã®ç”Ÿå­˜æœŸé–“ã¯ã€ã€Œéæ›éœ²ã€ã§ã‚ã‚‹ã¹ãã¨ãã«ã€Œæ›éœ²ã€ã¨ã—ã¦èª¤åˆ†é¡ã•ã‚Œã¦ã„ã¾ã™ã€‚",
              question: "ã“ã®ç ”ç©¶ã‚’ã©ã®ã‚ˆã†ã«ä¿®æ­£ã—ã¾ã™ã‹?",
              branches: [
                { text: "Use landmark analysis â€” start follow-up after a fixed period", nextNode: "fix_correct" },
                { text: "ä½µå­˜ç–¾æ‚£ã‚’èª¿æ•´ã—ã¾ã™", nextNode: "fix_wrong" },
                { text: "Exclude patients who died early", nextNode: "fix_wrong2" }
              ]
            },
            confounding: {
              type: 'outcome',
              outcome: 'partial',
              title: "å¯èƒ½ã§ã™ãŒã€ä¸»è¦ãªå•é¡Œã§ã¯ã‚ã‚Šã¾ã›ã‚“",
              text: "é©å¿œç—‡ã«ã‚ˆã‚‹æ··ä¹±ãŒæ‡¸å¿µã•ã‚Œã¾ã™ï¼ˆãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã¯ã€Œã‚ˆã‚Šå¥åº·ãªã€ç³–å°¿ç—…æ‚£è€…ã«æŠ•ä¸ã•ã‚Œã‚‹ï¼‰ã€‚ã—ã‹ã—ã€ç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã¯æ˜ã‚‰ã‹ã«ä¸æ»…ã®æ™‚é–“ã‚’ç”Ÿã¿å‡ºã—ã¾ã™ã€‚2 ã¤ã®å‡¦æ–¹ç®‹ãŒå¿…è¦ã¨ã„ã†ã“ã¨ã¯ã€ç”Ÿå­˜ãŒæš´éœ²ã•ã‚ŒãŸã‚‚ã®ã¨ã—ã¦åˆ†é¡ã•ã‚Œã‚‹å¿…è¦ãŒã‚ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ã“ã‚Œã¯æ”¯é…çš„ãªãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚",
              lesson: "When a study requires multiple events (prescriptions, visits, tests) to define exposure, immortal time bias is almost always present."
            },
            healthy_user: {
              type: 'outcome',
              outcome: 'partial',
              title: "é–¢é€£ã—ã¾ã™ãŒã€ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã§ã¯ã‚ã‚Šã¾ã›ã‚“",
              text: "Healthy user bias is a form of confounding â€” metformin users may be more health-conscious. But the study design creates a STRONGER bias: immortal time. Even if users and non-users were identical at baseline, requiring 2 prescriptions creates artificial immortality.",
              lesson: "ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã¯æ··ä¹±ã‚’æ‹›ãã‚‚ã®ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã‚Œã¯æ™‚é–“ã‚’èª¤ã£ã¦åˆ†é¡ã™ã‚‹ã“ã¨ã«ã‚ˆã‚‹æ§‹é€ çš„ãªãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚ã“ã‚Œã¯ã€ã‚°ãƒ«ãƒ¼ãƒ—é–“ã«å·®ãŒãªãã¦ã‚‚å­˜åœ¨ã—ã¾ã™ã€‚"
            },
            no_bias_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Narrow CI doesn't mean no bias!",
              text: "ä¿¡é ¼åŒºé–“ãŒç‹­ã„ã¨ã„ã†ã“ã¨ã¯ã€æ¨å®šå€¤ãŒæ­£ç¢ºã§ã‚ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ãŒã€ä¸åã§ã‚ã‚‹ã¨ã„ã†ã“ã¨ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã®ç ”ç©¶ã«ã¯å¤§ããªç³»çµ±èª¤å·®ãŒã‚ã‚Šã¾ã™ã€‚ CI ãŒ 0.63 ç¨‹åº¦ã§ã‚ã‚‹ã«ã‚‚ã‹ã‹ã‚ã‚‰ãšã€ã€ŒçœŸã®ã€åŠ¹æœã¯ã‚¼ãƒ­ (HR 1.0) ã«ãªã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "ç²¾åº¦ â‰  ç²¾åº¦ã€‚ãƒã‚¤ã‚¢ã‚¹ã¨ã¯ç³»çµ±èª¤å·®ã®ã“ã¨ã§ã™ã€‚ã‚µãƒ³ãƒ—ãƒ«ã‚µã‚¤ã‚ºã¨ç²¾åº¦ã¯åã‚Šã‚’ä¿®æ­£ã™ã‚‹ã‚‚ã®ã§ã¯ãªãã€ã‚ˆã‚Šæ­£ç¢ºã«é–“é•ã£ã¦ã„ã‚‹ã“ã¨ã‚’æ˜ã‚‰ã‹ã«ã™ã‚‹ã ã‘ã§ã™ã€‚"
            },
            fix_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent solution!",
              text: "ãƒ©ãƒ³ãƒ‰ãƒãƒ¼ã‚¯åˆ†æã§ã¯ã€è¿½è·¡èª¿æŸ»ãŒã€ãŸã¨ãˆã°è¨ºæ–­å¾Œ 6 ã‹æœˆå¾Œã«é–‹å§‹ã•ã‚Œã‚‹ã‚ˆã†ã«è¨­å®šã•ã‚Œã¾ã™ã€‚ 6 ã‹æœˆã¾ã§ç”Ÿå­˜ã™ã‚‹ã™ã¹ã¦ã®äººãŒå«ã¾ã‚Œã¾ã™ã€‚éœ²å‡ºã‚¹ãƒ†ãƒ¼ã‚¿ã‚¹ã¯ãã®æ™‚ç‚¹ã§å®šç¾©ã•ã‚Œã¾ã™ã€‚ä¸æ»…ã®æ™‚é–“ã‚’èª¤ã£ã¦åˆ†é¡ã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚",
              lesson: "ãƒ©ãƒ³ãƒ‰ãƒãƒ¼ã‚¯åˆ†æã¯ã€ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã«å¯¾ã™ã‚‹æœ€ã‚‚ç°¡å˜ãªä¿®æ­£ã§ã™ã€‚ ã€Œãƒ©ãƒ³ãƒ‰ãƒãƒ¼ã‚¯ã€ã¯è‡¨åºŠçš„ã«æ„å‘³ãŒã‚ã‚Šã€ã™ã¹ã¦ã®æ‚£è€…ã«å¹³ç­‰ã«é©ç”¨ã•ã‚Œã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚"
            },
            fix_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Adjustment doesn't fix immortal time",
              text: "Immortal time bias is NOT confounding â€” you can't adjust it away. No matter how many comorbidities you control for, the structural problem remains: time before first prescription is misclassified.",
              lesson: "Immortal time bias requires DESIGN fixes (landmark, time-varying exposure), not statistical adjustment."
            },
            fix_wrong2: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯äº‹æ…‹ã‚’ã•ã‚‰ã«æ‚ªåŒ–ã•ã›ã¾ã™!",
              text: "æ—©æœŸæ­»äº¡ã‚’é™¤å¤–ã™ã‚‹ã¨ã€ãƒã‚¤ã‚¢ã‚¹ã‚’ç¤ºã—ã¦ã„ã‚‹æ‚£è€…ãã®ã‚‚ã®ãŒæ’é™¤ã•ã‚Œã¾ã™ã€‚ç”Ÿå­˜è€…ã ã‘ã‚’æ®‹ã™ã“ã¨ã«ãªã‚Šã€ä¸æ»…ã®æ™‚é–“ã®å•é¡ŒãŒã•ã‚‰ã«æ¥µç«¯ã«ãªã‚Šã¾ã™ã€‚ã“ã‚Œã¯ã€ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã«åŠ ãˆã¦ç”Ÿå­˜ãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚",
              lesson: "ãƒ‡ãƒ¼ã‚¿ã‚’å‰Šé™¤ã—ã¦ãƒã‚¤ã‚¢ã‚¹ã‚’ã€Œä¿®æ­£ã€ã—ãªã„ã§ãã ã•ã„ã€‚æœ€åˆã‹ã‚‰æ™‚é–“ã‚’æ­£ã—ãåˆ†é¡ã™ã‚‹ã“ã¨ã§å•é¡Œã‚’ä¿®æ­£ã—ã¾ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "ã‚ã‚‹ç ”ç©¶ã«ã‚ˆã‚‹ã¨ã€ãŒã‚“è¨ºæ–­å¾Œ5å¹´ä»¥ä¸Šç”Ÿå­˜ã—ã€ãã®å¾Œç‘æƒ³ã‚’å§‹ã‚ãŸæ‚£è€…ã¯ã€ç‘æƒ³ã‚’ã—ãªã„æ‚£è€…ã«æ¯”ã¹ã¦æ­»äº¡ç‡ãŒ60ï¼…ä½ã„ã“ã¨ãŒåˆ¤æ˜ã—ãŸã€‚æœ€ã‚‚é‡å¤§ãªæ¬ é™¥ã¯ä½•ã§ã™ã‹?",
          options: [
            { id: 'a', text: "Confounding â€” meditators are healthier overall", correct: false },
            { id: 'b', text: "Immortal time bias â€” must survive 5 years to become a meditator", correct: true },
            { id: 'c', text: "Recall bias â€” survivors remember meditation better", correct: false },
            { id: 'd', text: "Selection bias â€” only motivated patients meditate", correct: false }
          ],
          explanation: "The study defines 'meditators' as those who survive 5+ years AND THEN start meditation. All 5 years of survival are 'immortal' â€” by definition, you can't die during time required to become exposed. This immortal time is then misclassified as 'exposed' time, artificially inflating survival in meditators."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "è¨˜æ†¶ã®ç½ : æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ã¨å¹»è¦šæš´éœ²",
          source: "Case-control studies of birth defects | Multiple examples | Information bias",
          timeline: [
            { year: "Classic Setup", text: "å…ˆå¤©ç•°å¸¸ã®ã‚ã‚‹èµ¤ã¡ã‚ƒã‚“ã®æ¯è¦ªã¯ã€ã€Œå¦Šå¨ ä¸­ã«ä½•ã‹è–¬ã‚’é£²ã¿ã¾ã—ãŸã‹?ã€ã¨å°‹ã­ã‚‰ã‚Œã¾ã™ã€‚å½¼å¥³ã¯å­ä¾›ã®çŠ¶æ…‹ã‚’èª¬æ˜ã§ãã‚‹ã‚‚ã®ãŒãªã„ã‹å¿…æ­»ã§è¨˜æ†¶ã‚’æ¤œç´¢ã—ã¾ã™ã€‚", type: "normal" },
            { year: "The Comparison", text: "Mother of healthy baby is asked same question. She shrugs: 'Maybe some Tylenol? I don't really remember.' No motivation to dig through memory.", type: "normal" },
            { year: "The Bias", text: "ç—‡ä¾‹ã®æ¯è¦ªã¯ã€å¯¾ç…§ã®æ¯è¦ªã‚ˆã‚Šã‚‚å¤šãã®æ›éœ²ã‚’è¦šãˆã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯å·®åˆ†å†ç¾ã§ã™ã€‚", type: "crisis" },
            { year: "Real Example", text: "ç—‡ä¾‹å¯¾ç…§ç ”ç©¶ã§ã¯ã€å¤šãã®è–¬å‰¤ã¨å…ˆå¤©æ€§æ¬ æç—‡ã¨ã®é–¢é€£æ€§ãŒç™ºè¦‹ã•ã‚Œã¾ã—ãŸã€‚ãƒªã‚³ãƒ¼ãƒ«ã®ä»£ã‚ã‚Šã«å‡¦æ–¹ç®‹è¨˜éŒ²ï¼ˆå®¢è¦³çš„ãƒ‡ãƒ¼ã‚¿ï¼‰ãŒä½¿ç”¨ã•ã‚ŒãŸå ´åˆã€ã»ã¨ã‚“ã©ã®é–¢é€£æ€§ã¯æ¶ˆãˆã¾ã—ãŸã€‚", type: "revelation" },
            { year: "Bendectin Disaster", text: "ã¤ã‚ã‚Šã®æ²»ç™‚è–¬ãƒ™ãƒ³ãƒ‡ã‚¯ãƒãƒ³ã¯ã€ç—‡ä¾‹å¯¾ç…§ãƒªã‚³ãƒ¼ãƒ«ç ”ç©¶ã‹ã‚‰ã®è¨´è¨Ÿåœ§åŠ›ã«ã‚ˆã‚Šä¸­æ­¢ã•ã‚Œã¾ã—ãŸã€‚ãã®å¾Œã®ç ”ç©¶ã§ã€ãã‚Œã¯å®‰å…¨ã§ã‚ã‚‹ã“ã¨ãŒåˆ¤æ˜ã—ã¾ã—ãŸã€‚å¦Šå¨ ä¸­ã®å¥³æ€§ã¯ã€æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ã«ã‚ˆã‚ŠåŠ¹æœçš„ãªæ²»ç™‚ã‚’å—ã‘ã‚‰ã‚Œãªããªã‚Šã¾ã—ãŸã€‚", type: "crisis" },
            { year: "Lesson", text: "When outcomes prompt memory searches, recall is biased. Use OBJECTIVE exposure data (records, biomarkers) when possible. When using recall, make interviewers BLIND to case/control status.", type: "revelation" }
          ],
          realData: {
            endpoint: "Various birth defects",
            drug: "Multiple medications (recall-based)",
            placebo: "No medication (recall-based)",
            rr: "OR 2-4x higher in recall studies vs objective records",
            ci: "Recall-based associations often spurious",
            nnh: "Bendectin withdrawn despite being safe"
          },
          hook: "THE HOOK: Recall bias is insidious because it feels like valid data. Mothers genuinely believe they're reporting accurately â€” but grief and guilt drive memory searches that control mothers don't perform. The cure? Objective data sources, or blinded interviewers."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'recall-bias-detection',
          title: "ã“ã‚Œã¯æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ã§ã™ã‹?",
          situation: "You're reviewing case-control studies. Identify whether recall bias is a major threat.",
          nodes: {
            start: {
              question: "ç ”ç©¶ A: è‚ºãŒã‚“ã®ç—‡ä¾‹ã§ã¯ã€å–«ç…™æ­´ã¨ãŒã‚“ã®ãªã„å¯¾ç…§ã«ã¤ã„ã¦å°‹ã­ã‚‰ã‚Œã¾ã—ãŸã€‚ã©ã¡ã‚‰ã®ã‚°ãƒ«ãƒ¼ãƒ—ã‚‚åŒã˜é¢æ¥å®˜ã‹ã‚‰åŒã˜è³ªå•ã‚’ã•ã‚Œã¾ã—ãŸã€‚æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ã¯æ‡¸å¿µäº‹é …ã§ã™ã‹?",
              branches: [
                { text: "Yes â€” lung cancer patients remember smoking differently", nextNode: "lung_cancer_wrong" },
                { text: "Minimal â€” smoking is a salient, memorable behavior", nextNode: "lung_cancer_correct" }
              ]
            },
            lung_cancer_correct: {
              situation: "æ­£è§£ã§ã™ã€‚å–«ç…™ã¯è¨˜æ†¶ã«æ®‹ã‚Šã€æ¤œè¨¼å¯èƒ½ã§ã™ã€‚ MAJOR SALIENT ã®ã‚¨ã‚¯ã‚¹ãƒãƒ¼ã‚¸ãƒ£ã§ã¯ã€ãƒªã‚³ãƒ¼ãƒ«ãƒã‚¤ã‚¢ã‚¹ã¯ãã‚Œã»ã©å•é¡Œã«ãªã‚Šã¾ã›ã‚“ã€‚ç ”ç©¶ B: å°å…ç™½è¡€ç—…ã®ç—‡ä¾‹ã¨å¯¾ç…§ã€‚ 5 å¹´å‰ã€ä¸¡è¦ªãŒå®¶åº­ç”¨æ®ºè™«å‰¤ã®ä½¿ç”¨ã«ã¤ã„ã¦å°‹ã­ã¾ã—ãŸã€‚",
              question: "Is recall bias a concern?",
              branches: [
                { text: "Major concern â€” parents of sick children search memory harder", nextNode: "leukemia_correct" },
                { text: "Minor concern â€” pesticide use is memorable", nextNode: "leukemia_wrong" }
              ]
            },
            lung_cancer_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Some concern, but limited",
              text: "æƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ãŒæœ€ã‚‚å•é¡Œã«ãªã‚‹ã®ã¯ã€è¨˜æ†¶æ¤œç´¢ãŒå¿…è¦ãªå¾®å¦™ã§è»½å¾®ãªæ›éœ²ã®å ´åˆã§ã™ã€‚å–«ç…™ã¯é¡•è‘—ã§ã™ã€‚äººã€…ã¯è‡ªåˆ†ãŒå–«ç…™ã—ãŸã‹ã©ã†ã‹ã‚’çŸ¥ã£ã¦ã„ã¾ã™ã€‚ãƒã‚¤ã‚ªãƒãƒ¼ã‚«ãƒ¼ã«ã‚ˆã£ã¦æ¤œè¨¼å¯èƒ½ã§ã™ã€‚è‚ºãŒã‚“ç ”ç©¶ã«å¯¾ã™ã‚‹ã‚ˆã‚Šå¤§ããªæ‡¸å¿µã¯æ··ä¹±ã‚’æ‹›ãã“ã¨ã§ã™ï¼ˆå–«ç…™è€…ã«ã¯ä»–ã®ãƒªã‚¹ã‚¯è¡Œå‹•ã‚‚ã‚ã‚Šã¾ã™ï¼‰ã€‚",
              lesson: "Recall bias is exposure-specific. Major behaviors (smoking, alcohol) are less affected than minor ones (dietary supplements, brief exposures)."
            },
            leukemia_correct: {
              situation: "ãã®é€šã‚Šã§ã™ã€‚ 5 å¹´å‰ã®å®¶åº­ç”¨è¾²è–¬ã®ä½¿ç”¨çŠ¶æ³ã¯æ›–æ˜§ã§æ¤œç´¢å¯èƒ½ã§ã™ã€‚ç ”ç©¶ C: å¿ƒç­‹æ¢—å¡ã®ç—‡ä¾‹ã€‚ MI ãŒç™ºç”Ÿã™ã‚‹å‰ã«è–¬å±€ã®å‡¦æ–¹ç®‹è¨˜éŒ²ã‹ã‚‰æŠ½å‡ºã•ã‚ŒãŸæ›éœ²ãƒ‡ãƒ¼ã‚¿ã€‚",
              question: "Is recall bias a concern?",
              branches: [
                { text: "Yes â€” patients still might misreport", nextNode: "mi_wrong" },
                { text: "ã„ã„ãˆ â€” ãƒ‡ãƒ¼ã‚¿ã¯çµæœãŒç™ºç”Ÿã™ã‚‹å‰ã«è¨˜éŒ²ã•ã‚Œã€å½±éŸ¿ã‚’å—ã‘ã‚‹ã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“", nextNode: "mi_correct" }
              ]
            },
            leukemia_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "High recall bias risk!",
              text: "Pesticide use 5 years ago is exactly the type of exposure prone to recall bias: (1) vague definition, (2) long ago, (3) guilt-inducing for parents of sick children. Parents of leukemia cases will search memory for ANY chemical exposure. Controls won't.",
              lesson: "Red flags for recall bias: vague exposures, long recall periods, emotionally-charged outcomes (especially children), differential motivation to remember."
            },
            mi_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "No recall bias possible!",
              text: "è»¢å¸°ãŒç™ºç”Ÿã™ã‚‹å‰ã«æ›éœ²ãƒ‡ãƒ¼ã‚¿ãŒè¨˜éŒ²ã•ã‚ŒãŸå ´åˆ (è¦‹é€šã—ã®ç¢ºèª)ã€ãƒªã‚³ãƒ¼ãƒ«ãƒã‚¤ã‚¢ã‚¹ã¯ä¸å¯èƒ½ã§ã™ã€‚çµæœã®ã‚¹ãƒ†ãƒ¼ã‚¿ã‚¹ã«åŸºã¥ã„ã¦ãƒ‡ãƒ¼ã‚¿ã‚’å¤‰æ›´ã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã‚„åŒ»ç™‚è¨˜éŒ²ã‚’ä½¿ç”¨ã—ãŸç ”ç©¶ãŒæƒ³èµ·ãƒã‚¤ã‚¢ã‚¹ã®å½±éŸ¿ã‚’å—ã‘ã«ãã„ã®ã¯ã“ã®ãŸã‚ã§ã™ã€‚",
              lesson: "The cure for recall bias: prospective data collection, medical/pharmacy records, biomarkers â€” anything recorded before the outcome is known."
            },
            mi_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "å®¢è¦³çš„ãªè¨˜éŒ²ã§ã¯ã‚ã‚Šã¾ã›ã‚“!",
              text: "è–¬å±€ã®è¨˜éŒ²ã¯ MI ã®å‰ã«è¨˜å…¥ã•ã‚Œã¾ã—ãŸã€‚æ‚£è€…ã¯éå»ã«æˆ»ã£ã¦ã€è¨˜å…¥ã—ãŸå‡¦æ–¹ç®‹ã‚’å¤‰æ›´ã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚ã“ã‚Œã¯ã€å†ç¾ãƒã‚¤ã‚¢ã‚¹ã®å½±éŸ¿ã‚’å—ã‘ãªã„ã€å®¢è¦³çš„ã‹ã¤å‰å‘ãã«è¨˜éŒ²ã•ã‚ŒãŸãƒ‡ãƒ¼ã‚¿ã§ã™ã€‚ã¾ã•ã«ã“ã‚ŒãŒã€ç ”ç©¶è€…ãŒé›»å­åŒ»ç™‚è¨˜éŒ²ã‚’ä½¿ç”¨ã™ã‚‹ç†ç”±ã§ã™ã€‚",
              lesson: "Objective records > memory. Prospective > retrospective. When you have records, use them instead of asking patients to remember."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: Selection bias, information bias, and time-related bias all make associations appear where none exist (or disappear when real). They are NOT fixed by larger sample sizes. They are NOT fixed by narrow confidence intervals. They are ONLY fixed by proper study design. A precise biased estimate is just precise bias."
        }
      },
      {
        type: 'principle',
        content: {
          text: "ğŸ¯ PROGRESS CHECK: You've mastered the bias zoo. Immortal time (survival to exposure), healthy user (who chooses treatment), sick quitter (who stops), recall bias (differential memory), Berkson's (hospital selection). Now you'll learn ROBINS-I â€” the systematic framework to assess all these biases together."
        }
      }
    ]
  },
  // MODULE 5: THE ASSESSMENT (ROBINS-I)
  {
    id: 5,
    title: "The Assessment",
    subtitle: "ãƒã‚¤ã‚¢ã‚¹ã«å¯¾ã™ã‚‹ ROBINS-I",
    principle: 4,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Measurement shapes reality"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ãƒ‘ãƒ³ãƒ‡ãƒŸãƒƒã‚¯ã®ç½ : ãƒ’ãƒ‰ãƒ­ã‚­ã‚·ã‚¯ãƒ­ãƒ­ã‚­ãƒ³ã¨è¦³å¯Ÿçš„æ··ä¹±",
          source: "Lancet 2020 (retracted) | Multiple observational studies | COVID-19 pandemic",
          timeline: [
            { year: "Mar 2020", text: "French study (Gautret): HCQ + azithromycin shows viral clearance. 'Cure found!' Small, non-randomized, methodologically flawed.", type: "normal" },
            { year: "Apr 2020", text: "Observational studies flood preprint servers. Some show benefit (confounding by indication, immortal time). Some show harm (sicker patients got HCQ).", type: "crisis" },
            { year: "May 2020", text: "ãƒ©ãƒ³ã‚»ãƒƒãƒˆãŒè¦³å¯Ÿç ”ç©¶ã‚’ç™ºè¡¨: HCQ ã¯æ­»äº¡ç‡ã‚’å¢—åŠ ã•ã›ã‚‹ (HR) 1.35ï¼‰ã€‚ä¸–ç•Œã¯è£åˆ¤ã‚’ä¸€æ™‚åœæ­¢ã™ã‚‹ã€‚ç ”ç©¶ã¯å¾Œã§æ’¤å› â€” ãƒ‡ãƒ¼ã‚¿ã¯æé€ ã•ã‚Œã¾ã—ãŸã€‚", type: "crisis" },
            { year: "Jun 2020", text: "WHO SOLIDARITYã€RECOVERY è©¦é¨“ (RCT) ã¯ã€HCQ ãŒæ©Ÿèƒ½ã—ãªã„ã“ã¨ã‚’ç¤ºã—ã¦ã„ã¾ã™ã€‚è¦³å¯Ÿç ”ç©¶ã§ã¯ä½•ã‹æœˆã‚‚ã®é–“ã€çŸ›ç›¾ã—ãŸç­”ãˆãŒå¾—ã‚‰ã‚Œã¦ã„ã¾ã—ãŸã€‚", type: "revelation" },
            { year: "The Problem", text: "å±æ©Ÿæ™‚ã®è¦³å¯Ÿç ”ç©¶ã«ã¯ã€é‡åº¦ã®äº¤çµ¡(é‡ç—‡æ‚£è€…ã¯HCQã‚’å–å¾—)ã€ä¸æ­»æ™‚é–“ãƒã‚¤ã‚¢ã‚¹(è–¬å‰¤æŠ•ä¸ã«ã¯ç”Ÿå­˜ãŒå¿…è¦)ã€é©å¿œãƒã‚¤ã‚¢ã‚¹ãŒã‚ã‚Šã¾ã—ãŸã€‚", type: "revelation" },
            { year: "The Lesson", text: "ä½“ç³»çš„ãƒã‚¤ã‚¢ã‚¹è©•ä¾¡(ROBINS-I)ã¯ã€æ”¿ç­–ãŒæ±ºå®šã•ã‚Œã‚‹å‰ã«æœ€ã‚‚ä¿¡é ¼æ€§ã®ä½ã„ç ”ç©¶ã«ãƒ•ãƒ©ã‚°ã‚’ç«‹ã¦ã¦ã„ãŸå¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚è³ªã®ãªã„ã‚¹ãƒ”ãƒ¼ãƒ‰ã¯å‘½ã‚’çŠ ç‰²ã«ã—ã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 mortality",
            drug: "Hydroxychloroquine observational",
            placebo: "No HCQ",
            rr: "Ranged from HR 0.50 to HR 2.60",
            ci: "Completely contradictory",
            nnh: "Months of confusion, RCTs delayed"
          },
          hook: "ã‚¶ãƒ»ãƒ•ãƒƒã‚¯: HCQ ã®å¤§å¤±æ•—ã¯ã€è¦³å¯Ÿç ”ç©¶ãŒå³æ ¼ãªãƒã‚¤ã‚¢ã‚¹è©•ä¾¡ãªã—ã§è¡Œã‚ã‚ŒãŸå ´åˆã«ä½•ãŒèµ·ã“ã‚‹ã‹ã‚’ç¤ºã—ã¾ã—ãŸã€‚ ROBINS-I ã¯ã€çµæœã‚’ä¿¡é ¼ã™ã‚‹å‰ã«ã€éãƒ©ãƒ³ãƒ€ãƒ åŒ–ç ”ç©¶ã«ãŠã‘ã‚‹ãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ã‚’è©•ä¾¡ã™ã‚‹ä½“ç³»çš„ãªãƒ•ãƒ¬ãƒ¼ãƒ ãƒ¯ãƒ¼ã‚¯ã‚’æä¾›ã—ã¾ã™ã€‚"
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ é‡è¦ãªæ´å¯Ÿ: ROBINS-I ã¯æ¬¡ã®ã‚ˆã†ã«å°‹ã­ã¾ã™ã€‚ã€Œã“ã®ç ”ç©¶ã¯ RCT ã¨ã—ã¦ã©ã®ã‚ˆã†ã«è¦‹ãˆã‚‹ã§ã—ã‚‡ã†ã‹?ã€æ¬¡ã«ã€ã©ã“ãŒé€¸è„±ã—ã¦ã„ã‚‹ã‹ã‚’ç³»çµ±çš„ã«ãƒã‚§ãƒƒã‚¯ã—ã¾ã™ã€‚ãã‚Œã¯è¦³å¯Ÿç ”ç©¶ãŒã€Œæ‚ªã„ã€ã‹ã©ã†ã‹ã§ã¯ãªãã€ãã®é™ç•Œã‚’æ­£ç›´ã«è©•ä¾¡ã™ã‚‹ã“ã¨ã§ã™ã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "ROBINS-I: Risk of Bias In Non-randomized Studies of Interventions",
          sections: [
            {
              heading: "What Is ROBINS-I?",
              items: [
                "Developed by Cochrane for systematic reviews",
                "Structured assessment of 7 bias domains",
                "ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆè©¦é¨“ã€ã«å›ºå®š - ã‚ãªãŸãŒæœ›ã‚€ç†æƒ³çš„ãªRCT",
                "Produces domain-level and overall risk of bias judgments",
                "Required by many journals and guideline bodies"
              ]
            },
            {
              heading: "The Target Trial Concept:",
              items: [
                "å€«ç†ã¨ãƒ­ã‚¸ã‚¹ãƒ†ã‚£ã‚¯ã‚¹ãŒè¨±ã›ã°ã©ã®ã‚ˆã†ãªRCTã‚’è¡Œã„ã¾ã™ã‹?",
                "Define: eligibility, interventions, outcomes, follow-up, analysis",
                "è¦³å¯Ÿç ”ç©¶ã¯ã“ã‚Œã‚’ã‚¨ãƒŸãƒ¥ãƒ¬ãƒ¼ãƒˆã—ã¾ã™ã€‚ãƒˆãƒ©ã‚¤ã‚¢ãƒ«",
                "Bias = deviation from the target trial"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: ROBINS-I ãƒ‰ãƒ¡ã‚¤ãƒ³",
          title: "Seven Sources of Bias",
          sections: [
            {
              heading: "Pre-Intervention Domains:",
              text: "1ã€‚æ··ä¹±: ã‚°ãƒ«ãƒ¼ãƒ—ã¯ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ã§æ¯”è¼ƒå¯èƒ½ã§ã—ãŸã‹? - æ¸¬å®šã•ã‚Œã¦ã„ãªã„äº¤çµ¡å› å­ã¯ã‚ã‚Šã¾ã™ã‹?æ™‚é–“å¤‰åŒ–äº¤çµ¡? - è€ƒãˆã¦ã¿ã¾ã—ã‚‡ã†: HRT ãƒ¦ãƒ¼ã‚¶ãƒ¼ vs éãƒ¦ãƒ¼ã‚¶ãƒ¼ 2. é¸æŠ: ç ”ç©¶ã¸ã®é¸æŠã¯ä»‹å…¥ã¨çµæœã«é–¢é€£ã—ã¦ã„ã¾ã—ãŸã‹? - ãƒ¦ãƒ¼ã‚¶ãƒ¼ã®åè¦‹ãŒè”“å»¶ã—ã¦ã„ã¾ã™ã‹?ç—…é™¢ãƒ™ãƒ¼ã‚¹ã®é¸æŠã§ã™ã‹ï¼Ÿ - è€ƒãˆã‚‹: ç”Ÿå­˜è€…ã®ã¿ã‚’é¸æŠ"
            },
            {
              heading: "At-Intervention Domain:",
              text: "3ã€‚ä»‹å…¥ã®åˆ†é¡: ä»‹å…¥ã®ã‚¹ãƒ†ãƒ¼ã‚¿ã‚¹ã¯æ˜ç¢ºã«å®šç¾©ã•ã‚Œã€ç¢ºèªã•ã‚Œã¾ã—ãŸã‹? - ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹?æš´éœ²ã®èª¤åˆ†é¡? - è€ƒãˆã¦ã¿ã¾ã—ã‚‡ã†: ã€Œä¸€åº¦ã‚‚è¡Œã†ã‹ã€æ±ºã—ã¦è¡Œã‚ãªã„ã€ã®å®šç¾©"
            },
            {
              heading: "Post-Intervention Domains:",
              text: "4. DEVIATIONS: Were there deviations from intended interventions?\n   - Non-adherence? Co-interventions?\n   - Think: Patients stopping treatment\n\n5. MISSING DATA: Were outcomes measured for all participants?\n   - Differential loss to follow-up?\n   - Think: Sicker patients dropping out\n\n6. MEASUREMENT: Could outcome measurement be affected by intervention status?\n   - Blinding? Detection bias?\n   - Think: Knowing treatment affects diagnosis\n\n7. SELECTION OF RESULTS: Were results selected from multiple analyses?\n   - Outcome switching? Subgroup fishing?\n   - Think: Reporting only favorable analyses"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "ROBINS-I Judgment Levels",
          sections: [
            {
              heading: "Low Risk of Bias:",
              text: "ã“ã®ç ”ç©¶ã¯ã€ã“ã®é ˜åŸŸã«é–¢ã—ã¦ã‚ˆãè¡Œã‚ã‚ŒãŸ RCT ã«åŒ¹æ•µã—ã¾ã™ã€‚äº¤çµ¡å› å­ã‚’ç‰¹å®šã—ã€èª¿æ•´ã—ã¾ã—ãŸã€‚ä¸æ»…ã®æ™‚é–“ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚å®Œå…¨ãªè¿½è·¡èª¿æŸ»ã€‚"
            },
            {
              heading: "Moderate Risk of Bias:",
              text: "éãƒ©ãƒ³ãƒ€ãƒ åŒ–ç ”ç©¶ã¨æ€ã‚ã‚Œã‚‹ãŒã€RCT ã«åŒ¹æ•µã™ã‚‹ã¨ã¯è€ƒãˆã‚‰ã‚Œãªã„ã€‚ã„ãã¤ã‹ã®æ··ä¹±ãŒæ®‹ã£ã¦ã„ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚æ–¹æ³•ã«é–¢ã™ã‚‹å°ã•ãªæ‡¸å¿µã€‚"
            },
            {
              heading: "Serious Risk of Bias:",
              text: "ã“ã®ç ”ç©¶ã«ã¯é‡è¦ãªå•é¡ŒãŒã‚ã‚Šã¾ã™ã€‚ã‹ãªã‚Šã®æ··ä¹±ãŒç”Ÿã˜ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚è¨­è¨ˆä¸Šã®æ¬ é™¥ (ä¸æ»…ã®æ™‚é–“ã€é¸æŠ)ã€‚çµæœã¯ååˆ†ã«æ³¨æ„ã—ã¦è§£é‡ˆã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚"
            },
            {
              heading: "Critical Risk of Bias:",
              text: "ã“ã®ç ”ç©¶ã¯å•é¡ŒãŒå¤šã™ãã¦æœ‰ç”¨ãªè¨¼æ‹ ã‚’æä¾›ã§ãã¾ã›ã‚“ã€‚å¯¾å‡¦ã§ããªã„æ ¹æœ¬çš„ãªæ¬ é™¥ã€‚é€šå¸¸ã€åˆæˆã«ã¯å«ã‚ã‚‹ã¹ãã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            {
              heading: "Overall Judgment:",
              text: "The overall risk of bias is the MOST SEVERE judgment across domains. One critical domain = critical overall. This is intentionally conservative."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'robins-assessment',
          title: "ROBINS-I Assessment Practice",
          situation: "è¦³å¯Ÿç ”ç©¶ã§ã¯ã€ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ã¨æ¨™æº–æ²»ç™‚ã‚’å—ã‘ãŸæ‚£è€…ã«ãŠã‘ã‚‹æ–°å‹ã‚³ãƒ­ãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã®è»¢å¸°ã‚’æ¯”è¼ƒã—ã¦ã„ã¾ã™ã€‚ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ã¯åŒ»å¸«ã®åˆ¤æ–­ã«åŸºã¥ã„ã¦æŠ•ä¸ã•ã‚ŒãŸã€‚ã“ã®ç ”ç©¶ã¯ã€å¹´é½¢ã€æ€§åˆ¥ã€ä½µå­˜ç–¾æ‚£ã‚’è€ƒæ…®ã—ã¦èª¿æ•´ã•ã‚Œã¾ã—ãŸã€‚æ²»ç™‚é–‹å§‹æ™‚ã®ç–¾æ‚£ã®é‡ç—‡åº¦ã«é–¢ã™ã‚‹ãƒ‡ãƒ¼ã‚¿ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚",
          nodes: {
            start: {
              question: "æ··ä¹±é ˜åŸŸã«ã¤ã„ã¦ã€ã‚ãªãŸã®åˆ¤æ–­ã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "Low risk â€” they adjusted for key confounders", nextNode: "confound_low" },
                { text: "Serious risk â€” disease severity unmeasured", nextNode: "confound_correct" },
                { text: "é‡å¤§ãªãƒªã‚¹ã‚¯ â€” ã“ã®ç ”ç©¶ã«ã¯æ ¹æœ¬çš„ã«æ¬ é™¥ãŒã‚ã‚Šã¾ã™", nextNode: "confound_critical" }
              ]
            },
            confound_correct: {
              situation: "Good judgment! Physicians gave remdesivir to sicker patients. Without adjusting for baseline severity, the study is biased AGAINST remdesivir (confounding by indication). Now assess CLASSIFICATION OF INTERVENTIONS:",
              question: "Patients were classified as 'remdesivir users' if they received at least one dose during hospitalization.",
              branches: [
                { text: "Low risk â€” clear definition", nextNode: "class_low" },
                { text: "Serious risk â€” immortal time bias possible", nextNode: "class_correct" }
              ]
            },
            confound_low: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too optimistic!",
              text: "Adjusting for age, sex, and comorbidities doesn't capture the most important confounder: DISEASE SEVERITY at treatment initiation. Physicians gave remdesivir to sicker patients. This creates confounding by indication â€” the treatment appears harmful because treated patients were sicker.",
              lesson: "Always ask: 'What determined who got treatment?' If it's disease severity and you can't measure that, confounding is serious."
            },
            confound_critical: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possibly too harsh",
              text: "æ··ä¹±ã¯æ·±åˆ»ã§ã™ãŒã€ã€Œé‡å¤§ã€ã¯åŸç†çš„ã«ã•ãˆä¿®æ­£ã§ããªã„ãƒã‚¤ã‚¢ã‚¹ã€ã¾ãŸã¯æ–¹å‘ã¨å¤§ãã•ãŒçµæœã‚’ã‚‚ãŸã‚‰ã™å ´åˆã«ç•™ä¿ã•ã‚Œã¾ã™ã€‚ã¾ã£ãŸãæƒ…å ±ãŒã‚ã‚Šã¾ã›ã‚“ã€‚æ¯”è¼ƒã«é–¢ã™ã‚‹ä¸€éƒ¨ã®æƒ…å ±ã¯ã€æ…é‡ã«æŠ½å‡ºã§ãã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "ãƒã‚¤ã‚¢ã‚¹ã®é‡å¤§ãªãƒªã‚¹ã‚¯ã¯ã€ä¸€èˆ¬çš„ã«ç ”ç©¶ã‚’åˆæˆã‹ã‚‰é™¤å¤–ã™ã‚‹å¿…è¦ãŒã‚ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚æœ¬å½“ã«è‡´å‘½çš„ãªæ¬ é™¥ãŒã‚ã‚‹å ´åˆã«å‚™ãˆã¦ãã ã•ã„ã€‚"
            },
            class_low: {
              type: 'outcome',
              outcome: 'danger',
              title: "ä¸æ»…ã®æ™‚é–“ã‚’ãƒã‚§ãƒƒã‚¯ã—ã¦ãã ã•ã„!",
              text: "å…¥é™¢ä¸­ã«ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ã‚’æŠ•ä¸ã™ã‚‹ã«ã¯ã€æ‚£è€…ã¯æ²»ç™‚ã¾ã§ç”Ÿãæ®‹ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚å…¥é™¢ã‹ã‚‰æœ€åˆã®æŠ•ä¸ã¾ã§ã®æ™‚é–“ã¯ã€Œä¸æ»…ã€ã§ã‚ã‚Šã€ãã®é–“ã«æ‚£è€…ãŒæ­»ã¬ã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã®æ™‚é–“ã‚’ã€Œæ²»ç™‚ã€æ™‚é–“ã¨ã—ã¦åˆ†é¡ã™ã‚‹ã¨ã€ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ã«æœ‰åˆ©ãªä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ãŒç”Ÿã˜ã¾ã™ã€‚",
              lesson: "Any time-to-treatment or requirement to survive to receive treatment creates potential immortal time bias."
            },
            class_correct: {
              situation: "æ­£è§£ã§ã™ã€‚ãƒ¬ãƒ ãƒ‡ã‚·ãƒ“ãƒ«ã®æŠ•ä¸ã‹ã‚‰å…¥é™¢ã¾ã§ã®æ™‚é–“ãŒã€Œæš´éœ²ã€ã¨ã—ã¦åˆ†é¡ã•ã‚ŒãŸå ´åˆã€ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ãŒå­˜åœ¨ã—ã¾ã™ã€‚ã•ã¦ã€ãƒã‚¤ã‚¢ã‚¹åˆ¤æ–­ã®å…¨ä½“çš„ãªãƒªã‚¹ã‚¯ã¯ã©ã‚Œãã‚‰ã„ã§ã™ã‹?",
              question: "Overall judgment:",
              branches: [
                { text: "ä¸­ç¨‹åº¦ â€” æ‡¸å¿µã¯ã‚ã‚Šã¾ã™ãŒã€ç ”ç©¶ã¯ä½¿ç”¨å¯èƒ½ã§ã™", nextNode: "overall_moderate" },
                { text: "Serious â€” multiple domains have important problems", nextNode: "overall_correct" },
                { text: "é‡å¤§ â€” ã“ã®ç ”ç©¶ã¯æœ‰ç”¨ãªè¨¼æ‹ ã‚’æä¾›ã—ã¾ã›ã‚“", nextNode: "overall_critical" }
              ]
            },
            overall_moderate: {
              type: 'outcome',
              outcome: 'partial',
              title: "Likely too generous",
              text: "é‡å¤§ãªäº¤çµ¡ã¨é‡å¤§ãªåˆ†é¡ãƒã‚¤ã‚¢ã‚¹ (æ°¸ä¹…çš„ãªæ™‚é–“) ãŒã‚ã‚‹ãŸã‚ã€å…¨ä½“çš„ãªåˆ¤æ–­ã¯å°‘ãªãã¨ã‚‚æ·±åˆ»ã§ã‚ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚å…¨ä½“ã¯æœ€æ‚ªã®é ˜åŸŸã«ã‚ˆã£ã¦æ±ºå®šã•ã‚Œã¾ã™ã€‚æ·±åˆ»ãªæ‡¸å¿µã‚’å¹³å‡ã—ã¦å–ã‚Šé™¤ãã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚",
              lesson: "Overall ROBINS-I judgment = worst single domain judgment. One serious domain = serious overall."
            },
            overall_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Appropriate judgment!",
              text: "æ·±åˆ»ãªäº¤çµ¡(æ¸¬å®šã•ã‚Œã¦ã„ãªã„é‡å¤§åº¦)ã¨é‡å¤§ãªåˆ†é¡ãƒã‚¤ã‚¢ã‚¹(ä¸æ»…ã®å¯èƒ½æ€§ã®ã‚ã‚‹æ™‚é–“)ãŒã‚ã‚‹ãŸã‚ã€ãƒã‚¤ã‚¢ã‚¹ã®å…¨ä½“çš„ãªãƒªã‚¹ã‚¯ã¯æ·±åˆ»ã§ã™ã€‚ç ”ç©¶çµæœã¯ååˆ†ã«æ³¨æ„ã—ã¦è§£é‡ˆã™ã‚‹å¿…è¦ãŒã‚ã‚Šã€å®šé‡çš„åˆæˆã«ã¯é©ã—ã¦ã„ãªã„å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "ROBINS-I ã¯æ„å›³çš„ã«ä¿å®ˆçš„ã§ã™ã€‚å®Ÿéš›ã®è–¬ç‰©è¦³å¯Ÿç ”ç©¶ã«ã¯ã€ãƒã‚¤ã‚¢ã‚¹ãŒç”Ÿã˜ã‚‹é‡å¤§ãªãƒªã‚¹ã‚¯ãŒä¼´ã†ã“ã¨ãŒã‚ˆãã‚ã‚Šã¾ã™ã€‚ã“ã®ã“ã¨ã‚’æ­£ç›´ã«èªã‚ã‚‹ã“ã¨ã¯ã€ãã†ã§ãªã„ãµã‚Šã‚’ã™ã‚‹ã‚ˆã‚Šã‚‚è‰¯ã„ã“ã¨ã§ã™ã€‚"
            },
            overall_critical: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possibly warranted, but justify carefully",
              text: "ã‚¯ãƒªãƒ†ã‚£ã‚«ãƒ« ãƒªã‚¹ã‚¯ã§ã¯ã€å°‘ãªãã¨ã‚‚ 1 ã¤ã®ãƒ‰ãƒ¡ã‚¤ãƒ³ãŒã‚¯ãƒªãƒ†ã‚£ã‚«ãƒ«ã§ã‚ã‚‹ã‹ã€è¤‡æ•°ã®æ·±åˆ»ãªãƒ‰ãƒ¡ã‚¤ãƒ³ãŒé‡ãªã£ã¦çµæœãŒæœ‰ç›Šã§ãªããªã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚æœ‰ç”¨ãªæƒ…å ±ãŒæŠ½å‡ºã§ããªã„ç†ç”±ã‚’æ˜ç¢ºã«èª¬æ˜ã§ãã‚‹å ´åˆã¯ã€æ‰¹åˆ¤çš„ãŒé©åˆ‡ã§ã‚ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "æ‰¹åˆ¤çš„åˆ¤æ–­ã¨ã¯ã€ã€Œã“ã®ç ”ç©¶ã¯è‡¨åºŠä¸Šã®æ±ºå®šã«å½±éŸ¿ã‚’ä¸ãˆã‚‹ã¹ãã§ã¯ãªã„ã€ã¨ã„ã†æ„å‘³ã§ã™ã€‚æ…é‡ã«ä½¿ç”¨ã—ã¦ãã ã•ã„ã€‚ãŸã ã—ã€æœ¬å½“ã«ä¿è¨¼ã•ã‚Œã¦ã„ã‚‹å ´åˆã¯é¿ã‘ãªã„ã§ãã ã•ã„ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "ã‚ã‚‹ç ”ç©¶ã§ã¯ã€6 ã¤ã® ROBINS-I ãƒ‰ãƒ¡ã‚¤ãƒ³ã®ãƒªã‚¹ã‚¯ã¯ã€Œä½ã„ã€ã§ã™ãŒã€äº¤çµ¡ã®ãƒªã‚¹ã‚¯ã¯ã€Œæ·±åˆ»ã€ã§ã™ã€‚ãƒã‚¤ã‚¢ã‚¹ã®å…¨ä½“çš„ãªãƒªã‚¹ã‚¯ã¯ä½•ã§ã™ã‹?",
          options: [
            { id: 'a', text: "Low â€” most domains are fine", correct: false },
            { id: 'b', text: "Moderate â€” one serious domain warrants caution", correct: false },
            { id: 'c', text: "Serious â€” overall is the worst single domain", correct: true },
            { id: 'd', text: "Cannot determine â€” need to average the domains", correct: false }
          ],
          explanation: "ROBINS-I ã§ã¯ã€ãƒã‚¤ã‚¢ã‚¹åˆ¤å®šã®å…¨ä½“çš„ãªãƒªã‚¹ã‚¯ã¯ã€ã™ã¹ã¦ã®ãƒ‰ãƒ¡ã‚¤ãƒ³ã«ã‚ãŸã‚‹æœ€ã‚‚æ·±åˆ»ãªåˆ¤å®šã¨åŒã˜ã§ã™ã€‚ã“ã‚Œã¯å¹³å‡åŒ–ã•ã‚ŒãŸã‚‚ã®ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚è‡´å‘½çš„ãªæ¬ é™¥ãŒ 1 ã¤ã‚ã‚‹ã®ã¯ä¾ç„¶ã¨ã—ã¦è‡´å‘½çš„ã§ã™ã€‚äº¤çµ¡ãŒæ·±åˆ»ãªå ´åˆã€ä»–ã®ãƒ‰ãƒ¡ã‚¤ãƒ³ãŒã©ã®ã‚ˆã†ã«é©åˆ‡ã«å‡¦ç†ã•ã‚Œã¦ã„ã‚‹ã‹ã«é–¢ä¿‚ãªãã€ç ”ç©¶å…¨ä½“ã®ãƒªã‚¹ã‚¯ãŒã€Œä½ã„ã€ã¾ãŸã¯ã€Œä¸­ç¨‹åº¦ã€ã§ã‚ã‚‹ã¨è¦‹ãªã™ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚"
        }
      }
    ]
  },
  // MODULE 6: THE ADJUSTMENT (Propensity Scores)
  {
    id: 6,
    title: "The Adjustment",
    subtitle: "Propensity Scores",
    principle: 5,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "èª¿æ•´ã¯é­”æ³•ã§ã¯ã‚ã‚Šã¾ã›ã‚“"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ãƒãƒ©ãƒ³ã‚¹ã®å¹»æƒ³: å‚¾å‘ã‚¹ã‚³ã‚¢ã¨æ¸¬å®šã•ã‚Œã¦ã„ãªã„",
          source: "King & Nielsen 2019 | Epidemiology debates | Propensity score wars",
          timeline: [
            { year: "1983", text: "ãƒ­ãƒ¼ã‚¼ãƒ³ãƒã‚¦ãƒ ã¨ãƒ«ãƒ¼ãƒ“ãƒ³ã¯ã€å‚¾å‘ã‚¹ã‚³ã‚¢: å…±å¤‰é‡ã‚’è€ƒæ…®ã—ãŸæ²»ç™‚ã®ç¢ºç‡ã‚’å°å…¥ã—ã¦ã„ã¾ã™ã€‚è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã«ãŠã‘ã‚‹å› æœæ¨è«–ã®é©å‘½ã€‚", type: "normal" },
            { year: "2000s", text: "å‚¾å‘ã‚¹ã‚³ã‚¢ ãƒãƒƒãƒãƒ³ã‚°ã¯è¦³å¯Ÿç ”ç©¶ã®ã€Œã‚´ãƒ¼ãƒ«ãƒ‰ ã‚¹ã‚¿ãƒ³ãƒ€ãƒ¼ãƒ‰ã€ã«ãªã‚Šã¾ã™ã€‚ ã€ŒRCT ã®ã‚ˆã†ãªã€ãƒãƒ©ãƒ³ã‚¹ã‚’ä¸»å¼µã™ã‚‹è«–æ–‡ãŒå¢—ãˆã¦ã„ã¾ã™ã€‚", type: "normal" },
            { year: "2010s", text: "Problems emerge: matching discards data, pruning can increase bias. IPTW and overlap weighting gain favor.", type: "crisis" },
            { year: "Key Issue", text: "Propensity scores balance MEASURED confounders only. If the key confounder is UNMEASURED, propensity scores give false confidence.", type: "revelation" },
            { year: "Example", text: "COX-2 inhibitors vs NSAIDs: propensity-matched studies showed safety. But unmeasured factors (channeling to lower-risk patients) weren't captured. RCTs revealed CV harm.", type: "crisis" },
            { year: "Lesson", text: "å‚¾å‘ã‚¹ã‚³ã‚¢ã¯ãƒ„ãƒ¼ãƒ«ã§ã‚ã‚Šã€æ²»ç™‚æ³•ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚å½¼ã‚‰ã¯ã‚ãªãŸãŒæ¸¬å®šã—ãŸã‚‚ã®ã®ãƒãƒ©ãƒ³ã‚¹ã‚’ã¨ã‚Šã¾ã™ã€‚æœªæ¸¬å®šã®äº¤çµ¡ãŒæ®‹ã‚‹ - æ„Ÿåº¦åˆ†æãŒä¸å¯æ¬ ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Cardiovascular events",
            drug: "COX-2 inhibitors (propensity-adjusted)",
            placebo: "Traditional NSAIDs",
            rr: "Observational: HR ~0.80 | RCT: HR 1.50+",
            ci: "Unmeasured channeling bias",
            nnh: "Vioxx withdrawn after 88,000+ cardiac events"
          },
          hook: "THE HOOK: å‚¾å‘ã‚¹ã‚³ã‚¢ã«ã‚ˆã‚Šã€è¦³å¯Ÿç ”ç©¶ãŒã€Œãƒãƒ©ãƒ³ã‚¹ãŒã¨ã‚Œã¦ã„ã‚‹ã€ã‚ˆã†ã«è¦‹ãˆã‚‹ã‚ˆã†ã«ãªã‚Šã¾ã—ãŸã€‚ã—ã‹ã—ã€æ¸¬å®šã•ã‚ŒãŸè¦ç´ ã®ãƒãƒ©ãƒ³ã‚¹ã¯ã€ã™ã¹ã¦ã®è¦ç´ ã®ãƒãƒ©ãƒ³ã‚¹ã‚’æ„å‘³ã™ã‚‹ã‚ã‘ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ COX-2/Vioxx ç½å®³ã¯ã€é«˜åº¦ãªçµ±è¨ˆã§ã¯æ¬ æãƒ‡ãƒ¼ã‚¿ã‚’ä¿®æ­£ã§ããªã„ã“ã¨ã‚’ç¤ºã—ã¾ã—ãŸã€‚"
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY INSIGHT: Propensity scores control for confounding by MEASURED variables. They create a pseudo-population where treatment is unrelated to those variables. But UNMEASURED confounders remain â€” and propensity scores can create false confidence by making studies look 'rigorous' when key confounders are missing."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is a Propensity Score?",
          sections: [
            {
              heading: "Definition:",
              items: [
                "Probability of receiving treatment given observed covariates",
                "PS = P(Treatment=1 | Xâ‚, Xâ‚‚, ..., Xâ‚–)",
                "Estimated using logistic regression (or machine learning)",
                "Summarizes many confounders into a single number"
              ]
            },
            {
              heading: "Why It Works (When It Works):",
              items: [
                "Balancing property: At each PS value, treatment is 'random' with respect to covariates",
                "Creates pseudo-randomization: mimics what an RCT would do",
                "Enables comparison of 'like with like'",
                "Reduces dimensionality: many confounders â†’ one score"
              ]
            },
            {
              heading: "The Limitation:",
              items: [
                "Only balances what's IN the model",
                "Unmeasured confounders remain unbalanced",
                "Can't balance what you don't know",
                "The 'strong ignorability' assumption is UNTESTABLE"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: å‚¾å‘ã‚¹ã‚³ã‚¢ã®ã‚¢ãƒ—ãƒ­ãƒ¼ãƒ",
          title: "Four Ways to Use Propensity Scores",
          sections: [
            {
              heading: "1. MATCHING",
              text: "åŒæ§˜ã® PS å€¤ã‚’æŒã¤æ²»ç™‚æ‚£è€…ã¨æœªæ²»ç™‚æ‚£è€…ã‚’ãƒšã‚¢ã«ã—ã¾ã™ã€‚ + ç›´æ„Ÿçš„ã§é€æ˜æ€§ãŒã‚ã‚‹ âˆ’ é©åˆã—ãªã„æ‚£è€…ã‚’ç ´æ£„ã™ã‚‹ âˆ’ ä¸‹æ‰‹ã‚’ã™ã‚‹ã¨ãƒã‚¤ã‚¢ã‚¹ãŒå¢—åŠ ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ (King & Nielsen)"
            },
            {
              heading: "2. STRATIFICATION",
              text: "Divide population into strata (e.g., quintiles) by PS.\n+ Simple, uses all data\nâˆ’ Residual confounding within strata\nâˆ’ Fewer strata = more bias; more = sparse data"
            },
            {
              heading: "3. INVERSE PROBABILITY WEIGHTING (IPTW)",
              text: "Weight patients by inverse of their PS.\n+ Uses all data, estimates population effect\nâˆ’ Extreme weights cause instability\nâˆ’ Sensitive to model misspecification"
            },
            {
              heading: "4. COVARIATE ADJUSTMENT",
              text: "Include PS as covariate in outcome model.\n+ Simple to implement\nâˆ’ Less efficient than other methods\nâˆ’ Doesn't check balance directly"
            },
            {
              heading: "Modern Preference:",
              text: "å®‰å®šã—ãŸé‡ã¿ã¾ãŸã¯é‡è¤‡é‡ã¿ã‚’å‚™ãˆãŸ IPTW ãŒå¥½ã¾ã‚Œã‚‹å ´åˆãŒå¤šã„ã€‚ãƒãƒƒãƒãƒ³ã‚°ã«å¯¾ã™ã‚‹æ‰¹åˆ¤ãŒé«˜ã¾ã£ã¦ã„ã‚‹ã€‚ãŸã ã—ã€ã™ã¹ã¦ã®æ‰‹æ³•ã«ã¯é©åˆ‡ãªå…±å¤‰é‡é¸æŠã¨æ„Ÿåº¦åˆ†æãŒå¿…è¦ã§ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Checking Balance: The Key Diagnostic",
          sections: [
            {
              heading: "Standardized Mean Difference (SMD):",
              items: [
                "SMD = (mean_treated - mean_control) / pooled_SD",
                "Before PS adjustment: expect large SMDs (confounding)",
                "After PS adjustment: SMDs should be <0.1 (balanced)",
                "If SMDs remain large, PS failed to balance"
              ]
            },
            {
              heading: "What to Check:",
              items: [
                "Balance on ALL measured confounders (not just PS)",
                "Balance on important interactions and non-linearities",
                "Overlap: both groups should have similar PS distributions",
                "é‡è¤‡ãŒãªã„å ´åˆã€åŠ¹æœã¯æ¨å®šã§ãã¾ã›ã‚“"
              ]
            },
            {
              heading: "Red Flags:",
              items: [
                "SMD >0.1 after adjustment = residual imbalance",
                "Non-overlapping PS distributions = positivity violation",
                "Extreme weights (>10 or <0.1) = instability",
                "Results sensitive to PS model specification = fragile"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "IPTW Deep Dive: Modern Weighting Methods",
          sections: [
            {
              heading: "Standard IPTW (Inverse Probability of Treatment Weighting)",
              items: [
                "Weight for treated: w = 1/PS",
                "Weight for untreated: w = 1/(1-PS)",
                "Creates pseudo-population where treatment is independent of covariates",
                "Estimates AVERAGE TREATMENT EFFECT (ATE) in full population",
                "Problem: extreme weights when PS near 0 or 1"
              ]
            },
            {
              heading: "Stabilized Weights (sw-IPTW)",
              items: [
                "Treated: sw = P(T=1)/PS",
                "Untreated: sw = P(T=0)/(1-PS)",
                "Numerator stabilizes by multiplying by marginal probability",
                "Reduces variance, preserves sample size interpretation",
                "Preferred over standard IPTW in modern practice"
              ]
            },
            {
              heading: "Overlap Weights (OW) â€” Modern Favorite",
              items: [
                "Treated: w = 1-PS",
                "Untreated: w = PS",
                "Targets patients with clinical equipoise (PS near 0.5)",
                "Automatically handles extreme PS â€” no trimming needed",
                "Estimates effect in population where treatment decision is uncertain",
                "Best balance properties; increasingly recommended"
              ]
            },
            {
              heading: "Weight Diagnostics:",
              items: [
                "Check weight distribution (mean, max, SD)",
                "Mean of weights should â‰ˆ 1 for stabilized",
                "Truncate at 99th percentile if extreme (but acknowledge sensitivity)",
                "Plot weighted SMDs â€” all should be <0.1",
                "Effective sample size: ESS = (Î£w)Â²/Î£wÂ² â€” watch for low ESS"
              ]
            },
            {
              heading: "When to Use Which:",
              text: "IPTW/stabilized: want population-average effect, have good overlap. Overlap weights: extreme PS values, want robust estimates, uncertain treatment decisions. Matching: want intuitive comparison, can afford data loss. Avoid matching if sample is small or effect heterogeneity matters."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'propensity-decision',
          title: "å‚¾å‘ã‚¹ã‚³ã‚¢ã®æ±ºå®š",
          situation: "You're analyzing whether a new anticoagulant (vs warfarin) reduces stroke in atrial fibrillation. You have data on age, sex, comorbidities, and CHAâ‚‚DSâ‚‚-VASc score. You DON'T have data on: renal function, patient frailty, or reason for drug choice.",
          nodes: {
            start: {
              question: "å‚¾å‘ã‚¹ã‚³ã‚¢ ãƒãƒƒãƒãƒ³ã‚°ã‚’ä½¿ç”¨ã™ã‚‹äºˆå®šã§ã™ã€‚æœ€åˆã«ç¢ºèªã™ã¹ãã“ã¨ã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "Whether the propensity score model is statistically significant", nextNode: "sig_wrong" },
                { text: "Whether covariates are balanced after matching (SMDs <0.1)", nextNode: "balance_correct" },
                { text: "Whether the treatment effect is statistically significant", nextNode: "effect_wrong" }
              ]
            },
            balance_correct: {
              situation: "Correct! After matching, your SMDs are all <0.1. But you're worried about unmeasured confounding (renal function, frailty). What should you do?",
              question: "How do you address unmeasured confounding?",
              branches: [
                { text: "Add more measured variables to the PS model", nextNode: "more_vars" },
                { text: "æœªæ¸¬å®šã®äº¤çµ¡ã«å¯¾ã™ã‚‹æ„Ÿåº¦åˆ†æã‚’å®Ÿè¡Œã—ã¾ã™", nextNode: "sensitivity_correct" },
                { text: "ä¸€è‡´ã—ãŸçµæœã‚’ã€Œäº¤çµ¡ã‚’èª¿æ•´æ¸ˆã¿ã€ã¨ã—ã¦å ±å‘Šã—ã¾ã™", nextNode: "report_wrong" }
              ]
            },
            sig_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Wrong focus!",
              text: "PS ãƒ¢ãƒ‡ãƒ«ã®çµ±è¨ˆçš„æœ‰æ„æ€§ã¯ç„¡é–¢ä¿‚ã§ã™ã€‚æ²»ç™‚ãŒã€Œäºˆæ¸¬å¯èƒ½ã€ã§ã‚ã‚‹ã‹ã©ã†ã‹ã¯æ°—ã«ã—ã¾ã›ã‚“ã€‚å…±å¤‰é‡ã®ãƒãƒ©ãƒ³ã‚¹ãŒå–ã‚Œã¦ã„ã‚‹ã‹ã©ã†ã‹ã‚’æ°—ã«ã—ã¾ã™ã€‚é‡è¦æ€§ã®é«˜ã„ PS ãƒ¢ãƒ‡ãƒ«ã§ã‚ã£ã¦ã‚‚ã€ä¸»è¦ãªäº¤çµ¡å› å­ã®ãƒãƒ©ãƒ³ã‚¹ã‚’ã¨ã‚‹ã“ã¨ãŒã§ããªã„å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "å‚¾å‘ã‚¹ã‚³ã‚¢ ãƒ¢ãƒ‡ãƒ«ã¯ã€p å€¤ã‚„ c çµ±è¨ˆé‡ã§ã¯ãªãã€é”æˆã•ã‚ŒãŸãƒãƒ©ãƒ³ã‚¹ã«ã‚ˆã£ã¦åˆ¤æ–­ã•ã‚Œã¾ã™ã€‚ãƒ¢ãƒ‡ãƒ«ã®é©åˆæ€§ã§ã¯ãªãã€SMD ã‚’ãƒã‚§ãƒƒã‚¯ã—ã¦ãã ã•ã„ã€‚"
            },
            effect_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Wrong order!",
              text: "ãƒãƒ©ãƒ³ã‚¹ã‚’æ¤œè¨¼ã™ã‚‹å‰ã«æ²»ç™‚åŠ¹æœã‚’æ±ºã—ã¦èª¿ã¹ãªã„ã§ãã ã•ã„ã€‚å…±å¤‰é‡ã®ãƒãƒ©ãƒ³ã‚¹ãŒå–ã‚Œã¦ã„ãªã„å ´åˆã€åŠ¹æœã®æ¨å®šå€¤ã«ã¯åã‚ŠãŒç”Ÿã˜ã¾ã™ã€‚æœ€åˆã«åŠ¹æœã‚’ç¢ºèªã™ã‚‹ã¨ã€å¿…è¦ãªç­”ãˆãŒå¾—ã‚‰ã‚Œã‚‹ã¾ã§å¾®èª¿æ•´ã‚’ç¶šã‘ãŸããªã‚Šã¾ã™ã€‚",
              lesson: "æ²»ç™‚åŠ¹æœã‚’èª¿ã¹ã‚‹å‰ã«ã€å¿…ãšãƒãƒ©ãƒ³ã‚¹ã‚’ç¢ºèªã—ã¦ãã ã•ã„ã€‚ PS ã‚¢ãƒ—ãƒ­ãƒ¼ãƒã¨ãƒãƒ©ãƒ³ã‚¹åŸºæº–ã‚’äº‹å‰ã«æŒ‡å®šã—ã¦ãã ã•ã„ã€‚"
            },
            more_vars: {
              type: 'outcome',
              outcome: 'partial',
              title: "Helpful but insufficient",
              text: "æ¸¬å®šå¤‰æ•°ã‚’è¿½åŠ ã™ã‚‹ã¨å½¹ç«‹ã¡ã¾ã™ãŒã€è…æ©Ÿèƒ½ã¨è™šå¼±æ€§ã¯æ¸¬å®šã•ã‚Œã¦ã„ãªã„ã¨ãŠã£ã—ã‚ƒã„ã¾ã—ãŸã€‚ You can't add what you don't have.çµè«–ã‚’å¤‰ãˆã‚‹ãŸã‚ã«ã©ã®ç¨‹åº¦ã®æœªæ¸¬å®šã®äº¤çµ¡ãŒå¿…è¦ã‹ã‚’è©•ä¾¡ã™ã‚‹ã«ã¯ã€æ„Ÿåº¦åˆ†æãŒå¿…è¦ã§ã™ã€‚",
              lesson: "æ¸¬å®šã—ãªã„ã‚‚ã®ã‚’èª¿æ•´ã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚æ„Ÿåº¦åˆ†æã«ã‚ˆã‚Šã€æ¬ è½ã—ã¦ã„ã‚‹ã‚‚ã®ã®æ½œåœ¨çš„ãªå½±éŸ¿ãŒå®šé‡åŒ–ã•ã‚Œã¾ã™ã€‚"
            },
            sensitivity_correct: {
              situation: "ç´ æ™´ã‚‰ã—ã„! E å€¤ã‚’ä½¿ç”¨ã—ã¦æ„Ÿåº¦åˆ†æã‚’å®Ÿè¡Œã—ã¾ã™ã€‚çµæœã¯ HR 0.75 (0.65-0.87) ã§ã™ã€‚ Eå€¤ã¯1.82ã§ã™ã€‚ã“ã‚Œã¯ä½•ã‚’æ„å‘³ã—ã¾ã™ã‹?",
              question: "Interpretation:",
              branches: [
                { text: "æ²»ç™‚ã¨è»¢å¸°ã®ä¸¡æ–¹ã§ RR â‰§ 1.82 ã®æœªæ¸¬å®šã®äº¤çµ¡å› å­ã«ã‚ˆã£ã¦ã€ãã®åŠ¹æœãŒèª¬æ˜ã§ãã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚", nextNode: "evalue_correct" },
                { text: "The result is robust because 1.82 is a large number", nextNode: "evalue_partial" }
              ]
            },
            report_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Misleading claim!",
              text: "ã€Œäº¤çµ¡ã‚’èª¿æ•´ã—ãŸã€ã¨å ±å‘Šã™ã‚‹ã“ã¨ã¯ã€ã™ã¹ã¦ã®äº¤çµ¡ãŒå¯¾å‡¦ã•ã‚Œã¦ã„ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ã—ã‹ã—ã€å‚¾å‘ã‚¹ã‚³ã‚¢ã¯æ¸¬å®šã•ã‚ŒãŸå¤‰æ•°ã®ãƒãƒ©ãƒ³ã‚¹ã®ã¿ã‚’ã¨ã‚Šã¾ã™ã€‚æœªæ¸¬å®šã®äº¤çµ¡å› å­ (è…æ©Ÿèƒ½ã€è™šå¼±ã€ãƒãƒ£ãƒãƒªãƒ³ã‚°) ãŒã‚ã‚‹å ´åˆã€æ¨å®šå€¤ã«ã¯ä¾ç„¶ã¨ã—ã¦å¤§ããªãƒã‚¤ã‚¢ã‚¹ãŒã‹ã‹ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "Always state: 'Adjusted for MEASURED confounders.' Acknowledge what's missing. Never claim full adjustment."
            },
            evalue_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Perfect interpretation!",
              text: "E å€¤ã¯å …ç‰¢æ€§ã‚’å®šé‡åŒ–ã—ã¾ã™ã€‚çµæœã‚’å®Œå…¨ã«èª¬æ˜ã™ã‚‹ã«ã¯ã€æœªæ¸¬å®šã®äº¤çµ¡å› å­ãŒæ›éœ²é‡ã¨çµæœã®ä¸¡æ–¹ã§ RR â‰¥1.82 ã‚’å¿…è¦ã¨ã—ã¾ã™ã€‚ã“ã“ã§ã€ã€ŒRR 1.82 ã¨ã®äº¤çµ¡å› å­ã¯ã‚‚ã£ã¨ã‚‚ã‚‰ã—ã„ã§ã™ã‹?ã€ã¨å°‹ã­ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚è…æ©Ÿèƒ½ãŒæŠ—å‡å›ºè–¬ã®é¸æŠã¨è„³å’ä¸­ã®ä¸¡æ–¹ã«å½±éŸ¿ã‚’ä¸ãˆã‚‹å ´åˆã€ãŠãã‚‰ããã®ã¨ãŠã‚Šã§ã™ã€‚",
              lesson: "E-values don't prove causation. They help you assess: 'How strong would hidden bias need to be?' Compare to known confounder strengths."
            },
            evalue_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Needs context!",
              text: "1.82 ãŒã€Œå¤§ãã„ã€ã‹ã©ã†ã‹ã¯çŠ¶æ³ã«ã‚ˆã£ã¦ç•°ãªã‚Šã¾ã™ã€‚å–«ç…™ã«ã‚ˆã‚‹è‚ºãŒã‚“ã®RRã¯ç´„20ã€å¿ƒè‡“ç—…ã®å ´åˆã¯ç´„2ï½3ã§ã™ã€‚ Renal function might have RR 1.5-2 for stroke.ä»»æ„ã®ã—ãã„å€¤ã§ã¯ãªãã€å¦¥å½“ãªäº¤çµ¡å› å­ã®å¼·åº¦ã¨æ¯”è¼ƒã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "E å€¤ã«ã¯è‡¨åºŠåˆ¤æ–­ãŒå¿…è¦ã§ã™ã€‚ 1.82 ã¯æœ¬è³ªçš„ã«å …ç‰¢ã§ã‚‚è„†å¼±ã§ã‚‚ã‚ã‚Šã¾ã›ã‚“ã€‚ãã‚Œã¯ã€ã©ã®ã‚ˆã†ãªæœªæ¸¬å®šã®äº¤çµ¡å› å­ãŒå­˜åœ¨ã™ã‚‹ã‹ã€ãŠã‚ˆã³ãã®å¼·ã•ã«ã‚ˆã£ã¦æ±ºã¾ã‚Šã¾ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "After propensity score matching, you achieve perfect balance (all SMDs <0.1) on 15 measured covariates. You can now conclude:",
          options: [
            { id: 'a', text: "æ²»ç™‚åŠ¹æœã¯äº¤çµ¡ã•ã‚Œã¾ã›ã‚“", correct: false },
            { id: 'b', text: "æ²»ç™‚åŠ¹æœã¯ 15 ã®æ¸¬å®šã•ã‚ŒãŸå…±å¤‰é‡ã«ã‚ˆã£ã¦äº¤çµ¡ã•ã‚Œã¾ã›ã‚“", correct: true },
            { id: 'c', text: "ã“ã®ç ”ç©¶ã¯ã€ RCT", correct: false },
            { id: 'd', text: "Unmeasured confounding has been addressed", correct: false }
          ],
          explanation: "å‚¾å‘ã‚¹ã‚³ã‚¢ã¯ã€ãƒ¢ãƒ‡ãƒ«å†…ã®å†…å®¹ã®ãƒãƒ©ãƒ³ã‚¹ã‚’ã¨ã‚‹ã ã‘ã§ã™ã€‚ 15 ã®å…±å¤‰é‡ã®å®Œç’§ãªãƒãƒ©ãƒ³ã‚¹ã¯ã€ãã‚Œã‚‰ã® 15 ãŒã‚‚ã¯ã‚„äº¤çµ¡å› å­ã§ã¯ãªã„ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ãŒã€æ¸¬å®šã•ã‚Œã¦ã„ãªã„å¤‰æ•°ã«ã¤ã„ã¦ã¯ä½•ã‚‚èªã£ã¦ã„ã¾ã›ã‚“ã€‚ç„¡ä½œç‚ºåŒ–ã§ã¯æ¸¬å®šæ¸ˆã¿ã¨æœªæ¸¬å®šã®ã™ã¹ã¦ã®äº¤çµ¡å› å­ã®ãƒãƒ©ãƒ³ã‚¹ã‚’ã¨ã‚‹ãŸã‚ã€ã“ã®ç ”ç©¶ã¯ RCT ã¨åŒç­‰ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "Negative Control Outcomes: Testing Your Adjustment",
          sections: [
            {
              heading: "The Brilliant Idea:",
              items: [
                "æ›éœ²ãŒãŠãã‚‰ãå½±éŸ¿ã‚’åŠã¼ã•ãªã„çµæœã‚’é¸æŠã—ã¦ãã ã•ã„",
                "åˆ†æã§ã“ã®é™°æ€§å¯¾ç…§ã«å¯¾ã™ã‚‹ã€Œå½±éŸ¿ã€ãŒç¤ºã•ã‚ŒãŸå ´åˆ â†’ äº¤çµ¡ãŒæ®‹ã£ã¦ã„ã‚‹å ´åˆ",
                "ä¾‹: ã‚¹ã‚¿ãƒãƒ³è‡ªå‹•è»Šäº‹æ•…ã«ã¯å½±éŸ¿ã—ãªã„ã¯ãšã§ã™ã€‚ã‚¹ã‚¿ãƒãƒ³ã®ç ”ç©¶ã§ã€ã‚¹ã‚¿ãƒãƒ³ä½¿ç”¨è€…ã®äº¤é€šäº‹æ•…ãŒå°‘ãªã„ã“ã¨ãŒç¤ºã•ã‚ŒãŸå ´åˆ â†’ æ··ä¹±ã™ã‚‹ (å¥åº·ãªäººã¯ã‚¹ã‚¿ãƒãƒ³ã‚’æœç”¨ã—ã€å®‰å…¨ã«é‹è»¢ã™ã‚‹)"
              ]
            },
            {
              heading: "How It Works:",
              items: [
                "Same exposure, same adjustment, different outcome",
                "Negative control outcome should share confounders with primary outcome",
                "But exposure has no biological pathway to negative control",
                "Association with negative control = confounding signal"
              ]
            },
            {
              heading: "Real Example:",
              items: [
                "Study: Do ACE inhibitors reduce COVID mortality?",
                "Primary outcome: COVID death",
                "Negative control: Injuries/accidents",
                "If ACE inhibitors 'reduce' injuries too â†’ healthy user confounding",
                "Used in major COVID-19 pharmacoepidemiology studies"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'negative-control-design',
          title: "Design a Negative Control Test",
          situation: "ã‚ãªãŸã¯ã€ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶ãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®ãŒå¿ƒè¡€ç®¡ã‚¤ãƒ™ãƒ³ãƒˆã‚’è»½æ¸›ã™ã‚‹ã‹ã©ã†ã‹ã‚’ç ”ç©¶ã—ã¦ã„ã¾ã™ã€‚ãƒã‚¬ãƒ†ã‚£ãƒ– ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã‚’ä½¿ç”¨ã—ã¦ã€å¥åº·ãªãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®è€…ã®äº¤çµ¡ã‚’ãƒ†ã‚¹ãƒˆã—ãŸã„ã¨è€ƒãˆã¦ã„ã¾ã™ã€‚",
          nodes: {
            start: {
              question: "Which outcome would be a good NEGATIVE CONTROL for flu vaccine â†’ cardiovascular events?",
              branches: [
                { text: "Pneumonia hospitalization", nextNode: "pneumonia_wrong" },
                { text: "Hip fracture", nextNode: "hip_correct" },
                { text: "Diabetes diagnosis", nextNode: "diabetes_wrong" }
              ]
            },
            pneumonia_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ãƒã‚¬ãƒ†ã‚£ãƒ– ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã¯é©åˆ‡ã§ã¯ã‚ã‚Šã¾ã›ã‚“!",
              text: "Flu vaccine MIGHT actually prevent pneumonia (flu can lead to secondary bacterial pneumonia). A negative control must be an outcome the exposure CANNOT plausibly affect. Pneumonia is biologically related to flu.",
              lesson: "ãƒã‚¬ãƒ†ã‚£ãƒ– ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã«ã¯ã€æ›éœ²ã«ã‚ˆã‚‹ç”Ÿç‰©å­¦çš„çµŒè·¯ãŒå­˜åœ¨ã—ã¦ã¯ãªã‚Šã¾ã›ã‚“ã€‚ã‚‚ã£ã¨ã‚‚ã‚‰ã—ã„ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ãŒã‚ã‚‹ã¨ã—ã¦ã‚‚ã€ãã‚Œã¯æœ‰åŠ¹ãªã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            hip_correct: {
              situation: "ç´ æ™´ã‚‰ã—ã„é¸æŠã§ã™ã€‚ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶ãƒ¯ã‚¯ãƒãƒ³ã«ã¯å¤§è…¿éª¨é ¸éƒ¨éª¨æŠ˜ã¸ã®ç”Ÿç‰©å­¦çš„çµŒè·¯ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã—ã‹ã—ã€è‚¡é–¢ç¯€éª¨æŠ˜ã¯å¿ƒè¡€ç®¡ã‚¤ãƒ™ãƒ³ãƒˆï¼ˆå¹´é½¢ã€è™šå¼±ã€å¥åº·ã‚’æ±‚ã‚ã‚‹è¡Œå‹•ï¼‰ã¨å…±é€šã®äº¤çµ¡å› å­ã‚’æŒã£ã¦ã„ã¾ã™ã€‚ã•ã¦ã€ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶ãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®ãŒè‚¡é–¢ç¯€éª¨æŠ˜ã® 20% æ¸›å°‘ã«é–¢é€£ã—ã¦ã„ã‚‹ã“ã¨ãŒã‚ã‹ã‚Šã¾ã—ãŸ (RR 0.80)ã€‚",
              question: "ã“ã‚Œã¯ã‚ãªãŸã®å¿ƒè¡€ç®¡æ‰€è¦‹ã«ã¤ã„ã¦ä½•ã‚’ç¤ºã—ã¦ã„ã¾ã™ã‹?",
              branches: [
                { text: "Flu vaccine might actually prevent fractures too â€” it's beneficial!", nextNode: "beneficial_wrong" },
                { text: "You have unmeasured confounding â€” healthy vaccinees have better outcomes generally", nextNode: "confounding_correct" }
              ]
            },
            diabetes_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "å¯èƒ½æ€§ã¯ã‚ã‚‹ãŒç†æƒ³çš„ã§ã¯ã‚ã‚Šã¾ã›ã‚“",
              text: "ç³–å°¿ç—…ã®è¨ºæ–­ã¯æ…¢æ€§çš„ã§ã‚ã‚Šã€äº¤çµ¡å› å­ã‚’å…±æœ‰ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ã—ã‹ã—ã€ã‚¿ã‚¤ãƒŸãƒ³ã‚°ã¯é›£ã—ã„ã€‚ãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®å¾Œã«ã¯æ–°ãŸãªçµæœãŒå¿…è¦ã ã€‚æ…¢æ€§çš„ãªçŠ¶æ…‹ã§ã¯ã€æ­£ç¢ºã«æ™‚é–“ã‚’è¨ˆã‚‹ã®ãŒé›£ã—ããªã‚Šã¾ã™ã€‚è‚¡é–¢ç¯€ã®éª¨æŠ˜ã‚„äº‹æ•…ã¯æ€¥æ€§ã®å‡ºæ¥äº‹ã§ã‚ã‚‹ãŸã‚ã€ã‚ˆã‚Šé©åˆ‡ã§ã™ã€‚",
              lesson: "Good negative controls are: (1) acute (clear timing), (2) share confounders with primary outcome, (3) have no biological link to exposure."
            },
            beneficial_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚ŒãŒäº¤çµ¡ã®ç½ ã§ã™!",
              text: "There is NO biological mechanism by which flu vaccine prevents hip fractures. The 'benefit' is confounding: people who get vaccinated are healthier, more mobile, less frail, and less likely to fall. This SAME confounding affects your cardiovascular finding.",
              lesson: "ãƒã‚¬ãƒ†ã‚£ãƒ–ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ãŒã€Œå½±éŸ¿ã€ã‚’ç¤ºã™ã¨ã€ä¸»è¦ãªåˆ†æãŒæ··ä¹±ã—ã¾ã™ã€‚ãƒã‚¬ãƒ†ã‚£ãƒ–ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«åŠ¹æœã®å¤§ãã•ã¯ã€ãƒã‚¤ã‚¢ã‚¹ã®å¤§ãã•ã‚’ç¤ºã—ã¾ã™ã€‚"
            },
            confounding_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶ãƒ¯ã‚¯ãƒãƒ³ãŒè‚¡é–¢ç¯€éª¨æŠ˜ã‚’ã€Œäºˆé˜²ã€ã—ï¼ˆRR 0.80ï¼‰ã€ç”Ÿç‰©å­¦çš„ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ãŒå­˜åœ¨ã—ãªã„å ´åˆã€è¦³å¯Ÿã•ã‚ŒãŸåŠ¹æœã®ç´„ 20% ã¯å¥åº·ãªãƒ¯ã‚¯ãƒãƒ³æ¥ç¨®è€…ã®äº¤çµ¡ã«ã‚ˆã‚‹ã‚‚ã®ã§ã™ã€‚å¿ƒè¡€ç®¡ã® RR 0.70 ã¯ã€å®Ÿéš›ã«ã¯ 0.88 (RR/0.80) ã«è¿‘ã„å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ãƒã‚¬ãƒ†ã‚£ãƒ–ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã¯ãƒã‚¤ã‚¢ã‚¹ã‚’å®šé‡åŒ–ã—ã¾ã™ã€‚",
              lesson: "Negative controls are diagnostic. Use them to: (1) detect confounding, (2) estimate its magnitude, (3) potentially calibrate your main estimate. This is essential for credible observational research."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: Propensity scores are TOOLS, not magic wands. They balance what you measure. They create false confidence when you haven't measured the key confounders. Always ask: 'What would a negative control show?' If your exposure 'prevents' outcomes it biologically cannot affect, your adjustment has failed."
        }
      }
    ]
  },
  // MODULE 7: THE TARGET TRIAL (Target Trial Emulation)
  {
    id: 7,
    title: "ã‚¿ãƒ¼ã‚²ãƒƒãƒˆè©¦é¨“",
    subtitle: "Emulating RCTs",
    principle: 1,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "é–¢é€£æ€§ã¯å› æœé–¢ä¿‚ã§ã¯ã‚ã‚Šã¾ã›ã‚“"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "æ˜ç¢ºåŒ–: ã‚¢ã‚¹ãƒ”ãƒªãƒ³ã¨ãŒã‚“ â€” ãƒ•ãƒ¬ãƒ¼ãƒ ãƒ¯ãƒ¼ã‚¯ãŒã™ã¹ã¦ã‚’å¤‰ãˆãŸã¨ã",
          source: "HernÃ¡n & Robins | Am J Epidemiol 2016 | Target trial framework",
          timeline: [
            { year: "1990s-2000s", text: "ã‚¢ã‚¹ãƒ”ãƒªãƒ³ã¨ãŒã‚“ã«é–¢ã™ã‚‹è¦³å¯Ÿç ”ç©¶ã¯çŸ›ç›¾ã—ã¦ã„ã¾ã™ã€‚ä¿è­·ã‚’ç¤ºã™ã‚‚ã®ã‚‚ã‚ã‚Œã°ã€ãã†ã§ãªã„ã‚‚ã®ã‚‚ã‚ã‚Šã¾ã™ã€‚ã•ã¾ã–ã¾ãªæ™‚é–“æ ã€æ¯é›†å›£ã€å®šç¾©ã€‚", type: "normal" },
            { year: "The Problem", text: "å„ç ”ç©¶ã¯ã‚ãšã‹ã«ç•°ãªã‚‹è³ªå•ã‚’ã—ã¾ã—ãŸã€‚ ã€Œã‚¢ã‚¹ãƒ”ãƒªãƒ³ã¯ã‚¬ãƒ³ã‚’äºˆé˜²ã—ã¾ã™ã‹?ã€æ›–æ˜§ã§ã™ã€‚ã©ã®ã‚¢ã‚¹ãƒ”ãƒªãƒ³å‡¦æ–¹ã§ã™ã‹?èª°ã®ä¸­ã§ï¼Ÿã„ã¤ã‹ã‚‰å§‹ã‚ã¾ã—ãŸã‹?ä½•ã¨æ¯”ã¹ã¦ï¼Ÿ", type: "crisis" },
            { year: "Target Trial", text: "Specify the RCT you WISH you could do: eligibility (healthy adults 50-70), intervention (aspirin 75mg daily), comparator (no aspirin), outcomes (cancer incidence at 10 years), time zero.", type: "revelation" },
            { year: "Emulation", text: "ã“ã“ã§ã€ã“ã®è©¦é¨“ãŒãã†ã ã£ãŸã¨ã—ã¦è¦³æ¸¬ãƒ‡ãƒ¼ã‚¿ã‚’åˆ†æã—ã¾ã™ã€‚æ™‚é–“ã‚¼ãƒ­ã§æ‚£è€…ã®ã‚¯ãƒ­ãƒ¼ãƒ³ã‚’ä½œæˆã—ã¾ã™ã€‚è³‡æ ¼åŸºæº–ã‚’é©ç”¨ã—ã¾ã™ã€‚åŒã˜é–‹å§‹ç‚¹ã‹ã‚‰è¿½è·¡ã—ã¾ã™ã€‚åŒã˜çµæœã‚’æ¯”è¼ƒã—ã¾ã™ã€‚", type: "revelation" },
            { year: "Resolution", text: "ç ”ç©¶ãŒåŒã˜å¯¾è±¡è©¦é¨“ã‚’ã‚¨ãƒŸãƒ¥ãƒ¬ãƒ¼ãƒˆã—ãŸå ´åˆã€çµæœã¯ä¸€è²«ã—ã¾ã—ãŸã€‚çŸ›ç›¾ã¯ã€ç•°ãªã‚‹ (å¤šãã®å ´åˆæš—é»™ã®) ç ”ç©¶ä¸Šã®ç–‘å•ã«ã‚ˆã‚‹ã‚‚ã®ã§ã—ãŸã€‚", type: "revelation" },
            { year: "Lesson", text: "è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã‚’åˆ†æã™ã‚‹å‰ã«ã€å¯¾è±¡ã¨ãªã‚‹ãƒˆãƒ©ã‚¤ã‚¢ãƒ«ã‚’æŒ‡å®šã—ã¦ãã ã•ã„ã€‚ã“ã‚Œã«ã‚ˆã‚Šã€ä»®å®šãŒæ˜ç¢ºã«ãªã‚Šã€ä¸€èˆ¬çš„ãªãƒã‚¤ã‚¢ã‚¹ãŒé˜²æ­¢ã•ã‚Œã€ç ”ç©¶é–“ã®æ¯”è¼ƒãŒå¯èƒ½ã«ãªã‚Šã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Cancer incidence/mortality",
            drug: "Aspirin (various regimens)",
            placebo: "No aspirin (various comparators)",
            rr: "Ranged HR 0.70 to 1.20 depending on implicit trial",
            ci: "Clarified once target trial specified",
            nnh: "Decades of confusion from ambiguous questions"
          },
          hook: "THE HOOK: 'Does aspirin prevent cancer?' isn't a research question â€” it's a family of questions. Target trial emulation forces you to be precise: WHICH intervention, in WHOM, compared to WHAT, measured HOW. Precision enables causal inference."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY INSIGHT: Every observational analysis implicitly emulates SOME randomized trial. The target trial framework makes this explicit. By specifying eligibility, interventions, outcomes, and time zero BEFORE analysis, you prevent biases like immortal time, prevalent user bias, and confounding by indication."
        }
      },
      {
        type: 'story-box',
        content: {
          icon: 'ğŸ¯',
          title: "The Target Trial Emulation Revolution",
          source: "Hernan & Robins, Am J Epidemiol 2016 | Causal Inference Framework",
          paragraphs: [
            "In 2016, Miguel Hernan and James Robins formalized a methodological revolution: 'target trial emulation.' The idea was deceptively simpleâ€”design your observational analysis as if it were the RCT you wish you could do.",
            "They applied this to a contentious question: do statins prevent death in primary prevention? Traditional observational methods showed a 25% mortality reduction. But when analyzed using target trial emulationâ€”proper time zero, new-user design, clear eligibilityâ€”the benefit dropped to 15%.",
            "The 10-percentage-point difference wasn't noiseâ€”it was bias that traditional methods had missed. Immortal time, prevalent user bias, and unclear time zero had all inflated the apparent benefit. Target trial emulation didn't just give a different answer; it gave a more honest one."
          ],
          lesson: "Target trial emulation is reshaping observational research. By forcing explicit specification of eligibility, interventions, time zero, and outcomes BEFORE analysis, it prevents the biases that have historically made observational studies unreliable. It's not a statistical trickâ€”it's a framework for honest causal thinking."
        }
      },
      {
        type: 'content',
        content: {
          title: "ã‚¿ãƒ¼ã‚²ãƒƒãƒˆè©¦é¨“ãƒ•ãƒ¬ãƒ¼ãƒ ãƒ¯ãƒ¼ã‚¯",
          sections: [
            {
              heading: "Step 1: Specify the Protocol (7 Components):",
              items: [
                "1. ELIGIBILITY: Who would be enrolled?",
                "2. INTERVENTIONS: What treatments, at what doses?",
                "3. ASSIGNMENT: How would randomization work?",
                "4. TIME ZERO: When does follow-up start?",
                "5. OUTCOMES: What do you measure, and when?",
                "6. FOLLOW-UP: How long do you track patients?",
                "7ã€‚åˆ†æ: æ²»ç™‚ã®æ„å›³?ãƒ—ãƒ­ãƒˆã‚³ãƒ«ã”ã¨?"
              ]
            },
            {
              heading: "Step 2: Emulate with Observational Data:",
              items: [
                "Apply eligibility criteria to your database",
                "Define time zero (same for all patients!)",
                "Classify exposure at time zero (not after)",
                "Use methods to handle confounding (PS, IPW)",
                "RCT ã¨åŒã˜ã‚ˆã†ã«åˆ†æã—ã¾ã™"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: ã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒˆãƒ©ã‚¤ã‚¢ãƒ«ã«ã‚ˆã‚‹ãƒã‚¤ã‚¢ã‚¹ã®å›é¿",
          title: "How Specification Prevents Bias",
          sections: [
            {
              heading: "Prevents IMMORTAL TIME BIAS:",
              text: "æ™‚é–“ã‚’ã‚¼ãƒ­ã¨å®šç¾©ã™ã‚‹ã“ã¨ã§ã€ç”Ÿå­˜æ™‚é–“ã‚’æ›éœ²æ™‚é–“ã¨ã—ã¦èª¤åˆ†é¡ã™ã‚‹ã“ã¨ãŒã§ããªããªã‚Šã¾ã™ã€‚å…¨å“¡ã®æ™‚è¨ˆã¯ã€ãŸã¾ãŸã¾æ²»ç™‚ã‚’å—ã‘ãŸã¨ãã§ã¯ãªãã€åŒã˜æ™‚ç‚¹ (è³‡æ ¼ + æ²»ç™‚ã®å‰²ã‚Šå½“ã¦) ã‹ã‚‰å§‹ã¾ã‚Šã¾ã™ã€‚"
            },
            {
              heading: "Prevents PREVALENT USER BIAS:",
              text: "å¯¾è±¡æ²»é¨“ã§ã¯ã€RCT ã¨åŒæ§˜ã«ã€æ–°è¦ãƒ¦ãƒ¼ã‚¶ãƒ¼ã‚’æŒ‡å®šã—ã¾ã™ã€‚æ²»ç™‚ã‚’å§‹ã‚ãŸã°ã‹ã‚Šã®äººï¼ˆç™ºç—‡ï¼‰ã¨ã€ä½•å¹´ã‚‚æ²»ç™‚ã‚’å—ã‘ã¦ã„ã‚‹äººï¼ˆè”“å»¶ä¸­ï¼‰ã‚’æ··åŒã™ã‚‹ã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã®ãƒˆãƒ©ã‚¤ã‚¢ãƒ«ã§ã¯ã€ä¸€èˆ¬çš„ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã¯ç™»éŒ²ã•ã‚Œã¾ã›ã‚“ã€‚"
            },
            {
              heading: "Prevents CONFOUNDING BY INDICATION:",
              text: "Eligibility criteria define who could receive either treatment. Propensity scores or IPW handle remaining confounding. You're comparing 'like with like' at time zero."
            },
            {
              heading: "Ensures CLEAR OUTCOMES:",
              text: "çµæœã®è©•ä¾¡ã¯äº‹å‰ã«å®šç¾©ã•ã‚Œã¾ã™ã€‚ãƒ‡ãƒ¼ã‚¿ã‚’ç¢ºèªã—ãŸå¾Œã«ã‚¨ãƒ³ãƒ‰ãƒã‚¤ãƒ³ãƒˆã‚’å¤‰æ›´ã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚ã‚¿ãƒ¼ã‚²ãƒƒãƒˆè©¦é¨“ãƒ—ãƒ­ãƒˆã‚³ãƒ«ã¯ã€åˆ†æè¨ˆç”»ã‚’å›ºå®šã—ã¾ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Time Zero: The Critical Concept",
          sections: [
            {
              heading: "What Is Time Zero?",
              items: [
                "ä»®èª¬è©¦é¨“ãŒãƒ©ãƒ³ãƒ€ãƒ åŒ–ã•ã‚Œã‚‹ç¬é–“",
                "åˆ†æã§ã¯ã™ã¹ã¦ã®æ‚£è€…ã§åŒã˜ã§ã‚ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™",
                "MUST be when exposure status is assigned",
                "Follow-up starts AT time zero, not before"
              ]
            },
            {
              heading: "Common Mistakes:",
              items: [
                "Using 'ever vs never' exposure (no time zero)",
                "Starting follow-up at diagnosis but assigning exposure later",
                "Mixing incident and prevalent users",
                "Different time zeros for different groups"
              ]
            },
            {
              heading: "Example: Statins After MI",
              items: [
                "Target trial: Randomize at hospital discharge",
                "Emulation: Time zero = discharge date",
                "Assign statin status AT DISCHARGE (not later prescriptions)",
                "é€€é™¢ã‹ã‚‰è»¢å¸°ã¾ã§ã‚’è¿½è·¡ã—ã¾ã™",
                "This prevents immortal time bias"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'target-trial-design',
          title: "ã‚¿ãƒ¼ã‚²ãƒƒãƒˆã‚’è¨­è¨ˆã—ã¾ã™ãƒˆãƒ©ã‚¤ã‚¢ãƒ«",
          situation: "å¿ƒè‡“ç™ºä½œå¾Œã«åœ°ä¸­æµ·é£Ÿã‚’é–‹å§‹ã™ã‚‹ã¨ã€é€šå¸¸ã®é£Ÿäº‹ã¨æ¯”è¼ƒã—ã¦æ­»äº¡ç‡ãŒä½ä¸‹ã™ã‚‹ã‹ã©ã†ã‹ã‚’ç ”ç©¶ã—ãŸã„ã¨è€ƒãˆã¦ã„ã¾ã™ã€‚ã•ã¾ã–ã¾ãªæ™‚ç‚¹ã§ã®é£Ÿäº‹è©•ä¾¡ã‚’å«ã‚€é›»å­å¥åº·è¨˜éŒ²ãŒã‚ã‚Šã¾ã™ã€‚",
          nodes: {
            start: {
              question: "What should be your time zero?",
              branches: [
                { text: "Date of first Mediterranean diet assessment", nextNode: "diet_date_wrong" },
                { text: "Hospital discharge after MI", nextNode: "discharge_correct" },
                { text: "Date of MI diagnosis", nextNode: "mi_date_partial" }
              ]
            },
            discharge_correct: {
              situation: "Good choice! Discharge is when a dietary intervention could plausibly start. Now, how do you define 'Mediterranean diet' exposure?",
              question: "Exposure definition:",
              branches: [
                { text: "Any Mediterranean diet assessment scored 'high' during follow-up", nextNode: "any_high_wrong" },
                { text: "Mediterranean diet score at the first post-discharge assessment", nextNode: "first_assessment_correct" },
                { text: "Sustained high Mediterranean diet score for 6+ months", nextNode: "sustained_partial" }
              ]
            },
            diet_date_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This creates immortal time bias!",
              text: "æ‚£è€…ã¯ã€æœ€åˆã®é£Ÿäº‹è©•ä¾¡ãŒã€Œåœ°ä¸­æµ·é£Ÿã€ã¨ã—ã¦åˆ†é¡ã•ã‚Œã‚‹ã¾ã§ç”Ÿãå»¶ã³ãªã‘ã‚Œã°ãªã‚Šã¾ã›ã‚“ã€‚ MI ã‹ã‚‰è©•ä¾¡ã¾ã§ã®æ™‚é–“ã¯ä¸æ»…ã®æ™‚é–“ã§ã™ã€‚èª¤ã£ã¦åˆ†é¡ã•ã‚ŒãŸå ´åˆã€é£Ÿäº‹ã‚°ãƒ«ãƒ¼ãƒ—ã®ç”Ÿå­˜ç‡ãŒäººç‚ºçš„ã«è†¨ã‚‰ã¿ã¾ã™ã€‚",
              lesson: "æ™‚é–“ã‚¼ãƒ­ã¯ã€ä»‹å…¥ãŒæ¸¬å®šã•ã‚ŒãŸã¨ãã§ã¯ãªãã€ä»‹å…¥ãŒé–‹å§‹ã§ãã‚‹ã¨ãã§ã‚ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚é£Ÿäº‹è©•ä¾¡ã®æ—¥ä»˜ã¯ç•°ãªã‚Šã¾ã™ã€‚ã“ã‚Œã«ã‚ˆã‚Šæ™‚é–“ã‚¼ãƒ­ã®å·®ãŒç”Ÿã˜ã¾ã™ã€‚"
            },
            mi_date_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Reasonable but challenging",
              text: "MI ã®æ—¥ä»˜ã¯æ™‚é–“ã‚¼ãƒ­ã¨ã—ã¦ã¯å¦¥å½“ã§ã™ãŒã€é£Ÿäº‹ä»‹å…¥ã¯æ‚£è€…ãŒå®‰å®šã™ã‚‹ (é€šå¸¸ã¯é€€é™¢ã™ã‚‹) ã¾ã§é–‹å§‹ã§ãã¾ã›ã‚“ã€‚ MI ã‹ã‚‰é–‹å§‹ã™ã‚‹å ´åˆã¯ã€é£Ÿäº‹ã¸ã®æ›éœ²ãŒå®šç¾©ã•ã‚Œã¦ã„ãªã„çŸ­æœŸé–“ã®ã€Œæ€¥æ€§æ²»ç™‚ã€ãŒå¿…è¦ã§ã™ã€‚",
              lesson: "ã‚¿ã‚¤ãƒ ã‚¼ãƒ­ã¯ã€ä»‹å…¥ãŒå®Ÿè¡Œå¯èƒ½ãªæ™‚ç‚¹ã§ã‚ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ MI å¾Œã®ãƒ©ã‚¤ãƒ•ã‚¹ã‚¿ã‚¤ãƒ«ä»‹å…¥ã§ã¯ã€MI ãã®ã‚‚ã®ã‚ˆã‚Šã‚‚é€€é™¢ã®æ–¹ãŒç¾å®Ÿçš„ã§ã‚ã‚‹ã“ã¨ãŒã‚ˆãã‚ã‚Šã¾ã™ã€‚"
            },
            any_high_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This is immortal time bias again!",
              text: "è¿½è·¡èª¿æŸ»ä¸­ã®ä»»æ„ã®è©•ä¾¡ã«ã‚ˆã£ã¦æ›éœ²ã‚’å®šç¾©ã™ã‚‹ã¨ã„ã†ã“ã¨ã¯ã€æ‚£è€…ãŒãã®è©•ä¾¡ã¾ã§ç”Ÿãæ®‹ã‚‰ãªã‘ã‚Œã°ãªã‚‰ãªã„ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ ã€Œé«˜ã€ã‚¹ã‚³ã‚¢ã«ãªã‚‹ã¾ã§ã®æ™‚é–“ã¯ä¸æ»…ã®æ™‚é–“ã§ã™ã€‚ã“ã‚Œã¯ã€ã‚¹ã‚¿ãƒãƒ³ã¨ç™Œã®ç ”ç©¶ã¨åŒã˜ãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚",
              lesson: "æ›éœ²ã¯ã€å°†æ¥ã®å‡ºæ¥äº‹ã«åŸºã¥ã„ã¦ã§ã¯ãªãã€æ™‚åˆ»ã‚¼ãƒ­ã«å‰²ã‚Šå½“ã¦ã‚‰ã‚Œã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚å¯¾è±¡ã®ãƒˆãƒ©ã‚¤ã‚¢ãƒ« ãƒ•ãƒ¬ãƒ¼ãƒ ãƒ¯ãƒ¼ã‚¯ã§ã¯ã€ãƒ•ã‚©ãƒ­ãƒ¼ã‚¢ãƒƒãƒ—ä¸­ã«ã€Œæš´éœ²ã•ã‚Œã‚‹ã€ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚"
            },
            first_assessment_correct: {
              situation: "ç´ æ™´ã‚‰ã—ã„!æ™‚é–“ã‚¼ãƒ­å¾Œã®æœ€åˆã®è©•ä¾¡æ™‚ã«å‰²ã‚Šå½“ã¦ã‚‰ã‚ŒãŸã‚¨ã‚¯ã‚¹ãƒãƒ¼ã‚¸ãƒ£ãƒ¼ã€‚ã§ã¯ã€é£Ÿäº‹è©•ä¾¡ã‚’å—ã‘ã¦ã„ãªã„æ‚£è€…ã¯ã©ã†ã™ã‚Œã°ã‚ˆã„ã§ã—ã‚‡ã†ã‹?",
              question: "ä¸è¶³ã—ã¦ã„ã‚‹é£Ÿäº‹ãƒ‡ãƒ¼ã‚¿ã¯ã©ã®ã‚ˆã†ã«å‡¦ç†ã—ã¾ã™ã‹?",
              branches: [
                { text: "Exclude them â€” they don't have the key variable", nextNode: "exclude_wrong" },
                { text: "ã€Œé€šå¸¸ã®é£Ÿäº‹ã€ (æ¯”è¼ƒå­) ã¨ã—ã¦åˆ†é¡ã—ã€æ„Ÿåº¦åˆ†æã‚’å®Ÿæ–½ã—ã¾ã™", nextNode: "classify_correct" }
              ]
            },
            sustained_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "ã“ã‚Œã¯åˆ¥ã®è³ªå•ã§ã™",
              text: "'Sustained' exposure over 6 months is a valid question, but it's a DIFFERENT target trial: one studying adherent patients (per-protocol effect). The primary analysis should be intention-to-treat: initial assignment regardless of subsequent adherence.",
              lesson: "Target trial can be ITT or per-protocol. ITT compares initial strategies. Per-protocol compares sustained adherence. State which you're emulating."
            },
            exclude_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã«ã‚ˆã‚Šé¸æŠãŒä½œæˆã•ã‚Œã¾ã™ãƒã‚¤ã‚¢ã‚¹!",
              text: "é£Ÿäº‹ãƒ‡ãƒ¼ã‚¿ã®ãªã„æ‚£è€…ã‚’é™¤å¤–ã™ã‚‹ã¨ã„ã†ã“ã¨ã¯ã€ãƒ©ãƒ³ãƒ€ãƒ ã§ã¯ãªã„ã‚µãƒ–ã‚»ãƒƒãƒˆã‚’é¸æŠã—ã¦ã„ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ç—…æ°—ã®æ‚£è€…ãŒé£Ÿäº‹è©•ä¾¡ã‚’å®Œäº†ã™ã‚‹å¯èƒ½æ€§ãŒä½ã„å ´åˆã€æ¯”è¼ƒã¯ã‚ˆã‚Šå¥åº·ãªæ‚£è€…é–“ã®ã¿ã§è¡Œã‚ã‚Œã¾ã™ã€‚é¸æŠãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚",
              lesson: "æ¬ æãƒ‡ãƒ¼ã‚¿ã¯é™¤å¤–ã«ã¯ä½¿ç”¨ã›ãšã€å‡¦ç†ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚å¯¾è±¡ã¨ãªã‚‹æ²»é¨“ã§ã¯ã€ã‚¢ãƒ³ã‚±ãƒ¼ãƒˆã«å›ç­”ã—ãªã‹ã£ãŸæ‚£è€…ã‚‚é™¤å¤–ã•ã‚Œãªã„ã€‚"
            },
            classify_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Thoughtful approach!",
              text: "è¡Œæ–¹ä¸æ˜è€…ã‚’ã€Œé€šå¸¸ã®é£Ÿäº‹ã€ã¨ã—ã¦æ‰±ã†ã“ã¨ã§ã€ã‚³ãƒ›ãƒ¼ãƒˆãŒç¶­æŒã•ã‚Œã¾ã™ã€‚æ„Ÿåº¦åˆ†æã«ã‚ˆã‚Šä»£æ›¿æ¡ˆã‚’æ¤œè¨ã§ãã¾ã™ã€‚ã“ã‚Œã¯ã€RCT ãŒè¡Œã†ã“ã¨ã‚’æ¨¡å€£ã—ã¦ã„ã¾ã™ã€‚é£Ÿäº‹ãƒ—ãƒ­ãƒˆã‚³ãƒ«ã«å¾“ã‚ãªã„æ‚£è€…ã‚‚ã€å‰²ã‚Šå½“ã¦ã‚‰ã‚ŒãŸã‚°ãƒ«ãƒ¼ãƒ— (ITT) ã§åˆ†æã•ã‚Œã¾ã™ã€‚",
              lesson: "æ¬ æãƒ‡ãƒ¼ã‚¿ã‚’åŸå‰‡çš„ãªæ–¹æ³• (å¤šé‡ä»£å…¥ã€é€†ç¢ºç‡é‡ã¿ä»˜ã‘) ã§å‡¦ç†ã—ã¾ã™ã€‚ã‚¿ã‚¤ãƒ ã‚¼ãƒ­ä»¥é™ã®ãƒ‡ãƒ¼ã‚¿ã®å¯ç”¨æ€§ã«åŸºã¥ã„ã¦é™¤å¤–ã—ãªã„ã§ãã ã•ã„ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A study compares 'metformin initiators' to 'sulfonylurea initiators' among patients with newly diagnosed diabetes. Time zero is defined as the date of first drug prescription. This study design:",
          options: [
            { id: 'a', text: "Has immortal time bias because patients must survive to get a prescription", correct: false },
            { id: 'b', text: "Appropriately emulates a target trial comparing these two treatments", correct: true },
            { id: 'c', text: "Has prevalent user bias because some patients are on long-term therapy", correct: false },
            { id: 'd', text: "Cannot estimate causal effects because it's observational", correct: false }
          ],
          explanation: "This is an ACTIVE COMPARATOR NEW USER (ACNU) design â€” the gold standard for drug safety studies. Time zero is first prescription (new users). Both groups start at the same point. There's no immortal time because patients are classified at the moment of first prescription, and no prevalent user bias because only new users are included."
        }
      }
    ]
  },
  // MODULE 8: THE SYNTHESIS (Meta-analysis of Observational Studies)
  {
    id: 8,
    title: "The Synthesis",
    subtitle: "è¦³å¯Ÿè¨¼æ‹ ã®ãƒ—ãƒ¼ãƒ«",
    principle: 6,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "å¹³å‡ã¯å˜˜ã‚’ã¤ã"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ãƒ—ãƒ¼ãƒ«å•é¡Œ: ãƒ“ã‚¿ãƒŸãƒ³ D ã¨æ­»äº¡ç‡ â€” ãƒ¡ã‚¿åˆ†æãŒåã‚Šã‚’æ‹¡å¤§ã—ãŸå ´åˆ",
          source: "Multiple vitamin D meta-analyses | Autier 2014 | Mendelian randomization studies",
          timeline: [
            { year: "2007-2012", text: "è¦³å¯Ÿç ”ç©¶ã§ã¯ä¸€è²«ã—ã¦ä½ã„ã“ã¨ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚ãƒ“ã‚¿ãƒŸãƒ³Dã¯æ­»äº¡ç‡ã®ä¸Šæ˜‡ã‚’äºˆæ¸¬ã—ã¾ã™ã€‚ã‚‚ã£ã¨ã‚‚ã‚‰ã—ã„ç”Ÿç‰©å­¦ã€‚ã‚³ãƒ›ãƒ¼ãƒˆã®ãƒ¡ã‚¿åˆ†æ: ä½ãƒ“ã‚¿ãƒŸãƒ³ D ã¨é«˜ãƒ“ã‚¿ãƒŸãƒ³ D ã®ãƒ—ãƒ¼ãƒ«ã•ã‚ŒãŸ RR ~1.5-2.0ã€‚", type: "normal" },
            { year: "The MA Problem", text: "ãƒ¡ã‚¿åˆ†æã®è¦³å¯Ÿç ”ç©¶ã§ã¯ã€ã‚·ã‚°ãƒŠãƒ«ã ã‘ã§ãªã BIAS ã‚‚ãƒ—ãƒ¼ãƒ«ã•ã‚Œã¾ã™ã€‚å„ç ”ç©¶ã«å¥å…¨ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã®ãƒã‚¤ã‚¢ã‚¹ãŒã‚ã‚‹å ´åˆã€ãƒ—ãƒ¼ãƒ«ã•ã‚ŒãŸæ¨å®šå€¤ã¯ã€ãƒã‚¤ã‚¢ã‚¹ã•ã‚ŒãŸåŠ¹æœã®æ­£ç¢ºãªæ¨å®šå€¤ã¨ãªã‚Šã¾ã™ã€‚", type: "crisis" },
            { year: "RCTs Arrive", text: "VITAL, ViDA, D-Health: large RCTs of vitamin D supplementation. Results: null effects on mortality, cardiovascular disease, cancer. RR ~1.00.", type: "revelation" },
            { year: "Mendelian Randomization", text: "MR ç ”ç©¶ (éºä¼å­å¤‰ç•°ã‚’æ‰‹æ®µã¨ã—ã¦ä½¿ç”¨): æ­»äº¡ç‡ã«å¯¾ã™ã‚‹ãƒ“ã‚¿ãƒŸãƒ³ D ã®å› æœé–¢ä¿‚ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚è¦³å¯Ÿä¸Šã®é–¢é€£æ€§ã¯æ··ä¹±ã—ã¦ã„ã¾ã—ãŸã€‚", type: "revelation" },
            { year: "The Explanation", text: "Reverse causation: illness lowers vitamin D levels. Confounding: outdoor activity, exercise, healthy lifestyle all correlate with vitamin D AND longevity.", type: "revelation" },
            { year: "Lesson", text: "åã£ãŸç ”ç©¶ã®ãƒ¡ã‚¿åˆ†æã«ã‚ˆã‚Šã€æ­£ç¢ºãªåã£ãŸç­”ãˆãŒå¾—ã‚‰ã‚Œã¾ã™ã€‚å¤§è¦æ¨¡ãªã€Œã‚´ãƒŸã®æµå…¥ã€ã‚´ãƒŸã®æµå‡ºã€ã€‚åŠ¹æœã ã‘ã§ãªãã€ãƒã‚¤ã‚¢ã‚¹ã®ä¸å‡ä¸€æ€§ã‚‚é‡è¦ã§ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "All-cause mortality",
            drug: "Vitamin D (observational low vs high)",
            placebo: "RCT supplementation vs placebo",
            rr: "Observational: RR 1.57 | RCT: RR 0.97 (0.93-1.02)",
            ci: "Confounding created false association",
            nnh: "Billions spent on vitamin D supplements"
          },
          hook: "THE HOOK: Meta-analysis of 50 biased studies doesn't give you the truth â€” it gives you a very precise biased estimate. Before pooling observational studies, assess each one's ROBINS-I risk of bias. Consider whether you're pooling signal or noise."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY INSIGHT: Heterogeneity in observational meta-analyses isn't just about effect size variation â€” it's about BIAS variation. Different studies have different confounding structures, selection mechanisms, and measurement approaches. Pooling doesn't solve this; it obscures it."
        }
      },
      {
        type: 'content',
        content: {
          title: "è¦³å¯Ÿç ”ç©¶ã‚’ãƒ¡ã‚¿åˆ†æã™ã‚‹æ™‚æœŸ",
          sections: [
            {
              heading: "Appropriate Situations:",
              items: [
                "RCTs are impossible (rare harms, long-term outcomes)",
                "Exposure cannot be randomized (smoking, environmental)",
                "Complementing RCT evidence (generalizability, subgroups)",
                "ç ”ç©¶ã¯åŒæ§˜ã®ãƒ‡ã‚¶ã‚¤ãƒ³ã‚’ä½¿ç”¨ã—ã€åŒæ§˜ã®ãƒã‚¤ã‚¢ã‚¹ã«å¯¾å‡¦ã—ã¦ã„ã¾ã™",
                "è³ªå•ã¯é–¢é€£æ€§ã«é–¢ã™ã‚‹ã‚‚ã®ã§ã™ (å› æœé–¢ä¿‚ã¨ã¯é™ã‚Šã¾ã›ã‚“)"
              ]
            },
            {
              heading: "Problematic Situations:",
              items: [
                "Studies have incompatible confounding structures",
                "Major unmeasured confounders likely differ across studies",
                "Studies use different exposure/outcome definitions",
                "Pooling to achieve 'statistical significance'",
                "Ignoring within-study bias to focus on between-study variance"
              ]
            },
            {
              heading: "The Fundamental Question:",
              text: "ã‚ãªãŸã¯ãã†ã§ã™ã‹STUDIESã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹ã®ã‹ã€BIASã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹ã®ã‹?å„ç ”ç©¶ãŒåŒã˜æ–¹å‘ã«äº¤çµ¡ã—ã¦ã„ã‚‹å ´åˆã€ãƒ¡ã‚¿åˆ†æã§ã¯çœŸå®Ÿã§ã¯ãªãã€ã‚ˆã‚Šæ­£ç¢ºãªäº¤çµ¡æ¨å®šå€¤ãŒå¾—ã‚‰ã‚Œã¾ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: è¦³å¯Ÿãƒ¡ã‚¿åˆ†æ",
          title: "Best Practices",
          sections: [
            {
              heading: "1. Use ROBINS-I for Each Study:",
              text: "ãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ã‚’ãƒ‰ãƒ¡ã‚¤ãƒ³ã”ã¨ã«è©•ä¾¡ã—ã¾ã™ã€‚ Critical-risk studies should generally be excluded or analyzed separately.é‡å¤§ãªãƒªã‚¹ã‚¯ã®ç ”ç©¶ã«ã¯æ„Ÿåº¦åˆ†æãŒå¿…è¦ã§ã™ã€‚"
            },
            {
              heading: "2. Don't Mix RCTs and Observational:",
              text: "ãƒã‚¤ã‚¢ã‚¹æ§‹é€ ãŒç•°ãªã‚‹ãŸã‚ã€çµ„ã¿åˆã‚ã›ã«å•é¡ŒãŒç”Ÿã˜ã¾ã™ã€‚åˆ¥é€”ã”æç¤ºãã ã•ã„ã€‚çµ„ã¿åˆã‚ã›ã‚‹å ´åˆã¯ã€åˆ†æ•£ã ã‘ã§ãªãç ”ç©¶è¨­è¨ˆã®è³ªã«ã‚ˆã£ã¦é‡ã¿ä»˜ã‘ã‚’è¡Œã„ã¾ã™ã€‚"
            },
            {
              heading: "3. Explore Heterogeneity by Bias:",
              text: "Subgroup by ROBINS-I risk level. If low-risk studies give different answers than high-risk studies, that's informative: bias explains heterogeneity."
            },
            {
              heading: "4. Consider Adjusted vs Crude:",
              text: "Meta-analyze adjusted estimates (not crude). But different adjustment sets = different estimands. Document what each study adjusted for."
            },
            {
              heading: "5. Use GRADE for Observational:",
              text: "ç¢ºå®Ÿæ€§ã¯ã€Œä½ã€ã‹ã‚‰é–‹å§‹ã—ã¾ã™ (RCT ã®ã‚ˆã†ãªã€Œé«˜ã€ã§ã¯ã‚ã‚Šã¾ã›ã‚“)ã€‚è¿½åŠ ã®ãƒã‚¤ã‚¢ã‚¹ã€çŸ›ç›¾ã€ä¸æ­£ç¢ºã•ã€é–“æ¥æ€§ãŒã‚ã‚‹å ´åˆã¯è©•ä¾¡ã‚’ä¸‹ã’ã¾ã™ã€‚ãƒ¬ãƒ¼ãƒˆã‚’ä¸Šã’ã‚‹å ´åˆã¯æ³¨æ„ãŒå¿…è¦ã§ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Heterogeneity: Different Sources in Observational Data",
          sections: [
            {
              heading: "Clinical Heterogeneity:",
              text: "Different populations, interventions, outcomes, timing â€” same as in RCT meta-analyses."
            },
            {
              heading: "Methodological Heterogeneity:",
              text: "ç•°ãªã‚‹ç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ (ã‚³ãƒ›ãƒ¼ãƒˆå¯¾ç—‡ä¾‹å¯¾ç…§)ã€ç•°ãªã‚‹èª¿æ•´æˆ¦ç•¥ã€ç•°ãªã‚‹æ›éœ²å®šç¾©ã€‚ã“ã‚Œã¯è¦³å¯Ÿ MA ã§ã¯ã•ã‚‰ã«é‡è¦ã§ã™ã€‚"
            },
            {
              heading: "Bias Heterogeneity:",
              text: "Different confounding structures, different amounts of unmeasured confounding, different selection mechanisms. This is UNIQUE to observational MA."
            },
            {
              heading: "What High IÂ² Means:",
              items: [
                "In RCT MA: treatment effects truly differ across populations",
                "In observational MA: could be effect heterogeneity OR bias heterogeneity",
                "ç ”ç©¶ã‚’èª¿ã¹ãªã„ã¨åŒºåˆ¥ã§ãã¾ã›ã‚“",
                "Meta-regression by study quality can help, but is often underpowered"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'obs-ma-decision',
          title: "ã“ã‚Œã‚‰ã®ç ”ç©¶ã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?",
          situation: "You're conducting a systematic review on coffee and cardiovascular disease. You found 15 cohort studies, 3 case-control studies, and 2 RCTs. ROBINS-I assessment: 5 cohorts at moderate risk, 8 at serious risk, 2 at critical risk. The case-controls are all serious risk. RCTs are low risk but underpowered.",
          nodes: {
            start: {
              question: "åˆæˆã¸ã®ã‚¢ãƒ—ãƒ­ãƒ¼ãƒã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "Pool all 20 studies to maximize power", nextNode: "pool_all_wrong" },
                { text: "Pool only low/moderate risk studies, exclude high risk", nextNode: "exclude_high" },
                { text: "Present stratified analyses by risk of bias level", nextNode: "stratified_correct" }
              ]
            },
            pool_all_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯ã•ã‚‰ã«é‡è¦ã§ã™ãƒã‚¤ã‚¢ã‚¹!",
              text: "10 ä»¶ä»¥ä¸Šã«é‡å¤§/é‡å¤§ãªãƒã‚¤ã‚¢ã‚¹ãŒã‚ã‚‹å ´åˆã« 20 ä»¶ã®ç ”ç©¶ã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹ã¨ã€ãƒ—ãƒ¼ãƒ«ã•ã‚ŒãŸæ¨å®šå€¤ãŒåã£ãŸãƒ‡ãƒ¼ã‚¿ã«ã‚ˆã£ã¦æ”¯é…ã•ã‚Œã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ç ”ç©¶å…¨ä½“ã«ã‚ãŸã‚‹å¹³å‡ãƒã‚¤ã‚¢ã‚¹ã®éå¸¸ã«æ­£ç¢ºãªæ¨å®šå€¤ãŒå¾—ã‚‰ã‚Œã¾ã™ã€‚",
              lesson: "ã‚ˆã‚Šå¤šãã®ç ”ç©¶ â‰  ã‚ˆã‚Šè‰¯ã„ãƒ¡ã‚¿åˆ†æã€‚é‡ã‚ˆã‚Šã‚‚è³ªãŒé‡è¦ã§ã™ã€‚ã‚¯ãƒªãƒ†ã‚£ã‚«ãƒ«ãƒªã‚¹ã‚¯ã®èª¿æŸ»ã‚’ãƒ¡ã‚¤ãƒ³åˆ†æã«æ±ºã—ã¦ãƒ—ãƒ¼ãƒ«ã—ãªã„ã§ãã ã•ã„ã€‚"
            },
            exclude_high: {
              situation: "ãã®æ–¹ãŒè‰¯ã„ã§ã™!ã—ã‹ã—ã€ç¾åœ¨ã¯ã‚³ãƒ›ãƒ¼ãƒˆãŒ 5 ã¤ï¼ˆä¸­ç¨‹åº¦ï¼‰ã€RCT ãŒ 2 ã¤ï¼ˆä½ï¼‰ã—ã‹ãªãã€ãƒ‡ãƒ¼ã‚¿ãŒé™ã‚‰ã‚Œã¦ã„ã¾ã™ã€‚æ¬¡ã«ä½•ã‚’ã—ã¾ã™ã‹?",
              question: "Synthesis approach:",
              branches: [
                { text: "5 ã¤ã®ã‚³ãƒ›ãƒ¼ãƒˆã¨ 2 ã¤ã® RCT ã‚’ãƒ—ãƒ¼ãƒ«ã—ã¾ã™", nextNode: "pool_mixed_wrong" },
                { text: "æ„Ÿåº¦åˆ†æã‚’ä½¿ç”¨ã—ã¦ RCTã€ã‚³ãƒ›ãƒ¼ãƒˆã‚’å€‹åˆ¥ã«æç¤ºã—ã¾ã™", nextNode: "separate_correct" }
              ]
            },
            stratified_correct: {
              situation: "Excellent! You plan to show: (1) RCTs alone, (2) Low/moderate risk cohorts, (3) All studies. This is transparent.",
              question: "RCT ã¯ RR 0.95 (0.60-1.50) ã‚’ç¤ºã—ã¾ã™ã€‚ä¸­ãƒªã‚¹ã‚¯ã®ã‚³ãƒ›ãƒ¼ãƒˆã¯RR 0.75ï¼ˆ0.70-0.80ï¼‰ã‚’ç¤ºã—ã¾ã™ã€‚é«˜ãƒªã‚¹ã‚¯ã®ç ”ç©¶ã§ã¯RR 0.65ï¼ˆ0.60-0.70ï¼‰ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚çµè«–ã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "Coffee protects â€” all estimates show benefit", nextNode: "conclude_benefit_wrong" },
                { text: "Lower quality studies show stronger effects â€” suggests bias", nextNode: "conclude_bias_correct" }
              ]
            },
            pool_mixed_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "æ··åˆã«ã¯æ³¨æ„ã—ã¦ãã ã•ã„!",
              text: "RCT ã¨è¦³å¯Ÿç ”ç©¶ã¯æ ¹æœ¬çš„ã«ç•°ãªã‚‹ãƒã‚¤ã‚¢ã‚¹æ§‹é€ ã‚’æŒã£ã¦ã„ã¾ã™ã€‚ãã‚Œã‚‰ã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹ã¨æ•°å€¤ãŒå¾—ã‚‰ã‚Œã¾ã™ãŒã€ãã®æ•°å€¤ãŒä½•ã‚’æ¨å®šã—ã¦ã„ã‚‹ã®ã‹ã¯æ˜ã‚‰ã‹ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚åˆ¥ã€…ã«æç¤ºã—ã€ä¸€è‡´/ä¸ä¸€è‡´ã«ã¤ã„ã¦è­°è«–ã—ãŸã»ã†ãŒã‚ˆã„ã§ã—ã‚‡ã†ã€‚",
              lesson: "RCT ã¨è¦³å¯Ÿç ”ç©¶ãŒä¸€è‡´ã™ã‚‹å ´åˆã€ä¿¡é ¼æ€§ã¯é«˜ã¾ã‚Šã¾ã™ã€‚æ„è¦‹ãŒä¸€è‡´ã—ãªã„å ´åˆã¯ã€ãã®ç†ç”±ã‚’èª¿æŸ»ã—ã¾ã™ (äº¤çµ¡? å½±éŸ¿ã®å¤‰æ›´?)ã€‚æ„è¦‹ã®ç›¸é•ã‚’ãƒ—ãƒ¼ãƒ«ã—ã¦éš ã•ãªã„ã§ãã ã•ã„ã€‚"
            },
            separate_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Rigorous approach!",
              text: "RCT ã¨è¦³å¯Ÿç ”ç©¶ã‚’åˆ¥ã€…ã«æç¤ºã™ã‚‹ã“ã¨ã§ã€èª­è€…ã¯ä¸€è‡´/ä¸ä¸€è‡´ã‚’ç¢ºèªã§ãã¾ã™ã€‚æ„Ÿåº¦åˆ†æã¯ã€ã•ã¾ã–ã¾ãªä»®å®šã«ã‚ˆã£ã¦çµæœãŒã©ã®ã‚ˆã†ã«å¤‰åŒ–ã™ã‚‹ã‹ã‚’ç¤ºã—ã¾ã™ã€‚ã“ã‚Œã¯é€æ˜æ€§ãŒã‚ã‚Šã€æœ‰ç›Šã§ã™ã€‚",
              lesson: "ãƒ¡ã‚¿åˆ†æã®ç›®æ¨™ã¯ã€è¨¼æ‹ ã‚’è¦ç´„ã™ã‚‹ã“ã¨ã§ã‚ã‚Šã€å˜ä¸€ã®æ•°å­—ã‚’ä½œã‚Šå‡ºã™ã“ã¨ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ç ”ç©¶ã®è³ªã«ã‚ˆã‚‹å±¤åˆ¥åŒ–ã¯ã€ã™ã¹ã¦ã‚’ãƒ—ãƒ¼ãƒ«ã™ã‚‹ã‚ˆã‚Šã‚‚æ­£ç›´ã§ã™ã€‚"
            },
            conclude_benefit_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ãƒ‘ã‚¿ãƒ¼ãƒ³ã«æ³¨ç›®ã—ã¦ãã ã•ã„!",
              text: "RCT (æœ€ã‚‚ä½ã„ãƒã‚¤ã‚¢ã‚¹) ã¯ç„¡åŠ¹åŠ¹æœ (0.95ã€CI ã‚¯ãƒ­ã‚¹ 1) ã‚’ç¤ºã—ã¦ã„ã¾ã™ã€‚ãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ãŒå¢—åŠ ã™ã‚‹ã«ã¤ã‚Œã¦ã€è¦‹ã‹ã‘ã®åˆ©ç›Šã‚‚å¢—åŠ ã—ã¾ã™ (0.75 â†’ 0.65)ã€‚ã“ã‚Œã¯ã€ã‚³ãƒ¼ãƒ’ãƒ¼ã§ã¯ãªãæ··ä¹±ã•ã›ã‚‹ã“ã¨ã§ã€Œåˆ©ç›Šã€ãŒèª¬æ˜ã•ã‚Œã‚‹ã¨ã„ã†å…¸å‹çš„ãªå…†å€™ã§ã™ã€‚",
              lesson: "åŠ¹æœã®å¤§ãã•ãŒãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ã¨ã¨ã‚‚ã«å¢—åŠ ã™ã‚‹å ´åˆã¯ã€å› æœé–¢ä¿‚ã§ã¯ãªããƒã‚¤ã‚¢ã‚¹ã‚’ç–‘ã£ã¦ãã ã•ã„ã€‚ RCT ã¯ã‚¢ãƒ³ã‚«ãƒ¼ã§ã™ã€‚è¦³å¯Ÿã«ã‚ˆã‚‹æ¨å®šå€¤ã¯ãã‚Œã«ç›¸å¯¾çš„ã«è§£é‡ˆã•ã‚Œã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚"
            },
            conclude_bias_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Astute interpretation!",
              text: "ã€Œãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ã¨åŠ¹æœã®å¤§ãã•ã€ã®ãƒ‘ã‚¿ãƒ¼ãƒ³ãŒç‰¹å®šã•ã‚Œã¾ã—ãŸã€‚ã¤ã¾ã‚Šã€ç ”ç©¶ã®è³ªãŒä½ã„ã»ã©åŠ¹æœãŒå¤§ãããªã‚Šã¾ã™ã€‚ã“ã‚Œã¯äº¤çµ¡ï¼ˆå¥å…¨ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ãƒã‚¤ã‚¢ã‚¹ï¼šã‚³ãƒ¼ãƒ’ãƒ¼ã‚’é£²ã‚€äººã¯ã‚ˆã‚Šå¥åº·ã§ã‚ã‚‹ï¼‰ã®å¼·åŠ›ãªè¨¼æ‹ ã§ã™ã€‚ RCT ã®ãƒŒãƒ«çµæœã¯çœŸå®Ÿã«è¿‘ã„ã¨è€ƒãˆã‚‰ã‚Œã¾ã™ã€‚",
              lesson: "ãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ã«ã‚ˆã‚‹å±¤åˆ¥åŒ–ã¯è¨ºæ–­ã«å½¹ç«‹ã¡ã¾ã™ã€‚è³ªã®é«˜ã„ç ”ç©¶ã¨è³ªã®ä½ã„ç ”ç©¶ã§ç•°ãªã‚‹ç­”ãˆãŒå¾—ã‚‰ã‚Œã‚‹å ´åˆã¯ã€è³ªã®é«˜ã„ç ”ç©¶ã‚’ä¿¡é ¼ã—ã€è³ªã®ä½ã„ç ”ç©¶ã«ä½•ãŒåã£ã¦ã„ã‚‹ã®ã‹ã‚’èª¿æŸ»ã—ã¦ãã ã•ã„ã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A meta-analysis of 30 observational studies shows a pooled OR of 0.72 (0.68-0.76) with IÂ² = 5%. What can you conclude?",
          options: [
            { id: 'a', text: "ãã®åŠ¹æœã¯æœ¬ç‰©ã§ã‚ã‚Šã€é«˜ç²¾åº¦ã§ç ”ç©¶å…¨ä½“ã§ä¸€è²«ã—ã¦ã„ã¾ã™", correct: false },
            { id: 'b', text: "ç ”ç©¶ã¯å‡è³ªã§ã‚ã‚‹ãŸã‚ã€æ¨å®šå€¤ã®ä¿¡é ¼æ€§ãŒé«˜ã¾ã‚Šã¾ã™", correct: false },
            { id: 'c', text: "IÂ² ãŒä½ã„ã¨ã„ã†ã“ã¨ã¯ã€ç ”ç©¶ãŒä¸€è‡´ã—ã¦ã„ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ãŒã€ã™ã¹ã¦ã®ç ”ç©¶ãŒåŒã˜ã‚ˆã†ã«åã£ã¦ã„ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™æ–¹å‘", correct: true },
            { id: 'd', text: "ã“ã‚Œã¯å› æœé–¢ä¿‚ã®ã‚ã‚‹ä¿è­·åŠ¹æœã®å¼·åŠ›ãªè¨¼æ‹ ã§ã‚ã‚‹", correct: false }
          ],
          explanation: "Low IÂ² means studies are consistent â€” but they could be consistently BIASED. If all 30 studies have healthy user bias, they'll all show a protective effect, and IÂ² will be low. Homogeneity is reassuring only if studies aren't all biased the same way. Without ROBINS-I assessment, you can't distinguish consistency of effect from consistency of bias."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE TIME ILLUSION: LEAD TIME BIAS â€” WHEN SCREENING LOOKED MIRACULOUS",
          source: "Welch 2010 | Overdiagnosed | Neuroblastoma screening | PSA debates",
          timeline: [
            { year: "The Promise", text: "Cancer screening finds disease early. 'Early detection saves lives.' 5-year survival with screening: 95%. Without screening: 60%. Screening works... right?", type: "normal" },
            { year: "The Illusion", text: "A patient diagnosed at age 60 (no screening) dies at 65. 5-year survival = 0%. The SAME patient diagnosed at 55 (screening) dies at 65. 5-year survival = 100%. NOTHING CHANGED except diagnosis date.", type: "revelation" },
            { year: "Neuroblastoma", text: "æ—¥æœ¬ã¯ã™ã¹ã¦ã®ä¹³å…ã«ç¥çµŒèŠ½è…«ï¼ˆå°å…ãŒã‚“ï¼‰ã®æ¤œæŸ»ã‚’å®Ÿæ–½ã—ãŸã€‚ 3 å€ä»¥ä¸Šã®ã‚±ãƒ¼ã‚¹ãŒè¦‹ã¤ã‹ã‚Šã¾ã—ãŸã€‚ 5å¹´ç”Ÿå­˜ç‡ãŒæ€¥ä¸Šæ˜‡ã—ã¾ã—ãŸã€‚ã—ã‹ã—: æ­»äº¡ç‡ã¯å¤‰ã‚ã£ã¦ã„ã¾ã›ã‚“ã§ã—ãŸã€‚å½¼ã‚‰ã¯ã€è‡ªç„¶ã«é€€ç¸®ã™ã‚‹ã§ã‚ã‚ã†ç™Œã‚’ç™ºè¦‹ã—ã¾ã—ãŸã€‚", type: "crisis" },
            { year: "PSA Screening", text: "å‰ç«‹è…ºã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã¯ 5 å¹´ç”Ÿå­˜ç‡ã‚’åŠ‡çš„ã«é«˜ã‚ã¾ã™ã€‚ã—ã‹ã—ã€å¤šãã®è©¦é¨“ã§ã¯æ­»äº¡ç‡ã®åˆ©ç›Šã¯ã”ãã‚ãšã‹ã‹ã‚¼ãƒ­ã§ã™ã€‚å¤šãã®ç”·æ€§ã¯ã€æ±ºã—ã¦å‘½ã‚’è½ã¨ã™ã“ã¨ã®ãªã‹ã£ãŸç™Œã®æ²»ç™‚ã‚’å—ã‘ã¦ã„ã¾ã™ã€‚", type: "crisis" },
            { year: "The Math", text: "Lead time = time between screen detection and when symptoms would appear. If lead time is 5 years, 5-year survival improves by 100% even with ZERO mortality benefit.", type: "revelation" },
            { year: "Lesson", text: "ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã®è©•ä¾¡ã«ç”Ÿå­˜çµ±è¨ˆã‚’æ±ºã—ã¦ä½¿ç”¨ã—ãªã„ã§ãã ã•ã„ã€‚ MORTALITY (äººå£ã‚ãŸã‚Šã®æ­»äº¡è€…æ•°) ã ã‘ãŒçœŸå®Ÿã‚’ä¼ãˆã¾ã™ã€‚ç”Ÿå­˜ã¯ãƒªãƒ¼ãƒ‰ã‚¿ã‚¤ãƒ ã¨éå‰°è¨ºæ–­ã«ã‚ˆã£ã¦æ±šæŸ“ã•ã‚Œã¦ã„ã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "5-year survival vs population mortality",
            drug: "Cancer screening programs",
            placebo: "No screening",
            rr: "Survival: dramatic improvement | Mortality: often minimal",
            ci: "Lead time creates illusion of benefit",
            nnh: "æ•°ç™¾ä¸‡äººãŒã€æ±ºã—ã¦å®³ã‚’åŠã¼ã™ã“ã¨ã®ãªã‹ã£ãŸã€ŒãŒã‚“ã€ã§éå‰°è¨ºæ–­ã•ã‚Œã¦ã„ã¾ã™"
          },
          hook: "THE HOOK: '5-year survival improved 50%' sounds like screening works. But it might just mean you moved the starting line. Survival measures time from DIAGNOSIS. If diagnosis is earlier but death is the same, survival 'improves' without anyone living longer. This is lead time bias â€” and it has fooled millions."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'screening-evaluation',
          title: "ã“ã®ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°è«‹æ±‚ã‚’è©•ä¾¡ã—ã¦ãã ã•ã„",
          situation: "è†µè‡“ãŒã‚“ã®æ–°ã—ã„ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°æ¤œæŸ»ãŒæ¨é€²ã•ã‚Œã¦ã„ã¾ã™ã€‚ãƒãƒ¼ã‚±ãƒ†ã‚£ãƒ³ã‚°è³‡æ–™ã«ã¯ã€ã€Œ5å¹´ç”Ÿå­˜ç‡ã¯ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã‚ã‚Šã®å ´åˆã¯25ï¼…ã€ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ãªã—ã®å ´åˆã¯5ï¼…ã§ã‚ã‚‹ã€ã¨ç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚æ¤œæŸ»ã®è²»ç”¨ã¯ 500 ãƒ‰ãƒ«ã§ã€å½é™½æ€§ç‡ã¯ 3% ã§ã€ä¾µè¥²çš„ãªè¿½è·¡èª¿æŸ»ãŒå¿…è¦ã§ã™ã€‚",
          nodes: {
            start: {
              question: "ã€Œç”Ÿå­˜ç‡ 25% å¯¾ 5%ã€ã«ã¤ã„ã¦ã®æœ€åˆã®æ‡¸å¿µã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "It's impressive â€” 5x better survival!", nextNode: "impressed_wrong" },
                { text: "Survival doesn't prove mortality benefit â€” could be lead time", nextNode: "lead_time_correct" },
                { text: "ã“ã®ç ”ç©¶ã¯ãŠãã‚‰ãç„¡ä½œç‚ºåŒ–ã•ã‚Œã¦ã„ã¾ã›ã‚“", nextNode: "randomization_partial" }
              ]
            },
            impressed_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "You've been fooled by lead time!",
              text: "è†µè‡“ãŒã‚“ã¯ã»ã¼æ™®éçš„ã«è‡´æ­»çš„ã§ã™ã€‚ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«ã‚ˆã‚Šè¨ºæ–­ãŒ 1 å¹´é€²ã‚“ã ã«ã‚‚ã‹ã‹ã‚ã‚‰ãšã€æ‚£è€…ãŒåŒã˜å¹´é½¢ã§æ­»äº¡ã—ãŸå ´åˆã€1 å¹´ç”Ÿå­˜ç‡ã¯ç´„ 20% ã‹ã‚‰ç´„ 40% ã«ä½ä¸‹ã—ã€æ•‘ã‚ã‚Œã‚‹å‘½ã¯ã‚¼ãƒ­ã«ãªã‚Šã¾ã™ã€‚ç”Ÿå­˜çµ±è¨ˆã¯ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã®è©•ä¾¡ã«ã¯ç„¡æ„å‘³ã§ã™ã€‚",
              lesson: "ç”Ÿå­˜ã‚’ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã®åˆ©ç‚¹ã®è¨¼æ‹ ã¨ã—ã¦æ±ºã—ã¦å—ã‘å…¥ã‚Œãªã„ã§ãã ã•ã„ã€‚ãƒ©ãƒ³ãƒ€ãƒ åŒ–è©¦é¨“ã‹ã‚‰ã®æ­»äº¡ç‡ãƒ‡ãƒ¼ã‚¿ã‚’è¦æ±‚ã—ã¾ã™ã€‚"
            },
            lead_time_correct: {
              situation: "Excellent skepticism! You ask for mortality data. They provide: 'In a cohort study, screened patients had 30% lower pancreatic cancer mortality.'",
              question: "Is this convincing?",
              branches: [
                { text: "Yes â€” mortality is the right endpoint", nextNode: "cohort_wrong" },
                { text: "No â€” cohort studies of screening have healthy screener bias", nextNode: "healthy_screener_correct" }
              ]
            },
            randomization_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Good instinct, but the specific bias matters",
              text: "ã¯ã„ã€ã“ã®ç ”ç©¶ã¯ãŠãã‚‰ãè¦³å¯Ÿçš„ã§ã™ã€‚ã—ã‹ã—ã€ç‰¹å®šã®ãƒã‚¤ã‚¢ã‚¹ã¯ãƒªãƒ¼ãƒ‰ã‚¿ã‚¤ãƒ ã§ã™ã€‚ãŸã¨ãˆæ­»äº¡æ—¥ãŒå¤‰ã‚ã‚‰ãªãã¦ã‚‚ã€æ—©æœŸã«è¨ºæ–­ã™ã‚‹ã ã‘ã§ç”Ÿå­˜ç‡ã¯å‘ä¸Šã—ã¾ã™ã€‚ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã¯å½¹ç«‹ã¡ã¾ã™ãŒã€ãã‚Œã§ã‚‚ã€ã‚¨ãƒ³ãƒ‰ãƒã‚¤ãƒ³ãƒˆã¨ã—ã¦ç”Ÿå­˜ã§ã¯ãªãæ­»äº¡ç‡ãŒå¿…è¦ã§ã™ã€‚",
              lesson: "For screening evaluation: (1) Must be mortality, not survival, (2) Must be randomized or very carefully designed to avoid healthy screener bias."
            },
            cohort_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Healthy screener bias!",
              text: "ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã‚’é¸æŠã—ãŸäººã€…ã¯ä½“ç³»çš„ã«ã‚ˆã‚Šå¥åº·ã§ã™ã€‚å½¼ã‚‰ã¯ã‚ˆã‚Šå¤šãã®é‹å‹•ã‚’ã—ã€ã‚ˆã‚Šè‰¯ã„é£Ÿäº‹ã‚’ã—ã€åŒ»ç™‚ã¸ã®ã‚ˆã‚Šè‰¯ã„ã‚¢ã‚¯ã‚»ã‚¹ã‚’æŒã£ã¦ã„ã¾ã™ã€‚ãŸã¨ãˆã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ãŒæ©Ÿèƒ½ã—ãªã‹ã£ãŸã¨ã—ã¦ã‚‚ã€è†µè‡“ãŒã‚“ã‚’å«ã‚€ã‚ã‚‰ã‚†ã‚‹é¢ã§æ­»äº¡ç‡ãŒä½ã„ã®ã§ã™ã€‚ã“ã‚Œã¯ HRT ã®ç¹°ã‚Šè¿”ã—ã§ã™ã€‚",
              lesson: "å¥å…¨ãªã‚¹ã‚¯ãƒªãƒ¼ãƒŠãƒ¼ ãƒã‚¤ã‚¢ã‚¹ã¯ã€ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«é©ç”¨ã•ã‚Œã‚‹å¥å…¨ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ ãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚ãã‚Œã‚’æ’é™¤ã§ãã‚‹ã®ã¯RCTã ã‘ã§ã™ã€‚ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã®ãŸã‚ã®è¦³å¯Ÿã«ã‚ˆã‚‹æ­»äº¡ç‡ã®æ¯”è¼ƒã¯ä¿¡é ¼æ€§ãŒã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            healthy_screener_correct: {
              situation: "Perfect! You demand RCT evidence. The company says: 'An RCT is ongoing but won't report for 10 years. In the meantime, shouldn't we offer screening?'",
              question: "Your response:",
              branches: [
                { text: "Yes â€” some benefit is likely, and screening is harmless", nextNode: "harmless_wrong" },
                { text: "No â€” unproven screening causes harm through false positives, overdiagnosis, and anxiety", nextNode: "wait_correct" }
              ]
            },
            harmless_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã¯ç„¡å®³ã§ã¯ã‚ã‚Šã¾ã›ã‚“!",
              text: "3% false positive rate Ã— millions screened = tens of thousands of invasive biopsies. Pancreas biopsies can cause pancreatitis, bleeding, death. Plus anxiety from false alarms. Plus overdiagnosis of indolent tumors treated unnecessarily. Screening without proven benefit is NET HARM.",
              lesson: "Screening has COSTS: false positives, overdiagnosis, anxiety, procedures. These are CERTAIN. Benefit is UNCERTAIN until RCT-proven. Uncertain benefit + certain harm = wait for evidence."
            },
            wait_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Evidence-based patience!",
              text: "You correctly identified: (1) survival claims mean nothing (lead time), (2) observational mortality claims have healthy screener bias, (3) screening has real harms. Until an RCT shows MORTALITY benefit outweighs harms, screening should not be implemented.",
              lesson: "Screening is INTERVENTION. It requires the same evidence standard as drugs: RCT showing benefits > harms. 'Early detection' sounds good but isn't automatically beneficial."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: Screening programs are among the most bias-prone topics in medicine. Lead time bias makes survival look better than reality. Length bias makes screening find slow-growing (less lethal) cancers. Healthy screener bias makes screened populations look healthier. Overdiagnosis turns healthy people into patients. DEMAND RCT mortality evidence before accepting screening claims."
        }
      },
      {
        type: 'principle',
        content: {
          text: "ğŸ¯ PROGRESS CHECK: You've learned to pool observational evidence carefully. You understand that meta-analysis can magnify bias as easily as signal. You can identify lead time bias in screening studies. You know when to trust pooled estimates and when to be skeptical. Next: pharmacovigilance â€” detecting drug safety signals."
        }
      }
    ]
  },
  // MODULE 9: THE PHARMACOVIGILANCE (Signal Detection)
  {
    id: 9,
    title: "The Pharmacovigilance",
    subtitle: "Signal Detection",
    principle: 2,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Time flows one direction"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE SIGNAL IGNORED: VIOXX â€” WHEN 88,000 HEARTS STOPPED",
          source: "NEJM 2005 | FDA | Merck internal documents | VIGOR, APPROVe trials",
          timeline: [
            { year: "1999", text: "Vioxx (rofecoxib) approved. COX-2 inhibitor for arthritis. Marketed as 'safer on stomach' than older NSAIDs. Billions in sales projected.", type: "normal" },
            { year: "2000", text: "VIGOR trial: 4x higher cardiovascular events vs naproxen. Merck interprets as 'naproxen is cardioprotective,' not 'Vioxx is cardiotoxic.' FDA concerned.", type: "crisis" },
            { year: "2001-04", text: "Observational studies show signal: cardiovascular events in Vioxx users. David Graham (FDA) estimates 88,000-140,000 excess cardiac events. Internal Merck data shows risk.", type: "crisis" },
            { year: "2004", text: "APPROVe trial (colon polyps): Stopped early for cardiovascular harm. RR 1.92 (95% CI 1.19-3.11). Merck withdraws Vioxx worldwide.", type: "revelation" },
            { year: "The Failure", text: "è‡ªç™ºçš„ãªå ±å‘Šã€è¦³æ¸¬ä¿¡å·ã€ã•ã‚‰ã«ã¯å†…éƒ¨ãƒ‡ãƒ¼ã‚¿ã•ãˆã‚‚ç„¡è¦–ã•ã‚Œã¾ã—ãŸã€‚è¨¼æ‹ ã®éšå±¤æ§‹é€ ã¯ã€RCT ã§å±å®³ãŒç¢ºèªã•ã‚Œã‚‹ã¾ã§è­¦å‘Šå…†å€™ã‚’ç„¡è¦–ã™ã‚‹ãŸã‚ã«ä½¿ç”¨ã•ã‚Œã¾ã—ãŸã€‚", type: "revelation" },
            { year: "Lesson", text: "å±å®³ã«é–¢ã™ã‚‹è¦³å¯Ÿè¨¼æ‹ ã¯ã€åˆ©ç‚¹ã«é–¢ã™ã‚‹è¨¼æ‹ ã¨åŒã˜é–¾å€¤ã‚’å¿…è¦ã¨ã™ã‚‹ã¹ãã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ä¿¡å·ã¯é‡è¦ã§ã™ã€‚ 88,000 äººã®æ­»äº¡ã¯ã€ã€Œå®Œç’§ãªã€è¨¼æ‹ ã‚’å¾…ã¤ã‚³ã‚¹ãƒˆã§ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Myocardial infarction / sudden cardiac death",
            drug: "Rofecoxib (Vioxx)",
            placebo: "Naproxen / placebo",
            rr: "RR 1.92 (1.19-3.11) in APPROVe",
            ci: "Signal present for 4 years before withdrawal",
            nnh: "88,000-140,000 excess cardiac events estimated"
          },
          hook: "THE HOOK: Pharmacovigilance failed because signals were dismissed as 'only observational.' The evidence hierarchy that protects against false positives for benefits should not be used to dismiss warnings of harm. When lives are at stake, false negatives kill."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY INSIGHT: For HARMS, the evidence threshold should be LOWER than for benefits. Why? False positive (thinking something harmful is safe) has worse consequences than false negative (thinking something safe is harmful). Observational signals for harm deserve urgent attention, not dismissal."
        }
      },
      {
        type: 'content',
        content: {
          title: "Pharmacovigilance: The Science of Safety Signals",
          sections: [
            {
              heading: "Why Observational Data Is Essential for Safety:",
              items: [
                "RCT ã¯ã¾ã‚Œãªå±å®³ã§ã¯ãªãåˆ©ç›Šã‚’ç›®çš„ã¨ã—ã¦ã„ã¾ã™",
                "100-patient RCT: can detect 3% event rate, NOT 0.1% rate",
                "Rare harms need millions of patient-years of exposure",
                "Post-marketing surveillance is the only way to detect them",
                "Thalidomide, Vioxx, DES â€” all detected observationally"
              ]
            },
            {
              heading: "Signal Detection Methods:",
              items: [
                "Spontaneous reporting (FAERS, Yellow Card) â€” passive surveillance",
                "Disproportionality analysis â€” observed vs expected reports",
                "Case series â€” temporal clustering of events",
                "Cohort studies â€” active surveillance in databases",
                "Self-controlled designs â€” within-person comparisons"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: å®‰å…¨ä¿¡å·ã®è©•ä¾¡",
          title: "ä¿¡å·ã‹ã‚‰è¡Œå‹•ã¾ã§",
          sections: [
            {
              heading: "Signal Detection (Is there something there?):",
              text: "â€¢ Spontaneous reports: PRR, ROR, IC (information component)\nâ€¢ Database studies: compare exposed vs unexposed rates\nâ€¢ Case series: temporal pattern, dose-response\nâ€¢ Biological plausibility: is there a mechanism?"
            },
            {
              heading: "Signal Validation (Is it real?):",
              text: "â€¢ä¿¡å·ã‚’åˆ¥ã®ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ã«è¤‡è£½ã§ãã¾ã™ã‹? â€¢ å…†å€™ã«ã‚ˆã‚‹äº¤çµ¡ã¯ã‚ã‚Šã¾ã™ã‹? â€¢ æ¤œå‡º/æ‚ªåã«ã‚ˆã‚‹ãƒã‚¤ã‚¢ã‚¹ã¯ã‚ã‚Šã¾ã™ã‹? â€¢ ç‹¬ç«‹ã—ãŸæ–¹æ³•ã§ä¸€è²«ã—ãŸçµæœãŒå¾—ã‚‰ã‚Œã¾ã™ã‹?"
            },
            {
              heading: "Signal Assessment (Is it clinically important?):",
              text: "â€¢ Absolute risk: how many excess events per 1,000 users?\nâ€¢ Comparison to alternatives: are other drugs safer?\nâ€¢ Severity: death/disability vs transient symptoms?\nâ€¢ Population at risk: vulnerable subgroups?"
            },
            {
              heading: "Action:",
              text: "â€¢ Communicate risk (label changes, dear doctor letters)\nâ€¢ Restrict use (contraindications, REMS)\nâ€¢ Withdraw (if risk outweighs all benefit)\nâ€¢ Request confirmatory studies (if uncertainty remains)"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Self-Controlled Designs: Eliminating Between-Person Confounding",
          sections: [
            {
              heading: "The Idea:",
              items: [
                "Use each person as their own control",
                "Compare risk during 'exposed' periods to 'unexposed' periods",
                "All time-invariant confounders automatically controlled",
                "No healthy user bias from comparing different people"
              ]
            },
            {
              heading: "Case-Crossover Design:",
              items: [
                "ç—‡ä¾‹ (ç™ºç—‡ã—ãŸäººã€…) ã‹ã‚‰é–‹å§‹",
                "Compare their exposure in the hazard period (just before event)",
                "To their exposure in control periods (earlier times)",
                "If exposure is higher in hazard periods â†’ association"
              ]
            },
            {
              heading: "Self-Controlled Case Series (SCCS):",
              items: [
                "Uses only people who had BOTH exposure and outcome",
                "Compares rate during exposed periods to unexposed periods",
                "Requires that exposure doesn't affect future outcome probability",
                "ãƒ¯ã‚¯ãƒãƒ³ã®å®‰å…¨æ€§ã®ãŸã‚ã«åºƒç¯„ã«ä½¿ç”¨ (MMR è‡ªé–‰ç—‡ã¯ã“ã®æ–¹æ³•ã§èª¤ã‚ŠãŒæš´ã‹ã‚Œã¾ã—ãŸ)"
              ]
            },
            {
              heading: "Limitations:",
              items: [
                "Can't control for TIME-VARYING confounders",
                "Assumes event doesn't change future exposure probability",
                "Needs intermittent exposure (not continuous use)",
                "Can be affected by exposure trends over time"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'signal-assessment',
          title: "ã“ã®å®‰å…¨æ€§ã‚·ã‚°ãƒŠãƒ«ã‚’è©•ä¾¡",
          situation: "æ–°ã—ã„æŠ—ã†ã¤è–¬ãŒå¸‚è²©ã•ã‚Œã¾ã—ãŸ2å¹´é–“ã€‚ FAERS ã¸ã®è‡ªç„¶å ±å‘Šã¯ã€å¿ƒè‡“çªç„¶æ­»ã¨ã®é–¢é€£ã®å¯èƒ½æ€§ã‚’ç¤ºå”†ã—ã¦ã„ã¾ã™ã€‚å ±å‘Šç‡ã¯ä»–ã®æŠ—ã†ã¤è–¬ã‚ˆã‚Šã‚‚ 3 å€é«˜ã„ã§ã™ã€‚ã“ã®è–¬ã®è©¦é¨“ã§ã¯QTå»¶é•·ã¯ç¢ºèªã•ã‚Œã¦ã„ã¾ã›ã‚“ã€‚ 500,000 äººã®æ‚£è€…ãŒä½¿ç”¨ã—ã¦ã„ã¾ã™ã€‚",
          nodes: {
            start: {
              question: "First step: Is this signal reliable?",
              branches: [
                { text: "No â€” spontaneous reports are unreliable, need RCT confirmation", nextNode: "dismiss_wrong" },
                { text: "ãŠãã‚‰ã â€” é©å¿œç—‡ã«ã‚ˆã‚‹å ±å‘Šã®åã‚Šã¨äº¤çµ¡ã‚’ç¢ºèªã—ã¦ãã ã•ã„", nextNode: "check_bias_correct" },
                { text: "Yes â€” 3x higher is definitely a signal, withdraw the drug", nextNode: "overreact_wrong" }
              ]
            },
            check_bias_correct: {
              situation: "Good. You investigate. The drug is preferentially prescribed to older, sicker patients (confounding by indication). But the disproportionality persists after adjusting for age and comorbidity in database studies. Rate ratio: 2.1 (95% CI 1.4-3.2) vs comparator antidepressants.",
              question: "Next step:",
              branches: [
                { text: "Validate in an independent database using different methods", nextNode: "validate_correct" },
                { text: "Issue immediate drug withdrawal â€” 2.1 RR is alarming", nextNode: "withdraw_early" },
                { text: "å´ä¸‹ â€” ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ç ”ç©¶ã¯è¦³å¯Ÿçš„ã§ã‚ã‚Šã€RCT ã‚’å¾…ã¡ã¾ã™", nextNode: "dismiss_again_wrong" }
              ]
            },
            dismiss_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Dangerous dismissal!",
              text: "è‡ªç™ºçš„ãªå ±å‘Šã¯ä¿¡é ¼ã§ããªã„å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ãŒã€å®‰å…¨ç›£è¦–ã®æœ€å‰ç·šã§ã™ã€‚å ±å‘Šç‡ãŒ 3 å€é«˜ã„å ´åˆã€è§£é›‡ã§ã¯ãªãèª¿æŸ»ãŒå¿…è¦ã«ãªã‚Šã¾ã™ã€‚ Vioxx ã®å¿ƒè‡“ä¿¡å·ã¯ã€æªç½®ãŒè¬›ã˜ã‚‰ã‚Œã‚‹ã¾ã§ä½•å¹´ã‚‚ã®é–“ã€è‡ªç™ºçš„ã«å ±å‘Šã•ã‚Œã¦ã„ã¾ã—ãŸã€‚",
              lesson: "ä¿¡å·ã¯èª¿æŸ»ã«å€¤ã—ã¾ã™ã€‚ ã€Œä¿¡é ¼ã§ããªã„ã€ã¨ã„ã†ã®ã¯ã€Œç„¡è¦–ã™ã‚‹ã€ã¨ã„ã†æ„å‘³ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã‚Œã¯ã€ã€Œã‚ˆã‚Šè‰¯ã„æ–¹æ³•ã§ã•ã‚‰ã«èª¿æŸ»ã™ã‚‹ã€ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚"
            },
            overreact_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Premature action!",
              text: "Spontaneous reporting has many biases: notoriety bias (more reports after media coverage), channeling (drug given to sicker patients), stimulated reporting. A 3x disproportionality needs confirmation before withdrawing a drug that may help millions.",
              lesson: "æŠœæœ¬çš„ãªã‚¢ã‚¯ã‚·ãƒ§ãƒ³ã®å‰ã«ã‚·ã‚°ãƒŠãƒ«ã®æ¤œè¨¼ãŒå¿…è¦ã§ã™ã€‚ãŸã ã—ã€æ¤œè¨¼ã¯é«˜é€Ÿã§ã‚ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚Vioxx ã®å ´åˆã« 4 å¹´ã‚‚ã‹ã‹ã£ãŸã‚ã‘ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            validate_correct: {
              situation: "2 ç•ªç›®ã®ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ã«ãƒ¬ãƒ—ãƒªã‚±ãƒ¼ãƒˆã™ã‚‹ã¨ã€åŒæ§˜ã®çµæœãŒå¾—ã‚‰ã‚Œã¾ã™: RR 1.9 (1.3-2.8)ã€‚è‡ªå·±ç®¡ç†ã•ã‚ŒãŸä¸€é€£ã®ç—‡ä¾‹ã§ã‚‚ã€æš´éœ²æœŸé–“ã«ãŠã‘ã‚‹ãƒªã‚¹ã‚¯ã®ä¸Šæ˜‡ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™: IRR 2.5 (1.6-3.9)ã€‚ã•ã¦ã©ã†ãªã‚‹ã§ã—ã‚‡ã†ã‹?",
              question: "Decision time:",
              branches: [
                { text: "å¼·åŠ›ãªè¨¼æ‹  â€” ãƒªã‚¹ã‚¯ã‚’ä¼ãˆã€åˆ¶é™ã‚’è€ƒæ…®ã™ã‚‹", nextNode: "action_correct" },
                { text: "Still observational â€” request an RCT before acting", nextNode: "request_rct_wrong" }
              ]
            },
            withdraw_early: {
              type: 'outcome',
              outcome: 'partial',
              title: "Maybe appropriate, but validate first",
              text: "å¿ƒè‡“çªç„¶æ­»ã®ç™ºç”Ÿç‡æ¯” 2.1 ã¯æ·±åˆ»ã§ã™ã€‚ã—ã‹ã—ã€ç‹¬ç«‹ã—ãŸãƒ‡ãƒ¼ã‚¿ã§ã®è¤‡è£½ã¯ä¿¡é ¼æ€§ã‚’å¼·åŒ–ã™ã‚‹ã§ã—ã‚‡ã†ã€‚ä¿¡å·ãŒæœ¬ç‰©ã®å ´åˆã¯ã€ã‚¢ã‚¯ã‚·ãƒ§ãƒ³ãŒå¿…è¦ã§ã™ã€‚ã—ã‹ã—ã€ãã‚ŒãŒäººç‚ºçš„ãªã‚‚ã®ã§ã‚ã‚Œã°ã€é›¢è„±ã¯è–¬ã®æ©æµã‚’å—ã‘ã¦ã„ã‚‹æ‚£è€…ã«å®³ã‚’åŠã¼ã—ã¾ã™ã€‚",
              lesson: "é‡å¤§ãªå®³ãŒã‚ã‚‹å ´åˆã¯ã€è¡Œå‹•ã‚’èª¤ã£ã¦ãã ã•ã„ã€‚ã—ã‹ã—ã€è¿…é€Ÿãªæ¤œè¨¼ (æ•°å¹´ã§ã¯ãªãæ•°æ—¥ã‹ã‚‰æ•°é€±é–“) ã«ã‚ˆã‚Šã€ä¸å¿…è¦ãªå¼•ãå‡ºã—ã¨è¡Œå‹•ã®é…ã‚Œã®ä¸¡æ–¹ã‚’é˜²ãã“ã¨ãŒã§ãã¾ã™ã€‚"
            },
            dismiss_again_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯ Vioxx ã®å¤±æ•—ã§ã™!",
              text: "æœ‰å®³æ€§ã® RCT è¨¼æ‹ ã‚’å¾…ã¤ã®ã¯é–“é•ã„ã§ã™ã€‚ã¾ã‚Œãªå±å®³ã«å¯¾ã™ã‚‹ RCT ã«ã¯è†¨å¤§ãªã‚µãƒ³ãƒ—ãƒ«æ•°ãŒå¿…è¦ã«ãªã‚Šã¾ã™ã€‚ Database studies with consistent results across methods (cohort, SCCS) and populations provide strong evidence. ã€Œè¦³å¯Ÿã€ã¯ã€Œç„¡è¦–ã€ã‚’æ„å‘³ã™ã‚‹ã‚‚ã®ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚",
              lesson: "å±å®³ã«ã¤ã„ã¦ã¯ã€(å¤šãã®å ´åˆä¸å¯èƒ½ãª) RCT ã‚’å¾…ã¤ã‚ˆã‚Šã‚‚è¤‡æ•°ã®ä¸€è²«ã—ãŸè¦³å¯Ÿç ”ç©¶ã®æ–¹ãŒå¼·åŠ›ãªè¨¼æ‹ ã‚’æä¾›ã™ã‚‹ã“ã¨ãŒã‚ˆãã‚ã‚Šã¾ã™ã€‚å…¥æ‰‹å¯èƒ½ãªæœ€è‰¯ã®è¨¼æ‹ ã«åŸºã¥ã„ã¦è¡Œå‹•ã—ã¾ã™ã€‚"
            },
            request_rct_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "An RCT for sudden cardiac death?",
              text: "å¿ƒè‡“çªç„¶æ­»ã®å€å¢— (ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ç‡ ~0.1%) ã‚’æ¤œå‡ºã™ã‚‹ã«ã¯ã€50,000 äººä»¥ä¸Šã®æ‚£è€…ã‚’ä½•å¹´ã‚‚è¿½è·¡ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚ã“ã‚Œã¯ç¾å®Ÿçš„ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ RCTãŒå®Œäº†ã™ã‚‹ã¾ã§ã«ã€ã•ã‚‰ã«æ•°åƒäººãŒæ­»äº¡ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã€‚è¦³å¯Ÿè¨¼æ‹ ã¯ã€ã¾ã‚Œã§æ·±åˆ»ãªå±å®³ã«å¯¾ã™ã‚‹ç§ãŸã¡ãŒã“ã‚Œã¾ã§ã«å¾—ãŸæœ€è‰¯ã®è¨¼æ‹ ã§ã™ã€‚",
              lesson: "è¨¼æ‹ ã«åŸºã¥ãåŒ»ç™‚ã¯ã€ã€ŒRCT ã‹ç„¡ã‹ã€ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ãã‚Œã¯ã€ã€Œå…¥æ‰‹å¯èƒ½ãªæœ€è‰¯ã®è¨¼æ‹ ã‚’ä½¿ç”¨ã™ã‚‹ã€ã“ã¨ã§ã™ã€‚ã¾ã‚Œãªå®³ã«ã¤ã„ã¦ã¯ã€é©åˆ‡ã«å®Ÿæ–½ã•ã‚ŒãŸè¦³å¯Ÿç ”ç©¶ã‚’æ„å‘³ã—ã¾ã™ã€‚"
            },
            action_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Appropriate response!",
              text: "With replicated observational evidence using multiple methods, action is warranted. Options: label warnings, contraindications for high-risk patients, REMS program, or (if alternatives exist and harm is severe) withdrawal. The exact action depends on benefit-harm balance.",
              lesson: "ã‚·ã‚°ãƒŠãƒ«â†’æ¤œè¨¼â†’è©•ä¾¡â†’ã‚¢ã‚¯ã‚·ãƒ§ãƒ³ã€‚ Vioxx ã®æƒ¨äº‹ã¯ã€è¡Œå‹•ãŒé…ã‚ŒãŸãŸã‚ã«èµ·ã“ã‚Šã¾ã—ãŸã€‚è¤‡æ•°ã®ä¸€è²«ã—ãŸè¦³å¯Ÿã‚·ã‚°ãƒŠãƒ« DEMAND åå¿œã€‚"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "è–¬ç‰©æœ‰å®³æ€§ã®è¨¼æ‹ é–¾å€¤ãŒè–¬ç‰©åˆ©ç›Šã®è¨¼æ‹ é–¾å€¤ã‚ˆã‚Šã‚‚ä¸€èˆ¬ã«ä½ã„ã®ã¯ãªãœã§ã™ã‹?",
          options: [
            { id: 'a', text: "Harms are easier to measure than benefits", correct: false },
            { id: 'b', text: "å½é™°æ€§ (å®³ã®æ¬ è½) ã®ã‚³ã‚¹ãƒˆã¯å½é™½æ€§ (åˆ©ç›Šã®æ¬ è½) ã®ã‚³ã‚¹ãƒˆã‚’ä¸Šå›ã‚Šã¾ã™", correct: true },
            { id: 'c', text: "è¦³å¯Ÿç ”ç©¶ã¯åˆ©ç›Šã‚ˆã‚Šã‚‚å®³ã®æ–¹ãŒä¿¡é ¼ã§ãã¾ã™", correct: false },
            { id: 'd', text: "RCTs cannot detect harms, only benefits", correct: false }
          ],
          explanation: "åˆ©ç›Šã®å ´åˆã€å½é™½æ€§ (åŠ¹æœã®ãªã„æ²»ç™‚ã‚’æ‰¿èªã™ã‚‹) ã¯ãƒªã‚½ãƒ¼ã‚¹ã‚’ç„¡é§„ã«ã—ã¾ã™ã€‚å±å®³ã«ã¤ã„ã¦ã¯ã€å½é™°æ€§ï¼ˆæœ‰å®³ãªå½±éŸ¿ã‚’è¦‹é€ƒã™ã“ã¨ï¼‰ã«ã‚ˆã£ã¦äººãŒæ­»äº¡ã—ã¾ã™ã€‚çµæœã®éå¯¾ç§°æ€§ã¯ã€è¨¼æ‹ ã®é–¾å€¤ãŒéå¯¾ç§°ã§ã‚ã‚‹ã“ã¨ã‚’æ­£å½“åŒ–ã—ã¾ã™ã€‚åˆ©ç›Šã‚’ä¿¡ã˜ã‚‹ã‚ˆã‚Šã‚‚å®³ã‚’ç–‘ã†æ–¹ãŒç¢ºå®Ÿæ€§ã‚’ä½ãã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚"
        }
      }
    ]
  },
  // MODULE 10: THE INTEGRATION (When to Trust Observational Evidence)
  {
    id: 10,
    title: "The Integration",
    subtitle: "When to Trust",
    principle: 6,
    estimatedTime: "35 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Replication builds confidence"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "åæŸ: å–«ç…™ã¨è‚ºãŒã‚“ â€” è¦³å¯ŸãŒååˆ†ã ã£ãŸå ´åˆ",
          source: "Doll & Hill 1950-2004 | Bradford Hill Criteria | Never randomized",
          timeline: [
            { year: "1950", text: "Doll & Hill case-control study: smokers 9x more likely to have lung cancer. Tobacco industry demands RCT proof. (Unethical to randomize smoking)", type: "normal" },
            { year: "1954", text: "British Doctors cohort begins. Prospective design addresses reverse causation. Shows dose-response: more cigarettes â†’ more cancer.", type: "normal" },
            { year: "1964", text: "US Surgeon General declares smoking causes lung cancer. Based entirely on observational evidence. No RCT ever conducted.", type: "revelation" },
            { year: "2004", text: "50-year follow-up: smokers lose 10 years of life expectancy. Quitting at any age helps. Observational evidence now indisputable.", type: "revelation" },
            { year: "How We Knew", text: "Strength (RR = 10-30), consistency (every study), temporality (smoking preceded cancer), dose-response, biological plausibility, coherence, specificity, analogy, experiment (cessation reduces risk).", type: "revelation" },
            { year: "Lesson", text: "ãƒ–ãƒ©ãƒƒãƒ‰ãƒ•ã‚©ãƒ¼ãƒ‰ ãƒ’ãƒ«åŸºæº–ã«ã‚ˆã‚Šã€RCT ãŒä¸å¯èƒ½ãªå ´åˆã§ã‚‚è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ã‹ã‚‰ã®å› æœé–¢ä¿‚ã®æ¨è«–ãŒå¯èƒ½ã«ãªã‚Šã¾ã—ãŸã€‚å¼·åŠ›ã§ä¸€è²«æ€§ãŒã‚ã‚Šã€ç”Ÿç‰©å­¦çš„ã«å¦¥å½“ãªé–¢é€£æ€§ãŒã‚ã‚Œã°ã€ç„¡ä½œç‚ºåŒ–ã›ãšã«å› æœé–¢ä¿‚ã‚’ç¢ºç«‹ã§ãã¾ã™ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "Lung cancer mortality",
            drug: "Heavy smoking (20+ cigarettes/day)",
            placebo: "Never smokers",
            rr: "RR 10-30 (study dependent)",
            ci: "Unmistakable association",
            nnh: "Millions of deaths attributable to smoking"
          },
          hook: "ã‚¶ãƒ»ãƒ•ãƒƒã‚¯: ç§ãŸã¡ã¯å–«ç…™ã‚’ç„¡ä½œç‚ºåŒ–ã—ãŸã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã—ã‹ã—ã€å–«ç…™ãŒè‚ºãŒã‚“ã®åŸå› ã¨ãªã‚‹ã“ã¨ã‚’ç–‘ã†äººã¯èª°ã‚‚ã„ã¾ã›ã‚“ã€‚è¦³å¯Ÿè¨¼æ‹ ã ã‘ã§ã©ã†ã—ã¦ä¸–ç•Œã‚’ç´å¾—ã•ã›ã‚‹ã“ã¨ãŒã§ããŸã®ã§ã—ã‚‡ã†ã‹ï¼Ÿ The Bradford Hill criteria â€” a framework for causal inference when RCTs are impossible or unethical."
        }
      },
      {
        type: 'principle',
        content: {
          text: "â¸ï¸ KEY INSIGHT: Observational evidence CAN establish causation when: (1) associations are STRONG, (2) results REPLICATE across studies/populations/methods, (3) temporality is clear, (4) dose-response exists, (5) biological mechanism is plausible, (6) findings are COHERENT with existing knowledge. No single criterion is required; it's the totality of evidence."
        }
      },
      {
        type: 'content',
        content: {
          title: "The Bradford Hill Criteria (Updated)",
          sections: [
            {
              heading: "1. Strength of Association:",
              text: "Larger effect sizes are less likely to be entirely due to confounding. RR = 10 is hard to explain by bias alone; RR = 1.2 might be entirely confounded."
            },
            {
              heading: "2. Consistency:",
              text: "Same finding across different populations, settings, methods, times. If it replicates everywhere, less likely to be artifact."
            },
            {
              heading: "3. Specificity:",
              text: "Exposure leads to specific outcome (not everything).ã—ã‹ã—ã€å¤šåŸå› ç–¾æ‚£ã¯ã“ã‚Œã«é•åã—ã¾ã™ã€‚å–«ç…™ã¯å¤šãã®ç—…æ°—ã‚’å¼•ãèµ·ã“ã—ã¾ã™ã€‚æœ€ã‚‚é‡è¦ã§ãªã„åŸºæº–ã€‚"
            },
            {
              heading: "4. Temporality:",
              text: "Cause MUST precede effect. This is essential. Cohort studies establish temporality; cross-sectional cannot."
            },
            {
              heading: "5. Biological Gradient (Dose-Response):",
              text: "More exposure â†’ more outcome. Supports causation. But non-linear relationships can be causal too."
            },
            {
              heading: "6. Plausibility:",
              text: "é–¢ä¿‚ã‚’èª¬æ˜ã§ãã‚‹ç”Ÿç‰©å­¦çš„ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ãŒå­˜åœ¨ã—ã¾ã™ã€‚ã—ã‹ã—ã€ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã¯çœŸã®åŸå› ã«ã¤ã„ã¦å¿…ãšã—ã‚‚çŸ¥ã‚‰ã‚Œã¦ã„ã‚‹ã‚ã‘ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚"
            },
            {
              heading: "7. Coherence:",
              text: "Association doesn't conflict with known biology, natural history, epidemiology. Should 'fit' existing knowledge."
            },
            {
              heading: "8. Experiment:",
              text: "æ›éœ²ã‚’é™¤å»ã™ã‚‹ã¨çµæœãŒæ¸›å°‘ã—ã¾ã™ (ä¸­æ­¢ç ”ç©¶)ã€‚ã¾ãŸã¯ã€è‡ªç„¶å®Ÿé¨“ã§åŠ¹æœãŒç¤ºã•ã‚Œã¾ã™ã€‚"
            },
            {
              heading: "9. Analogy:",
              text: "Similar exposures cause similar outcomes. If A causes X, then similar B might cause similar Y."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "æ–¹æ³•: ä¸‰è§’æ¸¬é‡",
          title: "Modern Approach to Causal Inference",
          sections: [
            {
              heading: "What Is Triangulation?",
              text: "ãã‚Œãã‚Œã«ç•°ãªã‚‹ãƒã‚¤ã‚¢ã‚¹æºã‚’æŒã¤è¤‡æ•°ã®ç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã‚’ä½¿ç”¨ã—ã¦ã€åŒã˜ç­”ãˆã«åæŸã™ã‚‹ã‹ã©ã†ã‹ã‚’ç¢ºèªã—ã¾ã™ã€‚ãƒã‚¤ã‚¢ã‚¹ãŒç•°ãªã‚‹ãŒçµæœãŒä¸€è‡´ã™ã‚‹å ´åˆã¯ã€å› æœé–¢ä¿‚ãŒã‚ã‚‹å¯èƒ½æ€§ãŒé«˜ããªã‚Šã¾ã™ã€‚"
            },
            {
              heading: "Example: Alcohol and Heart Disease",
              text: "â€¢ Cohort studies: moderate drinking appears protective (confounded by healthy user?)\nâ€¢ Mendelian randomization: genetic variants for alcohol metabolism show NO protection\nâ€¢ Sibling comparisons: within-family, no protective effect\n\nTriangulation: cohort studies were confounded. Observational 'benefit' is not causal."
            },
            {
              heading: "Key Insight:",
              text: "Different methods have different biases:\nâ€¢ Cohort studies: confounding, selection\nâ€¢ Case-control: recall bias\nâ€¢ Mendelian randomization: pleiotropy, weak instruments\nâ€¢ Within-family: shared family environment\n\nIf ALL methods agree despite DIFFERENT biases, confidence in causality increases."
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "è¦³å¯Ÿè¨¼æ‹ ã‚’ä¿¡é ¼ã™ã‚‹å ´åˆ",
          sections: [
            {
              heading: "HIGH Confidence When:",
              items: [
                "Large effect size (RR > 2-3) â€” hard to explain by bias alone",
                "ãƒã‚¤ã‚¢ã‚¹ãŒç•°ãªã‚‹è¤‡æ•°ã®æ–¹æ³•ã§ä¸€è²«ã—ã¦ã„ã‚‹",
                "Clear temporality (prospective cohort, not cross-sectional)",
                "Dose-response present",
                "Biologically plausible mechanism known",
                "Low risk of bias by ROBINS-I criteria",
                "Mendelian randomization agrees with observational"
              ]
            },
            {
              heading: "LOW Confidence When:",
              items: [
                "Small effect size (RR 1.0-1.5) â€” easily confounded",
                "çµæœã¯æ–¹æ³•ã«ã‚ˆã£ã¦ç•°ãªã‚Šã¾ã™ (ã‚³ãƒ›ãƒ¼ãƒˆã¨ç—‡ä¾‹å¯¾ç…§ãŒä¸€è‡´ã—ãªã„)",
                "Cross-sectional design (reverse causation possible)",
                "No dose-response or paradoxical patterns",
                "Mechanism unknown or contradicts biology",
                "High risk of bias across studies",
                "Mendelian randomization contradicts observational"
              ]
            },
            {
              heading: "The 'Smoking Test':",
              text: "å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™æœªæ¸¬å®šã®äº¤çµ¡ã¯å–«ç…™ã¨åŒã˜ãã‚‰ã„å¼·ã„ â†’ è‚ºãŒã‚“ (RR 10-30)?åŠ¹æœãŒ RR 1.3 ã®å ´åˆã€æ›éœ²ã¨çµæœã®ä¸¡æ–¹ã«ãŠã‘ã‚‹ RR 2 ã®äº¤çµ¡å› å­ã«ã‚ˆã£ã¦å®Œå…¨ã«èª¬æ˜ã§ãã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚åŠ¹æœãŒ RR 10 ã®å ´åˆã€èª¬æ˜ã™ã‚‹ã®ã¯ã¯ã‚‹ã‹ã«å›°é›£ã§ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'trust-decision',
          title: "ã“ã®è¦³å¯Ÿçµæœã‚’ä¿¡é ¼ã™ã¹ãã§ã™ã‹?",
          situation: "You've read that red meat consumption is associated with colorectal cancer. Cohort studies show RR ~1.2 (1.1-1.4) for high vs low consumption. This is consistent across multiple cohorts. Biological plausibility exists (heme iron, heterocyclic amines). No RCT is possible (can't randomize diet for decades).",
          nodes: {
            start: {
              question: "First consideration: What do you think of RR = 1.2?",
              branches: [
                { text: "Moderate effect â€” warrants public health attention", nextNode: "moderate_wrong" },
                { text: "Small effect â€” could easily be explained by confounding", nextNode: "small_correct" },
                { text: "Negligible â€” ignore it", nextNode: "ignore_wrong" }
              ]
            },
            small_correct: {
              situation: "æ­£è§£ã§ã™ã€‚ RR 1.2 ã¯å°ã•ã„ãŸã‚ã€æ··ä¹±ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ã—ã‹ã—ã€ãã‚Œã¯ã‚³ãƒ›ãƒ¼ãƒˆå…¨ä½“ã§ä¸€è²«ã—ã¦ã„ã¾ã™ã€‚ãã‚Œã«ã‚ˆã£ã¦çŠ¶æ³ã¯å¤‰ã‚ã‚Šã¾ã™ã‹?",
              question: "Consistency across cohorts means:",
              branches: [
                { text: "It's probably causal â€” too consistent to be chance", nextNode: "consistent_overinterpret" },
                { text: "ç ”ç©¶ã¯åŒã˜ãƒã‚¤ã‚¢ã‚¹ã‚’å…±æœ‰ã—ã¦ã„ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ (å¥åº·ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã€æ®‹ç•™äº¤çµ¡)", nextNode: "shared_bias_correct" }
              ]
            },
            moderate_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Be more skeptical",
              text: "RR 1.2 ã¯ç–«å­¦ã«ãŠã‘ã‚‹å½±éŸ¿ã¯å°ã•ã„ã§ã™ã€‚æ¯”è¼ƒã®ãŸã‚ã«ã€å–«ç…™ã¨è‚ºãŒã‚“ã¯RR 10ï½30ã§ã™ã€‚åŠ¹æœé‡ 1.2 ã¯ã€æ¸¬å®šã•ã‚Œã¦ã„ãªã„äº¤çµ¡ãŒå®¹æ˜“ã«ç”Ÿã˜ã‚‹å¯èƒ½æ€§ã®ã‚ã‚‹ç¯„å›²å†…ã§ã™ã€‚ãã‚Œã¯ã€Œä¸­ç¨‹åº¦ã€ã§ã¯ãªãã€ã€Œä¸ç¢ºå®Ÿã€ã§ã™ã€‚",
              lesson: "In observational epidemiology, be skeptical of RR < 2. Such effects could be entirely confounded."
            },
            ignore_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Don't dismiss entirely",
              text: "RR 1.2 at a population level still matters. If millions eat high red meat, even small excess risks produce substantial burden. The effect may be real but confounded; it's worth investigating with different methods.",
              lesson: "Small effects can have large public health impact. Don't dismiss, but be appropriately uncertain."
            },
            consistent_overinterpret: {
              type: 'outcome',
              outcome: 'partial',
              title: "ä¸€è²«æ€§ã«ã¯æ³¨æ„ã—ã¦ãã ã•ã„!",
              text: "Consistency is reassuring, but cohort studies share SIMILAR biases: all have healthy user effects, similar measurement error, similar confounding structures. Consistency within one method doesn't rule out systematic bias in that method.",
              lesson: "ãƒ¡ã‚½ãƒƒãƒ‰å…¨ä½“ã®ä¸€è²«æ€§ (ã‚³ãƒ›ãƒ¼ãƒˆã€ç—‡ä¾‹å¯¾ç…§ã€ãƒ¡ãƒ³ãƒ‡ãƒ«ãƒ©ãƒ³ãƒ€ãƒ åŒ–) ã¯ã€1 ã¤ã®ãƒ¡ã‚½ãƒƒãƒ‰å†…ã§ã®ä¸€è²«æ€§ã‚ˆã‚Šã‚‚å®‰å¿ƒã§ã™ã€‚"
            },
            shared_bias_correct: {
              situation: "ãã†ã§ã™ã€‚èµ¤èº«è‚‰ã®æ¶ˆè²»ã«å½±éŸ¿ã‚’ä¸ãˆã‚‹éºä¼çš„å¤‰ç•°ã‚’ä½¿ç”¨ã—ã¦ã€ãƒ¡ãƒ³ãƒ‡ãƒ«ãƒ©ãƒ³ãƒ€ãƒ åŒ– (MR) ç ”ç©¶ãŒè¡Œã‚ã‚ŒãŸã‚‰ã©ã†ãªã‚‹ã§ã—ã‚‡ã†ã‹? MR ãŒçµè…¸ç›´è…¸ãŒã‚“ã¨ã®é–¢é€£æ€§ã‚’ç¤ºã•ãªã‹ã£ãŸã¨ã—ã¾ã™ã€‚",
              question: "ä½•ã‚’çµè«–ä»˜ã‘ã¾ã™ã‹?",
              branches: [
                { text: "MR ã¯æ±ºå®šçš„ã§ã™ - ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã¯æ··ä¹±ã—ã¾ã—ãŸ", nextNode: "mr_definitive_partial" },
                { text: "Triangulation: discordant results suggest confounding, but MR has limitations too", nextNode: "triangulation_correct" }
              ]
            },
            mr_definitive_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "MR isn't perfect either",
              text: "Mendelian randomization has limitations: genetic variants may affect multiple pathways (pleiotropy), instruments may be weak, genetic effects operate lifelong (not same as adult dietary change). Discordant MR suggests confounding in cohorts, but doesn't definitively prove null effect.",
              lesson: "æ±ºå®šçš„ãªå˜ä¸€ã®æ–¹æ³•ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ä¸‰è§’æ¸¬é‡ã¨ã¯ã€ãã‚Œãã‚Œã«ç•°ãªã‚‹åˆ¶é™ãŒã‚ã‚‹è¤‡æ•°ã®ã‚¢ãƒ—ãƒ­ãƒ¼ãƒã‹ã‚‰ã®è¨¼æ‹ ã‚’æ¯”è¼ƒæ¤œè¨ã™ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚"
            },
            triangulation_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent triangulation!",
              text: "You've correctly identified: (1) small effect size â†’ possibly confounded; (2) consistency within method doesn't rule out shared bias; (3) discordant MR suggests confounding but isn't definitive. The appropriate conclusion is: 'Uncertain â€” possible small effect, possibly confounded.'",
              lesson: "This is the current scientific consensus on red meat and colorectal cancer: probably some effect, but magnitude uncertain due to potential confounding. Public health messaging should reflect this uncertainty."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "ã©ã®ã‚·ãƒŠãƒªã‚ªãŒå› æœé–¢ä¿‚ã«é–¢ã™ã‚‹æœ€ã‚‚å¼·åŠ›ãªè¦³å¯Ÿè¨¼æ‹ ã‚’æä¾›ã—ã¾ã™ã‹?",
          options: [
            { id: 'a', text: "RR 1.3 ã‚’ç¤ºã™ 20 ä»¶ã®ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã€‚ã™ã¹ã¦åŒæ§˜ã®äº¤çµ¡æ§‹é€ ã‚’ç¤ºã—ã¾ã™", correct: false },
            { id: 'b', text: "ç•°ãªã‚‹æ–¹æ³•ã‚’ä½¿ç”¨ã—ãŸ 5 ä»¶ã®ç ”ç©¶ (ã‚³ãƒ›ãƒ¼ãƒˆã€ç—‡ä¾‹å¯¾ç…§ã€ MRã€å…„å¼Ÿï¼‰å…¨å“¡ãŒRR ~3ã‚’ç¤ºã™", correct: true },
            { id: 'c', text: "100ä¸‡äººã®å‚åŠ è€…ã«ã‚ˆã‚‹1ã¤ã®å¤§è¦æ¨¡ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã§RR 1.5ã‚’ç¤ºã™", correct: false },
            { id: 'd', text: "A meta-analysis of 50 studies showing pooled RR 1.2 with IÂ² = 0%", correct: false }
          ],
          explanation: "Triangulation across different methods with different biases provides the strongest evidence. If cohort studies (confounding), case-control (recall bias), MR (pleiotropy), and sibling comparisons (genetic confounding) all converge on RR ~3, each method's biases are unlikely to produce the same false answer. Large N or many studies with the SAME bias doesn't help."
        }
      },
      {
        type: 'content',
        content: {
          title: "Mendelian Randomization: Nature's RCT",
          sections: [
            {
              heading: "The Brilliant Idea:",
              items: [
                "Genetic variants are assigned at conception (before any confounders)",
                "Like random assignment in an RCT",
                "Find a gene that affects exposure (e.g., alcohol metabolism)",
                "Compare outcomes in people with different gene variants",
                "Since genes are 'randomized,' confounding is eliminated"
              ]
            },
            {
              heading: "Example: Alcohol and Heart Disease",
              items: [
                "Observational: moderate drinkers have lower CVD than non-drinkers",
                "Confounding? Moderate drinkers may be healthier overall",
                "MR approach: Use ALDH2 gene (affects alcohol metabolism)",
                "People with 'slow metabolizer' variant drink less",
                "MR result: NO cardioprotection from moderate drinking",
                "è¦³å¯Ÿä¸Šã®é–¢é€£æ€§ã¯æ··ä¹±ã—ã¦ã„ãŸ"
              ]
            },
            {
              heading: "Limitations (IMPORTANT):",
              items: [
                "PLEIOTROPY: Gene may affect outcome through other pathways",
                "WEAK INSTRUMENTS: Gene may explain tiny fraction of exposure",
                "POPULATION STRATIFICATION: Ancestry can confound",
                "DEVELOPMENTAL EFFECTS: Lifelong genetic effect â‰  adult intervention",
                "MRã¯å¼·åŠ›ã ãŒç¢ºå®Ÿã§ã¯ãªã„ - ä¸‰è§’æ¸¬é‡ã«ä½¿ç”¨"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'mr-interpretation',
          title: "è§£é‡ˆã“ã®MRç ”ç©¶",
          situation: "Observational studies consistently show that higher vitamin D levels are associated with lower risk of multiple sclerosis (MS). RR = 0.60 (0.50-0.70) per 50 nmol/L higher vitamin D. An MR study uses genetic variants affecting vitamin D synthesis.",
          nodes: {
            start: {
              question: "MR ç ”ç©¶ã§ã¯ã€é«˜ãƒ“ã‚¿ãƒŸãƒ³ D ã«å¯¾ã™ã‚‹éºä¼çš„ç´ å› ã¯ MS ãƒªã‚¹ã‚¯ã®ä½ä¸‹ã¨é–¢é€£ã—ã¦ã„ã‚‹ (éºä¼çš„ã«äºˆæ¸¬ã•ã‚Œã‚‹ 50 nmol/L ã‚ãŸã‚Š OR 0.70) ã“ã¨ãŒåˆ¤æ˜ã—ã¾ã—ãŸã€‚ã“ã‚Œã¯ä½•ã‚’ç¤ºå”†ã—ã¦ã„ã¾ã™ã‹?",
              branches: [
                { text: "Vitamin D supplementation will prevent MS", nextNode: "supplement_wrong" },
                { text: "è¦³å¯Ÿä¸Šã®é–¢é€£æ€§ã¯å˜ãªã‚‹æ··ä¹±ã§ã¯ãªãã€å› æœé–¢ä¿‚ãŒã‚ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™", nextNode: "causal_correct" },
                { text: "è¦³å¯Ÿç ”ç©¶ã¯å´ä¸‹ã™ã¹ãã§ã™", nextNode: "dismiss_wrong" }
              ]
            },
            supplement_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too far!",
              text: "MR supports causality of vitamin D LEVELS, but: (1) Lifelong genetically-determined levels â‰  adult supplementation; (2) The genetic effect operates from birth; (3) There may be critical windows in childhood. MR suggests vitamin D matters but doesn't prove SUPPLEMENTATION works.",
              lesson: "MRæ¤œæŸ»ã§æš´éœ²ã®å› æœåŠ¹æœã‚’èª¿ã¹ã¾ã™ã€‚ç‰¹ã«ã‚¿ã‚¤ãƒŸãƒ³ã‚°ã€ç”¨é‡ã€ãƒ•ã‚©ãƒ¼ãƒ ãŒç•°ãªã‚‹å ´åˆã€ä»‹å…¥ãŒåŠ¹æœãŒã‚ã‚‹ã‹ã©ã†ã‹ã¯ã‚ã‹ã‚Šã¾ã›ã‚“ã€‚"
            },
            causal_correct: {
              situation: "æ­£ã—ã„è§£é‡ˆ! MR ã¯å› æœé–¢ä¿‚ã‚’ã‚µãƒãƒ¼ãƒˆã—ã¾ã™ã€‚ã—ã‹ã—ã€ç¢ºä¿¡ã‚’å¾—ã‚‹å‰ã«ã€ä½•ã‚’ç¢ºèªã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã‹?",
              question: "What's the key assumption to verify?",
              branches: [
                { text: "Sample size is adequate", nextNode: "sample_wrong" },
                { text: "The genetic variants don't affect MS through other pathways (pleiotropy)", nextNode: "pleiotropy_correct" }
              ]
            },
            dismiss_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Don't dismiss â€” triangulate!",
              text: "MR SUPPORTING observational findings is good news! When methods with different biases agree (observational: confounding; MR: pleiotropy), confidence increases. Consistency between methods is the goal of triangulation.",
              lesson: "è¦³å¯Ÿç ”ç©¶ã¨ MR ç ”ç©¶ã®é–“ã®åˆæ„ã«ã‚ˆã‚Šã€å› æœé–¢ä¿‚ã®æ ¹æ‹ ãŒå¼·åŒ–ã•ã‚Œã¾ã™ã€‚ä¸¡è€…ã«ã¯ç•°ãªã‚‹ãƒã‚¤ã‚¢ã‚¹ãŒã‚ã‚‹ãŸã‚ã€ä¸¡æ–¹ãŒä¸€è‡´ã™ã‚Œã°ã€è¦³å¯Ÿç ”ç©¶ã§ã®äº¤çµ¡ã®å¯èƒ½æ€§ã¯ä½ããªã‚Šã¾ã™ã€‚"
            },
            sample_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "ã“ã‚Œã¯æ­£ã—ã„ã§ã™ãŒã€é‡è¦ãªä»®å®šã§ã¯ã‚ã‚Šã¾ã›ã‚“",
              text: "ç²¾åº¦ã®ãŸã‚ã«ã¯é©åˆ‡ãªã‚µãƒ³ãƒ—ãƒ«ã‚µã‚¤ã‚ºãŒé‡è¦ã§ã™ãŒã€MR ã®åŸºæœ¬çš„ãªä»®å®šã¯ã€éºä¼çš„å¤‰ç•°ã¯æ›éœ²ã‚’é€šã˜ã¦ã®ã¿çµæœã«å½±éŸ¿ã‚’ä¸ãˆã‚‹ã¨ã„ã†ã“ã¨ã§ã™ã€‚ãƒ“ã‚¿ãƒŸãƒ³ D éºä¼å­ã‚‚å…ç–«æ©Ÿèƒ½ã«ç›´æ¥å½±éŸ¿ã‚’ä¸ãˆã‚‹ (å¤šé¢ç™ºç¾æ€§) å ´åˆã€MR ã¯åã£ã¦ã„ã¾ã™ã€‚",
              lesson: "MR validity depends on: (1) Genes affect exposure, (2) Genes don't affect outcome except through exposure, (3) Genes aren't confounded (usually satisfied). Violation of #2 (pleiotropy) is the main threat."
            },
            pleiotropy_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "å¤šé¢ç™ºç¾æ€§ã¯ MR ã®ã‚¢ã‚­ãƒ¬ã‚¹è…±ã§ã™ã€‚ãƒ“ã‚¿ãƒŸãƒ³ D éºä¼å­ãŒå…ç–«æ©Ÿèƒ½ã€æ—¥å…‰æ›éœ²è¡Œå‹•ã€ã¾ãŸã¯ MS ã¸ã®ä»–ã®çµŒè·¯ã«ã‚‚å½±éŸ¿ã‚’ä¸ãˆã‚‹å ´åˆã€MR æ¨å®šå€¤ã«ã¯åã‚ŠãŒç”Ÿã˜ã¾ã™ã€‚å¤šé¢ç™ºç¾æ€§ (MR-Eggerã€åŠ é‡ä¸­å¤®å€¤) ã‚’ãƒ†ã‚¹ãƒˆ/èª¿æ•´ã™ã‚‹æ–¹æ³•ã¯å­˜åœ¨ã—ã¾ã™ãŒã€æ‡¸å¿µã¯æ®‹ã‚Šã¾ã™ã€‚",
              lesson: "When reading MR studies, always ask: 'Could these genes affect the outcome through OTHER pathways?' If yes, interpret cautiously. Use multiple genetic variants and sensitivity analyses."
            }
          }
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ— ãƒˆãƒ©ãƒƒãƒ—: ACCORD â€” å¹³å‡ãŒå®³ã‚’éš ã—ãŸã¨ã",
          source: "NEJM 2008; ACCORD Study Group | Intensive glycemic control | Effect modification",
          timeline: [
            { year: "Hypothesis", text: "Lower blood sugar should prevent diabetic complications. Target HbA1c <6% (intensive) vs <7.5% (standard). Makes biological sense.", type: "normal" },
            { year: "2008", text: "ACCORD ã¯ HARM ã®ãŸã‚ã«æ—©æœŸã«åœæ­¢ã—ã¾ã—ãŸã€‚é›†ä¸­ç®¡ç†ã«ã‚ˆã‚Šæ­»äº¡ç‡ãŒå¢—åŠ : HR 1.22 (1.01-1.46)ã€‚æ­»äº¡è€…æ•°ã¯ 257 åã€å¯¾ 203 åã€‚äºˆæƒ³ã¨ã¯é€†ã§ã—ãŸã€‚", type: "crisis" },
            { year: "But Wait", text: "ADVANCE trial (similar design): NO mortality increase. VADT trial: NO mortality increase. Same intervention, different results. Why?", type: "crisis" },
            { year: "Subgroup Analysis", text: "ACCORD ã§ã¯ã€ä»¥å‰ã«å¿ƒè¡€ç®¡ç–¾æ‚£ã‚’æ‚£ã£ã¦ã„ãŸæ‚£è€…ã®æ­»äº¡ç‡ãŒé›†ä¸­ç®¡ç†ä¸‹ã§ã‚ˆã‚Šé«˜ããªã‚Šã¾ã—ãŸã€‚ CVD ã®ãªã„æ‚£è€…ã®æ­»äº¡ç‡ã¯ä½ã‹ã£ãŸã€‚å¹³å‡å€¤ã¯åå¯¾ã®åŠ¹æœã‚’è¦†ã„éš ã—ã¾ã—ãŸã€‚", type: "revelation" },
            { year: "The Lesson", text: "åŠ¹æœã®ä¿®æ­£: ä»‹å…¥ã¯ä¸€éƒ¨ã®äººã‚’åŠ©ã‘ã€ä»–ã®äººã‚’å‚·ã¤ã‘ã¾ã™ã€‚ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ—å…¨ä½“ã‚’å¹³å‡ã™ã‚‹ã¨ã€èª¤è§£ã‚’æ‹›ãã€Œã‚¼ãƒ­ã€ã¾ãŸã¯å°ã•ãªåŠ¹æœãŒç”Ÿã˜ã¾ã™ã€‚å€‹åˆ¥åŒ–åŒ»ç™‚ã«ã¯ã€WHO ã®åˆ©ç›Šã¨ WHO ã®è¢«å®³ã‚’ç†è§£ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚", type: "revelation" },
            { year: "Clinical Impact", text: "ã‚¬ã‚¤ãƒ‰ãƒ©ã‚¤ãƒ³ã¯ç¾åœ¨ã€é«˜é½¢ã® CVD æ‚£è€…ã«å¯¾ã—ã¦ç©æ¥µçš„ãªã‚°ãƒ«ã‚³ãƒ¼ã‚¹ç›®æ¨™ã‚’è¨­å®šã—ãªã„ã“ã¨ã‚’æ¨å¥¨ã—ã¦ã„ã¾ã™ã€‚ã—ã‹ã—ã€ã‚ˆã‚Šè‹¥ãã¦å¥åº·ãªç³–å°¿ç—…æ‚£è€…ã‚’é›†ä¸­çš„ã«ã‚³ãƒ³ãƒˆãƒ­ãƒ¼ãƒ«ã™ã‚‹ãŸã‚ã«ã¯ã€‚ 1 ã¤ã®ç­”ãˆãŒã™ã¹ã¦ã«å½“ã¦ã¯ã¾ã‚‹ã‚ã‘ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚", type: "revelation" }
          ],
          realData: {
            endpoint: "All-cause mortality",
            drug: "Intensive glycemic control (HbA1c <6%)",
            placebo: "Standard control (HbA1c <7.5%)",
            rr: "Overall: HR 1.22 (1.01-1.46) | By CVD: OPPOSITE directions",
            ci: "Heterogeneity of treatment effect",
            nnh: "One-size-fits-all kills"
          },
          hook: "THE HOOK: ACCORD ã¯ã€ã€Œå¹³å‡çš„ãªæ²»ç™‚åŠ¹æœã€ãŒå±é™ºã§ã‚ã‚‹ç†ç”±ã‚’ç¤ºã—ã¦ã„ã¾ã™ã€‚å…¨æ‚£è€…ã®å¹³å‡ã§ã¯å®³ã¯å°ã•ã‹ã£ãŸã€‚ã—ã‹ã—ã€ã“ã®ã€Œå¹³å‡ã€ã¯ã€é›†ä¸­çš„ãªç®¡ç†ã«ã‚ˆã£ã¦ä¸€éƒ¨ã®äººãŒåŠ©ã‘ã‚‰ã‚Œã€ä»–ã®äººãŒæ®ºã•ã‚ŒãŸã¨ã„ã†äº‹å®Ÿã‚’éš ã—ã¾ã—ãŸã€‚è¦³å¯Ÿç ”ç©¶ã§ã¯ã€RCT ãŒè¦‹é€ƒã™åŠ¹æœã®ä¿®æ­£ã‚’èª¿æŸ»ã§ãã¾ã™ã€‚"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'effect-modification',
          title: "ã“ã®åŠ¹æœã®ä¿®æ­£ã¾ãŸã¯äº¤çµ¡ã¯ã‚ã‚Šã¾ã™ã‹?",
          situation: "In your observational study, you find that a statin reduces cardiovascular events overall (HR 0.80). But when you stratify by age: <65 years HR 0.60; â‰¥65 years HR 0.95.",
          nodes: {
            start: {
              question: "What is happening here?",
              branches: [
                { text: "Confounding by age â€” need to adjust", nextNode: "confounding_wrong" },
                { text: "Effect modification â€” statin works better in younger patients", nextNode: "modification_correct" },
                { text: "Statistical artifact â€” subgroups are underpowered", nextNode: "artifact_partial" }
              ]
            },
            confounding_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯äº¤çµ¡ã§ã¯ã‚ã‚Šã¾ã›ã‚“!",
              text: "äº¤çµ¡ã¨ã¯ã€å¹´é½¢ãŒæ›éœ²ã¨çµæœã®é–¢ä¿‚ã‚’æ­ªã‚ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ (é«˜é½¢ã®æ‚£è€…ã¯ã‚¹ã‚¿ãƒãƒ³ã‚’æŠ•ä¸ã•ã‚Œã€CVD ã‚’æ‚£ã†å¯èƒ½æ€§ãŒé«˜ããªã‚Šã¾ã™)ã€‚åŠ¹æœã®å¤‰æ›´ã¨ã¯ã€ã‚¹ã‚¿ãƒãƒ³ã®åŠ¹æœãŒå¹´é½¢ã«ã‚ˆã£ã¦ç•°ãªã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚ã“ã‚Œã‚‰ã¯æ ¹æœ¬çš„ã«ç•°ãªã‚Šã¾ã™ã€‚ã™ã§ã«å¹´é½¢ã”ã¨ã«éšå±¤åŒ–ã•ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã«ã‚ˆã‚Šã€ã•ã¾ã–ã¾ãªåŠ¹æœãŒã‚ã‹ã‚Šã¾ã™ã€‚",
              lesson: "äº¤çµ¡: äº¤çµ¡å› å­ã¯ã€å½ã®é–¢é€£æ€§ã‚’ä½œæˆã—ã¾ã™ã€‚åŠ¹æœã®ä¿®æ­£: åŠ¹æœã¯ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ—ã«ã‚ˆã£ã¦ã¾ã£ãŸãç•°ãªã‚Šã¾ã™ã€‚å±¤åˆ¥åŒ–ã«ã‚ˆã‚ŠåŠ¹æœã®å¤‰æ›´ãŒæ˜ã‚‰ã‹ã«ãªã‚Šã¾ã™ã€‚"
            },
            modification_correct: {
              situation: "æ­£è§£ã§ã™ã€‚å¹´é½¢ã«ã‚ˆã£ã¦åŠ¹æœã¯å…¨ãç•°ãªã‚Šã¾ã™ã€‚ã“ã“ã§: å…¨ä½“çš„ãª HR 0.80 ã¨éšå±¤åŒ–ã•ã‚ŒãŸçµæœã‚’å ±å‘Šã™ã‚‹ã¹ãã§ã™ã‹?",
              question: "Best reporting:",
              branches: [
                { text: "å…¨ä½“çš„ãª HR 0.80 ã®ã¿ã‚’å ±å‘Šã—ã¾ã™ â€” éšå±¤åŒ–ã•ã‚ŒãŸçµæœã¯ä»®èª¬ã‚’ç”Ÿæˆã—ã¾ã™", nextNode: "overall_wrong" },
                { text: "åŠ¹æœã¯å¹´é½¢ã¨è‡¨åºŠçš„æ„å‘³ã«ã‚ˆã£ã¦ç•°ãªã‚‹ã“ã¨ã‚’å¼·èª¿ã—ã¦ã€ä¸¡æ–¹ã‚’å ±å‘Šã—ã¾ã™", nextNode: "both_correct" }
              ]
            },
            artifact_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Worth checking, but pattern suggests real modification",
              text: "ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ—ã®å·®ãŒå­˜åœ¨ã™ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã‹ã©ã†ã‹ã‚’å¸¸ã«ç¢ºèªã—ã¦ãã ã•ã„ãƒãƒ£ãƒ³ã‚¹ã€‚ã—ã‹ã—ã€HR 0.60 ã¨ HR 0.95 ã§ã¯å¤§ããªé•ã„ãŒã‚ã‚Šã¾ã™ã€‚ã‚¤ãƒ³ã‚¿ãƒ©ã‚¯ã‚·ãƒ§ãƒ³ã‚’ãƒ†ã‚¹ãƒˆã—ã¾ã™ (ã‚¤ãƒ³ã‚¿ãƒ©ã‚¯ã‚·ãƒ§ãƒ³ã®å ´åˆã¯ p)ã€‚é‡å¤§ãªå ´åˆã€åŠ¹æœã®å¤‰æ›´ã¯å®Ÿéš›ã«ã‚ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚ãŸã¨ãˆé‡å¤§ã§ãªãã¦ã‚‚ã€è‡¨åºŠçš„ãªé•ã„ãŒé‡è¦ã«ãªã‚‹å ´åˆãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "Test for statistical interaction. But don't dismiss clinically important differences just because p>0.05 â€” subgroup analyses are often underpowered."
            },
            overall_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯ ACCORD ã®é–“é•ã„ã§ã™ã€‚",
              text: "å…¨ä½“çš„ãªåŠ¹æœã®ã¿ã‚’å ±å‘Šã™ã‚‹ã¨ã€ã‚¹ã‚¿ãƒãƒ³ã¯è‹¥ã„æ‚£è€…ã«ã¯éå¸¸ã«ã‚ˆãåŠ¹ãã¾ã™ãŒã€é«˜é½¢ã®æ‚£è€…ã«ã¯ã»ã¨ã‚“ã©åŠ¹ã‹ãªã„ã¨ã„ã†äº‹å®ŸãŒéš è”½ã•ã‚Œã¾ã™ã€‚ 65 æ­³ã®æ‚£è€…ãŒã‚¹ã‚¿ãƒãƒ³ã®æŠ•ä¸ã‚’æ±ºå®šã™ã‚‹ã¨ã€èª¤è§£ã‚’æ‹›ãæƒ…å ±ã‚’å¾—ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚åŠ¹æœã®å¤‰æ›´ã«ã¯è‡¨åºŠçš„ãªå½±éŸ¿ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "åŠ¹æœã®å¤‰æ›´ãŒå­˜åœ¨ã™ã‚‹ã¨ã€å…¨ä½“çš„ãªå½±éŸ¿ãŒèª¤è§£ã‚’æ‹›ãå¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚å±¤åˆ¥çµæœã‚’å ±å‘Šã—ã€èª°ãŒæœ€ã‚‚åˆ©ç›Šã‚’å¾—ã‚‹ã®ã‹ã€èª°ãŒåˆ©ç›Šã‚’ã‚‚ãŸã‚‰ã•ãªã„ã®ã‹ã«ã¤ã„ã¦è­°è«–ã—ã¾ã™ã€‚"
            },
            both_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "é€æ˜æ€§ãŒã‚ã‚Šã€è‡¨åºŠçš„ã«æœ‰ç”¨ã§ã™!",
              text: "Reporting both allows clinicians to make better decisions. A 50-year-old might be more motivated to take statins (HR 0.60). An 80-year-old might reasonably decline (HR 0.95, with potential side effects). Personalized medicine requires understanding heterogeneity.",
              lesson: "åŠ¹æœã®å¤‰æ›´ã¯æƒ…å ±ã§ã‚ã‚Šã€è¿·æƒ‘ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚è¤‡æ•°ã®æ¤œæŸ»ã«ã¤ã„ã¦é©åˆ‡ãªæ³¨æ„ã‚’æ‰•ã£ã¦ã€ã‚µãƒ–ã‚°ãƒ«ãƒ¼ãƒ—ã®åŠ¹æœã‚’èª¿æŸ»ã—å ±å‘Šã™ã‚‹ã“ã¨ã§ã€è‡¨åºŠã‚±ã‚¢ãŒæ”¹å–„ã•ã‚Œã¾ã™ã€‚"
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Beyond PS: Instrumental Variables & Natural Experiments",
          sections: [
            {
              heading: "When PS Methods Fail:",
              text: "Propensity scores require the 'no unmeasured confounding' assumption. When key confounders are unmeasured, we need different approaches: instrumental variables (IV) and natural experiments."
            },
            {
              heading: "Instrumental Variable Intuition:",
              items: [
                "æ²»ç™‚ã«ã¯å½±éŸ¿ã™ã‚‹ãŒã€çµæœã«ã¯å½±éŸ¿ã—ãªã„ã‚‚ã®ã‚’è¦‹ã¤ã‘ã‚‹ (æ²»ç™‚ã«ã‚ˆã‚‹å ´åˆã‚’é™¤ã)",
                "ã“ã®ã€Œæ‰‹æ®µã€ã¯ã€æ‚£è€…ã®ã‚µãƒ–ã‚»ãƒƒãƒˆã«å¯¾ã™ã‚‹ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã‚’æ¨¡å€£ã—ã¾ã™",
                "Example: Distance to hospital affects treatment choice, not directly affecting outcome",
                "IV æ¨å®šå€¤ã¯ã€æœªæ¸¬å®šã®å ´åˆã§ã‚‚æœ‰åŠ¹ã§ã™äº¤çµ¡ - æ©Ÿå™¨ãŒæœ‰åŠ¹ãªå ´åˆ"
              ]
            },
            {
              heading: "Common Instruments in Healthcare:",
              items: [
                "Geographic variation (physician preference, facility availability)",
                "Calendar time (guideline changes, drug approvals)",
                "Mendelian randomization (genetic variants as instruments)",
                "Regression discontinuity (treatment thresholds based on arbitrary cutoffs)"
              ]
            },
            {
              heading: "Limitations:",
              items: [
                "Instruments often have weak correlation with treatment (low power)",
                "Exclusion restriction is untestable (must argue, can't prove)",
                "Estimates may be local (compliers only, not full population)",
                "Finding valid instruments is HARD â€” most proposed instruments fail scrutiny"
              ]
            },
            {
              heading: "Key Takeaway:",
              text: "æœ‰åŠ¹ãªæ©Ÿå™¨ãŒå­˜åœ¨ã™ã‚‹å ´åˆã€IV ãƒ¡ã‚½ãƒƒãƒ‰ã¯å¼·åŠ›ã§ã™ã€‚ãƒ¡ãƒ³ãƒ‡ãƒ«ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã¯ã€éºä¼çš„æ©Ÿå™¨ã‚’ä½¿ç”¨ã—ãŸ IV ã§ã™ã€‚ã—ã‹ã—ã€ãã®ä»®å®šã¯å¼·åŠ›ã§ã‚ã‚Šã€ã—ã°ã—ã°é•åã•ã‚Œã¾ã™ã€‚ IV ã‚’å”¯ä¸€ã®è¨¼æ‹ ã‚½ãƒ¼ã‚¹ã¨ã—ã¦ã§ã¯ãªãã€ä¸‰è§’æ¸¬é‡ã¨ã—ã¦ä½¿ç”¨ã—ã¾ã™ã€‚"
            }
          ]
        }
      },
      {
        type: 'principle',
        content: {
          text: "ğŸ¯ MASTERY CHECKPOINT: You've now learned the complete toolkit for observational evidence: bias identification, DAGs, study designs, ROBINS-I, propensity scores (matching, IPTW, overlap weights), target trial emulation, instrumental variables, Mendelian randomization, negative controls, Bradford Hill criteria, and triangulation. You can IDENTIFY when observational evidence is trustworthy and when it's not. This is the core competency of evidence-based medicine."
        }
      },
      {
        type: 'principle',
        content: {
          text: "âš ï¸ THE WARNING: Average effects can hide opposite effects in subgroups. 'No overall effect' might mean 'helps some, harms others.' Effect modification is not a statistical nuisance â€” it's clinical reality. When you find it, REPORT it. When you don't find it, you may have missed it."
        }
      }
    ]
  },
  // MODULE 11: THE CAPSTONE (Putting It All Together)
  {
    id: 11,
    title: "The Capstone",
    subtitle: "Putting It Together",
    principle: null,
    estimatedTime: "45 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "The Capstone",
          subtitle: "è¦³å¯Ÿç ”ç©¶ã®åˆ†æ",
          text: "å­¦ã‚“ã ã™ã¹ã¦ã‚’é©ç”¨ã—ã¦ã€å®Ÿéš›ã®è¦³å¯Ÿç ”ç©¶ã‚’æ‰¹åˆ¤çš„ã«è©•ä¾¡ã—ã¾ã™ã€‚ãƒã‚¤ã‚¢ã‚¹ã‚’è©•ä¾¡ã—ã€è¨ˆç”»ã‚’ç«‹ã¦ã€çµè«–ã‚’ä¿¡é ¼ã™ã‚‹ã‹ã©ã†ã‹ã‚’æ±ºå®šã—ã¾ã™ã€‚"
        }
      },
      {
        type: 'content',
        content: {
          title: "ã‚­ãƒ£ãƒƒãƒ—ã‚¹ãƒˆãƒ¼ãƒ³æ¼”ç¿’: ã“ã®ç ”ç©¶ã‚’è©•ä¾¡ã™ã‚‹",
          sections: [
            {
              heading: "The Study:",
              text: "ã‚ã‚‹ã‚³ãƒ›ãƒ¼ãƒˆç ”ç©¶ã§ã¯ã€æ–°ã—ã„è¡€åœ§æ²»ç™‚è–¬ (Drug X) ã¯å¤ã„è–¬å‰¤ã¨æ¯”è¼ƒã—ã¦è„³å’ä¸­ãƒªã‚¹ã‚¯ã‚’ 40% ä½æ¸›ã™ã‚‹ã¨ä¸»å¼µã—ã¦ã„ã¾ã™ (RR 0.60ã€95% CI 0.52-0.70)ã€‚ã“ã®ç ”ç©¶ã§ã¯ã€50,000 äººã®æ‚£è€…ã‚’ 3 å¹´é–“è¿½è·¡ã—ãŸå¥åº·ä¿é™ºãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ã‚’ä½¿ç”¨ã—ã¾ã—ãŸã€‚"
            },
            {
              heading: "Study Details:",
              items: [
                "Patients were classified as 'Drug X users' if they had â‰¥2 prescriptions",
                "Comparator was 'any other antihypertensive'",
                "å¹´é½¢ã€æ€§åˆ¥ã€ç³–å°¿ç—…ã€å¿ƒè¡€ç®¡ç–¾æ‚£ã®æ—¢å¾€ã‚’è€ƒæ…®ã—ã¦èª¿æ•´",
                "Follow-up started from first Drug X prescription",
                "è–¬å‰¤ X ã¯ã‚ˆã‚Šæ–°ã—ãé«˜ä¾¡ã§ã€ä»–ã®è–¬å‰¤ãŒå¤±æ•—ã—ãŸå¾Œã«ã‚ˆãä½¿ç”¨ã•ã‚Œã¦ã„ã¾ã—ãŸ"
              ]
            },
            {
              heading: "Your Task:",
              text: "ã“ã®ã‚³ãƒ¼ã‚¹ã®åŸå‰‡ã‚’ä½¿ç”¨ã—ã¦ã“ã®ç ”ç©¶ã‚’è©•ä¾¡ã—ã¾ã™ã€‚ãƒã‚¤ã‚¢ã‚¹ã€äº¤çµ¡ã€ç ”ç©¶ãƒ‡ã‚¶ã‚¤ãƒ³ã€çµæœãŒè‡¨åºŠå®Ÿè·µã‚’å¤‰ãˆã‚‹å¿…è¦ãŒã‚ã‚‹ã‹ã©ã†ã‹ã‚’è€ƒæ…®ã—ã¦ãã ã•ã„ã€‚"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-assessment',
          title: "Capstone: Full Evaluation",
          situation: "ã‚ãªãŸã¯ Drug X ç ”ç©¶ã‚’è©•ä¾¡ã—ã¦ã„ã¾ã™ã€‚ãã‚Œãã‚Œã®ãƒã‚¤ã‚¢ã‚¹ã‚’ä½“ç³»çš„ã«è§£æ±ºã—ã¦ãã ã•ã„ã€‚",
          nodes: {
            start: {
              question: "STEP 1 - IMMORTAL TIME: Patients needed â‰¥2 prescriptions to be 'Drug X users.' Time from first to second prescription is...",
              branches: [
                { text: "Correctly classified as unexposed â€” no problem", nextNode: "immortal_wrong" },
                { text: "Likely immortal time â€” must survive to get 2 prescriptions", nextNode: "immortal_correct" }
              ]
            },
            immortal_correct: {
              situation: "æ­£è§£ã§ã™ã€‚ 2 ã¤ã®å‡¦æ–¹ç®‹ãŒå¿…è¦ãªãŸã‚ã€ä¸æ»…ã®æ™‚é–“ãŒç”Ÿã¾ã‚Œã¾ã™ã€‚ã“ã‚Œã«ã‚ˆã‚Šã€è–¬å‰¤ X ã®åˆ©ç›Šã«åã‚ŠãŒç”Ÿã˜ã¾ã™ã€‚",
              question: "ã‚¹ãƒ†ãƒƒãƒ— 2 - é©å¿œç—‡ã«ã‚ˆã‚‹æ··ä¹±: è–¬å‰¤ X ã¯ã€Œä»–ã®è–¬å‰¤ãŒå¤±æ•—ã—ãŸå¾Œã«ä½¿ç”¨ã•ã‚ŒãŸã€ã€‚ã¤ã¾ã‚Šã€Drug X ã®ä½¿ç”¨è€…ã¯...",
              branches: [
                { text: "Sicker patients with harder-to-control BP â€” confounding AGAINST Drug X", nextNode: "indication_sicker_correct" },
                { text: "Healthier patients who can afford newer drugs â€” confounding FOR Drug X", nextNode: "indication_healthier_partial" }
              ]
            },
            immortal_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã§ã™!",
              text: "æœ€åˆã®å‡¦æ–¹å¾Œã€2 å›ç›®ã®å‡¦æ–¹å‰ã«æ‚£è€…ãŒæ­»äº¡ã—ãŸå ´åˆã€ãã®æ‚£è€…ã¯ã€ŒDrug X éä½¿ç”¨è€…ã€ã¨ã—ã¦åˆ†é¡ã•ã‚Œã¾ã™ãŒã€å®Ÿéš›ã«ã¯ Drug X ã‚’ä½¿ç”¨ã—ã¦ã„ã¾ã—ãŸã€‚å‡¦æ–¹é–“ã®æ™‚é–“ã¯ä¸æ»…ã§ã‚ã‚Šã€èª¤åˆ†é¡ã•ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯å¸¸ã«ã€ç”Ÿå­˜ã‚’å¿…è¦ã¨ã™ã‚‹æš´éœ²ã«å¯¾ã™ã‚‹æ˜ã‚‰ã‹ãªåˆ©ç›Šã«åã£ã¦ã„ã¾ã™ã€‚",
              lesson: "Any exposure definition requiring multiple events (prescriptions, visits, tests) creates immortal time bias."
            },
            indication_sicker_correct: {
              situation: "æ­£è§£ã§ã™ã€‚ç—…æ°—ã®æ‚£è€…ã«è–¬ X ã‚’æŠ•ä¸ã™ã‚‹ã¨ã€ãã®è–¬ã«åå¯¾ã™ã‚‹ãƒã‚¤ã‚¢ã‚¹ãŒã‹ã‹ã‚‹ã“ã¨ã«ãªã‚Šã¾ã™ã€‚ã—ã‹ã—ã€ç ”ç©¶ã§ã¯åˆ©ç‚¹ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚é©å¿œãƒã‚¤ã‚¢ã‚¹ãŒåå¯¾ã§ã‚ã‚Šã€ãã®çµæœãŒåˆ©ç›Šã‚’ç¤ºã—ã¦ã„ã‚‹å ´åˆã€ãã‚Œã¯ä½•ã‚’æ„å‘³ã—ã¾ã™ã‹?",
              question: "STEP 3 - DIRECTION OF BIAS: With immortal time (FOR) and confounding by indication (AGAINST), the NET bias is...",
              branches: [
                { text: "They cancel out â€” result is probably unbiased", nextNode: "cancel_wrong" },
                { text: "Unclear â€” depends on which bias is larger", nextNode: "direction_correct" }
              ]
            },
            indication_healthier_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possible, but consider the full picture",
              text: "ã€Œä»–ã®è–¬ãŒåŠ¹ã‹ãªããªã£ãŸå¾Œã«ä½¿ç”¨ã€ã¨ã¯ã€é€šå¸¸ã€ã‚ˆã‚Šå¥åº·ãªæ‚£è€…ã§ã¯ãªãã€æ²»ç™‚ãŒé›£ã—ã„æ‚£è€…ã‚’æ„å‘³ã—ã¾ã™ã€‚å½¼ã‚‰ã¯ç¬¬ä¸€é¸æŠã®æ²»ç™‚ã«å¤±æ•—ã—ã¾ã—ãŸã€‚ã“ã‚Œã¯ã€è–¬å‰¤ X ã«å¯¾ã™ã‚‹é©å¿œã«ã‚ˆã‚Šæ··ä¹±ã‚’å¼•ãèµ·ã“ã—ã¾ã™ã€‚ã“ã®ç ”ç©¶ã§ã¯ã€çœŸã®åˆ©ç‚¹ãŒéå°è©•ä¾¡ã•ã‚Œã‚‹ã“ã¨ã«ãªã‚Šã¾ã™ã€‚",
              lesson: "Confounding by indication in drug studies usually makes new/expensive drugs look WORSE (given to sicker patients) â€” unless healthy user bias dominates."
            },
            cancel_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Biases don't just 'cancel out'!",
              text: "ãƒã‚¤ã‚¢ã‚¹ãŒè§£æ¶ˆã•ã‚Œã‚‹ã¨æƒ³å®šã™ã‚‹ã“ã¨ã¯ã§ãã¾ã›ã‚“ã€‚ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã¯ã€ãƒ‡ã‚¶ã‚¤ãƒ³ãŒãã‚Œã‚’ä½œæˆã™ã‚‹ã¨ãã«ã»ã¼å¸¸ã«å­˜åœ¨ã—ã¾ã™ã€‚é©å¿œç—‡ã«ã‚ˆã‚‹æ··ä¹±ã¯å‡¦æ–¹ãƒ‘ã‚¿ãƒ¼ãƒ³ã«ã‚ˆã£ã¦ç•°ãªã‚Šã¾ã™ã€‚å„ãƒã‚¤ã‚¢ã‚¹ãŒç›¸æ®ºã•ã‚Œã‚‹ã¨ä»®å®šã™ã‚‹ã®ã§ã¯ãªãã€ãã‚Œãã‚Œã®ãƒã‚¤ã‚¢ã‚¹ã®å¤§ãã•ã‚’æ¨å®šã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚",
              lesson: "Identifying bias direction is step 1. Estimating bias MAGNITUDE requires sensitivity analysis or design changes."
            },
            direction_correct: {
              situation: "Correct! Net bias is unclear. You need more information.",
              question: "STEP 4 - ROBINS-I ASSESSMENT: Given what you know, what is your overall risk of bias judgment?",
              branches: [
                { text: "Moderate â€” some concerns but usable", nextNode: "robins_moderate_wrong" },
                { text: "Serious â€” important problems that require caution", nextNode: "robins_serious_correct" },
                { text: "Critical â€” too flawed to be useful", nextNode: "robins_critical_partial" }
              ]
            },
            robins_moderate_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too generous!",
              text: "ä¸æ»…ã®æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã¨æ¸¬å®šã•ã‚Œã¦ã„ãªã„äº¤çµ¡(é«˜è¡€åœ§ã®é‡ç—‡åº¦ã€ä»¥å‰ã®æ²»ç™‚å¤±æ•—)ã®ä¸¡æ–¹ã«ã‚ˆã‚Šã€ã“ã®ç ”ç©¶ã«ã¯æ–¹æ³•è«–çš„ã«é‡å¤§ãªå•é¡ŒãŒã‚ã‚Šã¾ã™ã€‚ ã€Œä¸­ç¨‹åº¦ã€ã¯ã€RCT ã¨ã»ã¼åŒã˜ãã‚‰ã„å„ªã‚Œã¦ã„ã‚‹ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ãŒã€ãã†ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚",
              lesson: "ROBINS-I is intentionally strict. Real-world drug studies rarely achieve 'low' or 'moderate' without careful design (new user, active comparator, etc.)."
            },
            robins_serious_correct: {
              situation: "Appropriate! The study has serious risk of bias. Final step:",
              question: "ã‚¹ãƒ†ãƒƒãƒ— 5 - è‡¨åºŠæ±ºå®š: åŒåƒšã¯ã€ã“ã®ç ”ç©¶ã«åŸºã¥ã„ã¦æ‚£è€…ã‚’è–¬å‰¤ X ã«åˆ‡ã‚Šæ›¿ãˆãŸã„ã¨è€ƒãˆã¦ã„ã¾ã™ã€‚ã‚ãªãŸã¯ã‚¢ãƒ‰ãƒã‚¤ã‚¹ã—ã¾ã™...",
              branches: [
                { text: "Switch â€” even with bias, 40% reduction is clinically meaningful", nextNode: "switch_wrong" },
                { text: "åˆ‡ã‚Šæ›¿ãˆãªã„ã§ãã ã•ã„ â€” ã‚ˆã‚Šè‰¯ã„è¨¼æ‹ ï¼ˆRCT ã¾ãŸã¯ã‚ˆã‚Šé©åˆ‡ã«è¨­è¨ˆã•ã‚ŒãŸè¦³å¯Ÿï¼‰ã‚’å¾…ã¡ã¾ã™", nextNode: "wait_correct" }
              ]
            },
            robins_critical_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Possible, but justify carefully",
              text: "ã€Œé‡å¤§ã€ã¨ã¯ã€ç ”ç©¶ãŒæœ¬è³ªçš„ã«æœ‰ç”¨ãªæƒ…å ±ã‚’æä¾›ã—ãªã„ã“ã¨ã‚’æ„å‘³ã—ã¾ã™ã€‚æ·±åˆ»ãªä¸æ­»æ™‚é–“ãƒã‚¤ã‚¢ã‚¹ã¨äº¤çµ¡ã«ã‚ˆã‚Šã€çµæœã«ã¯ç–‘å•ãŒã‚ã‚‹ãŒã€ã“ã®è–¬ã®å®Ÿä¸–ç•Œã§ã®ä½¿ç”¨ã«é–¢ã™ã‚‹æƒ…å ±ã¯ã¾ã å­˜åœ¨ã™ã‚‹ã€‚é‡å¤§ãªè­¦å‘Šã‚’ä¼´ã†ã€Œæ·±åˆ»ãªã€ã¨ã„ã†æ–¹ãŒé©åˆ‡ã‹ã‚‚ã—ã‚Œã¾ã›ã‚“ã€‚",
              lesson: "Reserve 'critical' for truly fatal flaws: fabricated data, fundamental design impossibilities, or complete uninformativeness."
            },
            switch_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "ã“ã‚Œã¯ã¾ã•ã« HRT ã®é–“é•ã„ã§ã™!",
              text: "A 40% reduction in an observational study with serious bias could easily be ENTIRELY artifactual. Remember: HRT showed 40-50% reduction in cohorts, but the truth was HARM. Immortal time alone can create 20-40% apparent benefit. Don't change practice based on seriously biased observational data.",
              lesson: "ã€Œçµ±è¨ˆçš„ã«æœ‰æ„ãªè¦³å¯Ÿçµæœã€ã‚’ã€ŒçœŸã®åŠ¹æœã€ã¨æ±ºã—ã¦åŒä¸€è¦–ã—ãªã„ã§ãã ã•ã„ã€‚ HRTã€ãƒ“ã‚¿ãƒŸãƒ³ Dã€ãŠã‚ˆã³ãã®ä»–ã®é€†è»¢ç¾è±¡ã¯ã™ã¹ã¦ã€ä¸€è¦‹èª¬å¾—åŠ›ã®ã‚ã‚‹è¦³å¯Ÿè¨¼æ‹ ã‹ã‚‰å§‹ã¾ã‚Šã¾ã—ãŸã€‚"
            },
            wait_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent clinical judgment!",
              text: "You've correctly identified that: (1) immortal time bias inflates benefit, (2) confounding direction is unclear, (3) ROBINS-I = serious risk, (4) a 40% reduction could be artifact. The appropriate response is to wait for better evidence while acknowledging uncertainty.",
              lesson: "This capstone synthesizes everything: bias identification, ROBINS-I assessment, and clinical decision-making under uncertainty. You've learned to see beyond the headline number."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-screening',
          title: "Capstone 2: ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°è«–äº‰",
          situation: "æ–°ã—ã„è¡€æ¶²æ¤œæŸ»ã¯ã€åˆæœŸã®ã‚¢ãƒ«ãƒ„ãƒã‚¤ãƒãƒ¼ç—…ã‚’æ¤œå‡ºã™ã‚‹ã¨ä¸»å¼µã—ã¦ã„ã¾ã™ã€‚ãƒãƒ¼ã‚±ãƒ†ã‚£ãƒ³ã‚°: ã€Œ5 å¹´ç”Ÿå­˜ç‡ã¯æ—©æœŸç™ºè¦‹ã§ 80%ã€æ—©æœŸç™ºè¦‹ã§ 40%ã€‚ã€è¦³å¯Ÿç ”ç©¶ã§ã¯ã€æ—©æœŸã«è¨ºæ–­ã•ã‚ŒãŸæ‚£è€…ã¯ã€Œé•·ç”Ÿãã€ã™ã‚‹ã“ã¨ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™ã€‚ã‚ãªãŸã¯ã€é›†å›£ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã‚’æ¨å¥¨ã™ã‚‹ã‹ã©ã†ã‹ã‚’æ±ºå®šã™ã‚‹åŒ»ç™‚æ”¿ç­–å§”å“¡ä¼šã«æ‰€å±ã—ã¦ã„ã¾ã™ã€‚",
          nodes: {
            start: {
              question: "æœ€åˆ: ã€Œç”Ÿå­˜ç‡ 80% å¯¾ 40%ã€ã¨ã„ã†ä¸»å¼µã«ã¤ã„ã¦ã€å½“é¢ã®æ‡¸å¿µã¯ä½•ã§ã™ã‹?",
              branches: [
                { text: "The numbers sound too good â€” probably exaggerated", nextNode: "exaggerated_partial" },
                { text: "This is lead time bias â€” survival improves just by diagnosing earlier", nextNode: "lead_time_correct" },
                { text: "Sample sizes must have been small", nextNode: "sample_wrong" }
              ]
            },
            lead_time_correct: {
              situation: "Exactly! You demand MORTALITY data. They provide: 'Observational cohort shows 25% lower dementia-related mortality in screened patients (HR 0.75, 95% CI 0.65-0.87).'",
              question: "ã“ã‚Œã¯é›†å›£ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«å¯¾ã™ã‚‹èª¬å¾—åŠ›ã®ã‚ã‚‹è¨¼æ‹ ã§ã™ã‹?",
              branches: [
                { text: "ã¯ã„ â€” æ­»äº¡ç‡ã¯æ­£ã—ã„çµæœã§ã‚ã‚Šã€HR ã¯æ­£ã—ã„çµæœã§ã™ã€‚é‡è¦", nextNode: "mortality_wrong" },
                { text: "No â€” observational screening studies have healthy screener bias", nextNode: "screener_bias_correct" }
              ]
            },
            exaggerated_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Skepticism is good, but identify the SPECIFIC bias",
              text: "ã‚ãªãŸã®ç›´æ„Ÿã¯æ­£ã—ã„ã§ã™ãŒã€å…·ä½“çš„ãªãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã¯ãƒªãƒ¼ãƒ‰ã‚¿ã‚¤ãƒ ãƒã‚¤ã‚¢ã‚¹ã§ã™ã€‚ã‚¢ãƒ«ãƒ„ãƒã‚¤ãƒãƒ¼ç—…ãŒã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«ã‚ˆã£ã¦ 3 å¹´æ—©ãæ¤œå‡ºã•ã‚ŒãŸã«ã‚‚ã‹ã‹ã‚ã‚‰ãšã€æ‚£è€…ãŒåŒã˜å¹´é½¢ã§æ­»äº¡ã—ãŸå ´åˆã€5 å¹´ç”Ÿå­˜ç‡ã¯ 40% ã‹ã‚‰ 80% ã«ãªã‚Šã€æ­»äº¡ç‡ã®åˆ©ç›Šã¯ã‚¼ãƒ­ã«ãªã‚Šã¾ã™ã€‚ç”Ÿå­˜çµ±è¨ˆã¯ä½“ç³»çš„ã«ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«ã¨ã£ã¦èª¤è§£ã‚’æ‹›ãã‚‚ã®ã§ã™ã€‚",
              lesson: "Always name the specific bias. 'Sounds too good' isn't actionable. 'Lead time bias inflates survival' is."
            },
            sample_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Sample size isn't the issue here!",
              text: "100 ä¸‡äººã®æ‚£è€…ãŒã„ã¦ã‚‚ã€ãƒªãƒ¼ãƒ‰ã‚¿ã‚¤ãƒ ã®â€‹â€‹åã‚Šã«ã‚ˆã‚Šã€ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã®ãŸã‚ã®ç”Ÿå­˜çµ±è¨ˆã¯æ„å‘³ãŒã‚ã‚Šã¾ã›ã‚“ã€‚ã“ã®ç ”ç©¶ã¯å®Œå…¨ã«æ­£ç¢ºã§ã‚ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ãŒã€ãã‚Œã§ã‚‚ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ãŒå‘½ã‚’æ•‘ã†ã‹ã©ã†ã‹ã«ã¤ã„ã¦ã¯ä½•ã‚‚æ•™ãˆã¦ãã‚Œã¾ã›ã‚“ã€‚ã“ã‚Œã¯ç³»çµ±çš„ãªãƒã‚¤ã‚¢ã‚¹ã§ã‚ã‚Šã€ãƒ©ãƒ³ãƒ€ãƒ ãªã‚¨ãƒ©ãƒ¼ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚",
              lesson: "Precision (large N) doesn't fix bias. A very precise estimate of the wrong thing is still wrong."
            },
            mortality_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "You forgot healthy screener bias!",
              text: "People who seek screening are systematically healthier: they exercise, eat well, have good healthcare access. They have lower mortality FROM EVERYTHING â€” including dementia â€” even if screening doesn't help. This is the same bias that fooled us with HRT, colonoscopy, and health checkups.",
              lesson: "Observational comparisons of screened vs unscreened populations are ALWAYS confounded by healthy screener bias. Only RCTs can eliminate it."
            },
            screener_bias_correct: {
              situation: "Perfect! You demand RCT evidence. They say: 'No RCT exists, but screening is harmless â€” it's just a blood test. Why not offer it while we wait for RCT results?'",
              question: "Your response:",
              branches: [
                { text: "Reasonable â€” a blood test has minimal harm", nextNode: "harmless_wrong" },
                { text: "ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã¯ç„¡å®³ã§ã¯ãªãã€ä¸‹æµã«å®³ãŒã‚ã‚Šã¾ã™", nextNode: "harms_correct" }
              ]
            },
            harmless_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Screening cascade causes real harm!",
              text: "The blood test may be harmless, but what happens NEXT? False positives lead to: anxiety, depression, insurance discrimination, further invasive testing, treatments with side effects for disease that may never cause symptoms. For Alzheimer's with no disease-modifying treatment, early diagnosis may cause psychological harm without benefit.",
              lesson: "Screening harms: false positives â†’ anxiety + invasive follow-up; overdiagnosis â†’ treating indolent disease; psychological burden of 'patient' label. These are CERTAIN. Benefits are UNCERTAIN until RCT-proven."
            },
            harms_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Outstanding policy reasoning!",
              text: "You correctly identified: (1) survival claims = lead time bias; (2) mortality observational data = healthy screener bias; (3) screening has real downstream harms. Your recommendation: NO population screening until RCT demonstrates that mortality benefits outweigh harms of false positives, overdiagnosis, and psychological burden.",
              lesson: "This capstone integrates: lead time bias, healthy screener confounding, harm-benefit balance, and evidence standards. You've learned to think critically about screening claims."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-safety-signal',
          title: "ã‚­ãƒ£ãƒƒãƒ—ã‚¹ãƒˆãƒ¼ãƒ³ 3: å®‰å…¨ä¿¡å·",
          situation: "A widely-used diabetes drug has been on the market for 8 years. Spontaneous reports suggest possible bladder cancer association. Observational studies show conflicting results: some OR 1.3, some OR 1.0. An industry-funded cohort shows no association. Patient advocacy groups demand withdrawal.",
          nodes: {
            start: {
              question: "æœ€åˆã®ã‚¹ãƒ†ãƒƒãƒ—: çŸ›ç›¾ã™ã‚‹è¦³å¯Ÿè¨¼æ‹ ã‚’ã©ã®ã‚ˆã†ã«è©•ä¾¡ã—ã¾ã™ã‹?",
              branches: [
                { text: "æ¥­ç•Œã‚’ä¿¡é ¼ã—ã¦ãã ã•ã„ã‚³ãƒ›ãƒ¼ãƒˆ â€” ã“ã‚Œã¯æœ€å¤§ã‹ã¤æœ€ã‚‚å³å¯†ã§ã™", nextNode: "industry_wrong" },
                { text: "Assess each study's risk of bias systematically using ROBINS-I", nextNode: "robins_correct" },
                { text: "ã™ã¹ã¦ã®ç ”ç©¶ã‚’å¹³å‡ã—ã¦ãã ã•ã„ â€” çœŸå®Ÿã¯ãŠãã‚‰ãçœŸã‚“ä¸­ã«ã‚ã‚Šã¾ã™", nextNode: "average_wrong" }
              ]
            },
            industry_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Funding bias is real!",
              text: "Industry-funded studies of their own drugs consistently show more favorable results than independent studies. This isn't necessarily fraud â€” it's design choices: shorter follow-up (bladder cancer takes years), healthier populations, favorable comparators. Evaluate the METHODS, not the sponsor.",
              lesson: "Assess risk of bias, not prestige. Large doesn't mean unbiased. Consider: follow-up duration, comparator choice, outcome ascertainment, time-related biases."
            },
            robins_correct: {
              situation: "è‰¯ã„ã‚¢ãƒ—ãƒ­ãƒ¼ãƒã§ã™! ROBINS-I ã¯æ¬¡ã®ã“ã¨ã‚’æ˜ã‚‰ã‹ã«ã—ã¾ã—ãŸ: OR 1.3 ã¯ã‚ˆã‚Šé•·æœŸã®è¿½è·¡èª¿æŸ» (5 å¹´ä»¥ä¸Š) ã§ã‚ã‚‹ã“ã¨ã‚’ç¤ºã™ç ”ç©¶ã€‚ãƒŒãƒ«ã‚’ç¤ºã—ãŸç ”ç©¶ã§ã¯è¿½è·¡æœŸé–“ãŒçŸ­ããªã‚Šã¾ã™ï¼ˆ2ï½3å¹´ï¼‰ã€‚è†€èƒ±ãŒã‚“ã¯æ½œä¼æœŸé–“ãŒé•·ã„ã§ã™ã€‚çµè«–ã¯ä½•ã§ã™ã‹?",
              question: "Your interpretation:",
              branches: [
                { text: "ãƒŒãƒ«ç ”ç©¶ã¯ãŠãã‚‰ãæ­£ã—ã„ã§ã™ - ã‚ˆã‚Šå¤šãã®ç ”ç©¶ã§ã¯åŠ¹æœãŒç¤ºã•ã‚Œã¦ã„ã¾ã›ã‚“", nextNode: "null_wrong" },
                { text: "é•·æœŸã®è¿½è·¡èª¿æŸ»ã¯æ½œåœ¨çš„ãªçµæœã«å¯¾ã—ã¦æ–¹æ³•è«–çš„ã«æ­£ã—ã„ã§ã™ - ä¿¡å·ã¯æœ¬ç‰©ã§ã‚ã‚‹å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™", nextNode: "latency_correct" }
              ]
            },
            average_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Don't average biased with unbiased!",
              text: "ä¸€éƒ¨ã®ç ”ç©¶ã«è¨­è¨ˆä¸Šã®æ¬ é™¥ãŒã‚ã‚‹å ´åˆ(æ½œåœ¨çš„ãªçµæœã«å¯¾ã™ã‚‹çŸ­ã„è¿½è·¡èª¿æŸ»)ã€ã‚ˆã‚Šå„ªã‚ŒãŸç ”ç©¶ã§ãã‚Œã‚‰ã‚’å¹³å‡ã™ã‚‹ã¨ã€ä¿¡å·ãŒè–„ã‚Œã¾ã™ã€‚ã‚ãªãŸã¯ã€è‰¯ã„è¨¼æ‹ ã¨æ‚ªã„è¨¼æ‹ ã®ã€Œå¹³å‡ã€ã‚’æœ›ã‚“ã§ã„ã¾ã›ã‚“ã€‚ãªãœãã‚Œã‚‰ãŒç•°ãªã‚‹ã®ã‹ã‚’ç†è§£ã—ã€æ–¹æ³•è«–çš„ã«æ­£ã—ã„è¨¼æ‹ ã‚’ä¿¡é ¼ã—ãŸã„ã®ã§ã™ã€‚",
              lesson: "ãƒ¡ã‚¿åˆ†æã¯å¹³å‡åŒ–ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚å“è³ªã®é‡ã¿ä»˜ã‘ã‚’è¡Œã£ãŸåˆæˆã§ã™ã€‚ãƒ—ãƒ¼ãƒ«ã™ã‚‹å‰ã«ç•°è³ªæ€§ã®åŸå› ã‚’ç†è§£ã—ã¾ã™ã€‚"
            },
            null_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Count of studies doesn't matter â€” quality does!",
              text: "Three studies with 2-year follow-up can't detect a cancer that takes 5+ years to develop. They're methodologically incapable of finding the signal even if it exists. The two studies with adequate follow-up both show elevated risk. For latent outcomes, insufficient follow-up = unable to detect, not 'no effect.'",
              lesson: "For safety signals with latent outcomes: (1) Longer follow-up is REQUIRED; (2) Short-term null studies are uninformative; (3) Trust methodologically adequate studies, not study counts."
            },
            latency_correct: {
              situation: "Correct! Now: The drug helps millions with diabetes. Bladder cancer is rare. Even if OR=1.3 is real, absolute risk is small. How do you weigh benefits vs harms?",
              question: "Your recommendation:",
              branches: [
                { text: "Withdraw the drug â€” any cancer signal is unacceptable", nextNode: "withdraw_extreme" },
                { text: "ãƒ¢ãƒ‹ã‚¿ãƒªãƒ³ã‚°ã®å¼·åŒ–ã€æ‚£è€…/å‡¦æ–¹è€…ã®æ•™è‚²ã€ç¶™ç¶šçš„ãªç ”ç©¶ã‚’ç¶™ç¶šã—ã¾ã™", nextNode: "monitor_correct" }
              ]
            },
            withdraw_extreme: {
              type: 'outcome',
              outcome: 'partial',
              title: "åˆ©ç›Šã¨å®³ã®ãƒãƒ©ãƒ³ã‚¹ã‚’è€ƒæ…®ã—ã¦ãã ã•ã„!",
              text: "Diabetes causes heart attacks, strokes, amputations, blindness. If this drug provides substantial benefit and the cancer risk is small (NNH > 1000), withdrawal might cause NET HARM â€” more deaths from uncontrolled diabetes than prevented cancers. Regulatory decisions must weigh absolute risks.",
              lesson: "Drug safety isn't binary. Weigh: (1) magnitude of benefit, (2) magnitude of harm, (3) availability of alternatives, (4) population affected. Small relative risks in rare outcomes may be acceptable if benefits are large."
            },
            monitor_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Balanced regulatory thinking!",
              text: "Your recommendation acknowledges: (1) Signal is plausible given latency-appropriate evidence; (2) Absolute risk is small; (3) Benefits are substantial; (4) Uncertainty remains. Enhanced monitoring allows continued benefit while gathering more data. Consider contraindication in patients with prior bladder cancer or other high-risk features.",
              lesson: "This capstone integrates: signal evaluation, bias assessment, benefit-harm balance, and proportionate response. Real pharmacovigilance is nuanced, not reflexive withdrawal or dismissal."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "ğŸ“ ã‚³ãƒ¼ã‚¹å®Œäº†: å­¦ã‚“ã ã“ã¨",
          sections: [
            {
              heading: "You can now:",
              items: [
                "âœ“ Distinguish confounding, selection bias, and information bias",
                "âœ“ Draw and interpret DAGs (Directed Acyclic Graphs)",
                "âœ“ Identify immortal time bias and other time-related biases",
                "âœ“ Recognize lead time bias in screening studies",
                "âœ“ Conduct ROBINS-I risk of bias assessments",
                "âœ“ Understand propensity scores and their limitations",
                "âœ“ Use negative controls to detect unmeasured confounding",
                "âœ“ Apply the target trial framework",
                "âœ“ ãƒ¡ãƒ³ãƒ‡ãƒªã‚¢ãƒ³ã®è§£é‡ˆãƒ©ãƒ³ãƒ€ãƒ åŒ–ç ”ç©¶",
                "âœ“ Evaluate when to meta-analyze observational studies",
                "âœ“ å› æœæ¨è«–ã«ãƒ–ãƒ©ãƒƒãƒ‰ãƒ•ã‚©ãƒ¼ãƒ‰ ãƒ’ãƒ«åŸºæº–ã¨ä¸‰è§’æ¸¬é‡ã‚’ä½¿ç”¨ã—ã¾ã™",
                "âœ“ Interpret pharmacovigilance signals appropriately",
                "âœ“ Understand effect modification and heterogeneity"
              ]
            },
            {
              heading: "The Seven Principles:",
              items: [
                "1. Association is not causation â€” confounding deceives",
                "2. Time flows one direction â€” temporality matters",
                "3ã€‚ã‚ãªãŸãŒæ¢ã—ã¦ã„ã‚‹ã‚‚ã®ãŒã‚ã‹ã‚Šã¾ã™â€”é¸æŠãƒã‚¤ã‚¢ã‚¹ãŒéš ã‚Œã¦ã„ã¾ã™",
                "4. Measurement shapes reality â€” information bias distorts",
                "5. Adjustment is not magic â€” residual confounding remains",
                "6. The average can lie â€” heterogeneity matters",
                "7. Replication builds confidence â€” one study is never enough"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Final Reflection",
          sections: [
            {
              heading: "Remember:",
              text: "è¦³å¯Ÿè¨¼æ‹ ã¯RCTè¨¼æ‹ ã«åŠ£ã‚‹ã‚‚ã®ã§ã¯ã‚ã‚Šã¾ã›ã‚“â€”ãã‚Œã¯ç•°ãªã‚Šã¾ã™ã€‚ RCT ãŒä¸å¯èƒ½ã€éå€«ç†çš„ã€ã¾ãŸã¯ä¸ååˆ†ãªå ´åˆã€è¦³å¯Ÿãƒ‡ãƒ¼ã‚¿ãŒç§ãŸã¡ãŒæŒã¤æœ€è‰¯ã®è¨¼æ‹ ã¨ãªã‚Šã¾ã™ã€‚ãŸã ã—ã€æ³¨æ„æ·±ã„è§£é‡ˆãŒå¿…è¦ã§ã™ã€‚"
            },
            {
              heading: "The Thalidomide-HRT Paradox:",
              items: [
                "Thalidomide: Observational evidence SAVED lives (detected harm RCTs missed)",
                "HRT: Observational evidence COST lives (confounding created false benefit)",
                "é•ã„ã¯è¦³å¯Ÿã‹ãƒ©ãƒ³ãƒ€ãƒ åŒ–ã‹ã§ã¯ãªãã€æ…é‡ã‹ä¸æ³¨æ„ãªåˆ†æã§ã—ãŸã€‚"
              ]
            },
            {
              heading: "Your Responsibility:",
              text: "è¦³å¯Ÿè¨¼æ‹ ã‚’ç†è§£ã§ãã‚‹ã‚ˆã†ã«ãªã‚‹ã¨ã€ãã‚ŒãŒã„ã¤ä¿¡é ¼ã§ãã‚‹ã®ã‹ã€ã„ã¤èª¤è§£ã‚’æ‹›ãã®ã‹ã€ã„ã¤ã‚ˆã‚Šè‰¯ã„ãƒ‡ãƒ¼ã‚¿ã‚’è¦æ±‚ã™ã¹ãã‹ã‚’ç‰¹å®šã§ãã‚‹ã‚ˆã†ã«ãªã‚Šã¾ã™ã€‚ã™ã¹ã¦ã®è¦³å¯Ÿç ”ç©¶ã‚’åå°„çš„ã«å´ä¸‹ã™ã‚‹ã®ã§ã¯ãªãã€æ‚£è€…ã‚’åŠ©ã‘ã‚‹ãŸã‚ã«ã“ã®çŸ¥è­˜ã‚’æ´»ç”¨ã—ã¦ãã ã•ã„ã€‚"
            },
            {
              heading: "The Straight Path:",
              text: "è¦³å¯Ÿçµæœã«å¯¾ã™ã‚‹ç›²ç›®çš„ãªä¿¡é ¼ã¨è‡ªå‹•çš„ãªå´ä¸‹ã¨ã®é–“ã«ã¯ã€æ‰¹åˆ¤çš„ãªè©•ä¾¡ãŒå­˜åœ¨ã—ã¾ã™ã€‚ã‚ãªãŸã¯ãã®é“ã‚’æ­©ã‚€ã“ã¨ã‚’å­¦ã³ã¾ã—ãŸã€‚è³¢ãåˆ©ç”¨ã—ã¦ãã ã•ã„ã€‚"
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "ã‚³ãƒ¼ã‚¹ã¯å®Œäº†ã—ã¾ã—ãŸã€‚ã“ã‚Œã¾ã§ã«å­¦ã‚“ã ã“ã¨ã‚’è¸ã¾ãˆã‚‹ã¨ã€åŒ»ç™‚ã«ãŠã‘ã‚‹è¦³å¯Ÿè¨¼æ‹ ã®å½¹å‰²ã‚’æœ€ã‚‚ã‚ˆãè¡¨ã—ã¦ã„ã‚‹ã®ã¯ã©ã‚Œã§ã™ã‹?",
          options: [
            { id: 'a', text: "è¦³å¯Ÿè¨¼æ‹ ã¯è‡¨åºŠæ±ºå®šã«ä½¿ç”¨ã•ã‚Œã‚‹ã¹ãã§ã¯ã‚ã‚Šã¾ã›ã‚“ - RCT ã®ã¿ãŒã‚«ã‚¦ãƒ³ãƒˆã•ã‚Œã¾ã™", correct: false },
            { id: 'b', text: "ã‚µãƒ³ãƒ—ãƒ«ã‚µã‚¤ã‚ºãŒååˆ†ã«å¤§ãã„å ´åˆã€è¦³å¯Ÿè¨¼æ‹ ã¯ RCT è¨¼æ‹ ã¨åŒã˜ãã‚‰ã„ä¿¡é ¼ã§ãã¾ã™", correct: false },
            { id: 'c', text: "è¦³å¯Ÿè¨¼æ‹ ã¯ä¸å¯æ¬ ã§ã™ãŒã€æ…é‡ãªè©•ä¾¡ãŒå¿…è¦ã§ã™ä¿¡é ¼ä»¥å‰ã®ãƒã‚¤ã‚¢ã‚¹ã€äº¤çµ¡ã€åå¾©ã®å½±éŸ¿", correct: true },
            { id: 'd', text: "è¦³å¯Ÿè¨¼æ‹ ã¯ä»®èª¬ã‚’ç”Ÿæˆã™ã‚‹ãŸã‚ã«ã®ã¿æœ‰ç”¨ã§ã‚ã‚Šã€ä»®èª¬ã‚’ç¢ºèªã™ã‚‹ãŸã‚ã«ã¯æ±ºã—ã¦å½¹ç«‹ã¡ã¾ã›ã‚“", correct: false }
          ],
          explanation: "Observational evidence is essential for rare harms, long-term outcomes, and questions that can't be randomized. But it requires rigorous bias assessment (ROBINS-I), understanding of confounding structures (DAGs), and triangulation across methods. The goal isn't to dismiss observational data â€” it's to know when it's trustworthy."
        }
      }
    ]
  }
];

// Render Functions
function renderModuleNav() {
  const nav = document.getElementById('module-nav');
  nav.innerHTML = modules.map((m, i) => `
    <button class="module-item ${i === currentModule ? 'active' : ''} ${gameState.modulesCompleted.includes(i) ? 'completed' : ''}"
            onclick="goToModule(${i})"
            aria-current="${i === currentModule ? 'true' : 'false'}">
      <div class="module-number">${gameState.modulesCompleted.includes(i) ? 'âœ“' : i}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}${m.estimatedTime ? ` Â· <span class="time-estimate">${m.estimatedTime}</span>` : ''}</div>
      </div>
    </button>
  `).join('');

  // Update total course time in header
  const totalMinutes = modules.reduce((sum, m) => {
    const mins = m.estimatedTime ? parseInt(m.estimatedTime) : 0;
    return sum + mins;
  }, 0);
  const hours = Math.floor(totalMinutes / 60);
  const mins = totalMinutes % 60;
  const timeDisplay = document.getElementById('total-time');
  if (timeDisplay) timeDisplay.textContent = `${hours}h ${mins}m total`;
}

// Badge checking and awarding
function checkBadges() {
  const newBadges = [];

  // Story Scholar - read all stories (complete modules with stories)
  if (gameState.modulesCompleted.length >= 10 && !gameState.earnedBadges.includes('story-scholar')) {
    newBadges.push('story-scholar');
  }

  // Decision Ace - complete significant decision trees
  const treesCompleted = Object.keys(gameState.decisionTrees).filter(k =>
    gameState.decisionTrees[k].history && gameState.decisionTrees[k].history.length > 0
  ).length;
  if (treesCompleted >= 15 && !gameState.earnedBadges.includes('decision-ace')) {
    newBadges.push('decision-ace');
  }

  // Methods Master - complete all modules
  if (gameState.modulesCompleted.length === 12 && !gameState.earnedBadges.includes('methods-master')) {
    newBadges.push('methods-master');
  }

  // Award new badges
  newBadges.forEach(badge => {
    gameState.earnedBadges.push(badge);
    showBadgeNotification(badge);
  });

  if (newBadges.length > 0) saveProgress();
}

function showBadgeNotification(badgeId) {
  const badge = BADGES[badgeId];
  if (!badge) return;

  const notification = document.createElement('div');
  notification.className = 'badge-notification';
  notification.innerHTML = `
    <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
    <div class="badge-info">
      <div class="badge-earned">Badge Earned!</div>
      <div class="badge-name">${badge.name}</div>
    </div>
  `;
  document.body.appendChild(notification);

  setTimeout(() => notification.classList.add('show'), 100);
  setTimeout(() => {
    notification.classList.remove('show');
    setTimeout(() => notification.remove(), 500);
  }, 3000);
}

function renderSlide() {
  const container = document.getElementById('slide-container');
  const module = modules[currentModule];
  const slide = module.slides[currentSlide];

  let html = '';

  switch(slide.type) {
    case 'title':
      html = `
        <div class="slide-title">
          <h1>${slide.content.title}</h1>
          <div class="subtitle">${slide.content.subtitle}</div>
          <p class="description">${slide.content.text}</p>
        </div>
      `;
      break;

    case 'principle-display':
      html = `
        <div class="principle-box">
          <div class="number">${module.principle !== null ? module.principle + 1 : ''}</div>
          <div class="text">"${slide.content.principle}"</div>
        </div>
      `;
      break;

    case 'principle':
      html = `
        <div class="principle-box" style="background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.1)); padding: 2rem;">
          <div class="text" style="font-size: 1.2rem; line-height: 1.6; white-space: pre-line;">${slide.content.text}</div>
        </div>
      `;
      break;

    case 'story-deep':
      html = renderStoryDeep(slide.content);
      break;

    case 'story-box':
      html = renderStoryBox(slide.content);
      break;

    case 'content':
      html = renderContent(slide.content);
      break;

    case 'method':
      html = renderMethod(slide.content);
      break;

    case 'tool':
      html = renderTool(slide.content);
      break;

    case 'decision-tree':
      html = renderDecisionTree(slide.content);
      break;

    case 'quiz':
      html = renderQuiz(slide.content);
      break;

    default:
      html = `<p>Unknown slide type: ${slide.type}</p>`;
  }

  container.innerHTML = html;
  updateProgress();
  updateNavButtons();

  // Announce slide change for screen readers
  const announcer = document.getElementById('slide-announce');
  if (announcer) {
    const module = modules[currentModule];
    announcer.textContent = `Slide ${currentSlide + 1} of ${module.slides.length}, Module: ${module.title}`;
  }
}

function renderStoryDeep(content) {
  return `
    <div class="story-deep">
      <div class="story-label">${content.label}</div>
      <div class="story-source">${content.source}</div>

      <div class="timeline">
        ${content.timeline.map(event => `
          <div class="timeline-event ${event.type}">
            <div class="timeline-year">${event.year}</div>
            <div class="timeline-text">${event.text}</div>
          </div>
        `).join('')}
      </div>

      <div class="real-data-card">
        <h4>The Data That Matters</h4>
        <div class="data-grid">
          <div class="data-item">
            <div class="data-value">${content.realData.endpoint}</div>
            <div class="data-label">Endpoint</div>
          </div>
          <div class="data-item">
            <div class="data-value">${content.realData.drug}</div>
            <div class="data-label">Exposed</div>
          </div>
          <div class="data-item">
            <div class="data-value">${content.realData.placebo}</div>
            <div class="data-label">Unexposed</div>
          </div>
          <div class="data-item">
            <div class="data-value">${content.realData.rr}</div>
            <div class="data-label">Effect</div>
          </div>
        </div>
      </div>

      <div class="story-hook">${content.hook}</div>
    </div>
  `;
}

function renderStoryBox(content) {
  return `
    <div class="story-box">
      <div class="story-box-header">
        <span class="story-box-icon">${content.icon || 'ğŸ“–'}</span>
        <span class="story-box-title">${content.title}</span>
      </div>
      ${content.source ? `<div class="story-box-source">${content.source}</div>` : ''}
      <div class="story-box-content">
        ${content.paragraphs.map(p => `<p>${p}</p>`).join('')}
      </div>
      <div class="story-box-lesson">
        <div class="story-box-lesson-label">The Lesson</div>
        <div class="story-box-lesson-text">${content.lesson}</div>
      </div>
    </div>
  `;
}

function renderContent(content) {
  return `
    <div class="content-box">
      <h3>${content.title}</h3>
      ${content.sections.map(section => `
        <div class="content-section">
          <h4>${section.heading}</h4>
          ${section.text ? `<p>${section.text}</p>` : ''}
          ${section.items ? `<ul>${section.items.map(item => `<li>${item}</li>`).join('')}</ul>` : ''}
        </div>
      `).join('')}
    </div>
  `;
}

function renderMethod(content) {
  return `
    <div class="method-box">
      <div class="method-label">${content.label}</div>
      <h3>${content.title}</h3>
      ${content.sections.map(section => `
        <div class="content-section">
          <h4>${section.heading}</h4>
          <p style="white-space: pre-line;">${section.text}</p>
        </div>
      `).join('')}
    </div>
  `;
}

function renderTool(content) {
  if (content.id === 'dag-builder') {
    return renderDAGBuilder(content);
  }
  return `
    <div class="tool-container">
      <h3>${content.title}</h3>
      <p class="tool-description">${content.description}</p>
      <p style="color: var(--light-text); font-style: italic;">Tool implementation coming soon...</p>
    </div>
  `;
}

function renderDAGBuilder(content) {
  return `
    <div class="tool-container">
      <h3>${content.title}</h3>
      <p class="tool-description">${content.description}</p>

      <div class="tool-inputs" style="grid-template-columns: 1fr 1fr;">
        <div class="input-group">
          <label>Exposure</label>
          <input type="text" id="dag-exposure" placeholder="e.g., HRT use" value="HRT use">
        </div>
        <div class="input-group">
          <label>Outcome</label>
          <input type="text" id="dag-outcome" placeholder="e.g., CHD" value="CHD">
        </div>
      </div>

      <div class="input-group">
        <label>Potential Confounders (one per line)</label>
        <textarea id="dag-confounders" rows="4" placeholder="e.g.,&#10;Socioeconomic status&#10;Exercise&#10;Education">Socioeconomic status
Exercise habits
Healthcare access
Education level</textarea>
      </div>

      <button class="tool-btn" onclick="generateDAG()">Generate DAG</button>

      <div class="tool-output" id="dag-output" style="display: none;">
        <div id="dag-plot" class="plot-area"></div>
        <div id="dag-interpretation"></div>
      </div>
    </div>
  `;
}

function escapeHTML(s) {
  const d = document.createElement('div');
  d.textContent = s;
  return d.innerHTML;
}

function generateDAG() {
  const exposureRaw = document.getElementById('dag-exposure').value || 'Exposure';
  const outcomeRaw = document.getElementById('dag-outcome').value || 'Outcome';
  const confoundersText = document.getElementById('dag-confounders').value;
  const confoundersRaw = confoundersText.split('\n').filter(c => c.trim());
  const exposure = escapeHTML(exposureRaw);
  const outcome = escapeHTML(outcomeRaw);
  const confounders = confoundersRaw.map(c => escapeHTML(c));

  const output = document.getElementById('dag-output');
  output.style.display = 'block';

  // Create nodes
  const nodes = [
    { id: 'exposure', label: exposure, x: 0, y: 0.5 },
    { id: 'outcome', label: outcome, x: 1, y: 0.5 }
  ];

  confounders.forEach((c, i) => {
    nodes.push({
      id: `conf${i}`,
      label: c.trim(),
      x: 0.5,
      y: 0.1 + (i * 0.2)
    });
  });

  // Create edges
  const edges = [];
  confounders.forEach((c, i) => {
    edges.push({ from: `conf${i}`, to: 'exposure' });
    edges.push({ from: `conf${i}`, to: 'outcome' });
  });
  edges.push({ from: 'exposure', to: 'outcome', style: 'dashed' });

  // Create Plotly visualization
  const nodeX = nodes.map(n => n.x);
  const nodeY = nodes.map(n => n.y);
  const nodeLabels = nodes.map(n => n.label);

  // Create edge traces
  const edgeTraces = edges.map(e => {
    const fromNode = nodes.find(n => n.id === e.from);
    const toNode = nodes.find(n => n.id === e.to);
    return {
      x: [fromNode.x, toNode.x],
      y: [fromNode.y, toNode.y],
      mode: 'lines',
      line: {
        color: e.style === 'dashed' ? '#D4AF37' : '#1e2761',
        width: 2,
        dash: e.style === 'dashed' ? 'dash' : 'solid'
      },
      hoverinfo: 'none'
    };
  });

  const nodeTrace = {
    x: nodeX,
    y: nodeY,
    mode: 'markers+text',
    marker: {
      size: 40,
      color: nodes.map(n => n.id === 'exposure' ? '#2D8B8B' : n.id === 'outcome' ? '#BF2D2D' : '#D4AF37')
    },
    text: nodeLabels,
    textposition: 'bottom center',
    hoverinfo: 'text'
  };

  const layout = {
    showlegend: false,
    xaxis: { showgrid: false, zeroline: false, showticklabels: false, range: [-0.2, 1.2] },
    yaxis: { showgrid: false, zeroline: false, showticklabels: false, range: [-0.1, 1.1] },
    margin: { t: 20, b: 40, l: 20, r: 20 },
    height: 350,
    paper_bgcolor: 'rgba(0,0,0,0)',
    plot_bgcolor: 'rgba(0,0,0,0)'
  };

  Plotly.newPlot('dag-plot', [...edgeTraces, nodeTrace], layout, { displayModeBar: false });

  // Interpretation
  document.getElementById('dag-interpretation').innerHTML = `
    <h4 style="color: var(--teal); margin-top: 1rem;">Interpretation</h4>
    <p><strong>Backdoor paths identified:</strong> ${confounders.length} potential confounders create backdoor paths from ${exposure} to ${outcome}.</p>
    <p><strong>To estimate the causal effect of ${exposure} on ${outcome}:</strong></p>
    <ul style="margin-left: 1rem;">
      <li>You must adjust for: ${confounders.join(', ') || 'No confounders identified'}</li>
      <li>The dashed arrow represents the causal effect of interest</li>
      <li>Solid arrows represent confounding paths that must be blocked</li>
    </ul>
    <p style="color: var(--red); margin-top: 0.5rem;"><strong>Warning:</strong> Unmeasured confounders may still exist!</p>
  `;

  addPoints(50);
  if (!gameState.toolsUsed.includes('dag-builder')) {
    gameState.toolsUsed.push('dag-builder');
  }
  saveProgress();
}

function renderDecisionTree(content) {
  const treeId = content.id;
  const treeState = gameState.decisionTrees[treeId] || { currentNode: 'start', history: [] };

  let node;
  if (content.nodes[treeState.currentNode]) {
    node = content.nodes[treeState.currentNode];
  } else {
    node = content.nodes.start;
    treeState.currentNode = 'start';
  }

  let html = `
    <div class="decision-tree">
      <h3>${content.title}</h3>
      <div class="decision-scenario">${content.situation}</div>
  `;

  // Show history
  if (treeState.history.length > 0) {
    html += `
      <div class="decision-history">
        ${treeState.history.map((h, i) => `<span class="history-step">${i + 1}. ${h}</span>`).join('')}
      </div>
      <button class="undo-btn" onclick="undoDecision('${treeId}')">â† Undo Last Choice</button>
    `;
  }

  // Current situation
  if (node.situation) {
    html += `<div class="decision-situation">${node.situation}</div>`;
  }

  // Check if it's an ending
  if (node.type === 'outcome' || node.isEnding) {
    html += `
      <div class="decision-outcome ${node.consequence || node.outcome}">
        <h4>${node.title || 'Outcome'}</h4>
        <p>${node.text || ''}</p>
        <div class="decision-lesson">${node.lesson || ''}</div>
      </div>
      <button class="tool-btn" style="margin-top: 1rem;" onclick="resetDecisionTree('${treeId}')">Try Again</button>
    `;
  } else {
    // Show question and branches
    html += `<div class="decision-question">${node.question}</div>`;
    html += `<div class="decision-branches">`;
    node.branches.forEach(branch => {
      html += `
        <button class="decision-branch" onclick="makeDecision('${treeId}', '${branch.nextNode}', '${branch.text.substring(0, 30).replace(/\\/g, '\\\\').replace(/'/g, "\\'")}...')">
          ${branch.text}
        </button>
      `;
    });
    html += `</div>`;
  }

  html += `</div>`;
  return html;
}

function makeDecision(treeId, nextNode, choiceText) {
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }
  gameState.decisionTrees[treeId].history.push({ nextNode: nextNode, choiceText: choiceText });
  gameState.decisionTrees[treeId].currentNode = nextNode;
  addPoints(10);
  saveProgress();
  renderSlide();
}

function undoDecision(treeId) {
  const tree = gameState.decisionTrees[treeId];
  if (tree && tree.history.length > 0) {
    tree.history.pop();
    // Replay from start using stored nextNode values
    tree.currentNode = 'start';
    for (const entry of tree.history) {
      // Support both old string format and new object format
      const node = typeof entry === 'object' ? entry.nextNode : null;
      if (node) tree.currentNode = node;
    }
    saveProgress();
    renderSlide();
  }
}

function resetDecisionTree(treeId) {
  gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  saveProgress();
  renderSlide();
}

function renderQuiz(content) {
  const quizId = `quiz_${currentModule}_${currentSlide}`;

  return `
    <div class="quiz-container" role="group" aria-labelledby="quiz-question">
      <div class="quiz-question" id="quiz-question">${content.question}</div>
      <div class="quiz-options" role="radiogroup">
        ${content.options.map((opt, i) => `
          <button class="quiz-option"
                  role="radio"
                  aria-checked="false"
                  data-correct="${opt.correct}"
                  data-option-id="${opt.id}"
                  onclick="selectQuizOption(this, '${quizId}', ${opt.correct})">
            ${opt.text}
          </button>
        `).join('')}
      </div>
      <div class="quiz-feedback" id="feedback-${quizId}" role="alert" aria-live="polite">
        <p>${content.explanation}</p>
      </div>
    </div>
  `;
}

const _answeredQuizzes = new Set();

function selectQuizOption(element, quizId, isCorrect) {
  // Prevent re-answering after first answer
  if (_answeredQuizzes.has(quizId)) return;

  const container = element.closest('.quiz-container');
  const options = container.querySelectorAll('.quiz-option');
  const feedback = document.getElementById(`feedback-${quizId}`);

  // Clear previous selections
  options.forEach(opt => {
    opt.classList.remove('selected', 'correct', 'incorrect');
    opt.setAttribute('aria-checked', 'false');
  });

  // Mark selection
  element.classList.add('selected');
  element.setAttribute('aria-checked', 'true');

  // Show result
  if (isCorrect) {
    element.classList.add('correct');
    feedback.classList.add('show', 'correct');
    feedback.classList.remove('incorrect');
    addPoints(30);
  } else {
    element.classList.add('incorrect');
    feedback.classList.add('show', 'incorrect');
    feedback.classList.remove('correct');
    // Show correct answer
    options.forEach(opt => {
      if (opt.dataset.correct === 'true') {
        opt.classList.add('correct');
      }
    });
  }

  // Lock quiz after answering
  _answeredQuizzes.add(quizId);
  options.forEach(opt => {
    opt.style.pointerEvents = 'none';
    opt.setAttribute('aria-disabled', 'true');
  });

  saveProgress();
}

// Navigation
function nextSlide() {
  const module = modules[currentModule];
  if (currentSlide < module.slides.length - 1) {
    currentSlide++;
  } else if (currentModule < modules.length - 1) {
    if (!gameState.modulesCompleted.includes(currentModule)) {
      gameState.modulesCompleted.push(currentModule);
      addPoints(100);
      checkBadges();
    }
    currentModule++;
    currentSlide = 0;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
  } else if (currentModule > 0) {
    currentModule--;
    currentSlide = modules[currentModule].slides.length - 1;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function goToModule(moduleIndex) {
  currentModule = moduleIndex;
  currentSlide = 0;
  saveProgress();
  renderSlide();
  renderModuleNav();
  closeSidebar();
  window.scrollTo(0, 0);
}

function updateNavButtons() {
  const prevBtn = document.getElementById('prev-btn');
  const nextBtn = document.getElementById('next-btn');

  prevBtn.disabled = currentModule === 0 && currentSlide === 0;

  const isLastSlide = currentModule === modules.length - 1 &&
                      currentSlide === modules[currentModule].slides.length - 1;
  nextBtn.textContent = isLastSlide ? 'Complete Course' : 'Next â†’';
}

function updateProgress() {
  let totalSlides = 0;
  let completedSlides = 0;

  modules.forEach((m, i) => {
    totalSlides += m.slides.length;
    if (i < currentModule) {
      completedSlides += m.slides.length;
    } else if (i === currentModule) {
      completedSlides += currentSlide;
    }
  });

  const percent = Math.round((completedSlides / totalSlides) * 100);
  document.getElementById('progress-fill').style.width = `${percent}%`;
  document.getElementById('progress-text').textContent = `${percent}% Complete`;
}

// Points System
function addPoints(points) {
  gameState.points += points;
  document.getElementById('points-display').textContent = gameState.points;
}

// Persistence
function saveProgress() {
  try {
    localStorage.setItem(STORAGE_KEY, JSON.stringify({
      currentModule,
      currentSlide,
      gameState
    }));
  } catch (e) {
    console.log('Could not save progress:', e);
  }
}

function loadProgress() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) {
      const data = JSON.parse(saved);
      if (data.gameState) {
        gameState = {
          points: data.gameState.points || 0,
          earnedBadges: data.gameState.earnedBadges || [],
          toolsUsed: data.gameState.toolsUsed || [],
          modulesCompleted: data.gameState.modulesCompleted || [],
          scenariosCompleted: data.gameState.scenariosCompleted || {},
          decisionTrees: data.gameState.decisionTrees || {}
        };
      }
      if (typeof data.currentModule === 'number' && data.currentModule >= 0 && data.currentModule < modules.length) {
        currentModule = data.currentModule;
      }
      if (typeof data.currentSlide === 'number' && data.currentSlide >= 0) {
        currentSlide = Math.min(data.currentSlide, modules[currentModule].slides.length - 1);
      }
    }
  } catch (e) {
    console.log('Could not load progress:', e);
  }
}

// Mobile Menu
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  const hamburger = document.querySelector('.hamburger');

  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
  hamburger.setAttribute('aria-expanded', sidebar.classList.contains('open'));
}

function closeSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  const hamburger = document.querySelector('.hamburger');

  sidebar.classList.remove('open');
  overlay.classList.remove('show');
  hamburger.setAttribute('aria-expanded', 'false');
}

// Modal utilities: close by ID, Escape key handler
function closeModalOverlay(id) {
  const el = document.getElementById(id);
  if (el) el.remove();
}

function _attachModalEscapeHandler(overlayId) {
  function handler(e) {
    if (e.key === 'Escape') {
      closeModalOverlay(overlayId);
      document.removeEventListener('keydown', handler);
    }
  }
  document.addEventListener('keydown', handler);
}

// Badges Modal
function openBadges() {
  const earnedCount = gameState.earnedBadges.length;
  const totalCount = Object.keys(BADGES).length;

  const html = `
    <div id="badges-modal-overlay" role="dialog" aria-modal="true" aria-label="Badges" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 700px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">ğŸ† Badges (${earnedCount}/${totalCount})</h2>
          <button id="badges-modal-close" onclick="closeModalOverlay('badges-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close badges">&times;</button>
        </div>
        <div class="badge-grid">
          ${Object.entries(BADGES).map(([id, badge]) => {
            const earned = gameState.earnedBadges.includes(id);
            return `
              <div class="badge-card ${earned ? 'earned' : 'locked'}">
                <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
                <div class="badge-name">${badge.name}</div>
                <div class="badge-requirement">${earned ? 'âœ“ Earned!' : badge.requirement}</div>
              </div>
            `;
          }).join('')}
        </div>
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('badges-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('badges-modal-overlay');
}

// Glossary
function openGlossary() {
  const terms = [
    { term: "Confounding", def: "ã‚¨ã‚¯ã‚¹ãƒãƒ¼ã‚¸ãƒ£ã¨çµæœã®ä¸¡æ–¹ã«é–¢é€£ä»˜ã‘ã‚‰ã‚Œã€ãã‚Œã‚‰ã®é–“ã®è¦‹ã‹ã‘ã®é–¢ä¿‚ã‚’æ­ªã‚ã‚‹å¤‰æ•°ã€‚" },
    { term: "Selection Bias", def: "å‚åŠ è€…ãŒé¸æŠã¾ãŸã¯ç¶­æŒã•ã‚Œã‚‹æ–¹æ³•ã‹ã‚‰ç”Ÿã˜ã‚‹ç³»çµ±èª¤å·®ã€‚ç ”ç©¶ã€‚" },
    { term: "Information Bias", def: "Systematic error in measurement or classification of exposure or outcome." },
    { term: "DAG", def: "Directed Acyclic Graph - a visual representation of causal relationships between variables." },
    { term: "Cohort Study", def: "èª°ãŒçµæœã‚’ç™ºç¾ã™ã‚‹ã‹ã‚’è¦³å¯Ÿã™ã‚‹ãŸã‚ã«ã‚°ãƒ«ãƒ¼ãƒ—ã‚’é•·æœŸã«ã‚ãŸã£ã¦è¿½è·¡ã™ã‚‹è¦³å¯Ÿç ”ç©¶ã€‚" },
    { term: "Case-Control Study", def: "æš´éœ²ã‚’ç‰¹å®šã™ã‚‹ãŸã‚ã«ã€çµæœã®ã‚ã‚‹äººã€…ï¼ˆç—‡ä¾‹ï¼‰ã¨ãã†ã§ãªã„äººã€…ï¼ˆå¯¾ç…§ï¼‰ã‚’æ¯”è¼ƒã™ã‚‹ç ”ç©¶ã€‚" },
    { term: "Odds Ratio", def: "Ratio of odds of exposure in cases vs controls; approximates RR when outcome is rare." },
    { term: "Risk Ratio", def: "Ratio of risk in exposed vs unexposed; measures strength of association." },
    { term: "Healthy User Bias", def: "Confounding where people who seek treatment are systematically healthier." },
    { term: "Immortal Time Bias", def: "æš´éœ²ã‚¹ãƒ†ãƒ¼ã‚¿ã‚¹ãŒå¤‰åŒ–ã—ãŸã¨ãã®æ»åœ¨æ™‚é–“ã®èª¤åˆ†é¡ã«ã‚ˆã‚‹ãƒã‚¤ã‚¢ã‚¹æ™‚é–“ã€‚" },
    { term: "ROBINS-I", def: "éãƒ©ãƒ³ãƒ€ãƒ åŒ–ç ”ç©¶ã«ãŠã‘ã‚‹ãƒã‚¤ã‚¢ã‚¹ã®ãƒªã‚¹ã‚¯ - ãƒã‚¤ã‚¢ã‚¹ã‚’è©•ä¾¡ã™ã‚‹ãŸã‚ã®ä»‹å…¥ãƒ„ãƒ¼ãƒ«ã€‚" },
    { term: "Propensity Score", def: "Probability of receiving treatment given observed covariates; used for adjustment." },
    { term: "Target Trial", def: "è¦³å¯Ÿåˆ†æãŒæ¨¡å€£ã—ã‚ˆã†ã¨ã™ã‚‹ä»®èª¬ã® RCTã€‚" },
    { term: "Residual Confounding", def: "Confounding that remains after adjustment due to unmeasured or imperfectly measured confounders." },
    { term: "Effect Modification", def: "When the effect of exposure on outcome differs across levels of another variable." },
    { term: "IPTW", def: "Inverse Probability of Treatment Weighting - weights subjects by inverse of propensity score to balance confounders." },
    { term: "Overlap Weights", def: "Modern PS weighting targeting patients with clinical equipoise; weights by 1-PS for treated, PS for untreated." },
    { term: "Instrumental Variable", def: "A variable affecting treatment but not outcome except through treatment; enables causal inference despite unmeasured confounding." },
    { term: "Mendelian Randomization", def: "Using genetic variants as instrumental variables; leverages random inheritance to mimic randomization." },
    { term: "Bradford Hill Criteria", def: "Nine criteria for assessing causation from observational data: strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experiment, analogy." },
    { term: "Triangulation", def: "Comparing evidence across multiple methods with different biases; concordance increases confidence in causal claims." },
    { term: "Negative Control", def: "An exposure-outcome pair with no expected causal relationship; association suggests unmeasured confounding." },
    { term: "Lead Time Bias", def: "Apparent survival improvement from earlier diagnosis without true mortality benefit; common in screening evaluation." },
    { term: "E-value", def: "Minimum strength of unmeasured confounding needed to explain away an observed association." },
    { term: "New User Design", def: "ç”Ÿå­˜è€…ãƒã‚¤ã‚¢ã‚¹ã‚’å›é¿ã—ã€æ—©æœŸã«æŠŠæ¡ã™ã‚‹ãŸã‚ã«ã€æ²»ç™‚ã‚’é–‹å§‹ã—ãŸæ‚£è€… (ä¸€èˆ¬çš„ãªãƒ¦ãƒ¼ã‚¶ãƒ¼ã§ã¯ãªã„) ã®ã¿ã‚’å«ã‚€ã€‚ã‚¨ãƒ•ã‚§ã‚¯ãƒˆã€‚" }
  ];

  const html = `
    <div id="glossary-modal-overlay" role="dialog" aria-modal="true" aria-label="Glossary" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 600px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">Glossary</h2>
          <button id="glossary-modal-close" onclick="closeModalOverlay('glossary-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close glossary">&times;</button>
        </div>
        ${terms.map(t => `
          <div style="margin-bottom: 1rem; padding-bottom: 1rem; border-bottom: 1px solid rgba(0,0,0,0.1);">
            <strong style="color: var(--teal);">${t.term}</strong>
            <p style="margin-top: 0.25rem; color: var(--navy);">${t.def}</p>
          </div>
        `).join('')}
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('glossary-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('glossary-modal-overlay');
}

function openToolLibrary() {
  alert('ãƒ„ãƒ¼ãƒ« ãƒ©ã‚¤ãƒ–ãƒ©ãƒªãŒè¿‘æ—¥å…¬é–‹ã•ã‚Œã¾ã™ã€‚ã“ã®ã‚³ãƒ¼ã‚¹ã§èª¬æ˜ã™ã‚‹ãƒ„ãƒ¼ãƒ«: â€¢ DAG Builder â€¢ Confounding Visualizer â€¢ ROBINS-I Assessment â€¢ Propensity Score Calculator â€¢ Target Trial Designer');
}

// Initialize
document.addEventListener('DOMContentLoaded', () => {
  loadProgress();
  renderModuleNav();
  renderSlide();
  document.getElementById('points-display').textContent = gameState.points;

  // Mobile menu handlers
  document.querySelector('.hamburger').addEventListener('click', toggleSidebar);
  document.querySelector('.sidebar-overlay').addEventListener('click', closeSidebar);

  // Keyboard navigation
  document.addEventListener('keydown', (e) => {
    if (e.key === 'ArrowRight' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      nextSlide();
    } else if (e.key === 'ArrowLeft' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      prevSlide();
    }
  });
});
</script>
</body>
</html>
